=== Generating (published_papers) === === Generating (teaching_experience) === === Generating (misc) === === Generating (research_projects) === === Generating (books_etc) === === Generating (committee_memberships) === === Generating (awards) === === Generating (association_memberships) === === Generating (presentations) === ==== begin registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/published_papers.jsonl) ==== line:1, {"insert":{"user_id":"B000341201","type":"published_papers","id":"46128753"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/38596695","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406619","label":"url"}],"paper_title":{"en":"Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil-Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General Hospital.","ja":"Usefulness of Palliative Prognostic Index, Objective Prognostic Score, and Neutrophil-Lymphocyte Ratio/Albumin Ratio As Prognostic Indicators for Patients Without Cancer Receiving Home-Visit Palliative Care: A Pilot Study at a Community General Hospital."},"authors":{"en":[{"name":"Hori Taiki"},{"name":"Aihara Ken-ichi"},{"name":"Ishida Koki"},{"name":"Inaba Kaori"},{"name":"Inaba Keisuke"},{"name":"Kaneko Yousuke"},{"name":"Kawahito Keisuke"},{"name":"Bekku Shoki"},{"name":"Hosoki Minae"},{"name":"Mori Kensuke"},{"name":"Itami Kanako"},{"name":"Katsuse Masayo"},{"name":"Hanaoka Yoshimi"},{"name":"Kageji Teruyoshi"},{"name":"Uraoka Hideyuki"},{"name":"Nakamura Shingen"}],"ja":[{"name":"堀 太貴"},{"name":"粟飯原 賢一"},{"name":"Ishida Koki"},{"name":"稲葉 香織"},{"name":"稲葉 圭佑"},{"name":"金子 遥祐"},{"name":"川人 圭祐"},{"name":"Bekku Shoki"},{"name":"Hosoki Minae"},{"name":"Mori Kensuke"},{"name":"Itami Kanako"},{"name":"Katsuse Masayo"},{"name":"Hanaoka Yoshimi"},{"name":"影治 照喜"},{"name":"Uraoka Hideyuki"},{"name":"中村 信元"}]},"description":{"en":"PPI, OPS, and NLR/Alb were useful in predicting the survival period and short-term prognosis within 21 days for patients without cancer who received home-visit palliative care.","ja":"< 0.001). The survival curves of the groups classified according to PPI, OPS, and NLR/Alb were significantly stratified. The predictive capacities of PPI, OPS, and NLR/Alb for death within 21 days were as follows: PPI (area under the curve [AUC]: 0.71; sensitivity: 59%; specificity: 68%), OPS (AUC: 0.73; sensitivity: 88%; specificity: 47%), and NLR/Alb (AUC: 0.72; sensitivity: 72%; specificity: 73%)."},"publication_date":"2024-04-04","publication_name":{"en":"Palliative medicine reports","ja":"Palliative medicine reports"},"volume":"Vol.5","number":"No.1","starting_page":"142","ending_page":"149","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1089/pmr.2023.0096"],"issn":["2689-2820"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000341201","type":"published_papers","id":"46113962"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/38592103","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406617","label":"url"}],"paper_title":{"en":"Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital.","ja":"Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011-2020) in Individuals with and without Diabetes at a Japanese Community General Hospital."},"authors":{"en":[{"name":"Hosoki Minae"},{"name":"Taiki HORI"},{"name":"Yohsuke KANEKO"},{"name":"Mori Kensuke"},{"name":"Yasui Saya"},{"name":"Tsuji Seijiro"},{"name":"Yamagami Hiroki"},{"name":"Kawata Saki"},{"name":"Hara Tomoyo"},{"name":"Masuda Shiho"},{"name":"Mitsui Yukari"},{"name":"Kurahashi Kiyoe"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Matsuhisa Munehide"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"Hosoki Minae"},{"name":"堀 太貴"},{"name":"金子 遥祐"},{"name":"Mori Kensuke"},{"name":"Yasui Saya"},{"name":"Tsuji Seijiro"},{"name":"山上 紘規"},{"name":"Kawata Saki"},{"name":"原 倫世"},{"name":"Masuda Shiho"},{"name":"Mitsui Yukari"},{"name":"倉橋 清衛"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"松久 宗英"},{"name":"粟飯原 賢一"}]},"description":{"en":"Since diabetes and its complications have been thought to exaggerate cardiorenal disease, resulting in a short lifespan, we investigated causes of death and lifespans in individuals with and without diabetes at a Japanese community general hospital during the period from 2011 to 2020. Causes of death and age of death in individuals with and those without diabetes were compared, and associations between medications used and age of death were statistically analyzed. A total of 2326 deaths were recorded during the 10-year period. There was no significant difference between the mean ages of death in individuals with and those without diabetes. Diabetic individuals had higher rates of hepato-pancreatic cancer and cardio-renal failure as causes of death. The prescription rates of antihypertensives, antiplatelets, and statins in diabetic individuals were larger than those in non-diabetic individuals. Furthermore, the use of sulfonyl urea or glinides and insulin was independently and inversely associated with the age of death. In conclusion, individuals with diabetes were treated with comprehensive pharmaceutical interventions and had life spans comparable to those of individuals without diabetes. This study's discovery of an inverse relationship between the use of insulin secretagogues or insulin and the age of death suggests that the prevention of life-threatening hypoglycemia is crucial for individuals with diabetes.","ja":"Since diabetes and its complications have been thought to exaggerate cardiorenal disease, resulting in a short lifespan, we investigated causes of death and lifespans in individuals with and without diabetes at a Japanese community general hospital during the period from 2011 to 2020. Causes of death and age of death in individuals with and those without diabetes were compared, and associations between medications used and age of death were statistically analyzed. A total of 2326 deaths were recorded during the 10-year period. There was no significant difference between the mean ages of death in individuals with and those without diabetes. Diabetic individuals had higher rates of hepato-pancreatic cancer and cardio-renal failure as causes of death. The prescription rates of antihypertensives, antiplatelets, and statins in diabetic individuals were larger than those in non-diabetic individuals. Furthermore, the use of sulfonyl urea or glinides and insulin was independently and inversely associated with the age of death. In conclusion, individuals with diabetes were treated with comprehensive pharmaceutical interventions and had life spans comparable to those of individuals without diabetes. This study's discovery of an inverse relationship between the use of insulin secretagogues or insulin and the age of death suggests that the prevention of life-threatening hypoglycemia is crucial for individuals with diabetes."},"publication_date":"2024-02-24","publication_name":{"en":"Journal of clinical medicine","ja":"Journal of clinical medicine"},"volume":"Vol.13","number":"No.5","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3390/jcm13051283"],"issn":["2077-0383"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000341201","type":"published_papers","id":"45781403"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405345","label":"url"}],"paper_title":{"en":"Raman Microspectroscopy for Label-Free Diagnosis of Amyloid Light-chain Amyloidosis in Various Organs","ja":"Raman Microspectroscopy for Label-Free Diagnosis of Amyloid Light-chain Amyloidosis in Various Organs"},"authors":{"en":[{"name":"Yanagiya Shin-ichiro"},{"name":"Honda Takeshi"},{"name":"Takanari Hiroki"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Bando Yoshimi"},{"name":"Abe Masahiro"},{"name":"Miki Hirokazu"}],"ja":[{"name":"柳谷 伸一郎"},{"name":"本田 剛士"},{"name":"髙成 広起"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"坂東 良美"},{"name":"安倍 正博"},{"name":"三木 浩和"}]},"publication_date":"2024-02","publication_name":{"en":"Journal of Raman Spectroscopy","ja":"Journal of Raman Spectroscopy"},"languages":["eng"],"referee":true,"identifiers":{"issn":["0377-0486"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000341201","type":"published_papers","id":"45822809"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/38245883","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405470","label":"url"}],"paper_title":{"en":"Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.","ja":"Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors."},"authors":{"en":[{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Higa Yoshiki"},{"name":"Miki Hirokazu"},{"name":"Oda Asuka"},{"name":"Maruhashi Tomoko"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Takahashi Mamiko"},{"name":"Nakamura Masafumi"},{"name":"Maeda Yusaku"},{"name":"Hara Tomoyo"},{"name":"Yamagami Hiroki"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Kurahashi Kiyoe"},{"name":"Endo Itsuro"},{"name":"Aihara Ken-ichi"},{"name":"Nakaue Emiko"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"比嘉 佳基"},{"name":"三木 浩和"},{"name":"Oda Asuka"},{"name":"丸橋 朋子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"Takahashi Mamiko"},{"name":"中村 昌史"},{"name":"前田 悠作"},{"name":"原 倫世"},{"name":"山上 紘規"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"倉橋 清衛"},{"name":"遠藤 逸朗"},{"name":"粟飯原 賢一"},{"name":"中上 絵美子"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"description":{"en":"Resistance to proteasome inhibitors (PIs) has emerged as an important clinical issue. We investigated the mechanisms underlying multiple myeloma (MM) cell resistance to PIs. To mimic their pharmacokinetic/pharmacodynamic (PK/PD) profiles, MM cells were treated with bortezomib and carfilzomib for 1 h at concentrations up to 400 and 1,000 nM, respectively. Susceptibility to these PIs markedly varied among MM cell lines. Pulsatile treatments with PIs suppressed translation, as demonstrated by incorporation of puromycin at 24 h in PI-susceptible MM.1S cells, but not PI-resistant KMS-11 cells. Inhibition of β5 subunit activity decreased at 24 h in KMS-11 cells, even with the irreversible PI carfilzomib, but not under suppression of protein synthesis with cycloheximide. Furthermore, the proteasome-degradable pro-survival factors PIM2 and NRF2 acutely accumulated in MM cells subjected to pulsatile PI treatments. Accumulated NRF2 was trans-localized into the nucleus to induce the expression of its target gene, HMOX1, in MM cells. PIM and Akt inhibition restored the anti-MM effects of PIs, even against PI-resistant KMS-11 cells. Collectively, these results suggest that increased synthesis of β5 proteasome subunit and acute accumulation of PIM2 and NRF2 reduce the anti-MM effects of PIs.","ja":"Resistance to proteasome inhibitors (PIs) has emerged as an important clinical issue. We investigated the mechanisms underlying multiple myeloma (MM) cell resistance to PIs. To mimic their pharmacokinetic/pharmacodynamic (PK/PD) profiles, MM cells were treated with bortezomib and carfilzomib for 1 h at concentrations up to 400 and 1,000 nM, respectively. Susceptibility to these PIs markedly varied among MM cell lines. Pulsatile treatments with PIs suppressed translation, as demonstrated by incorporation of puromycin at 24 h in PI-susceptible MM.1S cells, but not PI-resistant KMS-11 cells. Inhibition of β5 subunit activity decreased at 24 h in KMS-11 cells, even with the irreversible PI carfilzomib, but not under suppression of protein synthesis with cycloheximide. Furthermore, the proteasome-degradable pro-survival factors PIM2 and NRF2 acutely accumulated in MM cells subjected to pulsatile PI treatments. Accumulated NRF2 was trans-localized into the nucleus to induce the expression of its target gene, HMOX1, in MM cells. PIM and Akt inhibition restored the anti-MM effects of PIs, even against PI-resistant KMS-11 cells. Collectively, these results suggest that increased synthesis of β5 proteasome subunit and acute accumulation of PIM2 and NRF2 reduce the anti-MM effects of PIs."},"publication_date":"2024-01-21","publication_name":{"en":"International journal of hematology","ja":"International journal of hematology"},"volume":"Vol.119","number":"No.3","starting_page":"303","ending_page":"315","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s12185-023-03705-9"],"issn":["1865-3774"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000341201","type":"published_papers","id":"45822810"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/119108","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/38002020","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405468","label":"url"}],"paper_title":{"en":"Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes.","ja":"Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes."},"authors":{"en":[{"name":"Yamagami Hiroki"},{"name":"Hara Tomoyo"},{"name":"Yasui Saya"},{"name":"Hosoki Minae"},{"name":"Hori Taiki"},{"name":"Kaneko Yousuke"},{"name":"Mitsui Yukari"},{"name":"Kurahashi Kiyoe"},{"name":"Harada Takeshi"},{"name":"Yoshida Sumiko"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"原 倫世"},{"name":"Yasui Saya"},{"name":"Hosoki Minae"},{"name":"Hori Taiki"},{"name":"Kaneko Yousuke"},{"name":"Mitsui Yukari"},{"name":"倉橋 清衛"},{"name":"原田 武志"},{"name":"吉田 守美子"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"description":{"en":"= 0.026). In conclusion, SAF is positively correlated with uL-FABP but not with uACR in people with T2D. Thus, there is a possibility that SAF can serve as a novel predictor for the development of diabetic tubular injury.","ja":"= 0.026). In conclusion, SAF is positively correlated with uL-FABP but not with uACR in people with T2D. Thus, there is a possibility that SAF can serve as a novel predictor for the development of diabetic tubular injury."},"publication_date":"2023-11-10","publication_name":{"en":"Biomedicines","ja":"Biomedicines"},"volume":"Vol.11","number":"No.11","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3390/biomedicines11113020"],"issn":["2227-9059"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000341201","type":"published_papers","id":"45822811"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/119107","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37999225","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405467","label":"url"}],"paper_title":{"en":"Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes.","ja":"Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes."},"authors":{"en":[{"name":"Yasui Saya"},{"name":"Kaneko Yousuke"},{"name":"Yamagami Hiroki"},{"name":"Hosoki Minae"},{"name":"Hori Taiki"},{"name":"Tani Akihiro"},{"name":"Hara Tomoyo"},{"name":"Kurahashi Kiyoe"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Mori Hiroyasu"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Matsuhisa Munehide"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"Yasui Saya"},{"name":"Kaneko Yousuke"},{"name":"山上 紘規"},{"name":"Hosoki Minae"},{"name":"Hori Taiki"},{"name":"Tani Akihiro"},{"name":"原 倫世"},{"name":"倉橋 清衛"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"森 博康"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"松久 宗英"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"description":{"en":"Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. Although skeletal muscle disorders are often found in diabetic people, the clinical significance of DHEAS in skeletal muscle remains unclear. Therefore, we aimed to determine whether DHEAS is associated with the development of skeletal muscle disorders in individuals with type 2 diabetes (T2D). A cross-sectional study was conducted in 361 individuals with T2D. Serum DHEAS levels, skeletal muscle mass index (SMI), handgrip strength (HS), and gait speed (GS) were measured in the participants. Pre-sarcopenia, sarcopenia, and dynapenia were defined according to the definitions of the AWGS 2019 criteria. DHEAS level was positively associated with HS but not with SMI or GS after adjustment of confounding factors. Multiple logistic regression analyses in total subjects showed that DHEAS level had an inverse association with the prevalence of dynapenia but not with the prevalence of pre-sarcopenia or sarcopenia. Furthermore, a significant association between DHEAS level and dynapenia was found in males but not in females. ROC curve analysis indicated that cutoff values of serum DHEAS for risk of dynapenia in males was 92.0 μg/dL. Therefore, in male individuals with T2D who have low serum levels of DHEAS, adequate exercise might be needed to prevent dynapenia.","ja":"Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. Although skeletal muscle disorders are often found in diabetic people, the clinical significance of DHEAS in skeletal muscle remains unclear. Therefore, we aimed to determine whether DHEAS is associated with the development of skeletal muscle disorders in individuals with type 2 diabetes (T2D). A cross-sectional study was conducted in 361 individuals with T2D. Serum DHEAS levels, skeletal muscle mass index (SMI), handgrip strength (HS), and gait speed (GS) were measured in the participants. Pre-sarcopenia, sarcopenia, and dynapenia were defined according to the definitions of the AWGS 2019 criteria. DHEAS level was positively associated with HS but not with SMI or GS after adjustment of confounding factors. Multiple logistic regression analyses in total subjects showed that DHEAS level had an inverse association with the prevalence of dynapenia but not with the prevalence of pre-sarcopenia or sarcopenia. Furthermore, a significant association between DHEAS level and dynapenia was found in males but not in females. ROC curve analysis indicated that cutoff values of serum DHEAS for risk of dynapenia in males was 92.0 μg/dL. Therefore, in male individuals with T2D who have low serum levels of DHEAS, adequate exercise might be needed to prevent dynapenia."},"publication_date":"2023-11-03","publication_name":{"en":"Metabolites","ja":"Metabolites"},"volume":"Vol.13","number":"No.11","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3390/metabo13111129"],"issn":["2218-1989"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000341201","type":"published_papers","id":"42377956"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118250","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37081616","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396816","label":"url"}],"paper_title":{"en":"Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis.","ja":"Vascular Endothelial Function Is Associated with eGFR Slope in Female and Non-Smoking Male Individuals with Cardiovascular Risk Factors: A Pilot Study on the Predictive Value of FMD for Renal Prognosis."},"authors":{"en":[{"name":"Masuda Shiho"},{"name":"Hara Tomoyo"},{"name":"Yamagami Hiroki"},{"name":"Mitsui Yukari"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Harada Takeshi"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Nakamura Shingen"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"桝田 志保"},{"name":"原 倫世"},{"name":"山上 紘規"},{"name":"Mitsui Yukari"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"原田 武志"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"中村 信元"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"description":{"en":"In individuals with cardiovascular risk factors, evaluation of vascular endothelial function enables prediction of renal prognosis in females and non-smoking males.","ja":"In individuals with cardiovascular risk factors, evaluation of vascular endothelial function enables prediction of renal prognosis in females and non-smoking males."},"publication_date":"2023-04-19","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.63987"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118211","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/36129197","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396173","label":"url"}],"paper_title":{"en":"Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase","ja":"Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase"},"authors":{"en":[{"name":"Harada Takeshi"},{"name":"Ohguchi Hiroto"},{"name":"Oda Asuka"},{"name":"Nakao Michiyasu"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Maruhashi Tomoko"},{"name":"Takahashi Mamiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Sano Shigeki"},{"name":"Hideshima Teru"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"大口 裕人"},{"name":"小田 明日香"},{"name":"中尾 允泰"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"佐野 茂樹"},{"name":"秀島 輝"},{"name":"安倍 正博"}]},"description":{"en":"Multiple myeloma (MM) preferentially expands and acquires drug resistance in the bone marrow (BM). We herein examined the role of histone deacetylase 1 (HDAC1) in the constitutive activation of the master transcription factor IRF4 and the prosurvival mediator PIM2 kinase in MM cells. The knockdown or inhibition of HDAC1 by the class I HDAC inhibitor MS-275 reduced the basal expression of IRF4 and PIM2 in MM cells. Mechanistically, the inhibition of HDAC1 decreased IRF4 transcription through histone hyperacetylation and inhibiting the recruitment of RNA polymerase II at the IRF4 locus, thereby reducing IRF4-targeting genes, including PIM2. In addition to the transcriptional regulation of PIM2 by the HDAC1-IRF4 axis, PIM2 was markedly upregulated by external stimuli from BM stromal cells and interleukin-6 (IL-6). Upregulated PIM2 contributed to the attenuation of the cytotoxic effects of MS-275. Class I HDAC and PIM kinase inhibitors cooperatively suppressed MM cell growth in the presence of IL-6 and in vivo. Therefore, the present results demonstrate the potential of the simultaneous targeting of the intrinsic HDAC1-IRF4 axis plus externally activated PIM2 as an efficient therapeutic option for MM fostered in the BM.","ja":"Multiple myeloma (MM) preferentially expands and acquires drug resistance in the bone marrow (BM). We herein examined the role of histone deacetylase 1 (HDAC1) in the constitutive activation of the master transcription factor IRF4 and the prosurvival mediator PIM2 kinase in MM cells. The knockdown or inhibition of HDAC1 by the class I HDAC inhibitor MS-275 reduced the basal expression of IRF4 and PIM2 in MM cells. Mechanistically, the inhibition of HDAC1 decreased IRF4 transcription through histone hyperacetylation and inhibiting the recruitment of RNA polymerase II at the IRF4 locus, thereby reducing IRF4-targeting genes, including PIM2. In addition to the transcriptional regulation of PIM2 by the HDAC1-IRF4 axis, PIM2 was markedly upregulated by external stimuli from BM stromal cells and interleukin-6 (IL-6). Upregulated PIM2 contributed to the attenuation of the cytotoxic effects of MS-275. Class I HDAC and PIM kinase inhibitors cooperatively suppressed MM cell growth in the presence of IL-6 and in vivo. Therefore, the present results demonstrate the potential of the simultaneous targeting of the intrinsic HDAC1-IRF4 axis plus externally activated PIM2 as an efficient therapeutic option for MM fostered in the BM."},"publication_date":"2023-03-28","publication_name":{"en":"Blood Advances","ja":"Blood Advances"},"volume":"Vol.7","number":"No.6","starting_page":"1019","ending_page":"1032","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1182/bloodadvances.2022007155"],"issn":["2473-9537"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:9, {"insert":{"user_id":"B000341201","type":"published_papers","id":"42547182"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118251","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37057050","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396814","label":"url"}],"paper_title":{"en":"Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes.","ja":"Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes."},"authors":{"en":[{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Hosoki Minae"},{"name":"Hara Tomoyo"},{"name":"Mitsui Yukari"},{"name":"Masuda Shiho"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Harada Takeshi"},{"name":"Kuroda Akio"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"細木 美苗"},{"name":"原 倫世"},{"name":"Mitsui Yukari"},{"name":"桝田 志保"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"原田 武志"},{"name":"黒田 暁生"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"description":{"en":"PhA and ECW/TBW but not SMI were associated with levels of Hgb and Hct in patients with diabetes. Therefore, aberrant values of PhA and ECW/TBW suggest a risk of anemia in diabetic patients.","ja":"PhA and ECW/TBW but not SMI were associated with levels of Hgb and Hct in patients with diabetes. Therefore, aberrant values of PhA and ECW/TBW suggest a risk of anemia in diabetic patients."},"publication_date":"2023-03-21","publication_name":{"en":"Heliyon","ja":"Heliyon"},"volume":"Vol.9","number":"No.4","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.heliyon.2023.e14724"],"issn":["2405-8440"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:10, {"insert":{"user_id":"B000341201","type":"published_papers","id":"42260854"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/36856824","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395910","label":"url"}],"paper_title":{"en":"Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents.","ja":"Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents."},"authors":{"en":[{"name":"Teramachi Jumpei"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Hiasa Masahiro"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"日浅 雅博"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"description":{"en":"MM cells produce a variety of cytokines to stimulate receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis and suppress osteoblastic differentiation from bone marrow stromal cells, leading to extensive bone destruction with rapid loss of bone. MM cells alter the microenvironment through bone destruction where they colonize, which in turn favors tumor growth and survival, thereby forming a vicious cycle between tumor progression and bone destruction. Denosumab or zoledronic acid is currently recommended to be administered at the start of treatment in newly diagnosed patients with MM with bone disease. Proteasome inhibitors and the anti-CD38 monoclonal antibody daratumumab have been demonstrated to exert bone-modifying activity in responders. Besides their anti-tumor activity, the effects of new anti-MM agents on bone metabolism should be more precisely analyzed in patients with MM. Because prognosis in patients with MM has been significantly improved owing to the implementation of new agents, the therapeutic impact of bone-modifying agents should be re-estimated in the era of these new agents.","ja":"MM cells produce a variety of cytokines to stimulate receptor activator of nuclear factor-κB ligand-mediated osteoclastogenesis and suppress osteoblastic differentiation from bone marrow stromal cells, leading to extensive bone destruction with rapid loss of bone. MM cells alter the microenvironment through bone destruction where they colonize, which in turn favors tumor growth and survival, thereby forming a vicious cycle between tumor progression and bone destruction. Denosumab or zoledronic acid is currently recommended to be administered at the start of treatment in newly diagnosed patients with MM with bone disease. Proteasome inhibitors and the anti-CD38 monoclonal antibody daratumumab have been demonstrated to exert bone-modifying activity in responders. Besides their anti-tumor activity, the effects of new anti-MM agents on bone metabolism should be more precisely analyzed in patients with MM. Because prognosis in patients with MM has been significantly improved owing to the implementation of new agents, the therapeutic impact of bone-modifying agents should be re-estimated in the era of these new agents."},"publication_date":"2023-03-01","publication_name":{"en":"Journal of Bone and Mineral Metabolism","ja":"Journal of Bone and Mineral Metabolism"},"starting_page":"1","ending_page":"16","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00774-023-01403-4"],"issn":["1435-5604"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:11, {"insert":{"user_id":"B000341201","type":"published_papers","id":"43213466"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118610","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402666","label":"url"}],"paper_title":{"en":"Systemic amyloidosis associated with non-IgM type paraprotein with lymphoplasmacytic lymphoma","ja":"Systemic amyloidosis associated with non-IgM type paraprotein with lymphoplasmacytic lymphoma"},"authors":{"en":[{"name":"Hori Taiki"},{"name":"Yasui Saya"},{"name":"Hosoki Minae"},{"name":"Yamagami Hiroki"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Kenichi"},{"name":"Takishita Makoto"},{"name":"Yokohama Akihiko"},{"name":"Ueda Mitusharu"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"}],"ja":[{"name":"堀 太貴"},{"name":"安井 沙耶"},{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"},{"name":"Takishita Makoto"},{"name":"Yokohama Akihiko"},{"name":"Ueda Mitusharu"},{"name":"安倍 正博"},{"name":"中村 信元"}]},"publication_date":"2023","publication_name":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"volume":"Vol.13","number":"No.2","starting_page":"7","ending_page":"12","languages":["eng"],"referee":true,"identifiers":{"doi":["10.57352/ijm.13.2_7"],"issn":["2187-3143"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:12, {"insert":{"user_id":"B000341201","type":"published_papers","id":"43207400"},"force":{"see_also":[{"@id":"http://repo.lib.tokushima-u.ac.jp/117969","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050295181679877760/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402576","label":"url"}],"paper_title":{"en":"徳島県におけるHIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題","ja":"徳島県におけるHIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題"},"authors":{"en":[{"name":"高原 由実子"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"林 成樹"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"富永 誠記"},{"name":"岡本 秀樹"},{"name":"Okada Naoto"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"大坂 朱美"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Suge Toshiyuki"},{"name":"Aota Keiko"},{"name":"Ozaki Shuji"},{"name":"Abe Masahiro"}],"ja":[{"name":"高原 由実子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"林 成樹"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"富永 誠記"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"大坂 朱美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"菅 俊行"},{"name":"青田 桂子"},{"name":"尾崎 修治"},{"name":"安倍 正博"}]},"description":{"en":"【Introduction】The survival rate in patients with HIV infection and acquired immunodeficiency syndrome (AIDS) has been improved dramatically due to the advances in anti-HIV drug therapy, while aging-associated complications become a critical issue. The incidence of sudden occurrence of AIDS without prior detection of HIV infection, so called ``Ikinari AIDS'', still remains high. 【Objective】We retrospectively analyzed the incidence and clinical characteristics of HIV/AIDS patients in both Tokushima University Hospital and Tokushima Prefectural Central Hospital. 【Results】Eighty four patients (74 males and 10 females) with a median age of 39 years old (range 16 - 85) were enrolled. Thirty-four patients (40.5%) were diagnosed with ``Ikinari AIDS'' from 2001 to 2020. All 4 patients were diagnosed with ``Ikinari AIDS'' after 2020. AIDS-defining illnesses were diagnosed as follows ; pneumocystis pneumonia in 21 cases, CMV infection in 8 cases and candidiasis in 6 cases. All patients over 60 years old were suffered from AIDS. Other complications included syphilis in 17 cases, hepatitis B infection in 12 and herpes zoster in 7. 【Discussion/Conclusion】In Tokushima, the incidence rate of ``Ikinari AIDS'' appeared to be higher than that of national average. COVID - 19 pandemic hampered the public health care services of awareness-raising activity for HIV infection and telephone consultations about HIV, which may become more lease asymptomatic HIV patients without diagnosis. For early diagnosis of HIV/AIDS, it is becoming more important to share information to make early screening of HIV infection among medical staffs, such as medical doctors, dentists, nurses, pharmacists and MSWs.","ja":"【Introduction】The survival rate in patients with HIV infection and acquired immunodeficiency syndrome (AIDS) has been improved dramatically due to the advances in anti-HIV drug therapy, while aging-associated complications become a critical issue. The incidence of sudden occurrence of AIDS without prior detection of HIV infection, so called ``Ikinari AIDS'', still remains high. 【Objective】We retrospectively analyzed the incidence and clinical characteristics of HIV/AIDS patients in both Tokushima University Hospital and Tokushima Prefectural Central Hospital. 【Results】Eighty four patients (74 males and 10 females) with a median age of 39 years old (range 16 - 85) were enrolled. Thirty-four patients (40.5%) were diagnosed with ``Ikinari AIDS'' from 2001 to 2020. All 4 patients were diagnosed with ``Ikinari AIDS'' after 2020. AIDS-defining illnesses were diagnosed as follows ; pneumocystis pneumonia in 21 cases, CMV infection in 8 cases and candidiasis in 6 cases. All patients over 60 years old were suffered from AIDS. Other complications included syphilis in 17 cases, hepatitis B infection in 12 and herpes zoster in 7. 【Discussion/Conclusion】In Tokushima, the incidence rate of ``Ikinari AIDS'' appeared to be higher than that of national average. COVID - 19 pandemic hampered the public health care services of awareness-raising activity for HIV infection and telephone consultations about HIV, which may become more lease asymptomatic HIV patients without diagnosis. For early diagnosis of HIV/AIDS, it is becoming more important to share information to make early screening of HIV infection among medical staffs, such as medical doctors, dentists, nurses, pharmacists and MSWs."},"publication_date":"2022-12-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.78","number":"No.5-6","starting_page":"193","ending_page":"198","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:13, {"insert":{"user_id":"B000341201","type":"published_papers","id":"41302472"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118345","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35636450","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388296","label":"url"}],"paper_title":{"en":"Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination.","ja":"Autoimmune Acquired Factor XIII/13 Deficiency after SARS-CoV-2 mRNA Vaccination."},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Sugasaki Motoki"},{"name":"Souri Masayoshi"},{"name":"Akazawa Hirohito"},{"name":"Sogawa Maiko"},{"name":"Hori Taiki"},{"name":"Yamagami Hiroki"},{"name":"Takishita Makoto"},{"name":"Aihara Ken-ichi"},{"name":"Abe Masahiro"},{"name":"Yasumoto Atsushi"},{"name":"Morishita Eriko"},{"name":"Ichinose Akitada"}],"ja":[{"name":"中村 信元"},{"name":"Sugasaki Motoki"},{"name":"Souri Masayoshi"},{"name":"Akazawa Hirohito"},{"name":"Sogawa Maiko"},{"name":"堀 太貴"},{"name":"山上 紘規"},{"name":"Takishita Makoto"},{"name":"粟飯原 賢一"},{"name":"安倍 正博"},{"name":"Yasumoto Atsushi"},{"name":"Morishita Eriko"},{"name":"Ichinose Akitada"}]},"publication_date":"2022-07","publication_name":{"en":"Thrombosis and Haemostasis","ja":"Thrombosis and Haemostasis"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1055/a-1863-7265"],"issn":["2567-689X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:14, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35811059","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388295","label":"url"}],"paper_title":{"en":"First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapy.","ja":"First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapy."},"authors":{"en":[{"name":"Okada Naoto"},{"name":"Murakami Akikazu"},{"name":"Satou Masami"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Sogabe Kimiko"},{"name":"Takahashi Mamiko"},{"name":"Okada Asami"},{"name":"Abe Akane"},{"name":"Fujii Hideki"},{"name":"Abe Masahiro"},{"name":"Azuma Momoyo"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"村上 明一"},{"name":"Satou Masami"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"曽我部 公子"},{"name":"Takahashi Mamiko"},{"name":"Okada Asami"},{"name":"阿部 あかね"},{"name":"藤猪 英樹"},{"name":"安倍 正博"},{"name":"東 桃代"},{"name":"石澤 啓介"}]},"description":{"en":"During chemotherapy in patients with oral mucositis, we should consider the possibility of L. gingivalis bacteremia.","ja":"During chemotherapy in patients with oral mucositis, we should consider the possibility of L. gingivalis bacteremia."},"publication_date":"2022-07-08","publication_name":{"en":"Anaerobe","ja":"Anaerobe"},"volume":"Vol.76","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.anaerobe.2022.102610"],"issn":["1095-8274"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:15, {"insert":{"user_id":"B000341201","type":"published_papers","id":"38890566"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117583","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35752658","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386499","label":"url"}],"paper_title":{"en":"A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy","ja":"A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy"},"authors":{"en":[{"name":"Yamada Hiroki"},{"name":"Ohmori Rio"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"山田 博貴"},{"name":"大森 理央"},{"name":"Okada Naoto"},{"name":"中村 信元"},{"name":"Kagawa Kumiko"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"description":{"en":"Vincristine treatment may cause peripheral neuropathy. In this study, we identified the genes associated with the development of peripheral neuropathy due to vincristine therapy using a genome-wide association study (GWAS) and constructed a predictive model for the development of peripheral neuropathy using genetic information-based machine learning. The study included 72 patients admitted to the Department of Hematology, Tokushima University Hospital, who received vincristine. Of these, 56 were genotyped using the Illumina Asian Screening Array-24 Kit, and a GWAS for the onset of peripheral neuropathy caused by vincristine was conducted. Using Sanger sequencing for 16 validation samples, the top three single nucleotide polymorphisms (SNPs) associated with the onset of peripheral neuropathy were determined. Machine learning was performed using the statistical software R package \"caret\". The 56 GWAS and 16 validation samples were used as the training and test sets, respectively. Predictive models were constructed using random forest, support vector machine, naive Bayes, and neural network algorithms. According to the GWAS, rs2110179, rs7126100, and rs2076549 were associated with the development of peripheral neuropathy on vincristine administration. Machine learning was performed using these three SNPs to construct a prediction model. A high accuracy of 93.8% was obtained with the support vector machine and neural network using rs2110179 and rs2076549. Thus, peripheral neuropathy development due to vincristine therapy can be effectively predicted by a machine learning prediction model using SNPs associated with it.","ja":"Vincristine treatment may cause peripheral neuropathy. In this study, we identified the genes associated with the development of peripheral neuropathy due to vincristine therapy using a genome-wide association study (GWAS) and constructed a predictive model for the development of peripheral neuropathy using genetic information-based machine learning. The study included 72 patients admitted to the Department of Hematology, Tokushima University Hospital, who received vincristine. Of these, 56 were genotyped using the Illumina Asian Screening Array-24 Kit, and a GWAS for the onset of peripheral neuropathy caused by vincristine was conducted. Using Sanger sequencing for 16 validation samples, the top three single nucleotide polymorphisms (SNPs) associated with the onset of peripheral neuropathy were determined. Machine learning was performed using the statistical software R package \"caret\". The 56 GWAS and 16 validation samples were used as the training and test sets, respectively. Predictive models were constructed using random forest, support vector machine, naive Bayes, and neural network algorithms. According to the GWAS, rs2110179, rs7126100, and rs2076549 were associated with the development of peripheral neuropathy on vincristine administration. Machine learning was performed using these three SNPs to construct a prediction model. A high accuracy of 93.8% was obtained with the support vector machine and neural network using rs2110179 and rs2076549. Thus, peripheral neuropathy development due to vincristine therapy can be effectively predicted by a machine learning prediction model using SNPs associated with it."},"publication_date":"2022-06-25","publication_name":{"en":"The Pharmacogenomics Journal","ja":"The Pharmacogenomics Journal"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/s41397-022-00282-8"],"issn":["1473-1150"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:16, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35534187","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394086","label":"url"}],"paper_title":{"en":"Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strength.","ja":"Allogeneic haematopoietic stem cell transplantation and patient falls: impact of lower extremity muscle strength."},"authors":{"en":[{"name":"Kondo Shin"},{"name":"Inoue Tatsuro"},{"name":"Saito Takashi"},{"name":"Kawamura Yuka"},{"name":"Katayama Ayane"},{"name":"Nakamura Masafumi"},{"name":"Sumitani Ryohei"},{"name":"Takahashi Mamiko"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Sato Nori"},{"name":"Ono Rei"},{"name":"Abe Masahiro"},{"name":"Katoh Shinsuke"}],"ja":[{"name":"Kondo Shin"},{"name":"Inoue Tatsuro"},{"name":"Saito Takashi"},{"name":"Kawamura Yuka"},{"name":"Katayama Ayane"},{"name":"Nakamura Masafumi"},{"name":"住谷 龍平"},{"name":"Takahashi Mamiko"},{"name":"大浦 雅博"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"佐藤 紀"},{"name":"Ono Rei"},{"name":"安倍 正博"},{"name":"加藤 真介"}]},"description":{"en":"Pretransplant LEMS was a significant predictor of post-transplant falls. The results of this study may help to prevent falls in patients undergoing allo-HSCT.","ja":"Pretransplant LEMS was a significant predictor of post-transplant falls. The results of this study may help to prevent falls in patients undergoing allo-HSCT."},"publication_date":"2022-05-09","publication_name":{"en":"BMJ Supportive & Palliative Care","ja":"BMJ Supportive & Palliative Care"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1136/bmjspcare-2022-003582"],"issn":["2045-4368"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:17, {"insert":{"user_id":"B000341201","type":"published_papers","id":"36164916"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117584","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34657909","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=383649","label":"url"}],"paper_title":{"en":"A genome-wide association study predicts the onset of dysgeusia due to anti-cancer drug treatment","ja":"A genome-wide association study predicts the onset of dysgeusia due to anti-cancer drug treatment"},"authors":{"en":[{"name":"Takei Minori"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"武井 みのり"},{"name":"Okada Naoto"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"description":{"en":"Dysgeusia is a major side effect of anti-cancer drug treatment. Since dysgeusia significantly lowers the patient's QOL, predicting and avoiding its onset in advance is desirable. Accordingly, aims of the present study were to use a genome-wide association study (GWAS) to identify genes associated with the development of dysgeusia in patients taking anti-cancer drugs and to predict the development of dysgeusia using associated single nucleotide polymorphisms (SNPs). GWAS was conducted on 76 patients admitted to the Department of Hematology, Tokushima University Hospital. Using Sanger sequencing for 23 separately collected validation samples, the top two SNPs associated with the development of dysgeusia were determined. GWAS identified rs73049478 and rs41396146 SNPs on the retinoic acid receptor beta (RARB) gene associated with dysgeusia development due to the administration of anti-cancer drugs. Evaluation of the two SNPs using 23 validation samples indicated that the accuracy rate of rs73049478 was relatively high (87.0%). Thus, the findings of the present study suggest that the rs73049478 SNP of RARB can be used to predict the onset of dysgeusia caused by the administration of anti-cancer drugs.","ja":"Dysgeusia is a major side effect of anti-cancer drug treatment. Since dysgeusia significantly lowers the patient's QOL, predicting and avoiding its onset in advance is desirable. Accordingly, aims of the present study were to use a genome-wide association study (GWAS) to identify genes associated with the development of dysgeusia in patients taking anti-cancer drugs and to predict the development of dysgeusia using associated single nucleotide polymorphisms (SNPs). GWAS was conducted on 76 patients admitted to the Department of Hematology, Tokushima University Hospital. Using Sanger sequencing for 23 separately collected validation samples, the top two SNPs associated with the development of dysgeusia were determined. GWAS identified rs73049478 and rs41396146 SNPs on the retinoic acid receptor beta (RARB) gene associated with dysgeusia development due to the administration of anti-cancer drugs. Evaluation of the two SNPs using 23 validation samples indicated that the accuracy rate of rs73049478 was relatively high (87.0%). Thus, the findings of the present study suggest that the rs73049478 SNP of RARB can be used to predict the onset of dysgeusia caused by the administration of anti-cancer drugs."},"publication_date":"2022-01-01","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.45","number":"No.1","starting_page":"114","ending_page":"117","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b21-00745"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:18, {"insert":{"user_id":"B000341201","type":"published_papers","id":"39359771"},"force":{"see_also":[{"@id":"http://repo.lib.tokushima-u.ac.jp/117140","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050855267567099520/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387553","label":"url"}],"paper_title":{"en":"徳島大学病院における先天性血友病患者(成人例)の実態調査∼移行期医療の重要性∼","ja":"徳島大学病院における先天性血友病患者(成人例)の実態調査∼移行期医療の重要性∼"},"authors":{"en":[{"name":"西條 早希"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"谷口 早紀"},{"name":"岡本 秀樹"},{"name":"富永 誠記"},{"name":"Okada Naoto"},{"name":"矢野 由美子"},{"name":"髙橋 真理"},{"name":"Aota Keiko"},{"name":"Suge Toshiyuki"},{"name":"Watanabe Hiroyoshi"},{"name":"大坂 朱美"},{"name":"Abe Masahiro"}],"ja":[{"name":"西條 早希"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"谷口 早紀"},{"name":"岡本 秀樹"},{"name":"富永 誠記"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"髙橋 真理"},{"name":"青田 桂子"},{"name":"菅 俊行"},{"name":"渡邊 浩良"},{"name":"大坂 朱美"},{"name":"安倍 正博"}]},"description":{"en":"【Introduction】Congenital hemophilia is a category of hemorrhagic disease caused by a genetic defect in the production of coagulation factors. It is treated by administering regular coagulation factor injections on an ongoing basis. Hemophilia is a hereditary illness, often causing social and psychological problems as a result of the disease. To analyze the objective effects of hemophilia, we conducted a retrospective analysis in Tokushima University Hospital. 【Result】All 23 cases were men between the ages of20and72. Hemophilia A was present in17cases, and hemophilia B was present in six. Nineteen out of 23 cases were severe, and the others were intermediate. Medical assessments were conducted at pediatrics in seven cases and hematology in 16 cases. Adoption of the self-injection technique was not realized in five cases. Seventeen cases were complicated by hemophilic arthropathy, seven with human immunodeficiency virus(HIV), and 12 with hepatitis C virus. Eight participants were unemployed, and17were unmarried. 【Discussion】 Many adult hemophilia patients still visit pediatrics in our hospital. Hemophilia in the period of growth between adolescence and young adulthood is often accompanied by life-altering events such as entering higher education, marriage, and work experience. Therefore, collaboration among professionals of multiple occupations, such as doctors, nurses, pharmacists, medical social workers, and clinical psychologists, is essential. Furthermore, there are many cases of HIV and hepatitis C virus infections complicating hemophilia study due to the stigma surrounding HIV-tainted blood. 【Conclusion】It is imperative that we establish a long-term, sustainable, and multi-disciplinary transitional care and medical support system for patients and their families.","ja":"【Introduction】Congenital hemophilia is a category of hemorrhagic disease caused by a genetic defect in the production of coagulation factors. It is treated by administering regular coagulation factor injections on an ongoing basis. Hemophilia is a hereditary illness, often causing social and psychological problems as a result of the disease. To analyze the objective effects of hemophilia, we conducted a retrospective analysis in Tokushima University Hospital. 【Result】All 23 cases were men between the ages of20and72. Hemophilia A was present in17cases, and hemophilia B was present in six. Nineteen out of 23 cases were severe, and the others were intermediate. Medical assessments were conducted at pediatrics in seven cases and hematology in 16 cases. Adoption of the self-injection technique was not realized in five cases. Seventeen cases were complicated by hemophilic arthropathy, seven with human immunodeficiency virus(HIV), and 12 with hepatitis C virus. Eight participants were unemployed, and17were unmarried. 【Discussion】 Many adult hemophilia patients still visit pediatrics in our hospital. Hemophilia in the period of growth between adolescence and young adulthood is often accompanied by life-altering events such as entering higher education, marriage, and work experience. Therefore, collaboration among professionals of multiple occupations, such as doctors, nurses, pharmacists, medical social workers, and clinical psychologists, is essential. Furthermore, there are many cases of HIV and hepatitis C virus infections complicating hemophilia study due to the stigma surrounding HIV-tainted blood. 【Conclusion】It is imperative that we establish a long-term, sustainable, and multi-disciplinary transitional care and medical support system for patients and their families."},"publication_date":"2021-12-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.77","number":"No.5-6","starting_page":"261","ending_page":"268","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:19, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34949601","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394089","label":"url"}],"paper_title":{"en":"Allogeneic haematopoietic stem cell transplantation-clinical outcomes: impact of leg muscle strength.","ja":"Allogeneic haematopoietic stem cell transplantation-clinical outcomes: impact of leg muscle strength."},"authors":{"en":[{"name":"Kondo Shin"},{"name":"Kagawa Kumiko"},{"name":"Saito Takashi"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Sato Nori"},{"name":"Ono Rei"},{"name":"Abe Masahiro"},{"name":"Katoh Shinsuke"}],"ja":[{"name":"Kondo Shin"},{"name":"Kagawa Kumiko"},{"name":"Saito Takashi"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"佐藤 紀"},{"name":"Ono Rei"},{"name":"安倍 正博"},{"name":"加藤 真介"}]},"description":{"en":"Pre-transplant LEMS was a significant factor in predicting OS and NRM.","ja":"Pre-transplant LEMS was a significant factor in predicting OS and NRM."},"publication_date":"2021-12-23","publication_name":{"en":"BMJ Supportive & Palliative Care","ja":"BMJ Supportive & Palliative Care"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1136/bmjspcare-2021-003256"],"issn":["2045-4368"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:20, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118369","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34585530","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388299","label":"url"}],"paper_title":{"en":"Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent.","ja":"Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent."},"authors":{"en":[{"name":"Kaneko Yousuke"},{"name":"Sugasaki Motoki"},{"name":"Okada Naoto"},{"name":"Niimi Mako"},{"name":"Yasui Saya"},{"name":"Hori Taiki"},{"name":"Aihara Ken-ichi"},{"name":"Takishita Makoto"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"}],"ja":[{"name":"Kaneko Yousuke"},{"name":"Sugasaki Motoki"},{"name":"岡田 直人"},{"name":"Niimi Mako"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"粟飯原 賢一"},{"name":"Takishita Makoto"},{"name":"安倍 正博"},{"name":"中村 信元"}]},"publication_date":"2021-09-29","publication_name":{"en":"International Journal of Laboratory Hematology","ja":"International Journal of Laboratory Hematology"},"volume":"Vol.44","number":"No.2","starting_page":"e72","ending_page":"e75","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/ijlh.13718"],"issn":["1751-553X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:21, {"insert":{"user_id":"B000341201","type":"published_papers","id":"33352905"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33999338","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379402","label":"url"}],"paper_title":{"en":"Expression of activated integrin β7 in multiple myeloma patients.","ja":"Expression of activated integrin β7 in multiple myeloma patients."},"authors":{"en":[{"name":"Hosen Naoki"},{"name":"Yoshihara Satoshi"},{"name":"Takamatsu Hiroyuki"},{"name":"Morishima Masaki"},{"name":"Nagata Yasuyuki"},{"name":"Kosugi Hiroshi"},{"name":"Shimomura Yoshimitsu"},{"name":"Hanamura Ichiro"},{"name":"Fuji Shigeo"},{"name":"Minauchi Koichiro"},{"name":"Kuroda Junya"},{"name":"Suzuki Rikio"},{"name":"Nishimura Noriko"},{"name":"Uoshima Nobuhiko"},{"name":"Nakamae Hirohisa"},{"name":"Kawano Yawara"},{"name":"Mizuno Ishikazu"},{"name":"Gomyo Hiroshi"},{"name":"Suzuki Kenshi"},{"name":"Ozaki Shuji"},{"name":"Nakamura Shingen"},{"name":"Imai Yoichi"},{"name":"Kizaki Masahiro"},{"name":"Negoro Eiju"},{"name":"Handa Hiroshi"},{"name":"Iida Shinsuke"}],"ja":[{"name":"Hosen Naoki"},{"name":"Yoshihara Satoshi"},{"name":"Takamatsu Hiroyuki"},{"name":"森島 真幸"},{"name":"Nagata Yasuyuki"},{"name":"Kosugi Hiroshi"},{"name":"Shimomura Yoshimitsu"},{"name":"Hanamura Ichiro"},{"name":"Fuji Shigeo"},{"name":"Minauchi Koichiro"},{"name":"Kuroda Junya"},{"name":"Suzuki Rikio"},{"name":"Nishimura Noriko"},{"name":"Uoshima Nobuhiko"},{"name":"Nakamae Hirohisa"},{"name":"Kawano Yawara"},{"name":"Mizuno Ishikazu"},{"name":"Gomyo Hiroshi"},{"name":"鈴木 けんし"},{"name":"尾崎 修治"},{"name":"中村 信元"},{"name":"Imai Yoichi"},{"name":"Kizaki Masahiro"},{"name":"Negoro Eiju"},{"name":"Handa Hiroshi"},{"name":"Iida Shinsuke"}]},"description":{"en":"B cells, which reportedly include clonotypic B cells, in the bone marrow of MM patients. Taken together, these results suggest that CAR T-cell therapy targeting activated integrin β7 has the potential to benefit many patients with relapsed or refractory MM.","ja":"Multiple myeloma (MM) is still extremely difficult to cure, and new therapeutic drugs are needed. We recently found that integrin β7 is constitutively activated in MM cells, and chimeric antigen receptor (CAR) T cells targeting activated integrin β7 have a significant anti-MM effect. In this study, we performed flow cytometry analysis of the expression of activated integrin β7 in bone marrow cells from 137 symptomatic MM patients. In 60/137 (44%) MM patients, activated integrin β7 was detected in most MM cells (> 80% of MM cells were in the positive gate). Activated integrin β7 was highly expressed in MM cells even in heavily treated patients. It also showed high expression in many CD38"},"publication_date":"2021-05-17","publication_name":{"en":"International Journal of Hematology","ja":"International Journal of Hematology"},"volume":"Vol.114","number":"No.1","starting_page":"3","ending_page":"7","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s12185-021-03162-2"],"issn":["1865-3774"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:22, {"insert":{"user_id":"B000341201","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116529","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32273474","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377110","label":"url"}],"paper_title":{"en":"TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma","ja":"TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma"},"authors":{"en":[{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Ashtar Mohannad"},{"name":"Shimizu Sou"},{"name":"Iwasa Masami"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"Ariunzaya Bat-Erdene"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"ASHTAR MOHANNAD"},{"name":"清水 宗"},{"name":"岩佐 昌美"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Along with the tumor progression, the bone marrow microenvironment is skewed in multiple myeloma (MM), which underlies the unique pathophysiology of MM and confers aggressiveness and drug resistance in MM cells. TGF-β-activated kinase-1 (TAK1) mediates a wide range of intracellular signaling pathways. We demonstrate here that TAK1 is constitutively overexpressed and phosphorylated in MM cells, and that TAK1 inhibition suppresses the activation of NF-κB, p38MAPK, ERK and STAT3 to decrease the expression of critical mediators for MM growth and survival, including PIM2, MYC, Mcl-1, IRF4, and Sp1, along with a substantial reduction in the angiogenic factor VEGF in MM cells. Intriguingly, TAK1 phosphorylation was also induced along with upregulation of vascular cell adhesion molecule-1 (VCAM-1) in bone marrow stromal cells (BMSCs) in cocultures with MM cells, which facilitated MM cell-BMSC adhesion while inducing IL-6 production and receptor activator of nuclear factor κ-Β ligand (RANKL) expression by BMSCs. TAK1 inhibition effectively impaired MM cell adhesion to BMSCs to disrupt the support of MM cell growth and survival by BMSCs. Furthermore, TAK1 inhibition suppressed osteoclastogenesis enhanced by RANKL in cocultures of bone marrow cells with MM cells, and restored osteoblastic differentiation suppressed by MM cells or inhibitory factors for osteoblastogenesis overproduced in MM. Finally, treatment with the TAK1 inhibitor LLZ1640-2 markedly suppressed MM tumor growth and prevented bone destruction and loss in mouse MM models. Therefore, TAK1 inhibition may be a promising therapeutic option targeting not only MM cells but also the skewed bone marrow microenvironment in MM.","ja":"Along with the tumor progression, the bone marrow microenvironment is skewed in multiple myeloma (MM), which underlies the unique pathophysiology of MM and confers aggressiveness and drug resistance in MM cells. TGF-β-activated kinase-1 (TAK1) mediates a wide range of intracellular signaling pathways. We demonstrate here that TAK1 is constitutively overexpressed and phosphorylated in MM cells, and that TAK1 inhibition suppresses the activation of NF-κB, p38MAPK, ERK and STAT3 to decrease the expression of critical mediators for MM growth and survival, including PIM2, MYC, Mcl-1, IRF4, and Sp1, along with a substantial reduction in the angiogenic factor VEGF in MM cells. Intriguingly, TAK1 phosphorylation was also induced along with upregulation of vascular cell adhesion molecule-1 (VCAM-1) in bone marrow stromal cells (BMSCs) in cocultures with MM cells, which facilitated MM cell-BMSC adhesion while inducing IL-6 production and receptor activator of nuclear factor κ-Β ligand (RANKL) expression by BMSCs. TAK1 inhibition effectively impaired MM cell adhesion to BMSCs to disrupt the support of MM cell growth and survival by BMSCs. Furthermore, TAK1 inhibition suppressed osteoclastogenesis enhanced by RANKL in cocultures of bone marrow cells with MM cells, and restored osteoblastic differentiation suppressed by MM cells or inhibitory factors for osteoblastogenesis overproduced in MM. Finally, treatment with the TAK1 inhibitor LLZ1640-2 markedly suppressed MM tumor growth and prevented bone destruction and loss in mouse MM models. Therefore, TAK1 inhibition may be a promising therapeutic option targeting not only MM cells but also the skewed bone marrow microenvironment in MM."},"publication_date":"2021-05-01","publication_name":{"en":"Haematologica","ja":"Haematologica"},"volume":"Vol.106","number":"No.5","starting_page":"1401","ending_page":"1413","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3324/haematol.2019.234476"],"issn":["1592-8721"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:23, {"insert":{"user_id":"B000341201","type":"published_papers","id":"33352906"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116536","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33456032","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379404","label":"url"}],"paper_title":{"en":"Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis.","ja":"Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis."},"authors":{"en":[{"name":"Sumitani Ryohei"},{"name":"Hori Taiki"},{"name":"Murai Jumpei"},{"name":"Kawata Shiyori"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Takahashi Mamiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"}],"ja":[{"name":"住谷 龍平"},{"name":"Hori Taiki"},{"name":"Murai Jumpei"},{"name":"Kawata Shiyori"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"Takahashi Mamiko"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"中村 信元"}]},"description":{"en":"A 33-year-old man was admitted to our hospital for fever and abdominal pain. A blood analysis revealed pancytopenia and increased serum pancreatic enzymes with disseminated intravascular coagulation. A detailed examination revealed acute pancreatitis, with diffuse swelling of the pancreas and diffuse beaded dilatation of the main pancreatic duct, which mimicked autoimmune pancreatitis complicated by acute myeloid leukemia. Systemic cytotoxic chemotherapy led to the remission of leukemia and pancreatitis. We hypothesized that the etiology of acute pancreatitis was invasion of leukemia cells. Acute pancreatitis is rare as a symptom of leukemia; however, we should consider the possibility of leukemia during the differential diagnosis of acute pancreatitis.","ja":"A 33-year-old man was admitted to our hospital for fever and abdominal pain. A blood analysis revealed pancytopenia and increased serum pancreatic enzymes with disseminated intravascular coagulation. A detailed examination revealed acute pancreatitis, with diffuse swelling of the pancreas and diffuse beaded dilatation of the main pancreatic duct, which mimicked autoimmune pancreatitis complicated by acute myeloid leukemia. Systemic cytotoxic chemotherapy led to the remission of leukemia and pancreatitis. We hypothesized that the etiology of acute pancreatitis was invasion of leukemia cells. Acute pancreatitis is rare as a symptom of leukemia; however, we should consider the possibility of leukemia during the differential diagnosis of acute pancreatitis."},"publication_date":"2021-01-15","publication_name":{"en":"Internal Medicine","ja":"Internal Medicine"},"volume":"Vol.60","number":"No.11","starting_page":"1753","ending_page":"1757","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2169/internalmedicine.4916-20"],"issn":["1349-7235"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:24, {"insert":{"user_id":"B000341201","type":"published_papers","id":"36183959"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117585","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=383725","label":"url"}],"paper_title":{"en":"Association analysis between adverse drug reactions to cytarabine therapy and single nucleotide polymorphisms in cytarabine metabolic genes in patients with hematopoietic tumor","ja":"Association analysis between adverse drug reactions to cytarabine therapy and single nucleotide polymorphisms in cytarabine metabolic genes in patients with hematopoietic tumor"},"authors":{"en":[{"name":"Hozumi Tashima"},{"name":"Yuka Endo"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"田島 穂澄"},{"name":"遠藤 優香"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"publication_date":"2021","publication_name":{"en":"Personalized Medicine Universe","ja":"Personalized Medicine Universe"},"volume":"Vol.10","starting_page":"1","ending_page":"6","languages":["eng"],"referee":true,"identifiers":{"doi":["10.46459/pmu.2021002"],"issn":["2186-4950"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:25, {"insert":{"user_id":"B000341201","type":"published_papers","id":"33352907"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116021","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33994471","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379403","label":"url"}],"paper_title":{"en":"Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement.","ja":"Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement."},"authors":{"en":[{"name":"Takahashi Mamiko"},{"name":"Sumitani Ryohei"},{"name":"Hori Taiki"},{"name":"Murai Jumpei"},{"name":"Kawata Shiyori"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"}],"ja":[{"name":"Takahashi Mamiko"},{"name":"住谷 龍平"},{"name":"Hori Taiki"},{"name":"Murai Jumpei"},{"name":"Kawata Shiyori"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"中村 信元"}]},"description":{"en":"The prognosis of relapsed or refractory lymphoma with central nervous system (CNS) involvement remains poor because of the lack of anticancer drugs with sufficient CNS penetration. [Case 1] A 65-year-old man was diagnosed with Stage IV mantle cell lymphoma. After two courses of chemotherapy and autologous hematopoietic stem cell (HSC) collection, urinary retention with fever developed. Cerebrospinal fluid analysis revealed leptomeningeal involvement, which was refractory to high-dose methotrexate therapy. Autologous peripheral blood stem cell transplantation (ASCT) was performed, followed by intravenous busulfan (ivBU), cyclophosphamide, and etoposide ; thereafter, no relapse has been detected for over six years. [Case 2] A 40-year-old woman with right lower hemiplegia was diagnosed with primary CNS lymphoma. Although four courses of high-dose methotrexate therapy were administered, the cerebral tumor increased in size. HSCs were collected after methotrexate therapy, and ASCT was performed in addition to conditioning using ivBU, cyclophosphamide, and etoposide, followed by whole-brain and local boost irradiation. She achieved complete remission, but relapsed two years after ASCT. High-dose ivBU-containing conditioning regimens with ASCT may be useful for refractory B-cell lymphoma with CNS involvement. J. Med. Invest. 68 : 196-201, February, 2021.","ja":"The prognosis of relapsed or refractory lymphoma with central nervous system (CNS) involvement remains poor because of the lack of anticancer drugs with sufficient CNS penetration. [Case 1] A 65-year-old man was diagnosed with Stage IV mantle cell lymphoma. After two courses of chemotherapy and autologous hematopoietic stem cell (HSC) collection, urinary retention with fever developed. Cerebrospinal fluid analysis revealed leptomeningeal involvement, which was refractory to high-dose methotrexate therapy. Autologous peripheral blood stem cell transplantation (ASCT) was performed, followed by intravenous busulfan (ivBU), cyclophosphamide, and etoposide ; thereafter, no relapse has been detected for over six years. [Case 2] A 40-year-old woman with right lower hemiplegia was diagnosed with primary CNS lymphoma. Although four courses of high-dose methotrexate therapy were administered, the cerebral tumor increased in size. HSCs were collected after methotrexate therapy, and ASCT was performed in addition to conditioning using ivBU, cyclophosphamide, and etoposide, followed by whole-brain and local boost irradiation. She achieved complete remission, but relapsed two years after ASCT. High-dose ivBU-containing conditioning regimens with ASCT may be useful for refractory B-cell lymphoma with CNS involvement. J. Med. Invest. 68 : 196-201, February, 2021."},"publication_date":"2021","publication_name":{"en":"The Journal of Medical Investigation : JMI","ja":"The Journal of Medical Investigation : JMI"},"volume":"Vol.68","number":"No.1.2","starting_page":"196","ending_page":"201","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2152/jmi.68.196"],"issn":["1349-6867"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:26, {"insert":{"user_id":"B000341201","type":"published_papers","id":"33290861"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115932","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32880823","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85090162636&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342801","label":"url"}],"paper_title":{"en":"Involvement of oral bacteria and oral immunity as risk factors for chemotherapy- induced fever with neutropenia in patients with hematological cancer","ja":"Involvement of oral bacteria and oral immunity as risk factors for chemotherapy- induced fever with neutropenia in patients with hematological cancer"},"authors":{"en":[{"name":"Sogawa Yuka"},{"name":"Fukui Makoto"},{"name":"Nakamura Shingen"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Yoshioka Masami"},{"name":"Abe Masahiro"},{"name":"Hinode Daisuke"}],"ja":[{"name":"十川 悠香"},{"name":"福井 誠"},{"name":"中村 信元"},{"name":"曽我部 公子"},{"name":"住谷 龍平"},{"name":"吉岡 昌美"},{"name":"安倍 正博"},{"name":"日野出 大輔"}]},"description":{"en":"The aim of this study is to investigate the association between chemotherapy-induced fever with neutropenia less than 1500/μL (FwN) and oral bacteria and/or oral immunity in patients with hematological cancer. Thirty-two patients with hematological cancer were enrolled in the study. Secretory immunoglobulin A (sIgA) in saliva and the anaerobic bacteria in tongue coating of each subject were assessed before the first chemotherapy. Eleven subjects had an onset of FwN and 21 subjects did not during the observation periods. It was revealed by the Cox-proportional hazard model analysis that the levels of sIgA were low (HR 0.98, p < 0.05) and the rate of Fusobacterium nucleatum [F. nucleatum count per total bacterial count (%)] was high (HR 1.65, p < 0.05) in patients with FwN onset. Using ROC curve analysis, the optimal cutoff point based on the AUC in the F. nucleatum/sIgA ratio was 0.023, and this model had a 78.4% probability (p < 0.01). The risk of FwN onset was also significantly higher among the group of ≥ 0.023 F. nucleatum/sIgA ratio (HR 66.06, p < 0.01). These results suggest that the rate of F. nucleatum and the levels of sIgA at baseline might be related to FwN onset as risk factors.","ja":"The aim of this study is to investigate the association between chemotherapy-induced fever with neutropenia less than 1500/μL (FwN) and oral bacteria and/or oral immunity in patients with hematological cancer. Thirty-two patients with hematological cancer were enrolled in the study. Secretory immunoglobulin A (sIgA) in saliva and the anaerobic bacteria in tongue coating of each subject were assessed before the first chemotherapy. Eleven subjects had an onset of FwN and 21 subjects did not during the observation periods. It was revealed by the Cox-proportional hazard model analysis that the levels of sIgA were low (HR 0.98, p < 0.05) and the rate of Fusobacterium nucleatum [F. nucleatum count per total bacterial count (%)] was high (HR 1.65, p < 0.05) in patients with FwN onset. Using ROC curve analysis, the optimal cutoff point based on the AUC in the F. nucleatum/sIgA ratio was 0.023, and this model had a 78.4% probability (p < 0.01). The risk of FwN onset was also significantly higher among the group of ≥ 0.023 F. nucleatum/sIgA ratio (HR 66.06, p < 0.01). These results suggest that the rate of F. nucleatum and the levels of sIgA at baseline might be related to FwN onset as risk factors."},"publication_date":"2020-12","publication_name":{"en":"International Journal of Hematology","ja":"International Journal of Hematology"},"volume":"Vol.112","number":"No.6","starting_page":"851","ending_page":"859","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s12185-020-02975-x"],"issn":["1865-3774"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:27, {"insert":{"user_id":"B000341201","type":"published_papers","id":"33352908"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116538","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32891738","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379405","label":"url"}],"paper_title":{"en":"Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial.","ja":"Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial."},"authors":{"en":[{"name":"Kimura Shun-Ichi"},{"name":"Kanda Yoshinobu"},{"name":"Iino Masaki"},{"name":"Fukuda Takahiro"},{"name":"Sakaida Emiko"},{"name":"Oyake Tatsuo"},{"name":"Yamaguchi Hiroki"},{"name":"Fujiwara Shin-Ichiro"},{"name":"Jo Yumi"},{"name":"Okamoto Akinao"},{"name":"Fujita Hiroyuki"},{"name":"Takamatsu Yasushi"},{"name":"Saburi Yoshio"},{"name":"Matsumura Itaru"},{"name":"Yamanouchi Jun"},{"name":"Shiratori Souichi"},{"name":"Gotoh Moritaka"},{"name":"Nakamura Shingen"},{"name":"Tamura Kazuo"}],"ja":[{"name":"Kimura Shun-Ichi"},{"name":"Kanda Yoshinobu"},{"name":"Iino Masaki"},{"name":"Fukuda Takahiro"},{"name":"Sakaida Emiko"},{"name":"Oyake Tatsuo"},{"name":"Yamaguchi Hiroki"},{"name":"Fujiwara Shin-Ichiro"},{"name":"Jo Yumi"},{"name":"Okamoto Akinao"},{"name":"Fujita Hiroyuki"},{"name":"Takamatsu Yasushi"},{"name":"Saburi Yoshio"},{"name":"Matsumura Itaru"},{"name":"Yamanouchi Jun"},{"name":"Shiratori Souichi"},{"name":"Gotoh Moritaka"},{"name":"中村 信元"},{"name":"Tamura Kazuo"}]},"description":{"en":"The efficacy of micafungin in patients undergoing high-risk treatment was not strongly impaired in DET compared to that in EAT.","ja":"The efficacy of micafungin in patients undergoing high-risk treatment was not strongly impaired in DET compared to that in EAT."},"publication_date":"2020-09-03","publication_name":{"en":"International Journal of Infectious Diseases : IJID","ja":"International Journal of Infectious Diseases : IJID"},"volume":"Vol.100","starting_page":"292","ending_page":"297","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.ijid.2020.08.081"],"issn":["1878-3511"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:28, {"insert":{"user_id":"B000341201","type":"published_papers","id":"29515109"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115041","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32283857","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=365352","label":"url"}],"paper_title":{"en":"The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.","ja":"The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat."},"authors":{"en":[{"name":"Ashtar Mohannad"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tanimoto Kotaro"},{"name":"Shimizu Sou"},{"name":"Higa Yoshiki"},{"name":"Harada Takeshi"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Sumitani Ryohei"},{"name":"Miki Hirokazu"},{"name":"Udaka Kengo"},{"name":"Takahashi Mamiko"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"ASHTAR MOHANNAD"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Ariunzaya Bat-Erdene"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"谷本 幸多朗"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"原田 武志"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"住谷 龍平"},{"name":"三木 浩和"},{"name":"宇髙 憲吾"},{"name":"Takahashi Mamiko"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Receptor activator of NF-κB ligand (RANKL), a critical mediator of osteoclastogenesis, is upregulated in multiple myeloma (MM). The xanthine oxidase inhibitor febuxostat, clinically used for prevention of tumor lysis syndrome, has been demonstrated to effectively inhibit not only the generation of uric acid but also the formation of reactive oxygen species (ROS). ROS has been demonstrated to mediate RANKL-mediated osteoclastogenesis. In the present study, we therefore explored the role of cancer-treatment-induced ROS in RANKL-mediated osteoclastogenesis and the suppressive effects of febuxostat on ROS generation and osteoclastogenesis. RANKL dose-dependently induced ROS production in RAW264.7 preosteoclastic cells; however, febuxostat inhibited the RANKL-induced ROS production and osteoclast (OC) formation. Interestingly, doxorubicin (Dox) further enhanced RANKL-induced osteoclastogenesis through upregulation of ROS production, which was mostly abolished by addition of febuxostat. Febuxostat also inhibited osteoclastogenesis enhanced in cocultures of bone marrow cells with MM cells. Importantly, febuxostat rather suppressed MM cell viability and did not compromise Dox's anti-MM activity. In addition, febuxostat was able to alleviate pathological osteoclastic activity and bone loss in ovariectomized mice. Collectively, these results suggest that excessive ROS production by aberrant RANKL overexpression and/or anticancer treatment disadvantageously impacts bone, and that febuxostat can prevent the ROS-mediated osteoclastic bone damage.","ja":"Receptor activator of NF-κB ligand (RANKL), a critical mediator of osteoclastogenesis, is upregulated in multiple myeloma (MM). The xanthine oxidase inhibitor febuxostat, clinically used for prevention of tumor lysis syndrome, has been demonstrated to effectively inhibit not only the generation of uric acid but also the formation of reactive oxygen species (ROS). ROS has been demonstrated to mediate RANKL-mediated osteoclastogenesis. In the present study, we therefore explored the role of cancer-treatment-induced ROS in RANKL-mediated osteoclastogenesis and the suppressive effects of febuxostat on ROS generation and osteoclastogenesis. RANKL dose-dependently induced ROS production in RAW264.7 preosteoclastic cells; however, febuxostat inhibited the RANKL-induced ROS production and osteoclast (OC) formation. Interestingly, doxorubicin (Dox) further enhanced RANKL-induced osteoclastogenesis through upregulation of ROS production, which was mostly abolished by addition of febuxostat. Febuxostat also inhibited osteoclastogenesis enhanced in cocultures of bone marrow cells with MM cells. Importantly, febuxostat rather suppressed MM cell viability and did not compromise Dox's anti-MM activity. In addition, febuxostat was able to alleviate pathological osteoclastic activity and bone loss in ovariectomized mice. Collectively, these results suggest that excessive ROS production by aberrant RANKL overexpression and/or anticancer treatment disadvantageously impacts bone, and that febuxostat can prevent the ROS-mediated osteoclastic bone damage."},"publication_date":"2020-04-09","publication_name":{"en":"Cancers","ja":"Cancers"},"volume":"Vol.12","number":"No.4","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3390/cancers12040929"],"issn":["2072-6694"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:29, {"insert":{"user_id":"B000341201","type":"published_papers","id":"32804688"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=368355","label":"url"}],"paper_title":{"en":"Successful treatment of progressive multifocal leukoencephalopathy with mirtazapine and mefloquine in refractory myeloma","ja":"Successful treatment of progressive multifocal leukoencephalopathy with mirtazapine and mefloquine in refractory myeloma"},"authors":{"en":[{"name":"Udaka Kengo"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Miyamoto Ryosuke"},{"name":"Matsui Naoko"},{"name":"Kawata Shiyori"},{"name":"Hori Taiki"},{"name":"Murai Junpei"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Takahashi Mamiko"},{"name":"Harada Takeshi"},{"name":"Kagawa Kumiko"},{"name":"Izumi Yuishin"},{"name":"Abe Masahiro"},{"name":"Miki Hirokazu"}],"ja":[{"name":"宇髙 憲吾"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"宮本 亮介"},{"name":"松井 尚子"},{"name":"Kawata Shiyori"},{"name":"Hori Taiki"},{"name":"Murai Junpei"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"Takahashi Mamiko"},{"name":"原田 武志"},{"name":"賀川 久美子"},{"name":"和泉 唯信"},{"name":"安倍 正博"},{"name":"三木 浩和"}]},"publication_date":"2020","publication_name":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"volume":"Vol.10","number":"No.1","starting_page":"8","ending_page":"12","languages":["eng"],"referee":true,"identifiers":{"issn":["2187-3143"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:30, {"insert":{"user_id":"B000341201","type":"published_papers","id":"32804689"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115047","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/31861479","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85077198248&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364706","label":"url"}],"paper_title":{"en":"Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma","ja":"Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma"},"authors":{"en":[{"name":"Ozaki Shuji"},{"name":"Harada Takeshi"},{"name":"Yagi Hikaru"},{"name":"Sekimoto Etsuko"},{"name":"Shibata Hironobu"},{"name":"Shigekiyo Toshio"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"尾崎 修治"},{"name":"原田 武志"},{"name":"Yagi Hikaru"},{"name":"Sekimoto Etsuko"},{"name":"Shibata Hironobu"},{"name":"Shigekiyo Toshio"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"description":{"en":"We retrospectively analyzed multiple myeloma (MM) patients who underwent autologous stem cell transplantation (ASCT) without maintenance therapy to assess the impact of recovery of normal immunoglobulin (Ig) on clinical outcomes. The recovery of polyclonal Ig was defined as normalization of all values of serum IgG, IgA, and IgM 1 year after ASCT. Among 50 patients, 26 patients showed polyclonal Ig recovery; 14 patients were in ≥complete response (CR) and 12 remained in non-CR after ASCT. The patients with Ig recovery exhibited a significantly better progression-free survival (PFS, median, 46.8 vs 26.7 months, = 0.0071) and overall survival (OS, median, not reached vs 65.3 months, < 0.00001) compared with those without Ig recovery. The survival benefits of Ig recovery were similarly observed in ≥CR patients (median OS, not reached vs 80.5 months, = 0.061) and non-CR patients (median OS, not reached vs 53.2 months, = 0.00016). Multivariate analysis revealed that non-CR and not all Ig recovery were independent prognostic factors for PFS (HR, 4.284, 95%CI (1.868-9.826), = 0.00059; and HR, 2.804, 95%CI (1.334-5.896), = 0.0065, respectively) and also for OS (HR, 8.245, 95%CI (1.528-44.47), = 0.014; and HR, 36.55, 95%CI (3.942-338.8), = 0.0015, respectively). Therefore, in addition to the depth of response, the recovery of polyclonal Ig after ASCT is a useful indicator especially for long-term outcome and might be considered to prevent overtreatment with maintenance therapy in transplanted patients with MM.","ja":"We retrospectively analyzed multiple myeloma (MM) patients who underwent autologous stem cell transplantation (ASCT) without maintenance therapy to assess the impact of recovery of normal immunoglobulin (Ig) on clinical outcomes. The recovery of polyclonal Ig was defined as normalization of all values of serum IgG, IgA, and IgM 1 year after ASCT. Among 50 patients, 26 patients showed polyclonal Ig recovery; 14 patients were in ≥complete response (CR) and 12 remained in non-CR after ASCT. The patients with Ig recovery exhibited a significantly better progression-free survival (PFS, median, 46.8 vs 26.7 months, = 0.0071) and overall survival (OS, median, not reached vs 65.3 months, < 0.00001) compared with those without Ig recovery. The survival benefits of Ig recovery were similarly observed in ≥CR patients (median OS, not reached vs 80.5 months, = 0.061) and non-CR patients (median OS, not reached vs 53.2 months, = 0.00016). Multivariate analysis revealed that non-CR and not all Ig recovery were independent prognostic factors for PFS (HR, 4.284, 95%CI (1.868-9.826), = 0.00059; and HR, 2.804, 95%CI (1.334-5.896), = 0.0065, respectively) and also for OS (HR, 8.245, 95%CI (1.528-44.47), = 0.014; and HR, 36.55, 95%CI (3.942-338.8), = 0.0015, respectively). Therefore, in addition to the depth of response, the recovery of polyclonal Ig after ASCT is a useful indicator especially for long-term outcome and might be considered to prevent overtreatment with maintenance therapy in transplanted patients with MM."},"publication_date":"2019-12-18","publication_name":{"en":"Cancers","ja":"Cancers"},"volume":"Vol.12","number":"No.1","starting_page":"12","ending_page":"12","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3390/cancers12010012"],"issn":["2072-6694"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:31, {"insert":{"user_id":"B000341201","type":"published_papers","id":"24878643"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/31511938","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=361040","label":"url"}],"paper_title":{"en":"Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.","ja":"Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study."},"authors":{"en":[{"name":"Okada Naoto"},{"name":"Chuma Masayuki"},{"name":"Azuma Momoyo"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Hamano Hirofumi"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Abe Masahiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"中馬 真幸"},{"name":"東 桃代"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"Hamano Hirofumi"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"安倍 正博"},{"name":"石澤 啓介"}]},"description":{"en":"We retrospectively analysed 150 haematologic patients to whom VCM was administered between April 2010 and March 2018 at Tokushima University Hospital. VCM-induced AKI was defined according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. Multivariate logistic regression analyses were performed to identify risk factors for VCM-induced AKI.","ja":"The optimal initial VCM trough concentration was 10-15 mg/L in haematologic patients, considering safety and effectiveness. There were differences in the effect of VCM-induced AKI between nephrotoxic drugs."},"publication_date":"2019-09-11","publication_name":{"en":"European Journal of Clinical Pharmacology","ja":"European Journal of Clinical Pharmacology"},"volume":"Vol.75","number":"No.12","starting_page":"1695","ending_page":"1704","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00228-019-02756-4"],"issn":["1432-1041"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:32, {"insert":{"user_id":"B000341201","type":"published_papers","id":"32804690"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=367930","label":"url"}],"paper_title":{"en":"芽球様の形態を示した肝脾型T細胞リンパ腫の一症例","ja":"芽球様の形態を示した肝脾型T細胞リンパ腫の一症例"},"authors":{"en":[{"name":"井上 雄介"},{"name":"Ikegame Akishige"},{"name":"徳永 尚樹"},{"name":"井上 千尋"},{"name":"Nakao Takayuki"},{"name":"Nagai Kojiro"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"井上 雄介"},{"name":"池亀 彰茂"},{"name":"徳永 尚樹"},{"name":"井上 千尋"},{"name":"中尾 隆之"},{"name":"長井 幸二郎"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"安倍 正博"}]},"publication_date":"2019-07","publication_name":{"en":"日本検査血液学会雑誌","ja":"日本検査血液学会雑誌"},"volume":"Vol.20","number":"No.2","starting_page":"231","ending_page":"237","languages":["jpn"],"referee":true,"published_paper_type":"scientific_journal"},"priority":"input_data"} line:33, {"insert":{"user_id":"B000341201","type":"published_papers","id":"26416723"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113359","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30956773","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85062760316&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351838","label":"url"}],"paper_title":{"en":"PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ.","ja":"PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ."},"authors":{"en":[{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Ashtar Mohannad"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Udaka Kengo"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Abe Masahiro"}],"ja":[{"name":"Iwasa Masami"},{"name":"原田 武志"},{"name":"Oda Asuka"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Teramachi Jumpei"},{"name":"天眞 寛文"},{"name":"Ashtar Mohannad"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"宇髙 憲吾"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"Ozaki Shuji"},{"name":"Abe Masahiro"}]},"description":{"en":"gene silencing abolished the PD-L1 upregulation by panobinostat and IFN-γ in combination, indicating a critical role for STAT1. These results suggest that panobinostat enhances PD-L1 expression by facilitating the IFN-γ-STAT1 pathway in a ligand-dependent manner in MM cells with ambient IFN-γ. PD-L1 upregulation should be taken into account when combining immunotherapies with panobinostat.","ja":"gene silencing abolished the PD-L1 upregulation by panobinostat and IFN-γ in combination, indicating a critical role for STAT1. These results suggest that panobinostat enhances PD-L1 expression by facilitating the IFN-γ-STAT1 pathway in a ligand-dependent manner in MM cells with ambient IFN-γ. PD-L1 upregulation should be taken into account when combining immunotherapies with panobinostat."},"publication_date":"2019-03-08","publication_name":{"en":"Oncotarget","ja":"Oncotarget"},"volume":"Vol.10","number":"No.20","starting_page":"1903","ending_page":"1917","languages":["eng"],"referee":true,"identifiers":{"doi":["10.18632/oncotarget.26726"],"issn":["1949-2553"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:34, {"insert":{"user_id":"B000341201","type":"published_papers","id":"26416726"},"force":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/120006552370/","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112987","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050845763422780928/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=358522","label":"url"}],"paper_title":{"en":"De novo CD 20-negative diffuse large B-cell lymphoma developed with sustained fever and markedly high C-reactive protein level","ja":"不明熱と著明な高CRP血症で発症したde novo CD20陰性びまん性大細胞型B細胞リンパ腫の1例"},"authors":{"en":[{"name":"Miyakami Yuko"},{"name":"Nakamura Shingen"},{"name":"Oura Masahiro"},{"name":"Okamoto Yasunobu"},{"name":"高橋 真美子"},{"name":"Sogabe Kimiko"},{"name":"岩佐 昌美"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Uehara Hisanori"},{"name":"Abe Masahiro"}],"ja":[{"name":"宮上 侑子"},{"name":"中村 信元"},{"name":"大浦 雅博"},{"name":"岡本 惠暢"},{"name":"高橋 真美子"},{"name":"曽我部 公子"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"上原 久典"},{"name":"安倍 正博"}]},"description":{"en":"A 68-year-old woman presented with sustained fever for more than 1 month and admitted due to hematemesis and systemic edema. Computed tomography scan revealed swelling of the cervical, paraaortic lymph nodes. Blood test results showed severe anemia, elevation of white blood cell count, elevation of liver enzyme and coagulopathy with high C-reactive protein. Biopsy of the right cervical lymph node showed proliferation of abnormal lymphoid cells with necrosis and hemorrhage, which are positive for CD79α, CD30, MUM-1, and bcl-6 and negative for CD20, CD5, CD10, ALK, CD38, CD138, and EBER. Gene rearrangement of immunoglobulin heavy chain was detected in tumor cells. Bone marrow aspiration showed tumor involvement. The patient was diagnosed with de novo CD20-negative diffuse large B-cell lymphoma(DLBCL)stage IV B. Reduced CHOP therapy was performed under artificial respiration due to pulmonary edema and takotsubo cardiomyopathy. Although her general condition and high CRP levels temporarily improved, she died 47 days after admission due to rapid relapse. De novo CD20-negative DLBCL was rare and presented with high CRP levels and rapid progression, and was thought to be clinically different from the existing DLBCL. It is imperative to elucidate molecular pathophysiology and establish new treatment strategy for de novo CD20-negative DLBCL.","ja":"A 68-year-old woman presented with sustained fever for more than 1 month and admitted due to hematemesis and systemic edema. Computed tomography scan revealed swelling of the cervical, paraaortic lymph nodes. Blood test results showed severe anemia, elevation of white blood cell count, elevation of liver enzyme and coagulopathy with high C-reactive protein. Biopsy of the right cervical lymph node showed proliferation of abnormal lymphoid cells with necrosis and hemorrhage, which are positive for CD79α, CD30, MUM-1, and bcl-6 and negative for CD20, CD5, CD10, ALK, CD38, CD138, and EBER. Gene rearrangement of immunoglobulin heavy chain was detected in tumor cells. Bone marrow aspiration showed tumor involvement. The patient was diagnosed with de novo CD20-negative diffuse large B-cell lymphoma(DLBCL)stage IV B. Reduced CHOP therapy was performed under artificial respiration due to pulmonary edema and takotsubo cardiomyopathy. Although her general condition and high CRP levels temporarily improved, she died 47 days after admission due to rapid relapse. De novo CD20-negative DLBCL was rare and presented with high CRP levels and rapid progression, and was thought to be clinically different from the existing DLBCL. It is imperative to elucidate molecular pathophysiology and establish new treatment strategy for de novo CD20-negative DLBCL."},"publication_date":"2018-12-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.74","number":"No.5-6","starting_page":"193","ending_page":"200","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:35, {"insert":{"user_id":"B000341201","type":"published_papers","id":"26880634"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113393","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30474853","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85057280798&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=348588","label":"url"}],"paper_title":{"en":"Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA.","ja":"Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon-α and ATRA."},"authors":{"en":[{"name":"Bat-Erdene Ariunzaya"},{"name":"Nakamura Shingen"},{"name":"Oda Asuka"},{"name":"Iwasa Masami"},{"name":"Teramachi Jumpei"},{"name":"Ashtar Mohannad"},{"name":"Harada Takeshi"},{"name":"Miki Hirokazu"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Fujii Shiroh"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Udaka Kengo"},{"name":"Kagawa Kumiko"},{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Kurahashi Kiyoe"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"}],"ja":[{"name":"Bat-Erdene Ariunzaya"},{"name":"中村 信元"},{"name":"Oda Asuka"},{"name":"Iwasa Masami"},{"name":"寺町 順平"},{"name":"Ashtar Mohannad"},{"name":"原田 武志"},{"name":"三木 浩和"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"藤井 志朗"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"Udaka Kengo"},{"name":"賀川 久美子"},{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"倉橋 清衛"},{"name":"遠藤 逸朗"},{"name":"安倍 正博"}]},"publication_date":"2018-11-26","publication_name":{"en":"British Journal of Haematology","ja":"British Journal of Haematology"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/bjh.15673"],"issn":["1365-2141"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:36, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167263"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112935","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/27748523","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=321702","label":"url"}],"paper_title":{"en":"Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.","ja":"Pim-2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma."},"authors":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Amachi Ryota"},{"name":"Tenshin Hirofumi"},{"name":"Iwasa Masami"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"天知 良太"},{"name":"天眞 寛文"},{"name":"Iwasa Masami"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"publication_date":"2018-02-17","publication_name":{"en":"British Journal of Haematology","ja":"British Journal of Haematology"},"volume":"Vol.180","number":"No.4","starting_page":"581","ending_page":"585","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/bjh.14388"],"issn":["1365-2141"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:37, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167257"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113012","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29428565","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=345094","label":"url"}],"paper_title":{"en":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome.","ja":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome."},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Azuma Momoyo"},{"name":"Maruhashi Tomoko"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Uemura Munenori"},{"name":"Iwasa Masami"},{"name":"Fujii Shiro"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiraga Takashi"},{"name":"Kondo Noriyasu"},{"name":"Fujita Hiromi"},{"name":"Mahara Fumihiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"Azuma Momoyo"},{"name":"Maruhashi Tomoko"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Uemura Munenori"},{"name":"Iwasa Masami"},{"name":"Fujii Shiro"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiraga Takashi"},{"name":"Kondo Noriyasu"},{"name":"Fujita Hiromi"},{"name":"Mahara Fumihiko"},{"name":"Abe Masahiro"}]},"description":{"en":"Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). Clinical symptoms of SFTS often involve encephalopathy and other central neurological symptoms, particularly in seriously ill patients; however, pathogenesis of encephalopathy by SFTSV is largely unknown. Herein, we present case reports of three patients with SFTS, complicated by encephalopathy, admitted to Tokushima University hospital: one patient was a 63-year-old man, while the other two were 83- and 86-year-old women. All of them developed disturbance of consciousness around the 7th day post onset of fever. After methylprednisolone pulse therapy of 500 mg/day, all of them recovered without any neurological sequelae. SFTSV genome was not detected in the cerebrospinal fluid of 2 out of the 3 patients that were available for examination. In these patients, disturbance of consciousness seemed to be an indirect effect of the cytokine storm triggered by SFTSV infection. We propose that short-term glucocorticoid therapy might be beneficial in the treatment of encephalopathy during early phase of SFTSV infection.","ja":"Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by the SFTS virus (SFTSV). Clinical symptoms of SFTS often involve encephalopathy and other central neurological symptoms, particularly in seriously ill patients; however, pathogenesis of encephalopathy by SFTSV is largely unknown. Herein, we present case reports of three patients with SFTS, complicated by encephalopathy, admitted to Tokushima University hospital: one patient was a 63-year-old man, while the other two were 83- and 86-year-old women. All of them developed disturbance of consciousness around the 7th day post onset of fever. After methylprednisolone pulse therapy of 500 mg/day, all of them recovered without any neurological sequelae. SFTSV genome was not detected in the cerebrospinal fluid of 2 out of the 3 patients that were available for examination. In these patients, disturbance of consciousness seemed to be an indirect effect of the cytokine storm triggered by SFTSV infection. We propose that short-term glucocorticoid therapy might be beneficial in the treatment of encephalopathy during early phase of SFTSV infection."},"publication_date":"2018-02-07","publication_name":{"en":"Journal of Infection and Chemotherapy","ja":"Journal of Infection and Chemotherapy"},"volume":"Vol.24","number":"No.5","starting_page":"389","ending_page":"392","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jiac.2017.11.004"],"issn":["1437-7780"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:38, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167283"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112752","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29327347","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85040344893&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=341053","label":"url"}],"paper_title":{"en":"Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity.","ja":"Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity."},"authors":{"en":[{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Oda Asuka"},{"name":"Miki Hirokazu"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Maeda Yusaku"},{"name":"Oura Masahiro"},{"name":"Takahashi Mamiko"},{"name":"Iwasa Masami"},{"name":"Endo Itsuro"},{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Kurahashi Kiyoe"},{"name":"Harada Takeshi"},{"name":"Kagawa Kumiko"},{"name":"Nakao Michiyasu"},{"name":"Sano Shigeki"},{"name":"Abe Masahiro"}],"ja":[{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Oda Asuka"},{"name":"三木 浩和"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Maeda Yusaku"},{"name":"大浦 雅博"},{"name":"Takahashi Mamiko"},{"name":"Iwasa Masami"},{"name":"遠藤 逸朗"},{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"倉橋 清衛"},{"name":"原田 武志"},{"name":"賀川 久美子"},{"name":"中尾 允泰"},{"name":"佐野 茂樹"},{"name":"安倍 正博"}]},"description":{"en":"Proviral Integrations of Moloney virus 2 (PIM2) is overexpressed in multiple myeloma (MM) cells, and regarded as an important therapeutic target. Here, we aimed to validate the therapeutic efficacy of different types of PIM inhibitors against MM cells for their possible clinical application. Intriguingly, the thiazolidine-2,4-dione-family compounds SMI-16a and SMI-4a reduced PIM2 protein levels and impaired MM cell survival preferentially in acidic conditions, in contrast to other types of PIM inhibitors, including AZD1208, CX-6258 and PIM447. SMI-16a also suppressed the drug efflux function of breast cancer resistance protein, minimized the sizes of side populations and reduced in vitro colony-forming capacity and in vivo tumourigenic activity in MM cells, suggesting impairment of their clonogenic capacity. PIM2 is known to be subject to ubiquitination-independent proteasomal degradation. Consistent with this, the proteasome inhibitors bortezomib and carfilzomib increased PIM2 protein levels in MM cells without affecting its mRNA levels. However, SMI-16a mitigated the PIM2 protein increase and cooperatively enhanced anti-MM effects in combination with carfilzomib. Collectively, the thiazolidine-2,4-dione-family compounds SMI-16a and SMI-4a uniquely reduce PIM2 protein in MM cells, which may contribute to their profound efficacy in addition to their immediate kinase inhibition. Their combination with proteasome inhibitors is envisioned.","ja":"Proviral Integrations of Moloney virus 2 (PIM2) is overexpressed in multiple myeloma (MM) cells, and regarded as an important therapeutic target. Here, we aimed to validate the therapeutic efficacy of different types of PIM inhibitors against MM cells for their possible clinical application. Intriguingly, the thiazolidine-2,4-dione-family compounds SMI-16a and SMI-4a reduced PIM2 protein levels and impaired MM cell survival preferentially in acidic conditions, in contrast to other types of PIM inhibitors, including AZD1208, CX-6258 and PIM447. SMI-16a also suppressed the drug efflux function of breast cancer resistance protein, minimized the sizes of side populations and reduced in vitro colony-forming capacity and in vivo tumourigenic activity in MM cells, suggesting impairment of their clonogenic capacity. PIM2 is known to be subject to ubiquitination-independent proteasomal degradation. Consistent with this, the proteasome inhibitors bortezomib and carfilzomib increased PIM2 protein levels in MM cells without affecting its mRNA levels. However, SMI-16a mitigated the PIM2 protein increase and cooperatively enhanced anti-MM effects in combination with carfilzomib. Collectively, the thiazolidine-2,4-dione-family compounds SMI-16a and SMI-4a uniquely reduce PIM2 protein in MM cells, which may contribute to their profound efficacy in addition to their immediate kinase inhibition. Their combination with proteasome inhibitors is envisioned."},"publication_date":"2018-01","publication_name":{"en":"British Journal of Haematology","ja":"British Journal of Haematology"},"volume":"Vol.180","number":"No.2","starting_page":"246","ending_page":"258","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/bjh.15033"],"issn":["1365-2141"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:39, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167258"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113059","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29535808","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85041952629&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339730","label":"url"}],"paper_title":{"en":"Effective impairment of myeloma cells and their progenitors by hyperthermia.","ja":"Effective impairment of myeloma cells and their progenitors by hyperthermia."},"authors":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Maeda Yusaku"},{"name":"Oura Masahiro"},{"name":"Takahashi Mamiko"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Kenichi Aihara"},{"name":"Ikuo Mariko"},{"name":"Itou Kouji"},{"name":"Hayashi Koichiro"},{"name":"Nakamura Michihiro"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Maeda Yusaku"},{"name":"大浦 雅博"},{"name":"Takahashi Mamiko"},{"name":"Iwasa Masami"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"Kenichi Aihara"},{"name":"幾尾 真理子"},{"name":"伊藤 孝司"},{"name":"林 幸壱朗"},{"name":"中村 教泰"},{"name":"安倍 正博"}]},"description":{"en":"Multiple myeloma (MM) remains incurable, and MM-initiating cells or MM progenitors are considered to contribute to disease relapse through their drug-resistant nature. In order to improve the therapeutic efficacy for MM, we recently developed novel superparamagnetic nanoparticles which selectively accumulate in MM tumors and extirpate them by heat generated with magnetic resonance. We here aimed to clarify the therapeutic effects on MM cells and their progenitors by hyperthermia. Heat treatment at 43°C time-dependently induced MM cell death. The treatment upregulated endoplasmic reticulum (ER) stress mediators, ATF4 and CHOP, while reducing the protein levels of Pim-2, IRF4, c-Myc and Mcl-1. Combination with the proteasome inhibitor bortezomib further enhanced ER stress to potentiate MM cell death. The Pim inhibitor SMI-16a also enhanced the reduction of the Pim-2-driven survival factors, IRF4 and c-Myc, in combination with the heat treatment. The heat treatment almost completely eradicated \"side population\" fractions in RPMI8226 and KMS-11 cells and suppressed their clonogenic capacity as determined by colony formation and tumorigenic capacity in SCID mice. These results collectively demonstrated that hyperthermia is able to impair clonogenic drug-resistant fractions of MM cells and enhance their susceptibility to chemotherapeutic drugs.","ja":"Multiple myeloma (MM) remains incurable, and MM-initiating cells or MM progenitors are considered to contribute to disease relapse through their drug-resistant nature. In order to improve the therapeutic efficacy for MM, we recently developed novel superparamagnetic nanoparticles which selectively accumulate in MM tumors and extirpate them by heat generated with magnetic resonance. We here aimed to clarify the therapeutic effects on MM cells and their progenitors by hyperthermia. Heat treatment at 43°C time-dependently induced MM cell death. The treatment upregulated endoplasmic reticulum (ER) stress mediators, ATF4 and CHOP, while reducing the protein levels of Pim-2, IRF4, c-Myc and Mcl-1. Combination with the proteasome inhibitor bortezomib further enhanced ER stress to potentiate MM cell death. The Pim inhibitor SMI-16a also enhanced the reduction of the Pim-2-driven survival factors, IRF4 and c-Myc, in combination with the heat treatment. The heat treatment almost completely eradicated \"side population\" fractions in RPMI8226 and KMS-11 cells and suppressed their clonogenic capacity as determined by colony formation and tumorigenic capacity in SCID mice. These results collectively demonstrated that hyperthermia is able to impair clonogenic drug-resistant fractions of MM cells and enhance their susceptibility to chemotherapeutic drugs."},"publication_date":"2017-11-15","publication_name":{"en":"Oncotarget","ja":"Oncotarget"},"volume":"Vol.9","number":"No.12","starting_page":"10307","ending_page":"10316","languages":["eng"],"referee":true,"identifiers":{"doi":["10.18632/oncotarget.23121"],"issn":["1949-2553"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:40, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167259"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/111724","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29296860","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=336276","label":"url"}],"paper_title":{"en":"TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects.","ja":"TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects."},"authors":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Oda Asuka"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Watanabe Keiichiro"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Aihara Kenichi"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Oda Asuka"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Ariunzaya Bat-Erdene"},{"name":"渡邉 佳一郎"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"Aihara Kenichi"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) agonists induce tumor-specific apoptosis indicating that they may be an attractive therapeutic strategy against cancers, including multiple myeloma (MM). Osteoclastogenesis is highly induced in MM, which in turn enhances MM growth, thereby forming a vicious cycle between MM tumor expansion and bone destruction. However, the effects of TRAIL on MM-enhanced osteoclastogenesis remain largely unknown. Here, we show that TRAIL induced apoptosis in MM cells, but not in osteoclasts (OCs), and that it rather facilitated receptor activator of NF-B ligand-induced osteoclastogenesis along with upregulation of cellular FLICE inhibitory protein (c-FLIP). TRAIL did not induce death-inducing signaling complex formation in OCs, but formed secondary complex (complex II) with the phosphorylation of transforming growth factor -activated kinase-1 (TAK1), and thus activated NF-B signaling. c-FLIP knockdown abolished complex II formation, thus permitting TRAIL induction of OC cell death. The TAK1 inhibitor LLZ1640-2 abrogated the TRAIL-induced c-FLIP upregulation and NF-B activation, and triggered TRAIL-induced caspase-8 activation and cell death in OCs. Interestingly, the TRAIL-induced caspase-8 activation caused enzymatic degradation of the transcription factor Sp1 to noticeably reduce c-FLIP expression, which further sensitized OCs to TRAIL-induced apoptosis. Furthermore, the TAK1 inhibition induced antiosteoclastogenic activity by TRAIL even in cocultures with MM cells while potentiating TRAIL's anti-MM effects. These results demonstrated that osteoclastic lineage cells use TRAIL for their differentiation and activation through tilting caspase-8-dependent apoptosis toward NF-B activation, and that TAK1 inhibition subverts TRAIL-mediated NF-B activation to resume TRAIL-induced apoptosis in OCs while further enhancing MM cell death in combination with TRAIL.","ja":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) agonists induce tumor-specific apoptosis indicating that they may be an attractive therapeutic strategy against cancers, including multiple myeloma (MM). Osteoclastogenesis is highly induced in MM, which in turn enhances MM growth, thereby forming a vicious cycle between MM tumor expansion and bone destruction. However, the effects of TRAIL on MM-enhanced osteoclastogenesis remain largely unknown. Here, we show that TRAIL induced apoptosis in MM cells, but not in osteoclasts (OCs), and that it rather facilitated receptor activator of NF-B ligand-induced osteoclastogenesis along with upregulation of cellular FLICE inhibitory protein (c-FLIP). TRAIL did not induce death-inducing signaling complex formation in OCs, but formed secondary complex (complex II) with the phosphorylation of transforming growth factor -activated kinase-1 (TAK1), and thus activated NF-B signaling. c-FLIP knockdown abolished complex II formation, thus permitting TRAIL induction of OC cell death. The TAK1 inhibitor LLZ1640-2 abrogated the TRAIL-induced c-FLIP upregulation and NF-B activation, and triggered TRAIL-induced caspase-8 activation and cell death in OCs. Interestingly, the TRAIL-induced caspase-8 activation caused enzymatic degradation of the transcription factor Sp1 to noticeably reduce c-FLIP expression, which further sensitized OCs to TRAIL-induced apoptosis. Furthermore, the TAK1 inhibition induced antiosteoclastogenic activity by TRAIL even in cocultures with MM cells while potentiating TRAIL's anti-MM effects. These results demonstrated that osteoclastic lineage cells use TRAIL for their differentiation and activation through tilting caspase-8-dependent apoptosis toward NF-B activation, and that TAK1 inhibition subverts TRAIL-mediated NF-B activation to resume TRAIL-induced apoptosis in OCs while further enhancing MM cell death in combination with TRAIL."},"publication_date":"2017-10-26","publication_name":{"en":"Blood Advances","ja":"Blood Advances"},"volume":"Vol.1","number":"No.24","starting_page":"2124","ending_page":"2137","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1182/bloodadvances.2017008813"],"issn":["2473-9529"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:41, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167260"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/114702","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390292815268483584/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330796","label":"url"}],"paper_title":{"en":"Multiple myeloma with high adenosine deaminase expression","ja":"Multiple myeloma with high adenosine deaminase expression"},"authors":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"publication_date":"2017-08","publication_name":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"volume":"Vol.7","number":"No.1","starting_page":"1","ending_page":"5","languages":["eng"],"referee":true,"identifiers":{"issn":["2187-3143"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:42, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167261"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/109988","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/27738323","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326832","label":"url"}],"paper_title":{"en":"Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors.","ja":"Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors."},"authors":{"en":[{"name":"Bat-Erdene Ariunzaya"},{"name":"Miki Hirokazu"},{"name":"Oda Asuko"},{"name":"Nakamura Shingen"},{"name":"Teramachi Jumpei"},{"name":"Amachi Ryota"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Sogabe Kimiko"},{"name":"Kagawa Kumiko"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"},{"name":"Aihara Ken-ichi"},{"name":"Abe Masahiro"}],"ja":[{"name":"Bat-Erdene Ariunzaya"},{"name":"三木 浩和"},{"name":"Oda Asuko"},{"name":"中村 信元"},{"name":"寺町 順平"},{"name":"天知 良太"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"Iwasa Masami"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"Sogabe Kimiko"},{"name":"賀川 久美子"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"},{"name":"粟飯原 賢一"},{"name":"安倍 正博"}]},"description":{"en":"Panobinostat, a pan-deacetylase inhibitor, synergistically elicits cytotoxic activity against myeloma (MM) cells in combination with the proteasome inhibitor bortezomib. Because precise mechanisms for panobinostat's anti-MM action still remain elusive, we aimed to clarify the mechanisms of anti-MM effects of panobinostat and its synergism with proteasome inhibitors. Although the transcription factor Sp1 was overexpressed in MM cells, the Sp1 inhibitor terameprocol induced MM cell death in parallel with reduction of IRF4 and cMyc. Panobinostat induced activation of caspase-8, which was inversely correlated with reduction of Sp1 protein levels in MM cells. The panobinostat-mediated effects were further potentiated to effectively induce MM cell death in combination with bortezomib or carfilzomib even at suboptimal concentrations as a single agent. Addition of the caspase-8 inhibitor z-IETD-FMK abolished the Sp1 reduction not only by panobinostat alone but also by its combination with bortezomib, suggesting caspase-8-mediated Sp1 degradation. The synergistic Sp1 reduction markedly suppressed Sp1-driven prosurvival factors, IRF4 and cMyc. Besides, the combinatory treatment reduced HDAC1, another Sp1 target, in MM cells, which may potentiate HDAC inhibition. Collectively, caspase-8-mediated post-translational Sp1 degradation appears to be among major mechanisms for synergistic anti-MM effects of panobinostat and proteasome inhibitors in combination.","ja":"Panobinostat, a pan-deacetylase inhibitor, synergistically elicits cytotoxic activity against myeloma (MM) cells in combination with the proteasome inhibitor bortezomib. Because precise mechanisms for panobinostat's anti-MM action still remain elusive, we aimed to clarify the mechanisms of anti-MM effects of panobinostat and its synergism with proteasome inhibitors. Although the transcription factor Sp1 was overexpressed in MM cells, the Sp1 inhibitor terameprocol induced MM cell death in parallel with reduction of IRF4 and cMyc. Panobinostat induced activation of caspase-8, which was inversely correlated with reduction of Sp1 protein levels in MM cells. The panobinostat-mediated effects were further potentiated to effectively induce MM cell death in combination with bortezomib or carfilzomib even at suboptimal concentrations as a single agent. Addition of the caspase-8 inhibitor z-IETD-FMK abolished the Sp1 reduction not only by panobinostat alone but also by its combination with bortezomib, suggesting caspase-8-mediated Sp1 degradation. The synergistic Sp1 reduction markedly suppressed Sp1-driven prosurvival factors, IRF4 and cMyc. Besides, the combinatory treatment reduced HDAC1, another Sp1 target, in MM cells, which may potentiate HDAC inhibition. Collectively, caspase-8-mediated post-translational Sp1 degradation appears to be among major mechanisms for synergistic anti-MM effects of panobinostat and proteasome inhibitors in combination."},"publication_date":"2016-11-29","publication_name":{"en":"Oncotarget","ja":"Oncotarget"},"volume":"Vol.7","number":"No.48","starting_page":"79064","ending_page":"79075","languages":["eng"],"referee":true,"identifiers":{"doi":["10.18632/oncotarget.12594"],"issn":["1949-2553"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:43, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167262"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113048","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/27626482","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=323181","label":"url"}],"paper_title":{"en":"A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration.","ja":"A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration."},"authors":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Nakamura Shingen"},{"name":"Hanson Derek"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Iwasa Masami"},{"name":"Endo Itsuro"},{"name":"Kondo Takeshi"},{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Kurahashi Kiyoe"},{"name":"Kuroda Yoshiaki"},{"name":"Horikawa Hideaki"},{"name":"Tanaka Eiji"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"原田 武志"},{"name":"小田 明日香"},{"name":"中村 信元"},{"name":"Derek James Hanson"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"岩佐 昌美"},{"name":"遠藤 逸朗"},{"name":"近藤 剛史"},{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"倉橋 清衛"},{"name":"黒田 芳明"},{"name":"堀川 秀昌"},{"name":"田中 栄二"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"description":{"en":"Myeloma (MM) cells and osteoclasts are mutually interacted to enhance MM growth while creating acidic bone lesions. Here, we explored acid sensing of MM cells and its role in MM cell response to acidic conditions. Acidic conditions activated the PI3K-Akt signaling in MM cells while upregulating the pH sensor transient receptor potential cation channel subfamily V member 1 (TRPV1) in a manner inhibitable by PI3K inhibition. The acid-activated PI3K-Akt signaling facilitated the nuclear localization of the transcription factor Sp1 to trigger the expression of its target genes, including TRPV1 and HDAC1. Consistently, histone deacetylation was enhanced in MM cells in acidic conditions, while repressing a wide variety of genes, including DR4. Indeed, acidic conditions deacetylated histone H3K9 in a DR4 gene promoter and curtailed DR4 expression in MM cells. However, inhibition of HDAC as well as either Sp1 or PI3K was able to restore DR4 expression in MM cells suppressed in acidic conditions. These results collectively demonstrate that acid activates the TRPV1-PI3K-Akt-Sp1 signaling in MM cells while inducing HDAC-mediated gene repression, and suggest that a positive feedback loop between acid sensing and the PI3K-Akt signaling is formed in MM cells, leading to MM cell response to acidic bone lesions.","ja":"Myeloma (MM) cells and osteoclasts are mutually interacted to enhance MM growth while creating acidic bone lesions. Here, we explored acid sensing of MM cells and its role in MM cell response to acidic conditions. Acidic conditions activated the PI3K-Akt signaling in MM cells while upregulating the pH sensor transient receptor potential cation channel subfamily V member 1 (TRPV1) in a manner inhibitable by PI3K inhibition. The acid-activated PI3K-Akt signaling facilitated the nuclear localization of the transcription factor Sp1 to trigger the expression of its target genes, including TRPV1 and HDAC1. Consistently, histone deacetylation was enhanced in MM cells in acidic conditions, while repressing a wide variety of genes, including DR4. Indeed, acidic conditions deacetylated histone H3K9 in a DR4 gene promoter and curtailed DR4 expression in MM cells. However, inhibition of HDAC as well as either Sp1 or PI3K was able to restore DR4 expression in MM cells suppressed in acidic conditions. These results collectively demonstrate that acid activates the TRPV1-PI3K-Akt-Sp1 signaling in MM cells while inducing HDAC-mediated gene repression, and suggest that a positive feedback loop between acid sensing and the PI3K-Akt signaling is formed in MM cells, leading to MM cell response to acidic bone lesions."},"publication_date":"2016-10-25","publication_name":{"en":"Oncotarget","ja":"Oncotarget"},"volume":"Vol.7","number":"No.43","starting_page":"70447","ending_page":"70461","languages":["eng"],"referee":true,"identifiers":{"doi":["10.18632/oncotarget.11927"],"issn":["1949-2553"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:44, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167264"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/27698446","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326829","label":"url"}],"paper_title":{"en":"Expansion of Th1-like V9V2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid.","ja":"Expansion of Th1-like V9V2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid."},"authors":{"en":[{"name":"Harada Takeshi"},{"name":"Miki Hirokazu"},{"name":"Cui Q"},{"name":"Oda A"},{"name":"Amachi Ryota"},{"name":"Teramachi Jumpei"},{"name":"Bat-Erdene A"},{"name":"Sogabe K"},{"name":"Iwasa M"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Yoshida Sumiko"},{"name":"Endo I"},{"name":"Aihara Ken-ichi"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"三木 浩和"},{"name":"Cui Q"},{"name":"Oda A"},{"name":"天知 良太"},{"name":"寺町 順平"},{"name":"Bat-Erdene A"},{"name":"Sogabe K"},{"name":"Iwasa M"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"吉田 守美子"},{"name":"Endo I"},{"name":"粟飯原 賢一"},{"name":"尾崎 修治"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"publication_date":"2016-10-04","publication_name":{"en":"Leukemia","ja":"Leukemia"},"volume":"Vol.31","number":"No.1","starting_page":"258","ending_page":"262","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/leu.2016.273"],"issn":["1476-5551"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:45, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167266"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/109501","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26384349","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84946086135&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310845","label":"url"}],"paper_title":{"en":"Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation.","ja":"Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation."},"authors":{"en":[{"name":"Hanson Derek James"},{"name":"Nakamura Shingen"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tsuji Daisuke"},{"name":"Itoh Kohji"},{"name":"Harada Takeshi"},{"name":"Horikawa Kazuki"},{"name":"Teramachi Jumpei"},{"name":"Miki Hirokazu"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"Hanson Derek James"},{"name":"中村 信元"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"辻 大輔"},{"name":"Itoh Kohji"},{"name":"Harada Takeshi"},{"name":"堀川 一樹"},{"name":"寺町 順平"},{"name":"三木 浩和"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Cancer cells robustly expel lactate produced through enhanced glycolysis via monocarboxylate transporters (MCTs) and maintain alkaline intracellular pH. To develop a novel therapeutic strategy against multiple myeloma (MM), which still remains incurable, we explored the impact of perturbing a metabolism via inhibiting MCTs. All MM cells tested constitutively expressed MCT1 and MCT4, and most expressed MCT2. Lactate export was substantially suppressed to induce death along with lowering intracellular pH in MM cells by blockade of all three MCT molecules with -cyano-4-hydroxy cinnamate (CHC) or the MCT1 and MCT2 inhibitor AR-C155858 in combination with MCT4 knockdown, although only partially by knockdown of each MCT. CHC lowered intracellular pH and severely curtailed lactate secretion even when combined with metformin, which further lowered intracellular pH and enhanced cytotoxicity. Interestingly, an ambient acidic pH markedly enhanced CHC-mediated cytotoxicity, suggesting preferential targeting of MM cells in acidic MM bone lesions. Furthermore, treatment with CHC suppressed hexokinase II expression and ATP production to reduce side populations and colony formation. Finally, CHC caused downregulation of homing receptor CXCR4 and abrogated SDF-1-induced migration. Targeting tumor metabolism by MCT blockade therefore may become an effective therapeutic option for drug-resistant MM cells with elevated glycolysis.","ja":"Cancer cells robustly expel lactate produced through enhanced glycolysis via monocarboxylate transporters (MCTs) and maintain alkaline intracellular pH. To develop a novel therapeutic strategy against multiple myeloma (MM), which still remains incurable, we explored the impact of perturbing a metabolism via inhibiting MCTs. All MM cells tested constitutively expressed MCT1 and MCT4, and most expressed MCT2. Lactate export was substantially suppressed to induce death along with lowering intracellular pH in MM cells by blockade of all three MCT molecules with -cyano-4-hydroxy cinnamate (CHC) or the MCT1 and MCT2 inhibitor AR-C155858 in combination with MCT4 knockdown, although only partially by knockdown of each MCT. CHC lowered intracellular pH and severely curtailed lactate secretion even when combined with metformin, which further lowered intracellular pH and enhanced cytotoxicity. Interestingly, an ambient acidic pH markedly enhanced CHC-mediated cytotoxicity, suggesting preferential targeting of MM cells in acidic MM bone lesions. Furthermore, treatment with CHC suppressed hexokinase II expression and ATP production to reduce side populations and colony formation. Finally, CHC caused downregulation of homing receptor CXCR4 and abrogated SDF-1-induced migration. Targeting tumor metabolism by MCT blockade therefore may become an effective therapeutic option for drug-resistant MM cells with elevated glycolysis."},"publication_date":"2015-10-20","publication_name":{"en":"Oncotarget","ja":"Oncotarget"},"volume":"Vol.6","number":"No.32","starting_page":"33568","ending_page":"33586","languages":["eng"],"referee":true,"identifiers":{"doi":["10.18632/oncotarget.5598"],"issn":["1949-2553"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:46, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167256"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=318276","label":"url"}],"paper_title":{"en":"Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions","ja":"Susceptibility to bendamustine considerably varies among myeloma cells, but is enhanced in acidic conditions"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Oda Asuka"},{"name":"Amachi Ryota"},{"name":"Teramachi Jumpei"},{"name":"Sogabe Kimiko"},{"name":"Fujino Hikaru"},{"name":"Maruhashi Tomoko"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"Oda Asuka"},{"name":"Amachi Ryota"},{"name":"寺町 順平"},{"name":"曽我部 公子"},{"name":"Fujino Hikaru"},{"name":"Maruhashi Tomoko"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"publication_date":"2015-10","publication_name":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"volume":"Vol.6","number":"No.1","starting_page":"7","ending_page":"11","languages":["eng"],"referee":true,"identifiers":{"issn":["2187-3143"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:47, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167267"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/114924","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26115406","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84938631804&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303534","label":"url"}],"paper_title":{"en":"Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma","ja":"Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma"},"authors":{"en":[{"name":"Watanabe T"},{"name":"Mitsuhashi M"},{"name":"Sagawa M"},{"name":"Ri M"},{"name":"Suzuki K"},{"name":"Abe Masahiro"},{"name":"Ohmachi K"},{"name":"Nakagawa Y"},{"name":"Nakamura Shingen"},{"name":"Iida S"},{"name":"Kizaki M"}],"ja":[{"name":"Watanabe T"},{"name":"Mitsuhashi M"},{"name":"Sagawa M"},{"name":"Ri M"},{"name":"Suzuki K"},{"name":"安倍 正博"},{"name":"Ohmachi K"},{"name":"Nakagawa Y"},{"name":"中村 信元"},{"name":"Iida S"},{"name":"Kizaki M"}]},"description":{"en":"To identify predictive biomarkers for clinical responses to bortezomib treatment, 0.06 mL of each whole blood without any cell separation procedures was stimulated ex vivo using five agents, and eight mRNAs were quantified. In six centers, heparinized peripheral blood was prospectively obtained from 80 previously treated or untreated, symptomatic multiple myeloma (MM) patients with measurable levels of M-proteins. The blood sample was procured prior to treatment as well as 2-3 days and 1-3 weeks after the first dose of bortezomib, which was intravenously administered biweekly or weekly, during the first cycle. Six stimulant-mRNA combinations; that is, lipopolysaccharide (LPS)-granulocyte-macrophage colony-stimulating factor (GM-CSF), LPS-CXCL chemokine 10 (CXCL10), LPS-CCL chemokine 4 (CCL4), phytohemagglutinin-CCL4, zymosan A (ZA)-GMCSF and ZA-CCL4 showed significantly higher induction in the complete and very good partial response group than in the stable and progressive disease group, as determined by both parametric (t-test) and non-parametric (unpaired Mann-Whitney test) tests. Moreover, LPS-induced CXCL10 mRNA expression was significantly suppressed 2-3 days after the first dose of bortezomib in all patients, as determined by both parametric (t-test) and non-parametric (paired Wilcoxon test) tests, whereas the complete and very good partial response group showed sustained suppression 1-3 weeks after the first dose. Thus, pretreatment LPS-CXCL10 mRNA and/or the six combinations may serve as potential biomarkers for the response to bortezomib treatment in MM patients.","ja":"To identify predictive biomarkers for clinical responses to bortezomib treatment, 0.06 mL of each whole blood without any cell separation procedures was stimulated ex vivo using five agents, and eight mRNAs were quantified. In six centers, heparinized peripheral blood was prospectively obtained from 80 previously treated or untreated, symptomatic multiple myeloma (MM) patients with measurable levels of M-proteins. The blood sample was procured prior to treatment as well as 2-3 days and 1-3 weeks after the first dose of bortezomib, which was intravenously administered biweekly or weekly, during the first cycle. Six stimulant-mRNA combinations; that is, lipopolysaccharide (LPS)-granulocyte-macrophage colony-stimulating factor (GM-CSF), LPS-CXCL chemokine 10 (CXCL10), LPS-CCL chemokine 4 (CCL4), phytohemagglutinin-CCL4, zymosan A (ZA)-GMCSF and ZA-CCL4 showed significantly higher induction in the complete and very good partial response group than in the stable and progressive disease group, as determined by both parametric (t-test) and non-parametric (unpaired Mann-Whitney test) tests. Moreover, LPS-induced CXCL10 mRNA expression was significantly suppressed 2-3 days after the first dose of bortezomib in all patients, as determined by both parametric (t-test) and non-parametric (paired Wilcoxon test) tests, whereas the complete and very good partial response group showed sustained suppression 1-3 weeks after the first dose. Thus, pretreatment LPS-CXCL10 mRNA and/or the six combinations may serve as potential biomarkers for the response to bortezomib treatment in MM patients."},"publication_date":"2015-06-26","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.10","number":"No.6","starting_page":"e0128662","ending_page":"e0128662","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0128662"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:48, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167268"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2017035595","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390292815284471040/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303535","label":"url"}],"paper_title":{"en":"Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death","ja":"Induction of endoplasmic reticulum stress by bortezomib sensitizes myeloma cells to DR5-mediated cell death"},"authors":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Oda A"},{"name":"Amachi R"},{"name":"Watanabe Keiichiro"},{"name":"Hanson D"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Yagi H"},{"name":"Sogabe K"},{"name":"Takahashi M"},{"name":"Maruhashi T"},{"name":"Udaka K"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakano A"},{"name":"Kagawa Kumiko"},{"name":"Ri M"},{"name":"Iida S"},{"name":"Ozaki Shuji"},{"name":"Matsumoto T"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"Oda A"},{"name":"Amachi R"},{"name":"渡邉 佳一郎"},{"name":"Hanson D"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Yagi H"},{"name":"Sogabe K"},{"name":"Takahashi M"},{"name":"Maruhashi T"},{"name":"Udaka K"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"Nakano A"},{"name":"賀川 久美子"},{"name":"Ri M"},{"name":"Iida S"},{"name":"尾崎 修治"},{"name":"Matsumoto T"},{"name":"安倍 正博"}]},"description":{"en":"

TNF-related apoptosis-including ligand/Apo2 (TRAIL)-mediated immunotherapy is an attractive anti-tumor modality with high tumor specificity. In order to improve its therapeutic efficacy, we further need to implement a novel maneuver for sensitization of malignant cells to TRAIL. Bortezomib (BTZ), a novel anti-myeloma (MM) agent, potently induces endoplasmic reticulum (ER) stress to cause apoptosis. Here, we explored the roles of BTZ in the cytotoxicity of anti-TRAIL receptor agonistic antibodies against MM cells with special reference to ER stress. BTZ enhanced the expression of death receptor 5 (DR5) but not DR4 in MM cells at surface protein as well as mRNA levels. However, the DR5 expression was not affected by BTZ without ER stress induction in MM cells with a point mutation in a BTZ-binding proteasome β5 subunit. Tunicamycin, an ER stress inducer, was able to enhance the DR5 expression even in the BTZ-resistant MM cells, suggesting the role of ER stress in up-regulation of DR5 expression. Interestingly, BTZ facilitated extrinsic caspase-mediated apoptosis by anti-DR5 agonistic antibody in MM cells along with reducing c-FLICE-like interleukin protein, a caspase 8 inhibitor. These results suggest that BTZ enhances DR5 expression and its downstream apoptotic signaling through ER stress to sensitize MM cells to TRAIL-mediated immunotherapy.

","ja":"

TNF-related apoptosis-including ligand/Apo2 (TRAIL)-mediated immunotherapy is an attractive anti-tumor modality with high tumor specificity. In order to improve its therapeutic efficacy, we further need to implement a novel maneuver for sensitization of malignant cells to TRAIL. Bortezomib (BTZ), a novel anti-myeloma (MM) agent, potently induces endoplasmic reticulum (ER) stress to cause apoptosis. Here, we explored the roles of BTZ in the cytotoxicity of anti-TRAIL receptor agonistic antibodies against MM cells with special reference to ER stress. BTZ enhanced the expression of death receptor 5 (DR5) but not DR4 in MM cells at surface protein as well as mRNA levels. However, the DR5 expression was not affected by BTZ without ER stress induction in MM cells with a point mutation in a BTZ-binding proteasome β5 subunit. Tunicamycin, an ER stress inducer, was able to enhance the DR5 expression even in the BTZ-resistant MM cells, suggesting the role of ER stress in up-regulation of DR5 expression. Interestingly, BTZ facilitated extrinsic caspase-mediated apoptosis by anti-DR5 agonistic antibody in MM cells along with reducing c-FLICE-like interleukin protein, a caspase 8 inhibitor. These results suggest that BTZ enhances DR5 expression and its downstream apoptotic signaling through ER stress to sensitize MM cells to TRAIL-mediated immunotherapy.

"},"publication_date":"2015-01","publication_name":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"volume":"Vol.5","number":"No.1","starting_page":"1","ending_page":"7","languages":["eng"],"referee":true,"identifiers":{"doi":["10.57352/ijm.5.1_1"],"issn":["2187-3143"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:49, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167269"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/109757","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/109757","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050001337464993408/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303542","label":"url"}],"paper_title":{"en":"Successful treatment of refractory severe aplastic anemia with bone marrow transplantation from a genetically identical twin","ja":"同系骨髄移植が著効した最重症再生不良性貧血の1例"},"authors":{"en":[{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"八木 ひかる"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"宇髙 憲吾"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"八木 ひかる"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"宇髙 憲吾"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"description":{"en":"Aplastic anemia is a bone marrow failure caused by severely curtailed hematopoietic stem cells (HSCs) and dysregulation of ambient immune cells. Immumo-suppressive conditioning followed by allogeneic HSC transplantation is currently a mainstay in treatment for patients at a younger age or those refractory to conventional immunosuppressive remedies. Syngeneic HSC transplantation appears to be promising, but has been very rarely performed ; therefore, its impact on a long-term outcome as well as the best preparative measures for HSC engraftment and immune amelioration are still largely unknown. Here, we reported a successful and beneficial syngeneic HSC transplantation for a refractory case with very severe aplastic anemia. A 30-year-old female presented high fever after tooth extraction, and was diagnosed with very severe aplastic anemia. Cyclosporine and anti-thymocyte globulin were initiated, but showed no hematological effects. After obtaining an informed consent, she underwent bone marrow transplantation from a genetically identical twin following an non-myeloablative conditioning regimen consisted of cyclophosphamide (750mg/m2, 4 days), fludarabine phosphate (25mg/m2, 4 days). Cyclosporine was given for acute GvHD prophylaxis. Her neutrophils recovered over 500/μl on 12 days after the transplantation, and her blood counts have been maintained in a normal range over 7 years thereafter. Although a fate of HSCs from a genetically identical twin and an immune response of ambient cells in the bone marrow in recipients remains largely unknown, from the present case and previously reported cases, we dare to recommend immunoablative conditioning and acute GvHD prophylaxis in syngeneic HSC transplantation for a refractory case with aplastic anemia for better engraftment and sustained onward recovery of hematopoiesis.","ja":"Aplastic anemia is a bone marrow failure caused by severely curtailed hematopoietic stem cells (HSCs) and dysregulation of ambient immune cells. Immumo-suppressive conditioning followed by allogeneic HSC transplantation is currently a mainstay in treatment for patients at a younger age or those refractory to conventional immunosuppressive remedies. Syngeneic HSC transplantation appears to be promising, but has been very rarely performed ; therefore, its impact on a long-term outcome as well as the best preparative measures for HSC engraftment and immune amelioration are still largely unknown. Here, we reported a successful and beneficial syngeneic HSC transplantation for a refractory case with very severe aplastic anemia. A 30-year-old female presented high fever after tooth extraction, and was diagnosed with very severe aplastic anemia. Cyclosporine and anti-thymocyte globulin were initiated, but showed no hematological effects. After obtaining an informed consent, she underwent bone marrow transplantation from a genetically identical twin following an non-myeloablative conditioning regimen consisted of cyclophosphamide (750mg/m2, 4 days), fludarabine phosphate (25mg/m2, 4 days). Cyclosporine was given for acute GvHD prophylaxis. Her neutrophils recovered over 500/μl on 12 days after the transplantation, and her blood counts have been maintained in a normal range over 7 years thereafter. Although a fate of HSCs from a genetically identical twin and an immune response of ambient cells in the bone marrow in recipients remains largely unknown, from the present case and previously reported cases, we dare to recommend immunoablative conditioning and acute GvHD prophylaxis in syngeneic HSC transplantation for a refractory case with aplastic anemia for better engraftment and sustained onward recovery of hematopoiesis."},"publication_date":"2014-06","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.70","number":"No.3,4","starting_page":"77","ending_page":"80","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:50, {"insert":{"user_id":"B000341201","type":"published_papers","id":"25911417"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24787487","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=283755","label":"url"}],"paper_title":{"en":"Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.","ja":"Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma."},"authors":{"en":[{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Oda A"},{"name":"Amachi Ryota"},{"name":"Harada T"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Watanabe Keiichiro"},{"name":"Endo Itsuro"},{"name":"Kuroda Y"},{"name":"Yoneda T"},{"name":"Tsuji Daisuke"},{"name":"Nakao Michiyasu"},{"name":"Tanaka Eiji"},{"name":"Hamada Kenichi"},{"name":"Sano Shigeki"},{"name":"Itou Kouji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"Oda A"},{"name":"天知 良太"},{"name":"Harada T"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"渡邉 佳一郎"},{"name":"遠藤 逸朗"},{"name":"Kuroda Y"},{"name":"Yoneda T"},{"name":"辻 大輔"},{"name":"中尾 允泰"},{"name":"田中 栄二"},{"name":"浜田 賢一"},{"name":"佐野 茂樹"},{"name":"伊藤 孝司"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Pim-2 kinase is overexpressed in multiple myeloma (MM) cells to enhance their growth and survival, and regarded as a novel therapeutic target in MM. However, the impact of Pim-2 inhibition on bone disease in MM remains unknown. We demonstrated here that Pim-2 expression was also upregulated in bone marrow stromal cells and MC3T3-E1 preosteoblastic cells in the presence of cytokines known as the inhibitors of osteoblastogenesis in MM, including interleukin-3 (IL-3), IL-7, tumor necrosis factor-, transforming growth factor- (TGF-) and activin A, as well as MM cell conditioned media. The enforced expression of Pim-2 abrogated in vitro osteoblastogenesis by BMP-2, which suggested Pim-2 as a negative regulator for osteoblastogenesis. Treatment with Pim-2 short-interference RNA as well as the Pim inhibitor SMI-16a successfully restored osteoblastogenesis suppressed by all the above inhibitory factors and MM cells. The SMI-16a treatment potentiated BMP-2-mediated anabolic signaling while suppressing TGF- signaling. Furthermore, treatment with the newly synthesized thiazolidine-2,4-dione congener, 12a-OH, as well as its prototypic SMI-16a effectively prevented bone destruction while suppressing MM tumor growth in MM animal models. Thus, Pim-2 may have a pivotal role in tumor progression and bone loss in MM, and Pim-2 inhibition may become an important therapeutic strategy to target the MM cell-bone marrow interaction.Leukemia advance online publication, 30 May 2014; doi:10.1038/leu.2014.147.","ja":"Pim-2 kinase is overexpressed in multiple myeloma (MM) cells to enhance their growth and survival, and regarded as a novel therapeutic target in MM. However, the impact of Pim-2 inhibition on bone disease in MM remains unknown. We demonstrated here that Pim-2 expression was also upregulated in bone marrow stromal cells and MC3T3-E1 preosteoblastic cells in the presence of cytokines known as the inhibitors of osteoblastogenesis in MM, including interleukin-3 (IL-3), IL-7, tumor necrosis factor-, transforming growth factor- (TGF-) and activin A, as well as MM cell conditioned media. The enforced expression of Pim-2 abrogated in vitro osteoblastogenesis by BMP-2, which suggested Pim-2 as a negative regulator for osteoblastogenesis. Treatment with Pim-2 short-interference RNA as well as the Pim inhibitor SMI-16a successfully restored osteoblastogenesis suppressed by all the above inhibitory factors and MM cells. The SMI-16a treatment potentiated BMP-2-mediated anabolic signaling while suppressing TGF- signaling. Furthermore, treatment with the newly synthesized thiazolidine-2,4-dione congener, 12a-OH, as well as its prototypic SMI-16a effectively prevented bone destruction while suppressing MM tumor growth in MM animal models. Thus, Pim-2 may have a pivotal role in tumor progression and bone loss in MM, and Pim-2 inhibition may become an important therapeutic strategy to target the MM cell-bone marrow interaction.Leukemia advance online publication, 30 May 2014; doi:10.1038/leu.2014.147."},"publication_date":"2014-05-02","publication_name":{"en":"Leukemia","ja":"Leukemia"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/leu.2014.147"],"issn":["1476-5551"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:51, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167271"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/106068","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24386306","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84891280322&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=349631","label":"url"}],"paper_title":{"en":"Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors","ja":"Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors"},"authors":{"en":[{"name":"Harada Takeshi"},{"name":"Ozaki Shuji"},{"name":"Oda Asuka"},{"name":"Tsuji Daisuke"},{"name":"Ikegame Akishige"},{"name":"Iwasa Masami"},{"name":"Udaka Kengo"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Kuroda Yoshiaki"},{"name":"Kawai Shigeto"},{"name":"Itou Kouji"},{"name":"Yamada-Okabe Hisafumi"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"尾崎 修治"},{"name":"小田 明日香"},{"name":"辻 大輔"},{"name":"池亀 彰茂"},{"name":"岩佐 昌美"},{"name":"宇髙 憲吾"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"黒田 芳明"},{"name":"川合 重人"},{"name":"伊藤 孝司"},{"name":"岡部 尚文"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"The immunomodulatory drug lenalidomide (Len) has drawn attention to potentiate antibody-dependent cellular cytotoxicity (ADCC)-mediated immunotherapies. We developed the defucosylated version (YB-AHM) of humanized monoclonal antibody against HM1.24 (CD317) overexpressed in multiple myeloma (MM) cells. In this study, we evaluated ADCC by YB-AHM and Len in combination against MM cells and their progenitors. YB-AHM was able to selectively kill via ADCC MM cells in bone marrow samples from patients with MM with low effector/target ratios, which was further enhanced by treatment with Len. Interestingly, Len also up-regulated HM1.24 expression on MM cells in an effector-dependent manner. HM1.24 was found to be highly expressed in a drug-resistant clonogenic \"side population\" in MM cells; and this combinatory treatment successfully reduced SP fractions in RPMI 8226 and KMS-11 cells in the presence of effector cells, and suppressed a clonogenic potential of MM cells in colony-forming assays. Collectively, the present study suggests that YB-AHM and Len in combination may become an effective therapeutic strategy in MM, warranting further study to target drug-resistant MM clonogenic cells.","ja":"The immunomodulatory drug lenalidomide (Len) has drawn attention to potentiate antibody-dependent cellular cytotoxicity (ADCC)-mediated immunotherapies. We developed the defucosylated version (YB-AHM) of humanized monoclonal antibody against HM1.24 (CD317) overexpressed in multiple myeloma (MM) cells. In this study, we evaluated ADCC by YB-AHM and Len in combination against MM cells and their progenitors. YB-AHM was able to selectively kill via ADCC MM cells in bone marrow samples from patients with MM with low effector/target ratios, which was further enhanced by treatment with Len. Interestingly, Len also up-regulated HM1.24 expression on MM cells in an effector-dependent manner. HM1.24 was found to be highly expressed in a drug-resistant clonogenic \"side population\" in MM cells; and this combinatory treatment successfully reduced SP fractions in RPMI 8226 and KMS-11 cells in the presence of effector cells, and suppressed a clonogenic potential of MM cells in colony-forming assays. Collectively, the present study suggests that YB-AHM and Len in combination may become an effective therapeutic strategy in MM, warranting further study to target drug-resistant MM clonogenic cells."},"publication_date":"2013-12-26","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.8","number":"No.12","starting_page":"e83905","ending_page":"e83905","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0083905"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:52, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167272"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/105938","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23708974","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84880304849&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=284313","label":"url"}],"paper_title":{"en":"Activating transcription factor 4, an ER stress mediator, is required for, but exce ssive ER stress suppresses osteoblastogenesis by bortezomib.","ja":"Activating transcription factor 4, an ER stress mediator, is required for, but exce ssive ER stress suppresses osteoblastogenesis by bortezomib."},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kido Shinsuke"},{"name":"Nakano Ayako"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Amou Hiroe"},{"name":"Watanabe Keiichiro"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"Kido Shinsuke"},{"name":"Nakano Ayako"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"Amou Hiroe"},{"name":"渡邉 佳一郎"},{"name":"Harada Takeshi"},{"name":"藤井 志朗"},{"name":"Takeuchi Kyoko"},{"name":"賀川 久美子"},{"name":"Ozaki Shuji"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Endoplasmic reticulum (ER) stress is induced in matrix-producing osteoblasts and plays an essential role in osteoblastogenesis. Although the bone anabolic activity of proteasome inhibitors has been demonstrated, the roles of ER stress induced by proteasome inhibition in osteoblastogenesis remain largely unknown. Here we show that bortezomib translationally increases protein levels of activating transcription factor 4 (ATF4), a downstream mediator of ER stress, in bone marrow stromal cells and MC3T3-E1 preosteoblastic cells. The suppression of ATF4 expression by siRNA abrogated osteocalcin expression and mineralized nodule formation by MC3T3-E1 cells induced by bortezomib, indicating a critical role for ATF4 in bortezomib-mediated osteoblastogenesis. However, bortezomib at 20 nM or higher abolished the mineralized nodule formation along with reductions in the expression of osteoblastogenesis mediators β-catenin and Osterix. Furthermore, at 50 nM, bortezomib induced the expression of C/EBP homologous protein (CHOP), suggesting activation of the ATF4-CHOP pro-apoptotic pathway. These results suggest that a low dose of bortezomib induces osteogenic activity, but that, in contrast, excessive ER stress caused by bortezomib at higher doses hampers osteoblastogenesis. Therefore, dosing schedules for proteasome inhibitors warrant further study to maximize anabolic actions without compromising anti-MM activity in patients with multiple myeloma (MM).","ja":"Endoplasmic reticulum (ER) stress is induced in matrix-producing osteoblasts and plays an essential role in osteoblastogenesis. Although the bone anabolic activity of proteasome inhibitors has been demonstrated, the roles of ER stress induced by proteasome inhibition in osteoblastogenesis remain largely unknown. Here we show that bortezomib translationally increases protein levels of activating transcription factor 4 (ATF4), a downstream mediator of ER stress, in bone marrow stromal cells and MC3T3-E1 preosteoblastic cells. The suppression of ATF4 expression by siRNA abrogated osteocalcin expression and mineralized nodule formation by MC3T3-E1 cells induced by bortezomib, indicating a critical role for ATF4 in bortezomib-mediated osteoblastogenesis. However, bortezomib at 20 nM or higher abolished the mineralized nodule formation along with reductions in the expression of osteoblastogenesis mediators β-catenin and Osterix. Furthermore, at 50 nM, bortezomib induced the expression of C/EBP homologous protein (CHOP), suggesting activation of the ATF4-CHOP pro-apoptotic pathway. These results suggest that a low dose of bortezomib induces osteogenic activity, but that, in contrast, excessive ER stress caused by bortezomib at higher doses hampers osteoblastogenesis. Therefore, dosing schedules for proteasome inhibitors warrant further study to maximize anabolic actions without compromising anti-MM activity in patients with multiple myeloma (MM)."},"publication_date":"2013-05-25","publication_name":{"en":"International Journal of Hematology","ja":"International Journal of Hematology"},"volume":"Vol.98","number":"No.1","starting_page":"66","ending_page":"73","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s12185-013-1367-z"],"issn":["1865-3774"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:53, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167273"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40019180117/","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/97858","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050001337463886208/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253199","label":"url"}],"paper_title":{"en":"皮膚ランダム生検が診断に有用であった血管内リンパ腫の一例","ja":"皮膚ランダム生検が診断に有用であった血管内リンパ腫の一例"},"authors":{"en":[{"name":"Fujioka Keisuke"},{"name":"Saijo Atsuro"},{"name":"Toyoda Yuko"},{"name":"Kakiuchi Souji"},{"name":"Hanibuchi Masaki"},{"name":"Azuma Masahiko"},{"name":"Takeuchi Kyoko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Utaka Kengo"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Mizutani Tomoya"},{"name":"Nishioka Yasuhiko"}],"ja":[{"name":"藤岡 啓介"},{"name":"西條 敦郎"},{"name":"豊田 優子"},{"name":"柿内 聡司"},{"name":"埴淵 昌毅"},{"name":"吾妻 雅彦"},{"name":"竹内 恭子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"宇高 憲吾"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"水谷 友哉"},{"name":"西岡 安彦"}]},"description":{"en":"A62‐year‐old woman was referred to our hospital for further examination of fever of unknownorigin, splenomegaly and pancytopenia. On admission, she had persistent fever and psychologicalsymptoms. Blood examination showed pancytopenia and elevated level of LDH, soluble IL‐2receptorand ferritin. Computed tomography showed multiple low density areas in the spleen, but no systemiclymphadenopathy. In magnetic resonance imaging of the pons, a low and high intensity area onT1‐and T2‐weighted image, respectively, was detected. Taken together these findings, she wassuspected to have hepatosplentic T-cell lymphoma or intravascular large B-cell lymphoma. To makea definite diagnosis, random skin biopsy was performed. Immunohistochemical stainings revealedthe massive infiltration of CD20‐and CD79α‐positive large lymphoid cells inside the vessels, whichyielded the diagnosis of intravascular large B-cell lymphoma.","ja":"A62‐year‐old woman was referred to our hospital for further examination of fever of unknownorigin, splenomegaly and pancytopenia. On admission, she had persistent fever and psychologicalsymptoms. Blood examination showed pancytopenia and elevated level of LDH, soluble IL‐2receptorand ferritin. Computed tomography showed multiple low density areas in the spleen, but no systemiclymphadenopathy. In magnetic resonance imaging of the pons, a low and high intensity area onT1‐and T2‐weighted image, respectively, was detected. Taken together these findings, she wassuspected to have hepatosplentic T-cell lymphoma or intravascular large B-cell lymphoma. To makea definite diagnosis, random skin biopsy was performed. Immunohistochemical stainings revealedthe massive infiltration of CD20‐and CD79α‐positive large lymphoid cells inside the vessels, whichyielded the diagnosis of intravascular large B-cell lymphoma."},"publication_date":"2011-12-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.67","number":"No.5,6","starting_page":"257","ending_page":"262","languages":["jpn"],"referee":true,"invited":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:54, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167274"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21902681","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248823","label":"url"}],"paper_title":{"en":"KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.","ja":"KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts."},"authors":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Ozaki Shuji"},{"name":"Oda A"},{"name":"Amou H"},{"name":"Ikegame Akishige"},{"name":"Watanabe Keiichiro"},{"name":"Hiasa Masahiro"},{"name":"Cui Q"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakano A"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Yata Ken-ichiro"},{"name":"Sakai A"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"尾崎 修治"},{"name":"Oda A"},{"name":"Amou H"},{"name":"池亀 彰茂"},{"name":"渡邉 佳一郎"},{"name":"日浅 雅博"},{"name":"Cui Q"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"Nakano A"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"矢田 健一郎"},{"name":"Sakai A"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"description":{"en":"The spicamycin analogue KRN5500 alters glycoprotein processing and induces damage in the endoplasmic reticulum (ER)-Golgi apparatus in cancer cells. In the present study, we explored the cytotoxic effects of KRN5500 on multiple myeloma (MM) cells and the bone marrow microenvironment with special reference to ER stress. Cell proliferation assay showed that KRN5500 induced G1 arrest and apoptosis in MM cells in a time- and dose-dependent manner. KRN5500 enhanced ER stress independently of caspase activation in MM cells. This cell death was observed even in the presence of bone marrow stroma cells or osteoclasts. Notably, KRN5500 induced cell death also in osteoclasts. In vivo effects of KRN5500 were evaluated using two xenograft models established in severe combined immunodeficient (SCID) mice by either subcutaneous injection of RPMI 8226 cells or intra-bone injection of INA-6 cells to subcutaneously implanted rabbit bones (SCID-rab model). KRN5500 significantly inhibited tumour growth in both animal models, and decreased the number of osteoclasts, which resulted in prevention of bone destruction in the SCID-rab model. These results suggest that KRN5500 exerts anti-MM effects through impairing both MM cells and osteoclasts. Therefore, this unique mechanism of KRN5500 might be a useful therapeutic option in patients with MM.","ja":"The spicamycin analogue KRN5500 alters glycoprotein processing and induces damage in the endoplasmic reticulum (ER)-Golgi apparatus in cancer cells. In the present study, we explored the cytotoxic effects of KRN5500 on multiple myeloma (MM) cells and the bone marrow microenvironment with special reference to ER stress. Cell proliferation assay showed that KRN5500 induced G1 arrest and apoptosis in MM cells in a time- and dose-dependent manner. KRN5500 enhanced ER stress independently of caspase activation in MM cells. This cell death was observed even in the presence of bone marrow stroma cells or osteoclasts. Notably, KRN5500 induced cell death also in osteoclasts. In vivo effects of KRN5500 were evaluated using two xenograft models established in severe combined immunodeficient (SCID) mice by either subcutaneous injection of RPMI 8226 cells or intra-bone injection of INA-6 cells to subcutaneously implanted rabbit bones (SCID-rab model). KRN5500 significantly inhibited tumour growth in both animal models, and decreased the number of osteoclasts, which resulted in prevention of bone destruction in the SCID-rab model. These results suggest that KRN5500 exerts anti-MM effects through impairing both MM cells and osteoclasts. Therefore, this unique mechanism of KRN5500 might be a useful therapeutic option in patients with MM."},"publication_date":"2011-11","publication_name":{"en":"British Journal of Haematology","ja":"British Journal of Haematology"},"volume":"Vol.155","number":"No.3","starting_page":"328","ending_page":"339","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/j.1365-2141.2011.08844.x"],"issn":["1365-2141"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:55, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167275"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21698356","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231221","label":"url"}],"paper_title":{"en":"Targeting myeloma-osteoclast interaction with V9V2 T cells.","ja":"Targeting myeloma-osteoclast interaction with V9V2 T cells."},"authors":{"en":[{"name":"Cui Qu"},{"name":"Shibata Hironobu"},{"name":"Oda Asuka"},{"name":"Amou Hiroe"},{"name":"Nakano Ayako"},{"name":"Yata Kenichiro"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"Cui Qu"},{"name":"Shibata Hironobu"},{"name":"Oda Asuka"},{"name":"Amou Hiroe"},{"name":"Nakano Ayako"},{"name":"Yata Kenichiro"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"Miki Hirokazu"},{"name":"Harada Takeshi"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"description":{"en":"Multiple myeloma (MM) cells stimulate osteoclastogenesis, and osteoclasts (OCs) in turn enhance MM growth and drug resistance, resulting in a vicious cycle. V9V2 T cells exert potent anti-tumor effects, making T cell-based immunotherapies using these cells attractive candidates for currently incurable malignancies, such as MM. However, the impact of such treatments on the MM-OC interaction is largely unknown. We demonstrate here that V9V2 T cells expanded by zoledronic acid and IL-2 exerted potent cytotoxic effects on both MM cells and OCs, even in coculture settings, but showed no such effect on bone marrow stromal cells. V9V2 T cells marginally affected colony formation from normal hematopoietic progenitors, and furthermore migrated toward osteopontin and MIP-1, factors produced by the MM-OC interaction. These results suggest that V9V2 T cells expanded by zoledronic acid and IL-2 are able to migrate to MM bone lesions and preferentially target OCs as well as MM cells, thereby inhibiting both tumor expansion and bone destruction.","ja":"Multiple myeloma (MM) cells stimulate osteoclastogenesis, and osteoclasts (OCs) in turn enhance MM growth and drug resistance, resulting in a vicious cycle. V9V2 T cells exert potent anti-tumor effects, making T cell-based immunotherapies using these cells attractive candidates for currently incurable malignancies, such as MM. However, the impact of such treatments on the MM-OC interaction is largely unknown. We demonstrate here that V9V2 T cells expanded by zoledronic acid and IL-2 exerted potent cytotoxic effects on both MM cells and OCs, even in coculture settings, but showed no such effect on bone marrow stromal cells. V9V2 T cells marginally affected colony formation from normal hematopoietic progenitors, and furthermore migrated toward osteopontin and MIP-1, factors produced by the MM-OC interaction. These results suggest that V9V2 T cells expanded by zoledronic acid and IL-2 are able to migrate to MM bone lesions and preferentially target OCs as well as MM cells, thereby inhibiting both tumor expansion and bone destruction."},"publication_date":"2011-06-23","publication_name":{"en":"International Journal of Hematology","ja":"International Journal of Hematology"},"volume":"Vol.94","number":"No.1","starting_page":"63","ending_page":"70","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s12185-011-0885-9"],"issn":["1865-3774"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:56, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167276"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/130004501433/","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20805677","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001205037088512/","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-78349258607&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303541","label":"url"}],"paper_title":{"en":"Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy","ja":"ボルテゾミブ療法後に播種性接合菌症を合併した多発性骨髄腫"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"YATA Kenichiro"},{"name":"JINNO Tadashi"},{"name":"HARADA Takeshi"},{"name":"FUJII Shiro"},{"name":"MIKI Hirokazu"},{"name":"NAKANO Ayako"},{"name":"KAGAWA Kumiko"},{"name":"TAKEUCHI Kyoko"},{"name":"OZAKI Shuji"},{"name":"Abe Masahiro"},{"name":"MATSUMOTO Toshio"}],"ja":[{"name":"中村 信元"},{"name":"矢田 健一郎"},{"name":"神野 雅"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"description":{"en":"A 67-year-old man was diagnosed with multiple myeloma IgA-lambda type, Durie-Salmon classification stage IIIA in October 2001. He received five courses of induction chemotherapy consisting of vincristine, doxorubicin and dexamethasone and then underwent high dose chemotherapy followed by autologous stem cell transplantation in March 2003. He achieved partial response, but then relapsed after treatment with thalidomide and was admitted to our hospital in June 2007. The patient was complicated by tumor lysis syndrome (TLS) after receiving bortezomib therapy twice. Computed tomography after bortezomib therapy showed the rapid appearance of tumors in the right upper lobe of the lung, tail of the pancreas and the spleen. Though he was treated with antifungal agents, micafungin and voriconazole, he died eighty-five days after admission. Autopsy specimen showed fungal clumps and hemorrhagic infarction in the lung and spleen, and vegetation at the mitral valve was the same fungus as found in the lung. We diagnosed disseminated zygomycosis based on the pathological fungal morphology. This case suggested that metabolic acidosis was caused by TLS, while poorly controlled diabetes, secondary hemochromatosis due to transfusion, and breakthrough zygomycosis during antifungal therapy were thought to be factors contributing to the development of zygomycosis.","ja":"67歳男性,背部痛を契機に2001年10月に多発性骨髄腫IgA-λ stage IIIAと診断された.VAD療法5コース後の2003年3月に自家末梢血幹細胞移植併用大量化学療法を行うも再発した.以後,サリドマイド療法などを行うも再燃し,2007年6月入院した.入院後のボルテゾミブ(Bor)療法で,2度の腫瘍崩壊症候群をきたした.その後のCTで右肺上葉,膵尾部,脾臓の腫瘤が急速に出現し,ミカファンギンやボリコナゾールを投与するも,入院85日後に死亡した.剖検で,肺,脾臓に多発性の真菌塊と出血性梗塞が認められ,僧帽弁には真菌塊の疣贅を認め,組織学的に播種性接合菌症と診断した.Bor療法後の腫瘍崩壊によるアシドーシスや,コントロール不良の糖尿病,輸血による鉄過剰,抗真菌薬投与中のブレークスルー感染症などが発症の誘因と考えられた."},"publication_date":"2010-08","publication_name":{"en":"The Japanese Journal of Clinical Hematology","ja":"臨床血液"},"volume":"Vol.51","number":"No.8","starting_page":"690","ending_page":"695","languages":["jpn"],"referee":true,"identifiers":{"doi":["10.11406/rinketsu.51.690"],"issn":["0485-1439"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:57, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167277"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19098416","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=250561","label":"url"}],"paper_title":{"en":"[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy].","ja":"[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]."},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Kimura Shigeaki"},{"name":"Kashima Masahiro"},{"name":"Shichijo Kana"},{"name":"Yoshida Sumiko"},{"name":"Harada Eiji"},{"name":"Matsushita Takaya"},{"name":"Tamaki Yasutami"},{"name":"Horiuchi Noriaki"},{"name":"Takeichi Toshiaki"},{"name":"Fujimoto Hiroshi"},{"name":"Masuda Kazuhiko"},{"name":"Iwasaka Naohito"},{"name":"Shinomiya Sadao"}],"ja":[{"name":"中村 信元"},{"name":"Kimura Shigeaki"},{"name":"Kashima Masahiro"},{"name":"Shichijo Kana"},{"name":"吉田 守美子"},{"name":"Harada Eiji"},{"name":"松下 隆哉"},{"name":"Tamaki Yasutami"},{"name":"Horiuchi Noriaki"},{"name":"Takeichi Toshiaki"},{"name":"Fujimoto Hiroshi"},{"name":"Masuda Kazuhiko"},{"name":"Iwasaka Naohito"},{"name":"Shinomiya Sadao"}]},"description":{"en":"Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course. Most cases are young and early stage, and the surgical strategy is available. But appropriate chemotherapy for inoperable cases with peritoneal dissemination is not established. A 77-year-old woman with a past history of appendectomy was admitted to our hospital complaining of abdominal fullness. Abdominal computed tomography showed massive ascites and slight contrast enhancement of appendix. A tumor was found by colonoscopic examination at the orifice of vermiform and was diagnosed pathologically as goblet cell carcinoid of the appendix. Laparoscopy showed multiple peritoneal dissemination. We performed intraperitoneal paclitaxel(PTX)administration at 70 mg/m(2) week without any resection of the tumor. Ascites were reduced immediately, but drug-induced interstitial pneumonia occurred due to PTX. After steroid therapy, we switched to systemic S-1 therapy. For about one year, her tumor was controlled but became worse thirteen months after diagnosis and died. It is thought that intraabdominal paclitaxel administration and systemic S-1 therapy can be one of appropriate forms of chemotherapy for inoperable peritoneal carcinomatosis from goblet cell carcinoid of appendix.","ja":"Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course. Most cases are young and early stage, and the surgical strategy is available. But appropriate chemotherapy for inoperable cases with peritoneal dissemination is not established. A 77-year-old woman with a past history of appendectomy was admitted to our hospital complaining of abdominal fullness. Abdominal computed tomography showed massive ascites and slight contrast enhancement of appendix. A tumor was found by colonoscopic examination at the orifice of vermiform and was diagnosed pathologically as goblet cell carcinoid of the appendix. Laparoscopy showed multiple peritoneal dissemination. We performed intraperitoneal paclitaxel(PTX)administration at 70 mg/m(2) week without any resection of the tumor. Ascites were reduced immediately, but drug-induced interstitial pneumonia occurred due to PTX. After steroid therapy, we switched to systemic S-1 therapy. For about one year, her tumor was controlled but became worse thirteen months after diagnosis and died. It is thought that intraabdominal paclitaxel administration and systemic S-1 therapy can be one of appropriate forms of chemotherapy for inoperable peritoneal carcinomatosis from goblet cell carcinoid of appendix."},"publication_date":"2008-12","publication_name":{"en":"Japanese Journal of Cancer and Chemotherapy","ja":"癌と化学療法"},"volume":"Vol.35","number":"No.13","starting_page":"2425","ending_page":"2428","languages":["jpn"],"referee":true,"identifiers":{"issn":["0385-0684"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:58, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167278"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18633226","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-48249146275&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=250562","label":"url"}],"paper_title":{"en":"[A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy].","ja":"[A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy]."},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Horiuchi Noriaki"},{"name":"Katsura Daisuke"},{"name":"Shichijo Kana"},{"name":"Yoshida Sumiko"},{"name":"Harada Eiji"},{"name":"Matsushita Takaya"},{"name":"Matsuzaki Yasuyuki"},{"name":"Tamaki Yasutami"},{"name":"Kimura Shigeaki"},{"name":"Takeichi Toshiaki"},{"name":"Fujimoto Hiroshi"},{"name":"Masuda Kazuhiko"},{"name":"Iwasaka Naohito"},{"name":"Shinomiya Sadao"}],"ja":[{"name":"中村 信元"},{"name":"Horiuchi Noriaki"},{"name":"Katsura Daisuke"},{"name":"Shichijo Kana"},{"name":"吉田 守美子"},{"name":"Harada Eiji"},{"name":"松下 隆哉"},{"name":"Matsuzaki Yasuyuki"},{"name":"Tamaki Yasutami"},{"name":"Kimura Shigeaki"},{"name":"Takeichi Toshiaki"},{"name":"Fujimoto Hiroshi"},{"name":"Masuda Kazuhiko"},{"name":"Iwasaka Naohito"},{"name":"Shinomiya Sadao"}]},"description":{"en":"We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.","ja":"We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease."},"publication_date":"2008-06","publication_name":{"en":"Japanese Journal of Cancer and Chemotherapy","ja":"癌と化学療法"},"volume":"Vol.35","number":"No.6","starting_page":"965","ending_page":"968","languages":["jpn"],"referee":true,"identifiers":{"issn":["0385-0684"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:59, {"insert":{"user_id":"B000341201","type":"published_papers","id":"15167279"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269878","label":"url"}],"paper_title":{"en":"Part7. 2. 新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に). がん骨転移治療 ビスフォスフォネート治療によるBone Management","ja":"Part7. 2. 新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に). がん骨転移治療 ビスフォスフォネート治療によるBone Management"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"publication_date":"2012","publication_name":{"en":"先端医学者 高橋俊二 編集","ja":"先端医学者 高橋俊二 編集"},"starting_page":"206","ending_page":"214","languages":["jpn"],"published_paper_type":"research_institution"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/published_papers.jsonl, 2LoJ844B7kacV6CWoi8l) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/misc.jsonl) ==== line:1, {"insert":{"user_id":"B000341201","type":"misc","id":"43514557"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402668","label":"url"}],"paper_title":{"en":"【最新の骨粗鬆症学(第2版)-骨粗鬆症学の最新知見-】続発性骨粗鬆症の診断と治療 抗悪性腫瘍薬に伴う骨粗鬆症(解説)","ja":"【最新の骨粗鬆症学(第2版)-骨粗鬆症学の最新知見-】続発性骨粗鬆症の診断と治療 抗悪性腫瘍薬に伴う骨粗鬆症(解説)"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"publication_date":"2023","publication_name":{"en":"日本臨床(0047-1852)81巻増刊1 最新の骨粗鬆症学 Page580-584(2023.01)","ja":"日本臨床(0047-1852)81巻増刊1 最新の骨粗鬆症学 Page580-584(2023.01)"},"languages":["jpn"],"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000341201","type":"misc","id":"41593237"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2023027045","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390293412208923264/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394190","label":"url"}],"paper_title":{"en":"【骨髄腫と類縁疾患-全身をみわたす診断・治療】Overview 多発性骨髄腫の発症・進展機序","ja":"【骨髄腫と類縁疾患-全身をみわたす診断・治療】Overview 多発性骨髄腫の発症・進展機序"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"description":{"en":"<文献概要>▼多発性骨髄腫(MM)はゲノム不安定性や遺伝子プロモーターのメチル化などのepigeneticな制御の異常に加え多段階の分子遺伝学的異常により,意義不明の単クローン性ガンマグロブリン血症(MGUS)を経て発症・進展する.▼MMの発症原因は不明であるが,疫学調査により性差,地域差,人種差,遺伝学的要因,被曝歴,年齢との関連が示唆されている.▼全ゲノム解析やマウスモデル,腸内細菌叢の解析などからMMのさまざまな発症機序が推測されている.","ja":"<文献概要>▼多発性骨髄腫(MM)はゲノム不安定性や遺伝子プロモーターのメチル化などのepigeneticな制御の異常に加え多段階の分子遺伝学的異常により,意義不明の単クローン性ガンマグロブリン血症(MGUS)を経て発症・進展する.▼MMの発症原因は不明であるが,疫学調査により性差,地域差,人種差,遺伝学的要因,被曝歴,年齢との関連が示唆されている.▼全ゲノム解析やマウスモデル,腸内細菌叢の解析などからMMのさまざまな発症機序が推測されている."},"publication_date":"2022-10-01","publication_name":{"en":"Internal Medicine","ja":"臨床雑誌 内科"},"volume":"Vol.130","number":"No.4","starting_page":"691","ending_page":"694","languages":["jpn"],"identifiers":{"doi":["10.15106/j_naika130_691"],"issn":["0022-1961"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000341201","type":"misc","id":"41593236"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/WB16080025","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394191","label":"url"}],"paper_title":{"en":"【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】各種病態にみられる腎障害 造血器疾患 多発性骨髄腫","ja":"【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】各種病態にみられる腎障害 造血器疾患 多発性骨髄腫"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"publication_date":"2022-10","publication_name":{"en":"Nihon Rinsho. Japanese Journal of Clinical Medicine","ja":"日本臨牀"},"starting_page":"124","ending_page":"130","languages":["jpn"],"identifiers":{"issn":["0047-1852"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000341201","type":"misc","id":"33352909"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021054713","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379414","label":"url"}],"paper_title":{"en":"【骨粗鬆症 最新の知見に基づいた治療薬の考え方・使い方】薬剤性骨粗鬆症に対するマネジメントの勘所 がん治療に伴う骨粗鬆症","ja":"【骨粗鬆症 最新の知見に基づいた治療薬の考え方・使い方】薬剤性骨粗鬆症に対するマネジメントの勘所 がん治療に伴う骨粗鬆症"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"description":{"en":"◎がん治療およびがん治療の支持療法に使用する多くの薬剤が直接または間接的に骨吸収を亢進し骨喪失を来す.◎特に内分泌療法や造血幹細胞移植などのがん治療では急速に骨喪失がもたらされる.◎がん治療に伴う骨粗鬆症はQOLの低下や予後の悪化を来す.◎がんの治療と並行しがん治療に伴う骨粗鬆症に対する適切なスクリーニングと予防および治療を行う.(著者抄録)","ja":"◎がん治療およびがん治療の支持療法に使用する多くの薬剤が直接または間接的に骨吸収を亢進し骨喪失を来す.◎特に内分泌療法や造血幹細胞移植などのがん治療では急速に骨喪失がもたらされる.◎がん治療に伴う骨粗鬆症はQOLの低下や予後の悪化を来す.◎がんの治療と並行しがん治療に伴う骨粗鬆症に対する適切なスクリーニングと予防および治療を行う.(著者抄録)"},"publication_date":"2020-10","publication_name":{"en":"The Journal of Practical Pharmacy","ja":"薬局"},"volume":"Vol.71","number":"No.11","starting_page":"3313","ending_page":"3321","languages":["jpn"],"identifiers":{"issn":["0044-0035"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000341201","type":"misc","id":"11921831"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300208","label":"url"}],"paper_title":{"en":"骨髄腫骨病変の治療","ja":"骨髄腫骨病変の治療"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"publication_date":"2014-10","publication_name":{"en":"Hematology","ja":"血液内科"},"volume":"Vol.69","number":"No.4","starting_page":"525","ending_page":"533","languages":["jpn"],"identifiers":{"issn":["2185-582X"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000341201","type":"misc","id":"32804635"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2013213783","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=368373","label":"url"}],"paper_title":{"en":"【続発性骨粗鬆症-診断と対策-】移植医療と骨粗鬆症","ja":"【続発性骨粗鬆症-診断と対策-】移植医療と骨粗鬆症"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"description":{"en":"移植医療によって臓器不全の予後は飛躍的に向上しつつあるが,その一方で移植後の合併症の予防,対策の重要性が増している.骨粗鬆症とそれによる骨折は,移植医療における頻度の高い合併症であるが,その実態の解析は十分ではない.移植前の患者個々の背景因子や原疾患の病態,治療に伴う骨障害に加え,移植医療に伴うカルシニューリン阻害薬,ステロイドなどの免疫抑制薬の長期投与など,種々の要因が影響し,移植後骨粗鬆症が発症する.ビスフォスフォネートやビタミンDなどを早期から投与することにより,骨折を防ぎ移植後のQoLを維持することが重要である.(著者抄録)","ja":"移植医療によって臓器不全の予後は飛躍的に向上しつつあるが,その一方で移植後の合併症の予防,対策の重要性が増している.骨粗鬆症とそれによる骨折は,移植医療における頻度の高い合併症であるが,その実態の解析は十分ではない.移植前の患者個々の背景因子や原疾患の病態,治療に伴う骨障害に加え,移植医療に伴うカルシニューリン阻害薬,ステロイドなどの免疫抑制薬の長期投与など,種々の要因が影響し,移植後骨粗鬆症が発症する.ビスフォスフォネートやビタミンDなどを早期から投与することにより,骨折を防ぎ移植後のQoLを維持することが重要である.(著者抄録)"},"publication_date":"2013-05","publication_name":{"en":"THE BONE","ja":"THE BONE"},"volume":"Vol.27","number":"No.2","starting_page":"187","ending_page":"192","identifiers":{"issn":["0914-7047"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000341201","type":"misc","id":"32804636"},"force":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/40018931859/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001288080663552/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252734","label":"url"}],"paper_title":{"en":"骨病変/局所病変の管理 (特集 多発性骨髄腫診療の新時代を迎えて--診断と治療に吹き込む「新しい風」) -- (多発性骨髄腫の合併症の管理)","ja":"骨病変/局所病変の管理 (特集 多発性骨髄腫診療の新時代を迎えて--診断と治療に吹き込む「新しい風」) -- (多発性骨髄腫の合併症の管理)"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"description":{"en":"骨髄腫骨病変は,患者のQOLを大幅に低下させるだけでなく,放置すれば高カルシウム血症や脊髄圧迫などをきたし予後を悪化させる.・全身の骨単純X線写真(skeletal survey)で骨病変を評価する.MRIやPET/CTは病変の検出感度が高いため,これらを組み入れた評価が有用である.・骨病変の治療は,抗腫瘍療法が基本であるが,補助療法としてビスホスホネートの点滴投与を反復する.顎骨壊死や腎障害に対する予防策を行う.また,局所の疼痛に対し放射線照射や椎体形成術などが有用である.・高カルシウム血症は,進行例に出現する緊急性を要する病態である.初期には特徴的な症状がなく消化器症状や脱水症状からはじまり,腎不全や意識障害をきたす.(著者抄録)","ja":"骨髄腫骨病変は,患者のQOLを大幅に低下させるだけでなく,放置すれば高カルシウム血症や脊髄圧迫などをきたし予後を悪化させる.・全身の骨単純X線写真(skeletal survey)で骨病変を評価する.MRIやPET/CTは病変の検出感度が高いため,これらを組み入れた評価が有用である.・骨病変の治療は,抗腫瘍療法が基本であるが,補助療法としてビスホスホネートの点滴投与を反復する.顎骨壊死や腎障害に対する予防策を行う.また,局所の疼痛に対し放射線照射や椎体形成術などが有用である.・高カルシウム血症は,進行例に出現する緊急性を要する病態である.初期には特徴的な症状がなく消化器症状や脱水症状からはじまり,腎不全や意識障害をきたす.(著者抄録)"},"publication_date":"2011-08","publication_name":{"en":"内科","ja":"内科"},"volume":"Vol.108","number":"No.2","starting_page":"274","ending_page":"281","languages":["jpn"],"identifiers":{"issn":["0022-1961"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"B000341201","type":"misc","id":"11921861"},"force":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/40021456242/","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112059","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050001338847982080/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=345095","label":"url"}],"paper_title":{"en":"Development of adult T-cell leukemia/lymphoma during immunosuppressive Therapy for human T-cell leukemia virus type 1 associated arthropathy","ja":"リウマチ様関節炎に対する免疫抑制療法中に発症した成人T細胞性白血病/リンパ腫の1例"},"authors":{"en":[{"name":"山口 純代"},{"name":"Nakamura Shingen"},{"name":"住田 智志"},{"name":"前田 悠作"},{"name":"Oura Masahiro"},{"name":"高橋 真美子"},{"name":"岩佐 昌美"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Kishi Jun"},{"name":"Abe Masahiro"}],"ja":[{"name":"山口 純代"},{"name":"中村 信元"},{"name":"住田 智志"},{"name":"前田 悠作"},{"name":"大浦 雅博"},{"name":"高橋 真美子"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"岸 潤"},{"name":"安倍 正博"}]},"description":{"en":"A 64-year-old woman presented with lower leg edema, fever, and bilateral joint pain, involving the wrists, fingers, and knees, in April 201X. Serological test results were negative for rheumatoid factor, antinuclear antibody, and anti-cyclic citrullinated peptide antibody. A diagnosis of remitting seronegative symmetrical synovitis with pitting edema syndrome, a type of seronegative rheumatoid arthritis, was made and prednisolone was administered. The joint pain was refractory to prednisolone therapy. In February, 201X+2, the patient presented with right cervical lymphadenopathy. The CT scan revealed swelling of the cervical, axillary, and inguinal lymph nodes bilaterally and rapidly enlarged. In April, 18F-fluorodeoxyglucose PET/CT scan showed an abnormal collection in the enlarged lymph nodes. The patient subsequently developed hoarseness with dyspnea and attended our department. Blood test results showed high levels of lactate dehydrogenase (547U/L) and soluble interleukin‐2 receptor (34200 IU/L) and were positive for anti-human T-cell leukemia virus type1 (HTLV‐1) antibody. Biopsy of the right cervical lymph node showed proliferation of abnormal lymphoid cells positive for CD3, CD4, and CD25 and negative for CD7. Monoclonal integration of HTLV‐1 proviral DNA was detected in the lymph node. A diagnosis of adult T-cell leukemia/lymphoma (ATLL), lymphoma type was made. The pain involving multiple joints was attributed to HTLV‐1associated arthropathy. Immunosuppressive therapy for HTLV‐1 carrier status may have played a role in the development of ATLL.","ja":"A 64-year-old woman presented with lower leg edema, fever, and bilateral joint pain, involving the wrists, fingers, and knees, in April 201X. Serological test results were negative for rheumatoid factor, antinuclear antibody, and anti-cyclic citrullinated peptide antibody. A diagnosis of remitting seronegative symmetrical synovitis with pitting edema syndrome, a type of seronegative rheumatoid arthritis, was made and prednisolone was administered. The joint pain was refractory to prednisolone therapy. In February, 201X+2, the patient presented with right cervical lymphadenopathy. The CT scan revealed swelling of the cervical, axillary, and inguinal lymph nodes bilaterally and rapidly enlarged. In April, 18F-fluorodeoxyglucose PET/CT scan showed an abnormal collection in the enlarged lymph nodes. The patient subsequently developed hoarseness with dyspnea and attended our department. Blood test results showed high levels of lactate dehydrogenase (547U/L) and soluble interleukin‐2 receptor (34200 IU/L) and were positive for anti-human T-cell leukemia virus type1 (HTLV‐1) antibody. Biopsy of the right cervical lymph node showed proliferation of abnormal lymphoid cells positive for CD3, CD4, and CD25 and negative for CD7. Monoclonal integration of HTLV‐1 proviral DNA was detected in the lymph node. A diagnosis of adult T-cell leukemia/lymphoma (ATLL), lymphoma type was made. The pain involving multiple joints was attributed to HTLV‐1associated arthropathy. Immunosuppressive therapy for HTLV‐1 carrier status may have played a role in the development of ATLL."},"publication_date":"2017-12-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.73","number":"No.5,6","starting_page":"301","ending_page":"308","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]}},"priority":"input_data"} line:9, {"insert":{"user_id":"B000341201","type":"misc","id":"11921863"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26830489","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=305591","label":"url"}],"paper_title":{"en":"Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward","ja":"Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward"},"authors":{"en":[{"name":"Okada Naoto"},{"name":"Fushitani Shuji"},{"name":"Azuma Momoyo"},{"name":"Nakamura Shingen"},{"name":"Nakamura Toshimi"},{"name":"Teraoka Kazuhiko"},{"name":"Watanabe Hiroyoshi"},{"name":"Abe Masahiro"},{"name":"Kawazoe Kazuyoshi"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"伏谷 秀治"},{"name":"東 桃代"},{"name":"中村 信元"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"渡邊 浩良"},{"name":"安倍 正博"},{"name":"川添 和義"},{"name":"石澤 啓介"}]},"description":{"en":"The therapeutic effects of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents, vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK), depend on their concentrations in blood. Therefore, therapeutic drug monitoring (TDM) is important when these antibiotics are used. In the hematological ward at Tokushima University Hospital, pharmacists have ordered the measurement of blood VCM, TEIC, and ABK concentrations to promote the use of TDM in accordance with an agreed protocol since 2013. Moreover, the infection control team includes several medical disciplines and has advised on the optimal treatment using VCM, TEIC, and ABK since 2013. This study aimed to investigate the clinical effectiveness of these pharmacist interventions. We retrospectively studied 145 cases in which patients were treated with VCM, TEIC, or ABK between January 2012 and December 2013 in the hematological ward at Tokushima University Hospital. The patients were divided into a control group (71 cases) and an intervention group (74 cases), and their clinical outcomes were compared. The rate of achievement of effective drug concentrations significantly increased in the intervention group (74%), compared to the rate in the control group (55%). Moreover, univariate and multivariate Cox proportional hazard regression revealed that pharmacist intervention and appropriate concentrations of anti-MRSA agents were independent factors associated with reduced hospitalization periods in patients with lymphoma. Our study revealed that proactive pharmacist intervention may improve the therapeutic effect of anti-MRSA agents in hematology ward patients.","ja":"The therapeutic effects of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents, vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK), depend on their concentrations in blood. Therefore, therapeutic drug monitoring (TDM) is important when these antibiotics are used. In the hematological ward at Tokushima University Hospital, pharmacists have ordered the measurement of blood VCM, TEIC, and ABK concentrations to promote the use of TDM in accordance with an agreed protocol since 2013. Moreover, the infection control team includes several medical disciplines and has advised on the optimal treatment using VCM, TEIC, and ABK since 2013. This study aimed to investigate the clinical effectiveness of these pharmacist interventions. We retrospectively studied 145 cases in which patients were treated with VCM, TEIC, or ABK between January 2012 and December 2013 in the hematological ward at Tokushima University Hospital. The patients were divided into a control group (71 cases) and an intervention group (74 cases), and their clinical outcomes were compared. The rate of achievement of effective drug concentrations significantly increased in the intervention group (74%), compared to the rate in the control group (55%). Moreover, univariate and multivariate Cox proportional hazard regression revealed that pharmacist intervention and appropriate concentrations of anti-MRSA agents were independent factors associated with reduced hospitalization periods in patients with lymphoma. Our study revealed that proactive pharmacist intervention may improve the therapeutic effect of anti-MRSA agents in hematology ward patients."},"publication_date":"2015","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.39","number":"No.2","starting_page":"295","ending_page":"300","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b15-00774"],"issn":["1347-5215"]}},"priority":"input_data"} line:10, {"insert":{"user_id":"B000341201","type":"misc","id":"11921864"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26449225","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84943540407&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=360418","label":"url"}],"paper_title":{"en":"Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.","ja":"Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma."},"authors":{"en":[{"name":"Yamashita Michiko"},{"name":"Fujii Yoshiyuki"},{"name":"Ozaki Keiji"},{"name":"Urano Yoshio"},{"name":"Iwasa Masami"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Abe Masahiro"},{"name":"Sato Yasuharu"},{"name":"Yoshino Tadashi"}],"ja":[{"name":"山下 理子"},{"name":"Fujii Yoshiyuki"},{"name":"Ozaki Keiji"},{"name":"Urano Yoshio"},{"name":"岩佐 昌美"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"安倍 正博"},{"name":"Sato Yasuharu"},{"name":"Yoshino Tadashi"}]},"description":{"en":"Malignant syphilis or lues maligna is a severe form of secondary syphilis that was commonly reported in the pre-antibiotic era, and has now reemerged with the advent of the human immunodeficiency virus (HIV) epidemic. However, the characteristic histopathological findings of malignant syphilis remain controversial. The aim of this case report was to clarify the clinical and histopathological findings of HIV-positive malignant secondary syphilis. A Japanese man in his forties complained of fever, skin lesions, headache, and myalgia without lymphadenopathy during the previous 4 weeks. The skin lesions manifested as erythematous, nonhealing, ulcerated papules scattered on his trunk, extremities, palm, and face. Although the skin lesions were suspected to be cutaneous T-cell lymphomas on histological analyses, they lacked T-cell receptor Jγ rearrangement; moreover, immunohistochemical analyses confirmed the presence of spirochetes. The patient was administered antibiotics and anti-retroviral therapy, which dramatically improved the symptoms. On the basis of these observations of the skin lesions, we finally diagnosed the patient with HIV-associated secondary syphilis that mimicked cutaneous T-cell lymphoma. The patient's systemic CD4+ lymphocyte count was very low, and the infiltrate was almost exclusively composed of CD8+ atypical lymphocytes; therefore, the condition was easily misdiagnosed as cutaneous lymphoma. Although the abundance of plasma cells is a good indicator of malignant syphilis on skin histological analyses, in some cases, the plasma cell count may be very low. Therefore, a diagnosis of malignant secondary syphilis should be considered before making a diagnosis of primary cutaneous peripheral T-cell lymphoma or lymphoma associated with HIV infection.","ja":"Malignant syphilis or lues maligna is a severe form of secondary syphilis that was commonly reported in the pre-antibiotic era, and has now reemerged with the advent of the human immunodeficiency virus (HIV) epidemic. However, the characteristic histopathological findings of malignant syphilis remain controversial. The aim of this case report was to clarify the clinical and histopathological findings of HIV-positive malignant secondary syphilis. A Japanese man in his forties complained of fever, skin lesions, headache, and myalgia without lymphadenopathy during the previous 4 weeks. The skin lesions manifested as erythematous, nonhealing, ulcerated papules scattered on his trunk, extremities, palm, and face. Although the skin lesions were suspected to be cutaneous T-cell lymphomas on histological analyses, they lacked T-cell receptor Jγ rearrangement; moreover, immunohistochemical analyses confirmed the presence of spirochetes. The patient was administered antibiotics and anti-retroviral therapy, which dramatically improved the symptoms. On the basis of these observations of the skin lesions, we finally diagnosed the patient with HIV-associated secondary syphilis that mimicked cutaneous T-cell lymphoma. The patient's systemic CD4+ lymphocyte count was very low, and the infiltrate was almost exclusively composed of CD8+ atypical lymphocytes; therefore, the condition was easily misdiagnosed as cutaneous lymphoma. Although the abundance of plasma cells is a good indicator of malignant syphilis on skin histological analyses, in some cases, the plasma cell count may be very low. Therefore, a diagnosis of malignant secondary syphilis should be considered before making a diagnosis of primary cutaneous peripheral T-cell lymphoma or lymphoma associated with HIV infection."},"publication_date":"2015-10-08","publication_name":{"en":"Diagnostic Pathology","ja":"Diagnostic Pathology"},"volume":"Vol.10","starting_page":"185","ending_page":"185","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1186/s13000-015-0419-5"],"issn":["1746-1596"]}},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/misc.jsonl, 3roJ844B7kacV6CWpC_T) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/books_etc.jsonl) ==== line:1, {"insert":{"user_id":"B000341201","type":"books_etc","id":"32804637"},"force":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/130006246890/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390282680011466240/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351843","label":"url"}],"book_title":{"en":"Analysis of long-term survivors with cardiac AL amyloidosis","ja":"治療後長期生存が得られた心不全合併ALアミロイドーシス症例の検討"},"authors":{"en":[{"name":"Kagawa Kumiko"},{"name":"前田 悠作"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"藤野 ひかる"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"岩佐 昌美"},{"name":"宇高 憲吾"},{"name":"Harada Takeshi"},{"name":"Ise Takayuki"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Yagi Shusuke"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Abe Masahiro"},{"name":"藤野 ひかる"}],"ja":[{"name":"賀川 久美子"},{"name":"前田 悠作"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤野 ひかる"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"岩佐 昌美"},{"name":"宇高 憲吾"},{"name":"原田 武志"},{"name":"伊勢 孝之"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"八木 秀介"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"安倍 正博"},{"name":"藤野 ひかる"}]},"publisher":{"en":"The Japanese Society of Hematology","ja":"臨床血液"},"publication_date":"2017-10","description":{"en":"

Cardiac AL amyloidosis (CA) is generally known as a severe disease with very poor prognosis. Here we retrospectively examined seven patients with CA in our cohort who achieved long-term survival. All six patients who underwent high-dose melphalan and autologous stem cell transplantation (ASCT) survived for >3 years, whereas four patients survived for >5 years. Patients who underwent ASCT had prompt hematological responses, and five patients showed organ responses. ASCT helps to achieve a quick and deep hematological response required for long-term survival in patients with CA. New agents have been implemented for the treatment of CA. However, the risks and benefits of each treatment modality should be considered according to patient condition, thus making the best use of ASCT in combination with new agents for the treatment of CA.

","ja":"

ALアミロイドーシスは,多発性骨髄腫やMGUS(monoclonal gammopathy of undetermined significance)などのモノクローナルな形質細胞が産生する免疫グロブリン軽鎖および重鎖が,アミロイド線維として組織に沈着し,臓器障害を惹起する難治性疾患である.なかでも心アミロイドーシス(以下CA)は,心不全症状が出現してからは,無治療の場合極めて予後不良であるため,その管理・治療が重要である1).ALアミロイドーシスに対しては,自家末梢血幹細胞移植併用メルファラン大量療法(以下ASCT)の有効性が報告されているが,CAにおいては治療関連毒性が強く,その適応を慎重に検討する必要がある2, 3).近年,多発性骨髄腫において,ボルテゾミブ(Bor)や,免疫調節薬であるサリドマイド(Thal)やレナリドミド(Len)などの新規薬を用いた治療により,治療成績が向上している.ALアミロイドーシス症例においてもこれらの新規薬の有効性が示され,CAに対しても,重篤な有害事象の発生率が低く,有効であったとの報告がある4∼6).しかしながら,その長期の治療成績や予後については,十分な情報がない.そこで我々は,当科において治療し,長期生存が得られた心不全合併CA例について,後方視的に検討した.

"}},"priority":"input_data"} line:2, {"insert":{"user_id":"B000341201","type":"books_etc","id":"32804638"},"force":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/130005096286/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001205035009152/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=318297","label":"url"}],"book_title":{"en":"Management of bone disease in myeloma patients: zoledronic acid or denosumab?","ja":"「骨髄腫∼いつ治療するのか?∼初発,再発,そして早期介入」骨髄腫骨病変の管理:ゾレドロン酸かデノスマブか"},"authors":{"en":[{"name":"Abe Masahiro"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"}],"ja":[{"name":"安倍 正博"},{"name":"三木 浩和"},{"name":"中村 信元"}]},"publisher":{"en":"The Japanese Society of Hematology","ja":"臨床血液"},"publication_date":"2015","languages":["jpn"],"description":{"en":"With improvement of survival owing to the recent implementation of new anti-myeloma (MM) agents, bone management will become more important for maintaining the quality of life (QoL) of patients. Bisphosphonates are currently the standard of care for MM-related bone disease. Zoledronic acid is recommended for newly diagnosed MM patients receiving front-line anti-MM treatment regardless of existing detectable bone lesions. Intriguingly, an overall survival benefit has been observed with zoledronic acid in patients on anti-MM treatment with documented bone disease at baseline. Denosumab, a human monoclonal antibody against RANKL, has been demonstrated to reduce bone-related events in patients with MM as effectively as zoledronic acid. Hypocalcemia is generally accepted as occurring more frequently and more severely with denosumab than with zoledronic acid, especially in patients with renal insufficiency. Bisphosphonates but not denosumab deposit in bone with a long half-life, which may make a difference in long-term efficacy as well as adverse effects. Clinical benefits of long-term anti-resorptive therapies after achieving a good response should be clarified, in order to avoid the emergence of severe complications. Impacts of new agents in combination with these anti-resorptive agents on bone metabolism have yet to be studied.","ja":"新規薬が臨床応用され骨髄腫の治療成績が向上しているが,骨破壊病変は依然として生活の質(QoL)の低下の最も多い原因である.初回化学療法を受ける症候性骨髄腫患者すべてに骨病変の有無にかかわらずゾレドロン酸の点滴静注を反復することが骨病変の進行防止と予後の改善の点から推奨されている.デノスマブはゾレドロン酸と同等の治療効果を発揮する.デノスマブは即効性で皮下投与という利便性があり,腎機能にも影響を与えにくいが,低カルシウム血症を来しやすく,ゾレドロン酸と同程度に顎骨壊死の発生がみられる.ゾレドロン酸は骨に長期間蓄積するが,デノスマブは骨への蓄積性がない.したがって,長期投与後の骨質への影響などに両者の違いがある可能性がある.また,治療奏効後の強力な骨吸収抑制薬継続投与の有用性および新規薬との併用下での骨病変治療薬の至適な投与開始時期,投与方法や投与期間,予後に及ぼす影響が今後の検討課題である."}},"priority":"input_data"} line:3, {"insert":{"user_id":"B000341201","type":"books_etc","id":"12940224"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300218","label":"url"}],"book_title":{"en":"臓器移植.ALアミロイドーシス,多発性骨髄腫の類縁疾患","ja":"臓器移植.ALアミロイドーシス,多発性骨髄腫の類縁疾患"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"publisher":{"en":"Iyaku Journal Co., Ltd.","ja":"医薬ジャーナル社"},"publication_date":"2014-08-12","languages":["jpn"]},"priority":"input_data"} line:4, {"insert":{"user_id":"B000341201","type":"books_etc","id":"12940225"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300217","label":"url"}],"book_title":{"en":"アミロイドーシス効果判定基準 効果判定基準 2005コンセンサスクライテリア,2011新基準.ALアミロイドーシス,多発性骨髄腫の類縁疾患","ja":"アミロイドーシス効果判定基準 効果判定基準 2005コンセンサスクライテリア,2011新基準.ALアミロイドーシス,多発性骨髄腫の類縁疾患"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"}]},"publisher":{"en":"Iyaku Journal Co., Ltd.","ja":"医薬ジャーナル社"},"publication_date":"2014-08-12","languages":["jpn"]},"priority":"input_data"} line:5, {"insert":{"user_id":"B000341201","type":"books_etc","id":"12940226"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303540","label":"url"}],"book_title":{"en":"(chapter6)","ja":"(chapter6)"},"authors":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"publication_date":"2014-01","languages":["jpn"]},"priority":"input_data"} line:6, {"insert":{"user_id":"B000341201","type":"books_etc","id":"12940227"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=268244","label":"url"}],"book_title":{"en":"新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に)","ja":"新規治療薬の開発と臨床応用の可能性を探る (抗RANKL抗体などを中心に)"},"authors":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"publication_date":"2012-03-30","languages":["jpn"]},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/books_etc.jsonl, 4boJ844B7kacV6CWpS-j) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/awards.jsonl) ==== line:1, {"insert":{"user_id":"B000341201","type":"awards","id":"32804644"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232119","label":"url"}],"award_name":{"en":"Travel Grant Award, 2010.","ja":"Travel Grant Award, 2010."},"winners":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Kawatani Makoto"},{"name":"Hiasa Masahiro"},{"name":"Nakano Ayako"},{"name":"Jinno Tadashi"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Osada Hiroyuki"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"Kawatani Makoto"},{"name":"日浅 雅博"},{"name":"Nakano Ayako"},{"name":"Jinno Tadashi"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"Miki Hirokazu"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"Osada Hiroyuki"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"award_title":{"en":"The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma","ja":"The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma"},"association":{"en":"10th International Conference Cancer-Induced Bone Disease","ja":"10th International Conference Cancer-Induced Bone Disease"},"award_date":"2010-09-22"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000341201","type":"awards","id":"32804645"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=238356","label":"url"}],"award_name":{"en":"52nd ASH Travel Award","ja":"52nd ASH Travel Award"},"winners":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Cui Qu"},{"name":"Kawatani Makoto"},{"name":"Hiasa Masahiro"},{"name":"Nakano Ayako"},{"name":"Jinno Tadashi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Osada Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Cui Qu"},{"name":"Kawatani Makoto"},{"name":"日浅 雅博"},{"name":"Nakano Ayako"},{"name":"Jinno Tadashi"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Miki Hirokazu"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Osada Hiroyuki"},{"name":"松本 俊夫"}]},"award_title":{"en":"An acidic milieu created in myeloma-osteoclast interaction enhances tumor growth, but triggers anti-myeloma activity of Reveromycin A, a novel anti-resorptive agent","ja":"An acidic milieu created in myeloma-osteoclast interaction enhances tumor growth, but triggers anti-myeloma activity of Reveromycin A, a novel anti-resorptive agent"},"association":{"en":"52nd ASH","ja":"52nd ASH"},"award_date":"2010-12-06"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000341201","type":"awards","id":"32804646"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253680","label":"url"}],"award_name":{"en":"IOF-ANZBMS Travel Award.","ja":"IOF-ANZBMS Travel Award."},"winners":{"en":[{"name":"Hiasa Masahiro"},{"name":"Nakano A"},{"name":"Watanabe Keiichiro"},{"name":"Qu C"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Miki H"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"Nakano A"},{"name":"渡邉 佳一郎"},{"name":"Qu C"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"Miki H"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"award_title":{"en":"Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression","ja":"Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression"},"association":{"en":"Japanese Association for Dental Research","ja":"国際歯科研究学会日本部会"},"award_date":"2011-07-17"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000341201","type":"awards","id":"3035220"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253677","label":"url"}],"award_name":{"en":"優秀演題賞","ja":"優秀演題賞"},"winners":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"award_title":{"en":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する","ja":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する"},"association":{"en":"第29回日本骨代謝学会","ja":"第29回日本骨代謝学会"},"award_date":"2011-07-30"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000341201","type":"awards","id":"3035221"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253678","label":"url"}],"award_name":{"en":"高得点演題賞","ja":"高得点演題賞"},"winners":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"award_title":{"en":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する","ja":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する"},"association":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"award_date":"2011-07-30"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000341201","type":"awards","id":"32804647"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253682","label":"url"}],"award_name":{"en":"ASBMR Young Investigator Travel Grant.","ja":"4. Hiasa M, Nakano A, Watanabe K, Qu C, Harada T, Fujii S, Miki H, Nakamura S, Kagawa K, Takeuchi K, Tanaka E, Asaoka K, Ozaki S, Matsumoto T, Abe M:"},"winners":{"en":[{"name":"Hiasa Masahiro"},{"name":"Nakano A"},{"name":"Watanabe Keiichiro"},{"name":"Qu C"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Miki H"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"Nakano A"},{"name":"渡邉 佳一郎"},{"name":"Qu C"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"Miki H"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"award_title":{"en":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition.","ja":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition."},"association":{"en":"The American Society for Bone and Mineral Research","ja":"米国骨代謝学会"},"award_date":"2011-09-21"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000341201","type":"awards","id":"32804648"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=284290","label":"url"}],"award_name":{"en":"Plenary poster & Young Investigator Travel Award","ja":"Plenary poster & Young Investigator Travel Award"},"winners":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Mori H"},{"name":"Amachi R"},{"name":"Hiasa Masahiro"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Mori H"},{"name":"Amachi R"},{"name":"日浅 雅博"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"award_title":{"en":"5. Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combinat ion with the proteasome inhibitor bortezomib.","ja":"5. Potent induction of bone formation in myeloma bone lesions by the cathepsin K inhibitor KK1-300-01 in combinat ion with the proteasome inhibitor bortezomib."},"association":{"en":"The American Society for Bone and Mineral Research","ja":"米国骨代謝学会"},"award_date":"2013-10"},"priority":"input_data"} line:8, {"insert":{"user_id":"B000341201","type":"awards","id":"3035224"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332195","label":"url"}],"award_name":{"en":"第34回日本骨代謝学会学術集会・第3回アジア太平洋骨代謝学会議,Young investigator award.","ja":"第34回日本骨代謝学会学術集会・第3回アジア太平洋骨代謝学会議,Young investigator award."},"winners":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"award_title":{"en":"破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される","ja":"破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される"},"association":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"award_date":"2016-07-21"},"priority":"input_data"} line:9, {"insert":{"user_id":"B000341201","type":"awards","id":"32804649"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339342","label":"url"}],"award_name":{"en":"ANZBMS Plenary Poster Award.","ja":"ANZBMS Plenary Poster Award."},"winners":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Oda A"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Baterdene A"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Oda A"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Baterdene A"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"award_title":{"en":"Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.","ja":"Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts."},"association":{"en":"Australian and New Zealand Bone and Mineral Society","ja":"Australian and New Zealand Bone and Mineral Society"},"award_date":"2017-06-17"},"priority":"input_data"} line:10, {"insert":{"user_id":"B000341201","type":"awards","id":"32804650"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=358515","label":"url"}],"award_name":{"en":"Esmo asia travel grant 2018","ja":"Esmo asia travel grant 2018"},"winners":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"award_title":{"en":"Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma.","ja":"Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma."},"association":{"en":"Esmo asia","ja":"Esmo asia"},"award_date":"2018-11-23"},"priority":"input_data"} line:11, {"insert":{"user_id":"B000341201","type":"awards","id":"32804651"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=358517","label":"url"}],"award_name":{"en":"日本骨髄腫学会 優秀ポスター賞","ja":"日本骨髄腫学会 優秀ポスター賞"},"winners":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"award_title":{"en":"多発性骨髄腫患者におけるPIM2, TAK1 の重要性","ja":"多発性骨髄腫患者におけるPIM2, TAK1 の重要性"},"association":{"en":"日本骨髄腫学会","ja":"日本骨髄腫学会"},"award_date":"2019-05-12"},"priority":"input_data"} line:12, {"insert":{"user_id":"B000341201","type":"awards","id":"32804652"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=367671","label":"url"}],"award_name":{"en":"第36回日本骨代謝学会学術集会 研究奨励賞.","ja":"第36回日本骨代謝学会学術集会 研究奨励賞."},"winners":{"en":[{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mahannad"},{"name":"Ariunzaya Bat Erdene"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"遠藤 逸郎"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸郎"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"award_title":{"en":"カテプシンK阻害による多発性骨髄腫骨病変部の骨量回復プロセスにおける骨細胞の役割","ja":"カテプシンK阻害による多発性骨髄腫骨病変部の骨量回復プロセスにおける骨細胞の役割"},"association":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"award_date":"2019-07-26"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/awards.jsonl, 5LoJ844B7kacV6CWpy9W) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/presentations.jsonl) ==== line:1, {"insert":{"user_id":"B000341201","type":"presentations","id":"42921408"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=398926","label":"url"}],"presentation_title":{"en":"Dehydroepiandrosterone sulfate and skeletal muscle disorders in patients with type 2 diabetes","ja":"Dehydroepiandrosterone sulfate and skeletal muscle disorders in patients with type 2 diabetes"},"presenters":{"en":[{"name":"Kaneko Yosuke"},{"name":"Yasui Saya"},{"name":"Hosoi Minae"},{"name":"Tani Akihiro"},{"name":"Yamagami Hiroki"},{"name":"Mori Hiroyasu"},{"name":"Hara Tomoyo"},{"name":"Mitsui Yukari"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Nakamura Shingen"},{"name":"Kuroda Akio"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Soeki Takeshi"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"Kaneko Yosuke"},{"name":"安井 沙耶"},{"name":"Hosoi Minae"},{"name":"Tani Akihiro"},{"name":"山上 紘規"},{"name":"森 博康"},{"name":"原 倫世"},{"name":"Mitsui Yukari"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"中村 信元"},{"name":"黒田 暁生"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"添木 武"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"event":{"en":"IDF-WPR Congress 2023/15th Scientific Meeting of AASD","ja":"IDF-WPR Congress 2023/15th Scientific Meeting of AASD"},"publication_date":"2023-07-22","languages":["eng"],"location":{"en":"Tokyo","ja":"Tokyo"},"is_international_presentation":true},"priority":"input_data"} line:2, {"insert":{"user_id":"B000341201","type":"presentations","id":"42921409"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=398925","label":"url"}],"presentation_title":{"en":"Association between serum dehydroepiandrosterone sulfate levels and annual eGFR changes in people with type 2 diabetes","ja":"Association between serum dehydroepiandrosterone sulfate levels and annual eGFR changes in people with type 2 diabetes"},"presenters":{"en":[{"name":"Tsuji Seijiro"},{"name":"Mori Kensuke"},{"name":"Kaneko Yosuke"},{"name":"Kawata Saki"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"Tsuji Seijiro"},{"name":"Mori Kensuke"},{"name":"Kaneko Yosuke"},{"name":"Kawata Saki"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"IDF-WPR Congress 2023/15th Scientific Meeting of AASD","ja":"IDF-WPR Congress 2023/15th Scientific Meeting of AASD"},"publication_date":"2023-07-21","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:3, {"insert":{"user_id":"B000341201","type":"presentations","id":"41379389"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393950","label":"url"}],"presentation_title":{"en":"Pharmaceutical Influences on In-hospital Death in Patients with and Those without Diabetes at a Japanese General Hospital","ja":"Pharmaceutical Influences on In-hospital Death in Patients with and Those without Diabetes at a Japanese General Hospital"},"presenters":{"en":[{"name":"Hosoki Minae"},{"name":"Yamagami Hiroki"},{"name":"Hori Taiki"},{"name":"Yasui Saya"},{"name":"Hara Tomoyo"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"安井 沙耶"},{"name":"原 倫世"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"event":{"en":"The 29th Scientific Meeting of the International Society of Hypertension","ja":"The 29th Scientific Meeting of the International Society of Hypertension"},"publication_date":"2022-10-15","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:4, {"insert":{"user_id":"B000341201","type":"presentations","id":"41379390"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393949","label":"url"}],"presentation_title":{"en":"Evaluation of Vascular Function for Prediction of Renal Prognosis in Japanese Patients with Lifestyle-Related Diseases","ja":"Evaluation of Vascular Function for Prediction of Renal Prognosis in Japanese Patients with Lifestyle-Related Diseases"},"presenters":{"en":[{"name":"Masuda Shiho"},{"name":"Hara Tomoyo"},{"name":"Yamagami Hiroki"},{"name":"Yukari Mitsui"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Nakamura Shingen"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"桝田 志保"},{"name":"原 倫世"},{"name":"山上 紘規"},{"name":"三井 由加里"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"中村 信元"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"event":{"en":"The 29th Scientific Meeting of the International Society of Hypertension","ja":"The 29th Scientific Meeting of the International Society of Hypertension"},"publication_date":"2022-10-15","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:5, {"insert":{"user_id":"B000341201","type":"presentations","id":"42283817"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396174","label":"url"}],"presentation_title":{"en":"ADAR1-dsRNA metabolism in myeloma cells with 1q amplification: a novel therapeutic target","ja":"ADAR1-dsRNA metabolism in myeloma cells with 1q amplification: a novel therapeutic target"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Matsushita Yosuke"},{"name":"Sumitani Ryohei"},{"name":"Inoue Yusuke"},{"name":"Hara Tomoyo"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Maruhashi Tomoko"},{"name":"Takahashi Mamiko"},{"name":"Kurahashi Kiyoe"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Katagiri Toyomasa"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"小田 明日香"},{"name":"松下 洋輔"},{"name":"住谷 龍平"},{"name":"井上 雄介"},{"name":"原 倫世"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"倉橋 清衛"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"片桐 豊雅"},{"name":"安倍 正博"}]},"event":{"en":"19th International Myeloma Society Annual Meeting","ja":"19th International Myeloma Society Annual Meeting"},"publication_date":"2022-08-25","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:6, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890567"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386570","label":"url"}],"presentation_title":{"en":"Skin autofluorescence is associated with tubular injury represented by urinary excretion of liver-type fatty acid-binding protein in patients with diabetes","ja":"Skin autofluorescence is associated with tubular injury represented by urinary excretion of liver-type fatty acid-binding protein in patients with diabetes"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Saya Yasui"},{"name":"Minae Hosoki"},{"name":"Taiki Hori"},{"name":"Hara Tomoyo"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"Saya Yasui"},{"name":"Minae Hosoki"},{"name":"Taiki Hori"},{"name":"原 倫世"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"event":{"en":"American Diabetes Association 82nd Scientific Sessions","ja":"American Diabetes Association 82nd Scientific Sessions"},"publication_date":"2022-06-03","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:7, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890568"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386569","label":"url"}],"presentation_title":{"en":"Clinical Significance of Dehydroepiandrosterone Sulfate in Carotid Atherosclerosis and Nonalcoholic Fatty Liver Disease","ja":"Clinical Significance of Dehydroepiandrosterone Sulfate in Carotid Atherosclerosis and Nonalcoholic Fatty Liver Disease"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Hiroki Yamagami"},{"name":"Saya Yasui"},{"name":"Minae Hosoki"},{"name":"Taiki Hori"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"}],"ja":[{"name":"粟飯原 賢一"},{"name":"Hiroki Yamagami"},{"name":"Saya Yasui"},{"name":"Minae Hosoki"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"}]},"event":{"en":"ESMED Congress 2021","ja":"ESMED Congress 2021"},"publication_date":"2021-11-11","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:8, {"insert":{"user_id":"B000341201","type":"presentations","id":"39161458"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387138","label":"url"}],"presentation_title":{"en":"Novel strategy of elotuzumab and zoledronic acid with Th1-like T cells against myeloma","ja":"Novel strategy of elotuzumab and zoledronic acid with Th1-like T cells against myeloma"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Inoue Yusuke"},{"name":"Tenshin Hirofumi"},{"name":"Oda Asuka"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"18th International Myeloma Workshop","ja":"18th International Myeloma Workshop"},"publication_date":"2021-09-08","languages":["eng"],"location":{"en":"Wien","ja":"Wien"},"is_international_presentation":true},"priority":"input_data"} line:9, {"insert":{"user_id":"B000341201","type":"presentations","id":"39161459"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387137","label":"url"}],"presentation_title":{"en":"Induction of elotuzumabs ADCC activity by Th1-like T cells towards osteoclasts as well as myeloma cells","ja":"Induction of elotuzumabs ADCC activity by Th1-like T cells towards osteoclasts as well as myeloma cells"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Inoue Yusuke"},{"name":"Tenshin Hirofumi"},{"name":"Oda Asuka"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"EHA2021 Virtual Congress","ja":"EHA2021 Virtual Congress"},"publication_date":"2021-06-09","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:10, {"insert":{"user_id":"B000341201","type":"presentations","id":"39876171"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389245","label":"url"}],"presentation_title":{"en":"The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease.","ja":"The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease."},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Nakamura Masafumi"},{"name":"Mizuguchi Makiko"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Takahasi Mamiko"},{"name":"Maruhashi Tomoko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiro"},{"name":"Kagawa Kumiko"},{"name":"Hamano Hirofumi"},{"name":"Kondou Masateru"},{"name":"Okada Naoto"},{"name":"Bando Yoshimi"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"Nakamura Masafumi"},{"name":"Mizuguchi Makiko"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Takahasi Mamiko"},{"name":"Maruhashi Tomoko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiro"},{"name":"Kagawa Kumiko"},{"name":"Hamano Hirofumi"},{"name":"Kondou Masateru"},{"name":"Okada Naoto"},{"name":"Bando Yoshimi"},{"name":"Endo Itsuro"},{"name":"安倍 正博"}]},"event":{"en":"The 48th annual meeting of European Calcified Tissue Society (ECTS)","ja":"The 48th annual meeting of European Calcified Tissue Society (ECTS)"},"publication_date":"2021-05-06","languages":["eng"],"location":{"en":"Online","ja":"Online"},"is_international_presentation":true},"priority":"input_data"} line:11, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312411"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378485","label":"url"}],"presentation_title":{"en":"Risk factors for chemotherapy-induced febrile neutropenia in hematological cancer patients","ja":"Risk factors for chemotherapy-induced febrile neutropenia in hematological cancer patients"},"presenters":{"en":[{"name":"Sogawa Yuka"},{"name":"Fukui Makoto"},{"name":"Nakamura Shingen"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Yoshioka Masami"},{"name":"Abe Masahiro"},{"name":"Hinode Daisuke"}],"ja":[{"name":"十川 悠香"},{"name":"福井 誠"},{"name":"中村 信元"},{"name":"曽我部 公子"},{"name":"住谷 龍平"},{"name":"吉岡 昌美"},{"name":"安倍 正博"},{"name":"日野出 大輔"}]},"event":{"en":"106th Annual Meeting of American Academy of Periodontology","ja":"106th Annual Meeting of American Academy of Periodontology"},"publication_date":"2020-11","languages":["eng"],"location":{"en":"Honolulu","ja":"Honolulu"},"description":{"en":"1","ja":"1"},"is_international_presentation":true},"priority":"input_data"} line:12, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804653"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364701","label":"url"}],"presentation_title":{"en":"Novel therapeutic rationale for targeting HDAC1 and PIM2 in multiple myeloma","ja":"Novel therapeutic rationale for targeting HDAC1 and PIM2 in multiple myeloma"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Ohguchi Hiroto"},{"name":"Grondin Yohann"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Hideshima Teru"},{"name":"Anderson C. Kenneth"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"Oda Asuka"},{"name":"Ohguchi Hiroto"},{"name":"Grondin Yohann"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"Hideshima Teru"},{"name":"Anderson C. Kenneth"},{"name":"安倍 正博"}]},"event":{"en":"61th ASH Annual Meeting & Exposition","ja":"61th ASH Annual Meeting & Exposition"},"publication_date":"2019-12-08","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:13, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804654"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=359792","label":"url"}],"presentation_title":{"en":"Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy","ja":"Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Hideshima Teru"},{"name":"Anderson Kenneth C."},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"秀島 輝"},{"name":"Anderson Kenneth C."},{"name":"安倍 正博"}]},"event":{"en":"17th International Myeloma Workshop","ja":"17th International Myeloma Workshop"},"publication_date":"2019-09-13","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:14, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804655"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351307","label":"url"}],"presentation_title":{"en":"Peri-implantitis and the role of Febuxostat in osteoclast differentiation.","ja":"Peri-implantitis and the role of Febuxostat in osteoclast differentiation."},"presenters":{"en":[{"name":"Ashtar Mohannad"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Asuka Oda"},{"name":"Masami Iwasa"},{"name":"Harada Takeshi"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"},{"name":"Tanaka Eiji"}],"ja":[{"name":"ASHTAR MOHANNAD"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"Asuka Oda"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Ariunzaya Bat-Erdene"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"松本 俊夫"},{"name":"安倍 正博"},{"name":"田中 栄二"}]},"event":{"en":"AEEDC Dubai World Orthodontic Conference","ja":"AEEDC Dubai World Orthodontic Conference"},"publication_date":"2019-02-06","languages":["eng"],"location":{"en":"Dubai, UAE","ja":"Dubai, UAE"},"is_international_presentation":true},"priority":"input_data"} line:15, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804656"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=349640","label":"url"}],"presentation_title":{"en":"The critical role of the HDAC1-IRF4-Pim-2 axis in myeloma cell growth and survival: therapeutic impacts of targeting the HDAC1-IRF4-Pim-2 axis","ja":"The critical role of the HDAC1-IRF4-Pim-2 axis in myeloma cell growth and survival: therapeutic impacts of targeting the HDAC1-IRF4-Pim-2 axis"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Oda Asuka"},{"name":"Grondin Yohann"},{"name":"Teramachi Jumpei"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Oura Masahiro"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Okamoto Yasunobu"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ozaki Shuji"},{"name":"Hideshima Teru"},{"name":"Anderson C. Kenneth"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"Oda Asuka"},{"name":"Grondin Yohann"},{"name":"寺町 順平"},{"name":"Bat-Erdene Ariunzaya"},{"name":"岩佐 昌美"},{"name":"大浦 雅博"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"Okamoto Yasunobu"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"尾崎 修治"},{"name":"Hideshima Teru"},{"name":"Anderson C. Kenneth"},{"name":"安倍 正博"}]},"event":{"en":"60th ASH Annual Meeting & Exposition","ja":"60th ASH Annual Meeting & Exposition"},"publication_date":"2018-12-01","languages":["eng"],"location":{"en":"San Diego","ja":"San Diego"},"is_international_presentation":true},"priority":"input_data"} line:16, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804657"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=358521","label":"url"}],"presentation_title":{"en":"Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma.","ja":"Alteration of muscle mass after chemotherapy in patients with newly diagnosed multiple myeloma."},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Okamoto Yasunobu"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Takahashi Mamiko"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岡本 恵暢"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"Takahashi Mamiko"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"Esmo asia 2018","ja":"Esmo asia 2018"},"publication_date":"2018-11-24","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:17, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804658"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351358","label":"url"}],"presentation_title":{"en":"Disruption of a progressive vicious cycle between myeloma tumor growth and bone destruction by TAK1 inhibition","ja":"Disruption of a progressive vicious cycle between myeloma tumor growth and bone destruction by TAK1 inhibition"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"ASBMR 2018 Annual Meeting","ja":"ASBMR 2018 Annual Meeting"},"publication_date":"2018-09-28","languages":["eng"],"location":{"en":"Montreal","ja":"Montreal"},"is_international_presentation":true},"priority":"input_data"} line:18, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804659"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351306","label":"url"}],"presentation_title":{"en":"Opposite effects of TRAIL on the Sp-1-c-FLIP survival pathway in myeloma cells and osteoclasts.","ja":"Opposite effects of TRAIL on the Sp-1-c-FLIP survival pathway in myeloma cells and osteoclasts."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Mohannad Ashtar"},{"name":"Tanimoto Kotaro"},{"name":"Masami Iwasa"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"ASHTAR MOHANNAD"},{"name":"谷本 幸多朗"},{"name":"岩佐 昌美"},{"name":"Ariunzaya Bat-Erdene"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"ASBMR 2018 Annual Meeting","ja":"ASBMR 2018 Annual Meeting"},"publication_date":"2018-09-28","languages":["eng"],"promoter":{"en":"The American Society for Bone and Mineral Research","ja":"The American Society for Bone and Mineral Research"},"location":{"en":"Montreal","ja":"Montreal"},"is_international_presentation":true},"priority":"input_data"} line:19, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738060"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342580","label":"url"}],"presentation_title":{"en":"Selective inhibition of class-I HDAC induces myeloma cell death through targeting IRF4-Pim-2 axis","ja":"Selective inhibition of class-I HDAC induces myeloma cell death through targeting IRF4-Pim-2 axis"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Asuka Oda"},{"name":"Teramachi Jumpei"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Masami Iwasa"},{"name":"Masahiro Oura"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Yasunobu Okamoto"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Teru Hideshima"},{"name":"Kenneth C. Anderson"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"Asuka Oda"},{"name":"寺町 順平"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"Masahiro Oura"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"Yasunobu Okamoto"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"Teru Hideshima"},{"name":"Kenneth C. Anderson"},{"name":"安倍 正博"}]},"event":{"en":"The 9th JSH International Symposium 2018 in Kyoto","ja":"The 9th JSH International Symposium 2018 in Kyoto"},"publication_date":"2018-07-27","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:20, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804660"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351359","label":"url"}],"presentation_title":{"en":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction","ja":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Haneji Tatsuji"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"羽地 達次"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society 2018 Meeting","ja":"8th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone and other Musculoskeletal Diseases and Cancer and Bone Society 2018 Meeting"},"publication_date":"2018-06-30","languages":["eng"],"location":{"en":"Oxford","ja":"Oxford"},"is_international_presentation":true},"priority":"input_data"} line:21, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738061"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338459","label":"url"}],"presentation_title":{"en":"TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma tumor growth and bone destruction","ja":"TAK1 inhibition impairs myeloma cell-bone marrow interaction to reduce myeloma tumor growth and bone destruction"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting","ja":"American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting"},"publication_date":"2017-09-08","languages":["eng"],"location":{"en":"Denver","ja":"Denver"},"is_international_presentation":true},"priority":"input_data"} line:22, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738062"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338457","label":"url"}],"presentation_title":{"en":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction","ja":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"International Society for Experimental Hematology 46th Annual Scientific Meeting","ja":"International Society for Experimental Hematology 46th Annual Scientific Meeting"},"publication_date":"2017-08-24","languages":["eng"],"location":{"en":"Frankfurt","ja":"Frankfurt"},"is_international_presentation":true},"priority":"input_data"} line:23, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738063"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339343","label":"url"}],"presentation_title":{"en":"Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts.","ja":"Osteoclasts utilize TRAIL for their NF-B activation, but TAK1 inhibition resumes TRAIL-induced apoptosis in osteoclasts."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Oda A"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Baterdene A"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Oda A"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Baterdene A"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"Australian and New Zealand Bone and Mineral Society 2017","ja":"Australian and New Zealand Bone and Mineral Society 2017"},"publication_date":"2017-06-17","languages":["eng"],"location":{"en":"Brisbane, Australia.","ja":"Brisbane, Australia."},"is_international_presentation":true},"priority":"input_data"} line:24, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738064"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326823","label":"url"}],"presentation_title":{"en":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction","ja":"Therapeutic impact of TAK1 inhibition on myeloma tumor progression and bone destruction"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Yamamoto Akihito"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"山本 朗仁"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"Cancer and Bone Society Conference 2017","ja":"Cancer and Bone Society Conference 2017"},"publication_date":"2017-05-04","languages":["eng"],"location":{"en":"Indianapolis","ja":"Indianapolis"},"is_international_presentation":true},"priority":"input_data"} line:25, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738065"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333887","label":"url"}],"presentation_title":{"en":"Osteoblast Creates a Non-permissive Niche for Myeloma Cells","ja":"Osteoblast Creates a Non-permissive Niche for Myeloma Cells"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Matsumoto Toshio"},{"name":"Tanaka Eiji"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"松本 俊夫"},{"name":"田中 栄二"},{"name":"安倍 正博"}]},"event":{"en":"95th General Session & Exhibition of the IADR program book","ja":"95th General Session & Exhibition of the IADR program book"},"publication_date":"2017-03-25","languages":["eng"],"location":{"en":"San Francisco","ja":"San Francisco"},"is_international_presentation":true},"priority":"input_data"} line:26, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738066"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330801","label":"url"}],"presentation_title":{"en":"Pseudo-outbreak of Mycobacterium chimaera in hematopoietic stem cell transplantation center due to sterile hand-washing machine","ja":"Pseudo-outbreak of Mycobacterium chimaera in hematopoietic stem cell transplantation center due to sterile hand-washing machine"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Azuma Momoyo"}],"ja":[{"name":"中村 信元"},{"name":"東 桃代"}]},"event":{"en":"ID week 2016","ja":"ID week 2016"},"publication_date":"2016-10-26","languages":["eng"],"location":{"en":"New Orleans","ja":"New Orleans"},"is_international_presentation":true},"priority":"input_data"} line:27, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738067"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=321704","label":"url"}],"presentation_title":{"en":"TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma","ja":"TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Kurahashi Kiyoe"},{"name":"Kondo Takeshi"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"倉橋 清衛"},{"name":"近藤 剛史"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"American Society for Bone and Mineral Research 2016 Annual Meeting","ja":"American Society for Bone and Mineral Research 2016 Annual Meeting"},"publication_date":"2016-09-18","languages":["eng"],"location":{"en":"Atlanta","ja":"Atlanta"},"is_international_presentation":true},"priority":"input_data"} line:28, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738068"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=315913","label":"url"}],"presentation_title":{"en":"Therapeutic impact of TAK-1 inhibition on tumor growth and bone destruction in myeloma","ja":"Therapeutic impact of TAK-1 inhibition on tumor growth and bone destruction in myeloma"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"21st Congress European Hematology Association","ja":"21st Congress European Hematology Association"},"publication_date":"2016-06-09","languages":["eng"],"location":{"en":"Copenhagen","ja":"Copenhagen"},"is_international_presentation":true},"priority":"input_data"} line:29, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738069"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311252","label":"url"}],"presentation_title":{"en":"Pim inhibition suppresses osteoclastogenesis and tumor growth in myeloma","ja":"Pim inhibition suppresses osteoclastogenesis and tumor growth in myeloma"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Hanson Derek"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"Hanson Derek"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"尾崎 修治"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"57th ASH Annual Meeting and Exposition","ja":"57th ASH Annual Meeting and Exposition"},"publication_date":"2015-12","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:30, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738070"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314285","label":"url"}],"presentation_title":{"en":"Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment","ja":"Up-regulation of the pH sensor TRPV1 in myeloma cells and their adaption to an acidic microenvironment"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"ASBMR 2015 Annual Meeting","ja":"ASBMR 2015 Annual Meeting"},"publication_date":"2015-10-10","languages":["eng"],"location":{"en":"Seattle","ja":"Seattle"},"is_international_presentation":true},"priority":"input_data"} line:31, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738071"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311241","label":"url"}],"presentation_title":{"en":"Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: Therapeutic impact of TAK-1 inhibition","ja":"Pivotal role of TAK-1 in tumor growth and bone destruction in myeloma: Therapeutic impact of TAK-1 inhibition"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"American Society for Bone and Mineral Research 2015 Annual Meeting","ja":"American Society for Bone and Mineral Research 2015 Annual Meeting"},"publication_date":"2015-10","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:32, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738072"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319690","label":"url"}],"presentation_title":{"en":"Effective impairment of myeloma progenitors by hyperthermia: augmentation with bortezomib and Pim inhibition in combination","ja":"Effective impairment of myeloma progenitors by hyperthermia: augmentation with bortezomib and Pim inhibition in combination"},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"Clinical Lymphoma, Myeloma & Leukemia","ja":"Clinical Lymphoma, Myeloma & Leukemia"},"publication_date":"2015-09","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:33, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738073"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319689","label":"url"}],"presentation_title":{"en":"Alteration of Pim-2 expression by clinically available anti-myeloma agents: combinatory anti-myeloma effects with Pim inhibition","ja":"Alteration of Pim-2 expression by clinically available anti-myeloma agents: combinatory anti-myeloma effects with Pim inhibition"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"Clinical Lymphoma, Myeloma & Leukemia","ja":"Clinical Lymphoma, Myeloma & Leukemia"},"publication_date":"2015-09","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:34, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738074"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287374","label":"url"}],"presentation_title":{"en":"Critical role of Pim-2 in NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis: Therapeutic impact of Pim inhibition on myeloma bone disease.","ja":"Critical role of Pim-2 in NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis: Therapeutic impact of Pim inhibition on myeloma bone disease."},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Fujii Shiroh"},{"name":"Watanabe Keiichiro"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"藤井 志朗"},{"name":"渡邉 佳一郎"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"2014 ASBMR Annual Meeting","ja":"2014 ASBMR Annual Meeting"},"publication_date":"2014-09-13","languages":["eng"],"location":{"en":"Houston","ja":"Houston"},"is_international_presentation":true},"priority":"input_data"} line:35, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738075"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=284295","label":"url"}],"presentation_title":{"en":"Induction of bone formation in myeloma osteolytic lesions by cathepsinK inhibition","ja":"Induction of bone formation in myeloma osteolytic lesions by cathepsinK inhibition"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Mori H"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"Mori H"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"publication_date":"2013-04","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:36, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738076"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=284292","label":"url"}],"presentation_title":{"en":"An acidic milieu suppersses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression.","ja":"An acidic milieu suppersses histone acetylation in myeloma cells to down-regulate the TRAIL receptor DR4 expression."},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Harada T"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Oda A"},{"name":"Hiasa Masahiro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"Harada T"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"Oda A"},{"name":"日浅 雅博"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"publication_date":"2013-04","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:37, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738077"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269242","label":"url"}],"presentation_title":{"en":"Combination therapy of a defucosylated anti-HM1.24 monoclonal antibody plus Ienalidomide induces marked antibody-dependent cellular cytotoxicity and inhibits the clonogenic potential of myeloma cancer stem-like cells. Atlanta, Dec. 2012.","ja":"Combination therapy of a defucosylated anti-HM1.24 monoclonal antibody plus Ienalidomide induces marked antibody-dependent cellular cytotoxicity and inhibits the clonogenic potential of myeloma cancer stem-like cells. Atlanta, Dec. 2012."},"presenters":{"en":[{"name":"Takeshi Harada"},{"name":"Shuji Ozaki"},{"name":"Asuka Oda"},{"name":"Masami Iwasa"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Hironobu Shibata"},{"name":"Ikegame Akishige"},{"name":"Tsuji Daisuke"},{"name":"Kohji Ito"},{"name":"Masaki Ri"},{"name":"Shinsuke Iida"},{"name":"Yukimasa Shiotsu"},{"name":"Shigeto Kawai"},{"name":"Hisafumi Yamada-Okabe"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Takeshi Harada"},{"name":"Shuji Ozaki"},{"name":"Asuka Oda"},{"name":"Masami Iwasa"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"Hironobu Shibata"},{"name":"池亀 彰茂"},{"name":"辻 大輔"},{"name":"Kohji Ito"},{"name":"Masaki Ri"},{"name":"Shinsuke Iida"},{"name":"Yukimasa Shiotsu"},{"name":"Shigeto Kawai"},{"name":"Hisafumi Yamada-Okabe"},{"name":"松本 俊夫"}]},"event":{"en":"The 54th Annual Meeting of the American Society of Hamatology","ja":"The 54th Annual Meeting of the American Society of Hamatology"},"publication_date":"2012-12-08","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:38, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738078"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=264577","label":"url"}],"presentation_title":{"en":"Combination Therapy of a Defucosylated Anti-HM1.24 Monoclonal Antibody Plus Lenalidomide Induces Marked Antibody-Dependent Cellular Cytotoxicity and Inhibits the Clonogenic Potential of Myeloma Cancer Stem-Like Cells.","ja":"Combination Therapy of a Defucosylated Anti-HM1.24 Monoclonal Antibody Plus Lenalidomide Induces Marked Antibody-Dependent Cellular Cytotoxicity and Inhibits the Clonogenic Potential of Myeloma Cancer Stem-Like Cells."},"presenters":{"en":[{"name":"Harada T"},{"name":"Ozaki Shuji"},{"name":"Oda A"},{"name":"Iwasa M"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Shibata Hirofumi"},{"name":"Ikegame Akishige"},{"name":"Tsuji Daisuke"},{"name":"Itou Kouji"},{"name":"Ri M"},{"name":"Iida S"},{"name":"Shiotsu Y"},{"name":"Kawai S"},{"name":"Yamada-Okabe H"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Harada T"},{"name":"尾崎 修治"},{"name":"Oda A"},{"name":"Iwasa M"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"柴田 洋文"},{"name":"池亀 彰茂"},{"name":"辻 大輔"},{"name":"伊藤 孝司"},{"name":"Ri M"},{"name":"Iida S"},{"name":"Shiotsu Y"},{"name":"Kawai S"},{"name":"Yamada-Okabe H"},{"name":"松本 俊夫"}]},"event":{"en":"54th ASH Annual Meeting and Exposition","ja":"54th ASH Annual Meeting and Exposition"},"publication_date":"2012-12-08","languages":["eng"],"location":{"en":"USA, Atlanta","ja":"USA, Atlanta"},"is_international_presentation":true},"priority":"input_data"} line:39, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738079"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=265726","label":"url"}],"presentation_title":{"en":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition","ja":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Takeshi Harada"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"Takeshi Harada"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"12th Int'l Meeting on Cancer Induced Bone Disease","ja":"12th Int'l Meeting on Cancer Induced Bone Disease"},"publication_date":"2012-11-15","languages":["eng"],"promoter":{"en":"IBMS","ja":"IBMS"},"location":{"en":"Lyon","ja":"Lyon"},"is_international_presentation":true},"priority":"input_data"} line:40, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738080"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=265725","label":"url"}],"presentation_title":{"en":"Pim-2 suppresses BMP-2 signaling as a common inhibitory mediator of osteoblastogenesis in myeloma","ja":"Pim-2 suppresses BMP-2 signaling as a common inhibitory mediator of osteoblastogenesis in myeloma"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Takeshi Harada"},{"name":"Shirou Fujii"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"Takeshi Harada"},{"name":"Shirou Fujii"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"ASBMR 2012 Anuual Meeting","ja":"ASBMR 2012 Anuual Meeting"},"publication_date":"2012-10-15","languages":["eng"],"promoter":{"en":"The American Society for Bone and Mineral Research","ja":"The American Society for Bone and Mineral Research"},"location":{"en":"Minneapolis","ja":"Minneapolis"},"is_international_presentation":true},"priority":"input_data"} line:41, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738081"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=251273","label":"url"}],"presentation_title":{"en":"Aggravation of myeloma growth and drug resistance by an acidic created in myeloma-osteoclast interaction.","ja":"Aggravation of myeloma growth and drug resistance by an acidic created in myeloma-osteoclast interaction."},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Kawatani M"},{"name":"Hiasa Masahiro"},{"name":"Kawano A"},{"name":"Jinno T"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Osada H"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Kawatani M"},{"name":"日浅 雅博"},{"name":"Kawano A"},{"name":"Jinno T"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Osada H"},{"name":"松本 俊夫"}]},"event":{"en":"ASBMR 2011 Annual Meeting","ja":"ASBMR 2011 Annual Meeting"},"publication_date":"2011-09-17","languages":["eng"],"location":{"en":"San Diego","ja":"San Diego"},"is_international_presentation":true},"priority":"input_data"} line:42, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738082"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248829","label":"url"}],"presentation_title":{"en":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition.","ja":"Prevention of tumor growth and bone destruction in myeloma by Pim kinase inhibition."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"ayako nakano"},{"name":"Watanabe Keiichiro"},{"name":"Qu C"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"ayako nakano"},{"name":"渡邉 佳一郎"},{"name":"Qu C"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"尾崎 修治"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"ASBMR 2011 Annual Meeting","ja":"ASBMR 2011 Annual Meeting"},"publication_date":"2011-09-17","languages":["eng"],"location":{"en":"San Diego","ja":"San Diego"},"is_international_presentation":true},"priority":"input_data"} line:43, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738083"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248831","label":"url"}],"presentation_title":{"en":"Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression.","ja":"Dual effects of Pim inhibition on myeloma: induction of bone formation and tumor suppression."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"ayako nakano"},{"name":"Watanabe Keiichiro"},{"name":"Qu C"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"ayako nakano"},{"name":"渡邉 佳一郎"},{"name":"Qu C"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"尾崎 修治"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"IOF-ANZBMS 2011 Annual Meeting","ja":"IOF-ANZBMS 2011 Annual Meeting"},"publication_date":"2011-09-06","languages":["eng"],"location":{"en":"Gold Coast","ja":"Gold Coast"},"is_international_presentation":true},"priority":"input_data"} line:44, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738084"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231770","label":"url"}],"presentation_title":{"en":"An Acidic Mileu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent","ja":"An Acidic Mileu Created In Myeloma-Osteoclast Interaction Enhances Tumor Growth, but Triggers Anti-Myeloma Activity of Reveromycin A, a Novel Anti-Resorptive Agent"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Hirokazu Miki"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Hiroyuki Osada"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Hirokazu Miki"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Hiroyuki Osada"},{"name":"松本 俊夫"}]},"event":{"en":"52th American Society of Hematology","ja":"52th American Society of Hematology"},"publication_date":"2010-12-06","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:45, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738085"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231799","label":"url"}],"presentation_title":{"en":"Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment","ja":"Lenalidomide In Combination with Zoledronic Acid Restores the Activation and Anti-Myeloma Effects of γδT Cells Attenuated by the Bone Marrow Microenvironment"},"presenters":{"en":[{"name":"Qu Cui"},{"name":"Abe Masahiro"},{"name":"Hirokazu Miki"},{"name":"Nakamura Shingen"},{"name":"Watanabe Keiichiro"},{"name":"Ikegame Akishige"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Qu Cui"},{"name":"安倍 正博"},{"name":"Hirokazu Miki"},{"name":"中村 信元"},{"name":"渡邉 佳一郎"},{"name":"池亀 彰茂"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"event":{"en":"52th American Society of Hematology","ja":"52th American Society of Hematology"},"publication_date":"2010-12-05","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:46, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738086"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231769","label":"url"}],"presentation_title":{"en":"A Novel Anti-resorptive Agent, Reveromycin A, Ameliorates Bone Destruction and Tumor Growth in Myeloma","ja":"A Novel Anti-resorptive Agent, Reveromycin A, Ameliorates Bone Destruction and Tumor Growth in Myeloma"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Hirokazu Miki"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Hiroyuki Osada"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Hirokazu Miki"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Hiroyuki Osada"},{"name":"松本 俊夫"}]},"event":{"en":"ASBMR 2010 Annual Meeting","ja":"ASBMR 2010 Annual Meeting"},"publication_date":"2010-10-15","languages":["eng"],"location":{"en":"Toronto","ja":"Toronto"},"is_international_presentation":true},"priority":"input_data"} line:47, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738087"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231227","label":"url"}],"presentation_title":{"en":"Bone Marrow Stromal Cells Suppress TACE-mediated M-CSFR and RANK Shedding to Facilitate Osteoclastogenesis and Suppress DC Differentiation from Monocytes.","ja":"Bone Marrow Stromal Cells Suppress TACE-mediated M-CSFR and RANK Shedding to Facilitate Osteoclastogenesis and Suppress DC Differentiation from Monocytes."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"ayako nakano"},{"name":"aska oda"},{"name":"hiroe amo"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"hirokazu miki"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"ayako nakano"},{"name":"aska oda"},{"name":"hiroe amo"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"hirokazu miki"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"event":{"en":"ASBMR 2010 Annual Meeting","ja":"ASBMR 2010 Annual Meeting"},"publication_date":"2010-10-15","languages":["eng"],"location":{"en":"Toronto","ja":"Toronto"},"is_international_presentation":true},"priority":"input_data"} line:48, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738088"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231768","label":"url"}],"presentation_title":{"en":"TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma","ja":"TIMP-3 up-regulation facilitates osteoclastogenesis and suppresses DC differentiation from monocytes in the bone marrow microenvironment in myeloma"},"presenters":{"en":[{"name":"Abe Masahiro"},{"name":"Hiasa Masahiro"},{"name":"A Nakano"},{"name":"Nakamura Shingen"},{"name":"H Miki"},{"name":"C Qu"},{"name":"Watanabe Keiichiro"},{"name":"T Harada"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"安倍 正博"},{"name":"日浅 雅博"},{"name":"A Nakano"},{"name":"中村 信元"},{"name":"H Miki"},{"name":"C Qu"},{"name":"渡邉 佳一郎"},{"name":"T Harada"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"event":{"en":"10th International Conference Cancer-induced Bone Disease","ja":"10th International Conference Cancer-induced Bone Disease"},"publication_date":"2010-09-23","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:49, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738089"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231773","label":"url"}],"presentation_title":{"en":"The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma","ja":"The novel anti-resorptive agent reveromycin A ameliorates bone destruction and tumor growth in myeloma"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Hirokazu Miki"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Hiroyuki Osada"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Hirokazu Miki"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Hiroyuki Osada"},{"name":"松本 俊夫"}]},"event":{"en":"10th International Conference Cancer-induced Bone Disease","ja":"10th International Conference Cancer-induced Bone Disease"},"publication_date":"2010-09-22","languages":["eng"],"location":{"en":"Sheffield (United Kingdom)","ja":"Sheffield (United Kingdom)"},"is_international_presentation":true},"priority":"input_data"} line:50, {"insert":{"user_id":"B000341201","type":"presentations","id":"45827861"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405482","label":"url"}],"presentation_title":{"en":"非がん在宅療養患者における予後予測指標の有用性についての検討","ja":"非がん在宅療養患者における予後予測指標の有用性についての検討"},"presenters":{"en":[{"name":"Hori Taiki"},{"name":"Aihara Ken-ichi"},{"name":"石田 晃基"},{"name":"Inaba Kaori"},{"name":"Inaba Keisuke"},{"name":"Kaneko Yohsuke"},{"name":"Kawahito Keisuke"},{"name":"別宮 彰起"},{"name":"Hosoki Minae"},{"name":"Mori Kensuke"},{"name":"Kanako ITAMI"},{"name":"勝瀬 昌代"},{"name":"花岡 賀美"},{"name":"Kageji Teruyoshi"},{"name":"浦岡 秀行"},{"name":"Nakamura Shingen"}],"ja":[{"name":"堀 太貴"},{"name":"粟飯原 賢一"},{"name":"石田 晃基"},{"name":"稲葉 香織"},{"name":"稲葉 圭佑"},{"name":"金子 遥祐"},{"name":"川人 圭祐"},{"name":"別宮 彰起"},{"name":"細木 美苗"},{"name":"森 建介"},{"name":"伊丹 加奈子"},{"name":"勝瀬 昌代"},{"name":"花岡 賀美"},{"name":"影治 照喜"},{"name":"浦岡 秀行"},{"name":"中村 信元"}]},"event":{"en":"第268回徳島医学会学術集会","ja":"第268回徳島医学会学術集会"},"publication_date":"2024-03-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:51, {"insert":{"user_id":"B000341201","type":"presentations","id":"44251427"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404611","label":"url"}],"presentation_title":{"en":"初回再発した成人期の造血器腫瘍患者が捉える化学療法への構え","ja":"初回再発した成人期の造血器腫瘍患者が捉える化学療法への構え"},"presenters":{"en":[{"name":"明石 和子"},{"name":"Imai Yoshie"},{"name":"Nakamura Shingen"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"}],"ja":[{"name":"明石 和子"},{"name":"今井 芳枝"},{"name":"中村 信元"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"}]},"event":{"en":"第21回日本臨床腫瘍学会学術集","ja":"第21回日本臨床腫瘍学会学術集"},"publication_date":"2024-02-22","is_international_presentation":false},"priority":"input_data"} line:52, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404266","label":"url"}],"presentation_title":{"en":"初回再発した成人期の造血器腫瘍患者が捉える化学療法への構え","ja":"初回再発した成人期の造血器腫瘍患者が捉える化学療法への構え"},"presenters":{"en":[{"name":"明石 和子"},{"name":"Imai Yoshie"},{"name":"Nakamura Shingen"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"}],"ja":[{"name":"明石 和子"},{"name":"今井 芳枝"},{"name":"中村 信元"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"}]},"event":{"en":"第21回日本臨床腫瘍学会学術集","ja":"第21回日本臨床腫瘍学会学術集"},"publication_date":"2024-02-22","is_international_presentation":false},"priority":"input_data"} line:53, {"insert":{"user_id":"B000341201","type":"presentations","id":"43919279"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403690","label":"url"}],"presentation_title":{"en":"2型糖尿病患者の推定塩分摂取量に関わる臨床因子解析","ja":"2型糖尿病患者の推定塩分摂取量に関わる臨床因子解析"},"presenters":{"en":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"日本糖尿病学会中国四国地方会第61回総会","ja":"日本糖尿病学会中国四国地方会第61回総会"},"publication_date":"2023-10-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:54, {"insert":{"user_id":"B000341201","type":"presentations","id":"43919280"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403689","label":"url"}],"presentation_title":{"en":"当院糖尿病患者における高血圧治療の現況","ja":"当院糖尿病患者における高血圧治療の現況"},"presenters":{"en":[{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"日本糖尿病学会中国四国地方会第61回総会","ja":"日本糖尿病学会中国四国地方会第61回総会"},"publication_date":"2023-10-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:55, {"insert":{"user_id":"B000341201","type":"presentations","id":"44251428"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404265","label":"url"}],"presentation_title":{"en":"再発・難治性造血器腫瘍患者が捉えるアドバンス・ケア・プランニング","ja":"再発・難治性造血器腫瘍患者が捉えるアドバンス・ケア・プランニング"},"presenters":{"en":[{"name":"明石 和子"},{"name":"Imai Yoshie"},{"name":"Nakamura Shingen"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"}],"ja":[{"name":"明石 和子"},{"name":"今井 芳枝"},{"name":"中村 信元"},{"name":"西條 早希"},{"name":"前田 悠作"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"}]},"event":{"en":"第61回日本癌治療学会学術集会","ja":"第61回日本癌治療学会学術集会"},"publication_date":"2023-10-19","is_international_presentation":false},"priority":"input_data"} line:56, {"insert":{"user_id":"B000341201","type":"presentations","id":"43919281"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403688","label":"url"}],"presentation_title":{"en":"2 型糖尿病患者における血圧・血糖管理目標達成下での腎糸球体・尿細管障害のリスク因子の検討","ja":"2 型糖尿病患者における血圧・血糖管理目標達成下での腎糸球体・尿細管障害のリスク因子の検討"},"presenters":{"en":[{"name":"Hara Tomoyo"},{"name":"Yamagami Hiroki"},{"name":"三井 由加里"},{"name":"Kurahashi Kiyoe"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"原 倫世"},{"name":"山上 紘規"},{"name":"三井 由加里"},{"name":"倉橋 清衛"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"粟飯原 賢一"}]},"event":{"en":"第45回日本高血圧学会総会","ja":"第45回日本高血圧学会総会"},"publication_date":"2023-09-17","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:57, {"insert":{"user_id":"B000341201","type":"presentations","id":"43919282"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403687","label":"url"}],"presentation_title":{"en":"2 型糖尿病患者の年間収縮期血圧変動に関連する臨床因子の解析","ja":"2 型糖尿病患者の年間収縮期血圧変動に関連する臨床因子の解析"},"presenters":{"en":[{"name":"Mori Kensuke"},{"name":"Kaneko Yohsuke"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"三宅 南帆"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"森 建介"},{"name":"金子 遥祐"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"三宅 南帆"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第45回日本高血圧学会総会","ja":"第45回日本高血圧学会総会"},"publication_date":"2023-09-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:58, {"insert":{"user_id":"B000341201","type":"presentations","id":"43919283"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403686","label":"url"}],"presentation_title":{"en":"2 型糖尿病患者における推定塩分摂取量に関連する臨床因子の検討","ja":"2 型糖尿病患者における推定塩分摂取量に関連する臨床因子の検討"},"presenters":{"en":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"Hara Tomoyo"},{"name":"Yamagami Hiroki"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"原 倫世"},{"name":"山上 紘規"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第45回日本高血圧学会総会","ja":"第45回日本高血圧学会総会"},"publication_date":"2023-09-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:59, {"insert":{"user_id":"B000341201","type":"presentations","id":"45822812"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405477","label":"url"}],"presentation_title":{"en":"2型糖尿病患者における推定塩分摂取量に関わる臨床因子の探索","ja":"2型糖尿病患者における推定塩分摂取量に関わる臨床因子の探索"},"presenters":{"en":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"三宅 南帆"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第267回徳島医学会","ja":"第267回徳島医学会"},"publication_date":"2023-08-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:60, {"insert":{"user_id":"B000341201","type":"presentations","id":"43307763"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402858","label":"url"}],"presentation_title":{"en":"A case of ascitic plasmacytosis needed to distinguish to the fluid overload large B cell lymphoma FO-LBCL","ja":"Fluid overload large B cell lymphoma FO-LBCLとの鑑別を要した腹水 plasmacytosisの1例"},"presenters":{"en":[{"name":"Ohara Natsumi"},{"name":"Yamashita Yumiko"},{"name":"Masumi Ayumi"},{"name":"Nakamura Shingen"},{"name":"Ogawa Hirohisa"},{"name":"Tsuneyama Koichi"},{"name":"Yamashita Michiko"}],"ja":[{"name":"大原 菜摘"},{"name":"山下 由美子"},{"name":"倍味 歩実"},{"name":"中村 信元"},{"name":"小川 博久"},{"name":"常山 幸一"},{"name":"山下 理子"}]},"event":{"en":"第267回徳島医学会学術集会","ja":"第267回徳島医学会学術集会"},"publication_date":"2023-08-20","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:61, {"insert":{"user_id":"B000341201","type":"presentations","id":"43213469"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402667","label":"url"}],"presentation_title":{"en":"周期的な発熱,血小板減少,高LDH血症で発症したびまん性大細胞型B細胞リンパ腫の1例","ja":"周期的な発熱,血小板減少,高LDH血症で発症したびまん性大細胞型B細胞リンパ腫の1例"},"presenters":{"en":[{"name":"Sumitani Ryohei"},{"name":"Nakamura Shingen"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Harada Takeshi"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"住谷 龍平"},{"name":"中村 信元"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"藤井 志朗"},{"name":"原田 武志"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"第128回日本内科学会四国地方会","ja":"第128回日本内科学会四国地方会"},"publication_date":"2023-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:62, {"insert":{"user_id":"B000341201","type":"presentations","id":"42547183"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397982","label":"url"}],"presentation_title":{"en":"運動習慣及び体組成が2型糖尿病患者受診時HbA1cに及ぼす影響の解析","ja":"運動習慣及び体組成が2型糖尿病患者受診時HbA1cに及ぼす影響の解析"},"presenters":{"en":[{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"Mori Kensuke"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"森 建介"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第96回日本内分泌学会学術総会","ja":"第96回日本内分泌学会学術総会"},"publication_date":"2023-06-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:63, {"insert":{"user_id":"B000341201","type":"presentations","id":"42547184"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397980","label":"url"}],"presentation_title":{"en":"2型糖尿病患者における糖尿病治療薬の年間収縮期血圧変動への影響","ja":"2型糖尿病患者における糖尿病治療薬の年間収縮期血圧変動への影響"},"presenters":{"en":[{"name":"Mori Kensuke"},{"name":"Kaneko Yohsuke"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"森 建介"},{"name":"金子 遥祐"},{"name":"辻 誠士郎"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第96回日本内分泌学会学術集会","ja":"第96回日本内分泌学会学術集会"},"publication_date":"2023-06-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:64, {"insert":{"user_id":"B000341201","type":"presentations","id":"42547185"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397981","label":"url"}],"presentation_title":{"en":"2型糖尿病患者における年間腎機能変化とdehydroepiandrosterone sulfate(DHEAS)の連関解析","ja":"2型糖尿病患者における年間腎機能変化とdehydroepiandrosterone sulfate(DHEAS)の連関解析"},"presenters":{"en":[{"name":"辻 誠士郎"},{"name":"Mori Kensuke"},{"name":"Kaneko Yohsuke"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"辻 誠士郎"},{"name":"森 建介"},{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第96回日本内分泌学会学術総会","ja":"第96回日本内分泌学会学術総会"},"publication_date":"2023-06-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:65, {"insert":{"user_id":"B000341201","type":"presentations","id":"42369584"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396809","label":"url"}],"presentation_title":{"en":"2型糖尿病患者の年間収縮期血圧変動における糖尿病治療薬の影響","ja":"2型糖尿病患者の年間収縮期血圧変動における糖尿病治療薬の影響"},"presenters":{"en":[{"name":"Mori Kensuke"},{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"森 建介"},{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第66回日本糖尿病学会年次学術集会","ja":"第66回日本糖尿病学会年次学術集会"},"publication_date":"2023-05-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:66, {"insert":{"user_id":"B000341201","type":"presentations","id":"42369585"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396807","label":"url"}],"presentation_title":{"en":"2型糖尿病患者の年間HbA1c変動における糖尿病治療薬の影響","ja":"2型糖尿病患者の年間HbA1c変動における糖尿病治療薬の影響"},"presenters":{"en":[{"name":"Kaneko Yohsuke"},{"name":"河田 沙紀"},{"name":"Mori Kensuke"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"森 建"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第66回日本糖尿病学会年次学術集会","ja":"第66回日本糖尿病学会年次学術集会"},"publication_date":"2023-05-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:67, {"insert":{"user_id":"B000341201","type":"presentations","id":"42369586"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396790","label":"url"}],"presentation_title":{"en":"2型糖尿病患者のeGFR slopeにおけるdehydroepiandrosterone sulfate(DHEAS)の意義","ja":"2型糖尿病患者のeGFR slopeにおけるdehydroepiandrosterone sulfate(DHEAS)の意義"},"presenters":{"en":[{"name":"辻 誠士郎"},{"name":"Mori Kensuke"},{"name":"Kaneko Yohsuke"},{"name":"河田 沙紀"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"辻 誠士郎"},{"name":"森 建介"},{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第66回日本糖尿病学会年次学術集会","ja":"第66回日本糖尿病学会年次学術集会"},"publication_date":"2023-05-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:68, {"insert":{"user_id":"B000341201","type":"presentations","id":"42369587"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396788","label":"url"}],"presentation_title":{"en":"2型糖尿病患者の受診時HbA1cにおける運動習慣及び体組成の影響","ja":"2型糖尿病患者の受診時HbA1cにおける運動習慣及び体組成の影響"},"presenters":{"en":[{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"Mori Kensuke"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"森 建介"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第66回日本糖尿病学会年次学術集会","ja":"第66回日本糖尿病学会年次学術集会"},"publication_date":"2023-05-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:69, {"insert":{"user_id":"B000341201","type":"presentations","id":"41399560"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393958","label":"url"}],"presentation_title":{"en":"多発腹腔内リンパ節腫脹を契機に診断に至ったPSA正常進行前立腺癌の一例","ja":"多発腹腔内リンパ節腫脹を契機に診断に至ったPSA正常進行前立腺癌の一例"},"presenters":{"en":[{"name":"Kaneko Yohsuke"},{"name":"河田 沙紀"},{"name":"Mori Kensuke"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"井上 善雄"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"森 建介"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"井上 善雄"},{"name":"粟飯原 賢一"}]},"event":{"en":"第266回徳島医学会学術集会","ja":"第266回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:70, {"insert":{"user_id":"B000341201","type":"presentations","id":"41399561"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393957","label":"url"}],"presentation_title":{"en":"高齢2型糖尿病患者におけるGNRIスコアと骨格筋異常病態の検討","ja":"高齢2型糖尿病患者におけるGNRIスコアと骨格筋異常病態の検討"},"presenters":{"en":[{"name":"Mori Kensuke"},{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"Tani Akihiro"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"森 建介"},{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第266回徳島医学会学術集会","ja":"第266回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:71, {"insert":{"user_id":"B000341201","type":"presentations","id":"41399562"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393956","label":"url"}],"presentation_title":{"en":"集学的治療にて救命し得た未治療糖尿病合併咽後膿瘍の1例","ja":"集学的治療にて救命し得た未治療糖尿病合併咽後膿瘍の1例"},"presenters":{"en":[{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"Mori Kensuke"},{"name":"Tani Akihiro"},{"name":"辻 誠士郎"},{"name":"Yuasa Tomoyuki"},{"name":"Otoda Toshiki"},{"name":"Nakamura Shingen"},{"name":"Toda Naoki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"森 建介"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"湯浅 智之"},{"name":"乙田 敏城"},{"name":"中村 信元"},{"name":"戸田 直紀"},{"name":"粟飯原 賢一"}]},"event":{"en":"第266回徳島医学会学術集会","ja":"第266回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:72, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565336"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394201","label":"url"}],"presentation_title":{"en":"ITP,自己免疫性出血病F13に続発しTAFRO症候群を発症した1例","ja":"ITP,自己免疫性出血病F13に続発しTAFRO症候群を発症した1例"},"presenters":{"en":[{"name":"林 成樹"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Mori Ayaka"},{"name":"Tamaki Masanori"},{"name":"Abe Masahiro"}],"ja":[{"name":"林 成樹"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"森 彩花"},{"name":"田蒔 昌憲"},{"name":"安倍 正博"}]},"event":{"en":"第127回日本内科学会四国地方会","ja":"第127回日本内科学会四国地方会"},"publication_date":"2022-12-18","is_international_presentation":false},"priority":"input_data"} line:73, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593217"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394200","label":"url"}],"presentation_title":{"en":"帯状疱疹後急速に汎発性帯状疱疹に移行した2例","ja":"帯状疱疹後急速に汎発性帯状疱疹に移行した2例"},"presenters":{"en":[{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"河田 沙紀"},{"name":"Kaneko Yohsuke"},{"name":"Mori Kensuke"},{"name":"滝下 誠"},{"name":"祖川 麻衣子"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"森 建介"},{"name":"滝下 誠"},{"name":"祖川 麻衣子"},{"name":"粟飯原 賢一"}]},"event":{"en":"第127回日本内科学会四国地方会","ja":"第127回日本内科学会四国地方会"},"publication_date":"2022-12-18","is_international_presentation":false},"priority":"input_data"} line:74, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593218"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/WC27350037","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394193","label":"url"}],"presentation_title":{"en":"ダラツムマブ投与患者における間接抗グロブリン試験干渉期間の検討","ja":"ダラツムマブ投与患者における間接抗グロブリン試験干渉期間の検討"},"presenters":{"en":[{"name":"佃 恵里加"},{"name":"李 悦子"},{"name":"瀧本 朋美"},{"name":"小田 直輝"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"佃 恵里加"},{"name":"李 悦子"},{"name":"瀧本 朋美"},{"name":"小田 直輝"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"Japanese Journal of Transfusion and Cell Therapy","ja":"日本輸血細胞治療学会誌"},"publication_date":"2022-12","promoter":{"en":"(一社)日本輸血・細胞治療学会","ja":"(一社)日本輸血・細胞治療学会"},"is_international_presentation":false},"priority":"input_data"} line:75, {"insert":{"user_id":"B000341201","type":"presentations","id":"41379391"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393952","label":"url"}],"presentation_title":{"en":"2型糖尿病患者の骨格筋異常におけるGNRIスコアの意義","ja":"2型糖尿病患者の骨格筋異常におけるGNRIスコアの意義"},"presenters":{"en":[{"name":"森 建介"},{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"森 建介"},{"name":"河田 沙紀"},{"name":"金子 遥祐"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"日本糖尿病学会中国四国地方会第60回総会","ja":"日本糖尿病学会中国四国地方会第60回総会"},"publication_date":"2022-11-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:76, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565337"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394202","label":"url"}],"presentation_title":{"en":"Importance of skeletal muscle mass during chemotherapies in patients with hematological malignancies","ja":"Importance of skeletal muscle mass during chemotherapies in patients with hematological malignancies"},"presenters":{"en":[{"name":"Takahashi Mamiko"},{"name":"Nakamura Shingen"},{"name":"Kondo Shin"},{"name":"Nakamura Masafuumi"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"Takahashi Mamiko"},{"name":"中村 信元"},{"name":"Kondo Shin"},{"name":"Nakamura Masafuumi"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"JSH2022","ja":"JSH2022"},"publication_date":"2022-10-16","is_international_presentation":false},"priority":"input_data"} line:77, {"insert":{"user_id":"B000341201","type":"presentations","id":"42283818"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396176","label":"url"}],"presentation_title":{"en":"The therapeutic potential targeting ADAR1-dsRNA metabolism in myeloma cells with 1q amplification","ja":"The therapeutic potential targeting ADAR1-dsRNA metabolism in myeloma cells with 1q amplification"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Sumitani Ryohei"},{"name":"Oda Asuka"},{"name":"Inoue Yusuke"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Maruhashi Tomoko"},{"name":"Takahashi Mamiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Ozaki Shuji"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"住谷 龍平"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"尾崎 修治"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"The 84th Annual Meeting of the Japanese Society of Hematology","ja":"The 84th Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2022-10-15","languages":["eng"],"location":{"en":"福岡県","ja":"福岡県"},"is_international_presentation":false},"priority":"input_data"} line:78, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593219"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/WC08160174","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394192","label":"url"}],"presentation_title":{"en":"新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例","ja":"新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"Yamagami Hiroki"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"Japanese Journal of Geriatrics","ja":"日本老年医学会雑誌"},"publication_date":"2022-10","promoter":{"en":"(一社)日本老年医学会","ja":"(一社)日本老年医学会"},"is_international_presentation":false},"priority":"input_data"} line:79, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550744"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388257","label":"url"}],"presentation_title":{"en":"免疫不全リスクを有する患者における 新型コロナワクチンによる抗体獲得能に 関連する因子の検討","ja":"免疫不全リスクを有する患者における 新型コロナワクチンによる抗体獲得能に 関連する因子の検討"},"presenters":{"en":[{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Shimizu Taro"},{"name":"ANDO Hidenori"},{"name":"Aizawa Fuka"},{"name":"Niimura Takahiro"},{"name":"Yagi Kenta"},{"name":"Goda Mitsuhiro"},{"name":"Ishida Tatsuhiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"清水 太郎"},{"name":"安藤 英紀"},{"name":"相澤 風花"},{"name":"新村 貴博"},{"name":"八木 健太"},{"name":"合田 光寛"},{"name":"石田 竜弘"},{"name":"石澤 啓介"}]},"event":{"en":"第32回日本医療薬学学会","ja":"第32回日本医療薬学学会"},"publication_date":"2022-09-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:80, {"insert":{"user_id":"B000341201","type":"presentations","id":"43457306"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403044","label":"url"}],"presentation_title":{"en":"免疫不全リスクを有する患者における新型コロナワクチンによる抗体獲得能に影響を与える因子の検討","ja":"免疫不全リスクを有する患者における新型コロナワクチンによる抗体獲得能に影響を与える因子の検討"},"presenters":{"en":[{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Shimizu Taro"},{"name":"ANDO Hidenori"},{"name":"Aizawa Fuka"},{"name":"Niimura Takahiro"},{"name":"Yagi Kenta"},{"name":"Goda Mitsuhiro"},{"name":"Ishida Tatsuhiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"清水 太郎"},{"name":"安藤 英紀"},{"name":"相澤 風花"},{"name":"新村 貴博"},{"name":"八木 健太"},{"name":"合田 光寛"},{"name":"石田 竜弘"},{"name":"石澤 啓介"}]},"event":{"en":"第32回日本医療薬学会年会","ja":"第32回日本医療薬学会年会"},"publication_date":"2022-09","languages":["jpn"],"location":{"en":"Takasaki","ja":"高崎"},"is_international_presentation":false},"priority":"input_data"} line:81, {"insert":{"user_id":"B000341201","type":"presentations","id":"41379392"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393941","label":"url"}],"presentation_title":{"en":"当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響","ja":"当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響"},"presenters":{"en":[{"name":"細木 美苗"},{"name":"Yamagami Hiroki"},{"name":"安井 沙耶"},{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第22回日本糖尿病インフォマティクス学会年次学術集会","ja":"第22回日本糖尿病インフォマティクス学会年次学術集会"},"publication_date":"2022-08-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:82, {"insert":{"user_id":"B000341201","type":"presentations","id":"43207401"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402591","label":"url"}],"presentation_title":{"en":"ループス腎炎に対してミコフェノール酸モフェチル投与中に発症した他の医原性免疫不全関連リンパ増殖性疾患の1例","ja":"ループス腎炎に対してミコフェノール酸モフェチル投与中に発症した他の医原性免疫不全関連リンパ増殖性疾患の1例"},"presenters":{"en":[{"name":"新居 寛子"},{"name":"髙橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Sogabe Kimiko"},{"name":"林 成樹"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"安積 麻衣"},{"name":"湊 将典"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"新居 寛子"},{"name":"髙橋 真美子"},{"name":"藤井 志朗"},{"name":"曽我部 公子"},{"name":"林 成樹"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"安積 麻衣"},{"name":"湊 将典"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"第265回徳島医学会学術集会","ja":"第265回徳島医学会学術集会"},"publication_date":"2022-07","location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:83, {"insert":{"user_id":"B000341201","type":"presentations","id":"41379393"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393940","label":"url"}],"presentation_title":{"en":"SGLT2阻害薬内服中のシックデイ対応困難が契機となり,糖尿病性ケトアシドーシスを認めた認知症高齢2型糖尿病の1例","ja":"SGLT2阻害薬内服中のシックデイ対応困難が契機となり,糖尿病性ケトアシドーシスを認めた認知症高齢2型糖尿病の1例"},"presenters":{"en":[{"name":"米田 健一"},{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"森 建介"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"Yuasa Tomoyuki"},{"name":"Otoda Toshiki"},{"name":"Nakamura Shingen"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"米田 健一"},{"name":"金子 遥祐"},{"name":"河田 沙紀"},{"name":"森 建介"},{"name":"谷 彰浩"},{"name":"辻 誠士郎"},{"name":"湯浅 智之"},{"name":"乙田 敏城"},{"name":"中村 信元"},{"name":"粟飯原 賢一"}]},"event":{"en":"第265回 徳島医学会学術集会","ja":"第265回 徳島医学会学術集会"},"publication_date":"2022-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:84, {"insert":{"user_id":"B000341201","type":"presentations","id":"42064979"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395323","label":"url"}],"presentation_title":{"en":"不動は骨髄腫骨病変部DPP-4発現増加と骨髄腫の腫瘍進展・髄外播種を加速させる","ja":"不動は骨髄腫骨病変部DPP-4発現増加と骨髄腫の腫瘍進展・髄外播種を加速させる"},"presenters":{"en":[{"name":"Mariko TANAKA"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Tenshin Hirofumi"},{"name":"Shimizu Sou"},{"name":"Higa Yoshiki"},{"name":"Nakaue Emiko"},{"name":"Suha KIMU"},{"name":"Teramachi Jumpei"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"田中 茉里子"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"天眞 寛文"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"中上 絵美子"},{"name":"金 秀河"},{"name":"寺町 順平"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第40回日本骨代謝学会学術集会","ja":"第40回日本骨代謝学会学術集会"},"publication_date":"2022-07-23","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:85, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550745"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394198","label":"url"}],"presentation_title":{"en":"初発時にヘルペスウイルス属の再活性化と中枢浸潤を伴い急速に悪化した成人T細胞白血病リンパ腫の1例","ja":"初発時にヘルペスウイルス属の再活性化と中枢浸潤を伴い急速に悪化した成人T細胞白血病リンパ腫の1例"},"presenters":{"en":[{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Tani Akihiro"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Miyata Yoshihiro"},{"name":"Yamagami Hiroki"},{"name":"辻 誠士郎"},{"name":"Aihara Ken-ichi"},{"name":"滝下 誠"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"山上 紘規"},{"name":"辻 誠士郎"},{"name":"粟飯原 賢一"},{"name":"滝下 誠"}]},"event":{"en":"第126回日本内科学会四国地方会","ja":"第126回日本内科学会四国地方会"},"publication_date":"2022-06-05","is_international_presentation":false},"priority":"input_data"} line:86, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565338"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394197","label":"url"}],"presentation_title":{"en":"126","ja":"126"},"presenters":{"en":[{"name":"Sumitani Ryohei"},{"name":"Mizuguchi Makiko"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hashimoto Toshihiro"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"住谷 龍平"},{"name":"水口 槙子"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"橋本 年弘"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"event":{"en":"第126回日本内科学会四国地方会","ja":"第126回日本内科学会四国地方会"},"publication_date":"2022-06-05","is_international_presentation":false},"priority":"input_data"} line:87, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565339"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394196","label":"url"}],"presentation_title":{"en":"FXIII/13","ja":"FXIII/13"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Taiki HORI"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"赤澤 啓人"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"赤澤 啓人"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第126回日本内科学会四国地方会","ja":"第126回日本内科学会四国地方会"},"publication_date":"2022-06-05","is_international_presentation":false},"priority":"input_data"} line:88, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550746"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388259","label":"url"}],"presentation_title":{"en":"新型コロナワクチン接種後に発覚した自己免疫性出血病FXIII/13","ja":"新型コロナワクチン接種後に発覚した自己免疫性出血病FXIII/13"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Taiki HORI"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"赤澤 啓人"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"赤澤 啓人"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第126回日本内科学会四国地方会","ja":"第126回日本内科学会四国地方会"},"publication_date":"2022-06-05","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:89, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550747"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388258","label":"url"}],"presentation_title":{"en":"地域での造血腫瘍の診療を考える","ja":"地域での造血腫瘍の診療を考える"},"presenters":{"en":[{"name":"本田 壮一"},{"name":"Nakamura Shingen"},{"name":"高橋 啓輝"},{"name":"Taiki HORI"},{"name":"Abe Masahiro"}],"ja":[{"name":"本田 壮一"},{"name":"中村 信元"},{"name":"高橋 啓輝"},{"name":"堀 太貴"},{"name":"安倍 正博"}]},"event":{"en":"第126回日本内科学会四国地方会","ja":"第126回日本内科学会四国地方会"},"publication_date":"2022-06-05","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:90, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593220"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022279560","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394188","label":"url"}],"presentation_title":{"en":"ALアミロイドーシスの肝病変の評価における超音波エラストグラフィの有用性","ja":"ALアミロイドーシスの肝病変の評価における超音波エラストグラフィの有用性"},"presenters":{"en":[{"name":"中村 昌史"},{"name":"Miki Hirokazu"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"西尾 進"},{"name":"Tomonari Tetsu"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 昌史"},{"name":"三木 浩和"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"西尾 進"},{"name":"友成 哲"},{"name":"安倍 正博"}]},"event":{"en":"The Japanese Journal of Clinical Hematology","ja":"臨床血液"},"publication_date":"2022-06","promoter":{"en":"(一社)日本血液学会-東京事務局","ja":"(一社)日本血液学会-東京事務局"},"is_international_presentation":false},"priority":"input_data"} line:91, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550748"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388265","label":"url"}],"presentation_title":{"en":"血液疾患,自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討","ja":"血液疾患,自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Taiki HORI"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"滝下 誠"},{"name":"答島 章公"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"答島 章公"},{"name":"粟飯原 賢一"}]},"event":{"en":"第96回日本感染症学会総会","ja":"第96回日本感染症学会総会"},"publication_date":"2022-05-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:92, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550749"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388264","label":"url"}],"presentation_title":{"en":"Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia","ja":"Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Taiki HORI"},{"name":"Nakamura Masafumi"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Maruhashi Tomoko"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"event":{"en":"The 47th annual meeting of Japanese Society of Myeloma","ja":"The 47th annual meeting of Japanese Society of Myeloma"},"publication_date":"2022-05-22","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:93, {"insert":{"user_id":"B000341201","type":"presentations","id":"42283819"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396179","label":"url"}],"presentation_title":{"en":"Osteoclasts robustly express SLAMF7 and secrete soluble SLAMF7","ja":"破骨細胞はSLAMF7を強発現し可溶性SLAMF7を産生する"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Harada Takeshi"},{"name":"井上 雄介"},{"name":"菊池 次郎"},{"name":"小田 明日香"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"鈴木 敦"},{"name":"角川 学士"},{"name":"峯畑 健一"},{"name":"古川 雄祐"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"菊池 次郎"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"鈴木 敦"},{"name":"角川 学士"},{"name":"峯畑 健一"},{"name":"古川 雄祐"},{"name":"安倍 正博"}]},"event":{"en":"The 47th Annual Meeting of the Japanese Society of Myeloma","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-21","languages":["jpn"],"location":{"en":"岐阜県","ja":"岐阜県"},"is_international_presentation":false},"priority":"input_data"} line:94, {"insert":{"user_id":"B000341201","type":"presentations","id":"42283820"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=396178","label":"url"}],"presentation_title":{"en":"Leverage of Th1-like γδT cells into antibody-mediated immunotherapy against myeloma","ja":"骨髄腫に対する抗体免疫療法へのTh1様γδT細胞の応用"},"presenters":{"en":[{"name":"井上 雄介"},{"name":"Harada Takeshi"},{"name":"Tenshin Hirofumi"},{"name":"小田 明日香"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"井上 雄介"},{"name":"原田 武志"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"The 47th Annual Meeting of the Japanese Society of Myeloma","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-21","languages":["jpn"],"location":{"en":"岐阜県","ja":"岐阜県"},"is_international_presentation":false},"priority":"input_data"} line:95, {"insert":{"user_id":"B000341201","type":"presentations","id":"39161460"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387140","label":"url"}],"presentation_title":{"en":"Therapeutic impact of targeting RNA editing enzyme ADAR1 on myeloma cells with 1q amplification","ja":"RNA編集酵素ADAR1を標的にする1q増幅骨髄腫細胞に対する治療法の開発"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Sumitani Ryohei"},{"name":"Oda Asuka"},{"name":"Yusuke Inoue"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Maruhashi Tomoko"},{"name":"Mamiko Takahashi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"住谷 龍平"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"第47回日本骨髄腫学会学術集会","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-21","languages":["jpn"],"location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:96, {"insert":{"user_id":"B000341201","type":"presentations","id":"43207402"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402590","label":"url"}],"presentation_title":{"en":"TAK1 阻害は骨髄腫の細胞間相互作用による骨破壊と薬剤耐性を改善する","ja":"TAK1 阻害は骨髄腫の細胞間相互作用による骨破壊と薬剤耐性を改善する"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Shimizu Sou"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"清水 宗"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"event":{"en":"第47回日本骨髄腫学会学術集会","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-20","location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:97, {"insert":{"user_id":"B000341201","type":"presentations","id":"43207403"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402588","label":"url"}],"presentation_title":{"en":"骨髄腫細胞のプロテアソーム阻害薬への抵抗性の機序と温熱療法によるその克服の可能性","ja":"骨髄腫細胞のプロテアソーム阻害薬への抵抗性の機序と温熱療法によるその克服の可能性"},"presenters":{"en":[{"name":"丸橋 朋子"},{"name":"Miki Hirokazu"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"小田 明日香"},{"name":"Nakamura Shingen"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Abe Masahiro"}],"ja":[{"name":"丸橋 朋子"},{"name":"三木 浩和"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"小田 明日香"},{"name":"中村 信元"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"安倍 正博"}]},"event":{"en":"第47回日本骨髄腫学会学術集会","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-20","location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:98, {"insert":{"user_id":"B000341201","type":"presentations","id":"43207404"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402587","label":"url"}],"presentation_title":{"en":"形質細胞疾患における新型コロナワクチンの有効性","ja":"形質細胞疾患における新型コロナワクチンの有効性"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"髙橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Harada Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"髙橋 真美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"原田 武志"},{"name":"安倍 正博"}]},"event":{"en":"第47回日本骨髄腫学会学術集会","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-20","location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:99, {"insert":{"user_id":"B000341201","type":"presentations","id":"43207405"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=402585","label":"url"}],"presentation_title":{"en":"肝臓アミロイドーシスに対する超音波エラストグラフィを用いた非侵襲的診断法の有用性","ja":"肝臓アミロイドーシスに対する超音波エラストグラフィを用いた非侵襲的診断法の有用性"},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"西尾 進"},{"name":"友成 哲"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"西尾 進"},{"name":"友成 哲"},{"name":"安倍 正博"}]},"event":{"en":"第47回日本骨髄腫学会学術集会","ja":"第47回日本骨髄腫学会学術集会"},"publication_date":"2022-05-20","location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:100, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890569"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386566","label":"url"}],"presentation_title":{"en":"Skin Autofluorescenceの糖尿病性腎臓病における臨床的意義の解析","ja":"Skin Autofluorescenceの糖尿病性腎臓病における臨床的意義の解析"},"presenters":{"en":[{"name":"山上 紘規"},{"name":"細木 美苗"},{"name":"Taiki HORI"},{"name":"安井 沙耶"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"細木 美苗"},{"name":"堀 太貴"},{"name":"安井 沙耶"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第65回日本糖尿病学会年次学術集会","ja":"第65回日本糖尿病学会年次学術集会"},"publication_date":"2022-05-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:101, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890570"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386565","label":"url"}],"presentation_title":{"en":"当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響","ja":"当院10年間における死亡患者の年齢・死因および併存合併症における糖尿病と治療薬剤の影響"},"presenters":{"en":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第65回日本糖尿病学会年次学術集会","ja":"第65回日本糖尿病学会年次学術集会"},"publication_date":"2022-05-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:102, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593221"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022277139","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394186","label":"url"}],"presentation_title":{"en":"形質細胞異常症患者におけるSARS-CoV-2に対するmRNAワクチンの液性免疫応答の評価(Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia)","ja":"形質細胞異常症患者におけるSARS-CoV-2に対するmRNAワクチンの液性免疫応答の評価(Humoral response of the mRNA vaccine against SARS-CoV-2 in patients with plasma cell dyscrasia)"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Harada Takeshi"},{"name":"Aihara Ken-ichi"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"原田 武志"},{"name":"粟飯原 賢一"},{"name":"安倍 正博"}]},"event":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"publication_date":"2022-05","promoter":{"en":"(一社)日本骨髄腫学会","ja":"(一社)日本骨髄腫学会"},"is_international_presentation":false},"priority":"input_data"} line:103, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593222"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022277092","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394185","label":"url"}],"presentation_title":{"en":"The impact of pulsatile proteasome inhibitor on bone metabolism","ja":"プロテアソーム阻害薬のパルス投与の骨代謝への影響"},"presenters":{"en":[{"name":"Nakaue Emiko"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Harada Takeshi"},{"name":"Tanimoto Kotaro"},{"name":"Shimizu Sou"},{"name":"Higa Yoshiki"},{"name":"Sumitani Ryohei"},{"name":"丸橋 朋子"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Abe Masahiro"}],"ja":[{"name":"中上 絵美子"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"原田 武志"},{"name":"谷本 幸多朗"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"住谷 龍平"},{"name":"丸橋 朋子"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"安倍 正博"}]},"event":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"publication_date":"2022-05","promoter":{"en":"(一社)日本骨髄腫学会","ja":"(一社)日本骨髄腫学会"},"is_international_presentation":false},"priority":"input_data"} line:104, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593223"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022277090","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394184","label":"url"}],"presentation_title":{"en":"破骨細胞はSLAMF7を強発現し可溶性SLAMF7を産生する(Osteoclasts robustly express SLAMF7 and secrete soluble SLAMF7)","ja":"破骨細胞はSLAMF7を強発現し可溶性SLAMF7を産生する(Osteoclasts robustly express SLAMF7 and secrete soluble SLAMF7)"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Harada Takeshi"},{"name":"井上 雄介"},{"name":"菊池 次郎"},{"name":"小田 明日香"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"鈴木 敦"},{"name":"角川 学士"},{"name":"峯畑 健一"},{"name":"古川 雄祐"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"菊池 次郎"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"鈴木 敦"},{"name":"角川 学士"},{"name":"峯畑 健一"},{"name":"古川 雄祐"},{"name":"安倍 正博"}]},"event":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"publication_date":"2022-05","promoter":{"en":"(一社)日本骨髄腫学会","ja":"(一社)日本骨髄腫学会"},"is_international_presentation":false},"priority":"input_data"} line:105, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593224"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022245092","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394182","label":"url"}],"presentation_title":{"en":"高齢者透析患者における新型コロナワクチン抗体価に影響する因子の検討","ja":"高齢者透析患者における新型コロナワクチン抗体価に影響する因子の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"辻 誠士郎"},{"name":"宮 恵子"},{"name":"島 久登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"岡田 一義"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"吉田 守美子"},{"name":"辻 誠士郎"},{"name":"宮 恵子"},{"name":"島 久登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"岡田 一義"},{"name":"中村 信元"},{"name":"安倍 正博"}]},"event":{"en":"Japanese Journal of Geriatrics","ja":"日本老年医学会雑誌"},"publication_date":"2022-05","promoter":{"en":"(一社)日本老年医学会","ja":"(一社)日本老年医学会"},"is_international_presentation":false},"priority":"input_data"} line:106, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550750"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388256","label":"url"}],"presentation_title":{"en":"自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討","ja":"自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Nakamura Shingen"},{"name":"Tani Akihiro"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Miyata Yoshihiro"},{"name":"堀 太貴"},{"name":"答島 章公"},{"name":"Aihara Ken-ichi"},{"name":"滝下 誠"}],"ja":[{"name":"山上 紘規"},{"name":"中村 信元"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"堀 太貴"},{"name":"答島 章公"},{"name":"粟飯原 賢一"},{"name":"滝下 誠"}]},"event":{"en":"第119回日本内科学会総会","ja":"第119回日本内科学会総会"},"publication_date":"2022-04-17","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:107, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550751"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388255","label":"url"}],"presentation_title":{"en":"血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討","ja":"血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討"},"presenters":{"en":[{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Tani Akihiro"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Miyata Yoshihiro"},{"name":"Yamagami Hiroki"},{"name":"答島 章公"},{"name":"Aihara Ken-ichi"},{"name":"滝下 誠"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"山上 紘規"},{"name":"答島 章公"},{"name":"粟飯原 賢一"},{"name":"滝下 誠"}]},"event":{"en":"第119回日本内科学会総会","ja":"第119回日本内科学会総会"},"publication_date":"2022-04-17","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:108, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593225"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022274209","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394183","label":"url"}],"presentation_title":{"en":"透析患者における新型コロナワクチン抗体と糖尿病の関連の検討","ja":"透析患者における新型コロナワクチン抗体と糖尿病の関連の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"辻 誠士郎"},{"name":"Kurahashi Kiyoe"},{"name":"宮 恵子"},{"name":"島 久登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"Nakamura Shingen"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"},{"name":"Matsuhisa Munehide"}],"ja":[{"name":"吉田 守美子"},{"name":"辻 誠士郎"},{"name":"倉橋 清衛"},{"name":"宮 恵子"},{"name":"島 久登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"中村 信元"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"安倍 正博"},{"name":"松久 宗英"}]},"event":{"en":"Journal of the The Japan Diabetes Society","ja":"糖尿病"},"publication_date":"2022-04","promoter":{"en":"(一社)日本糖尿病学会","ja":"(一社)日本糖尿病学会"},"is_international_presentation":false},"priority":"input_data"} line:109, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593226"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/W615480043","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388292","label":"url"}],"presentation_title":{"en":"HIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題","ja":"HIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題"},"presenters":{"en":[{"name":"高原 由実子"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"高橋 真美子"},{"name":"丸橋 朋子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Abe Masahiro"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"青田 桂子"},{"name":"Ozaki Shuji"}],"ja":[{"name":"高原 由実子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"丸橋 朋子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"安倍 正博"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"青田 桂子"},{"name":"尾崎 修治"}]},"event":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"publication_date":"2022-04","promoter":{"en":"Tokushima Medical Association","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:110, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593227"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022220337","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394181","label":"url"}],"presentation_title":{"en":"血液疾患,自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討","ja":"血液疾患,自己免疫疾患における新型コロナワクチン接種後の抗体獲得能の検討"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"Yamagami Hiroki"},{"name":"答島 章公"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"答島 章公"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"Kansenshōgaku Zasshi","ja":"感染症学雑誌"},"publication_date":"2022-03","promoter":{"en":"(一社)日本感染症学会","ja":"(一社)日本感染症学会"},"is_international_presentation":false},"priority":"input_data"} line:111, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593228"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022279525","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389373","label":"url"}],"presentation_title":{"en":"少量methotrexate療法が有効であった進行期原発性皮膚未分化大細胞型リンパ腫.","ja":"少量methotrexate療法が有効であった進行期原発性皮膚未分化大細胞型リンパ腫."},"presenters":{"en":[{"name":"Sumitani Ryohei"},{"name":"Harada Takeshi"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"髙橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Yada Mio"},{"name":"Matsudate Yoshihiro"},{"name":"Uehara Hisanori"},{"name":"Abe Masahiro"}],"ja":[{"name":"住谷 龍平"},{"name":"原田 武志"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"髙橋 真美子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"矢田 未央"},{"name":"松立 吉弘"},{"name":"上原 久典"},{"name":"安倍 正博"}]},"event":{"en":"The Japanese Journal of Clinical Hematology","ja":"臨床血液"},"publication_date":"2022-03","languages":["jpn"],"promoter":{"en":"Japanese Society of Hematology","ja":"一般社団法人 日本血液学会"},"description":{"en":"進行期の原発性皮膚未分化大細胞リンパ腫(pcALCL)に対する標準治療は定まっていない.症例は71歳,男性.多発性の皮膚紅斑と結節病変を認め,左耳介後部からの生検でリンパ腫性丘疹症(LyP)と診断された.局所電子線照射にて全ての病変は消退したが,5ヵ月後に両内眼角に結節病変が出現し,同部位の生検ではCD30陽性大型細胞が大部分を占めpcALCLと診断された.PET/CTにて右口蓋扁桃腫大,頸部,鼠径部の表在リンパ節腫大およびFDG集積を認め,TNM分類T3bN3M0であった.慢性閉塞性肺疾患による呼吸機能低下と肺炎を反復していたため,多剤併用化学療法ではなくmethotrexate(MTX)15mg/週の内服療法を選択した.皮膚,リンパ節病変は縮小し,副作用なく長期間病勢コントロールが可能であった.pcALCLの標準治療は確立されていないが様々な治療法が開発されてきており,少量MTX療法は呼吸器感染症を繰り返すフレイルな患者に有用であった.LyPにpcALCLが続発する機序や本疾患群に対する少量MTX療法の作用機序の解明が望まれる.(著者抄録)","ja":"進行期の原発性皮膚未分化大細胞リンパ腫(pcALCL)に対する標準治療は定まっていない.症例は71歳,男性.多発性の皮膚紅斑と結節病変を認め,左耳介後部からの生検でリンパ腫性丘疹症(LyP)と診断された.局所電子線照射にて全ての病変は消退したが,5ヵ月後に両内眼角に結節病変が出現し,同部位の生検ではCD30陽性大型細胞が大部分を占めpcALCLと診断された.PET/CTにて右口蓋扁桃腫大,頸部,鼠径部の表在リンパ節腫大およびFDG集積を認め,TNM分類T3bN3M0であった.慢性閉塞性肺疾患による呼吸機能低下と肺炎を反復していたため,多剤併用化学療法ではなくmethotrexate(MTX)15mg/週の内服療法を選択した.皮膚,リンパ節病変は縮小し,副作用なく長期間病勢コントロールが可能であった.pcALCLの標準治療は確立されていないが様々な治療法が開発されてきており,少量MTX療法は呼吸器感染症を繰り返すフレイルな患者に有用であった.LyPにpcALCLが続発する機序や本疾患群に対する少量MTX療法の作用機序の解明が望まれる.(著者抄録)"},"is_international_presentation":false},"priority":"input_data"} line:112, {"insert":{"user_id":"B000341201","type":"presentations","id":"41578980"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389084","label":"url"}],"presentation_title":{"en":"新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例.","ja":"新型コロナワクチン接種後にvaccine-induced immune thrombotic thrombocytopeniaを疑われた症例."},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第33回日本老年病学会四国地方会, 2022年1月23日(Web開催)","ja":"第33回日本老年病学会四国地方会, 2022年1月23日(Web開催)"},"publication_date":"2022-02-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:113, {"insert":{"user_id":"B000341201","type":"presentations","id":"41578981"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389082","label":"url"}],"presentation_title":{"en":"HIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題. --- 264 ( 3 )","ja":"HIV感染症および後天性免疫不全症候群患者の臨床的特徴と今後の課題. --- 264 ( 3 )"},"presenters":{"en":[{"name":"高原 由実子"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"中村 昌史"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"岡本 秀樹"},{"name":"Okada Naoto"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Aota Keiko"},{"name":"Ozaki Shuji"},{"name":"Abe Masahiro"}],"ja":[{"name":"高原 由実子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"中村 昌史"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"青田 桂子"},{"name":"尾崎 修治"},{"name":"安倍 正博"}]},"event":{"en":"第264回徳島医学会学術集会(令和3年度冬期), 2022年2月20日(Web開催)","ja":"第264回徳島医学会学術集会(令和3年度冬期), 2022年2月20日(Web開催)"},"publication_date":"2022-02-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:114, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593229"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022138070","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394174","label":"url"}],"presentation_title":{"en":"自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討","ja":"自己免疫疾患における新型コロナワクチンによる抗体獲得能の検討"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Nakamura Shingen"},{"name":"細木 美苗"},{"name":"堀 太貴"},{"name":"安井 沙耶"},{"name":"Aihara Ken-ichi"},{"name":"答島 章公"},{"name":"滝下 誠"}],"ja":[{"name":"山上 紘規"},{"name":"中村 信元"},{"name":"細木 美苗"},{"name":"堀 太貴"},{"name":"安井 沙耶"},{"name":"粟飯原 賢一"},{"name":"答島 章公"},{"name":"滝下 誠"}]},"event":{"en":"The Journal of the Japanese Society of Internal Medicine","ja":"日本内科学会雑誌"},"publication_date":"2022-02","promoter":{"en":"(一社)日本内科学会","ja":"(一社)日本内科学会"},"is_international_presentation":false},"priority":"input_data"} line:115, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593230"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022138079","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388282","label":"url"}],"presentation_title":{"en":"血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討","ja":"血液疾患患者における新型コロナウイルスワクチン接種による抗体獲得能の検討"},"presenters":{"en":[{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"Yamagami Hiroki"},{"name":"答島 章公"},{"name":"Aihara Ken-ichi"},{"name":"滝下 誠"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"宮田 好裕"},{"name":"山上 紘規"},{"name":"答島 章公"},{"name":"粟飯原 賢一"},{"name":"滝下 誠"}]},"event":{"en":"The Journal of the Japanese Society of Internal Medicine","ja":"日本内科学会雑誌"},"publication_date":"2022-02","promoter":{"en":"(一社)日本内科学会","ja":"(一社)日本内科学会"},"is_international_presentation":false},"priority":"input_data"} line:116, {"insert":{"user_id":"B000341201","type":"presentations","id":"36577028"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=384840","label":"url"}],"presentation_title":{"en":"65歳以上の透析患者における新型コロナワクチン抗体価の検討","ja":"65歳以上の透析患者における新型コロナワクチン抗体価の検討"},"presenters":{"en":[{"name":"辻 誠士郎"},{"name":"Yoshida Sumiko"},{"name":"宮 恵子"},{"name":"島久 登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"Nakamura Shingen"},{"name":"Endo Itsuro"},{"name":"Abe Masahiro"}],"ja":[{"name":"辻 誠士郎"},{"name":"吉田 守美子"},{"name":"宮 恵子"},{"name":"島久 登"},{"name":"田代 学"},{"name":"井上 朋子"},{"name":"水口 潤"},{"name":"中村 信元"},{"name":"遠藤 逸朗"},{"name":"安倍 正博"}]},"event":{"en":"第33回日本老年医学会四国地方会","ja":"第33回日本老年医学会四国地方会"},"publication_date":"2022-01-23","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:117, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565340"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394195","label":"url"}],"presentation_title":{"en":"T1","ja":"T1"},"presenters":{"en":[{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Tani Akihiro"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Aihara Ken-ichi"},{"name":"Miyagami Yuko"},{"name":"Oya Takeshi"},{"name":"滝下 誠"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷 彰浩"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"粟飯原 賢一"},{"name":"宮上 侑子"},{"name":"尾矢 剛志"},{"name":"滝下 誠"}]},"event":{"en":"第125回日本内科学会四国地方会","ja":"第125回日本内科学会四国地方会"},"publication_date":"2021-12-05","is_international_presentation":false},"priority":"input_data"} line:118, {"insert":{"user_id":"B000341201","type":"presentations","id":"39550752"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388261","label":"url"}],"presentation_title":{"en":"血管中心性に浸潤し急速な経過で死に至った末梢性T細胞リンパ腫の1剖検例","ja":"血管中心性に浸潤し急速な経過で死に至った末梢性T細胞リンパ腫の1剖検例"},"presenters":{"en":[{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第125回日本内科学会四国地方会","ja":"第125回日本内科学会四国地方会"},"publication_date":"2021-12-05","languages":["jpn"],"location":{"en":"web","ja":"web"},"is_international_presentation":false},"priority":"input_data"} line:119, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593231"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022081464","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394173","label":"url"}],"presentation_title":{"en":"アミノグリコシド系抗菌薬がAPTTに与える影響の検討","ja":"アミノグリコシド系抗菌薬がAPTTに与える影響の検討"},"presenters":{"en":[{"name":"菅崎 幹樹"},{"name":"Nakamura Shingen"},{"name":"寺本 継脩"},{"name":"漆原 南実"},{"name":"秦 真公人"},{"name":"三好 雅士"},{"name":"Nakao Takayuki"}],"ja":[{"name":"菅崎 幹樹"},{"name":"中村 信元"},{"name":"寺本 継脩"},{"name":"漆原 南実"},{"name":"秦 真公人"},{"name":"三好 雅士"},{"name":"中尾 隆之"}]},"event":{"en":"日本臨床衛生検査技師会中四国支部医学検査学会抄録集","ja":"日本臨床衛生検査技師会中四国支部医学検査学会抄録集"},"publication_date":"2021-12","promoter":{"en":"中四国支部医学検査学会","ja":"中四国支部医学検査学会"},"is_international_presentation":false},"priority":"input_data"} line:120, {"insert":{"user_id":"B000341201","type":"presentations","id":"35944945"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=383285","label":"url"}],"presentation_title":{"en":"ゲノムワイド関連解析によるビンクリスチン副作用発現関連遺伝子の同定と機械学習を用いた副作用発現予測モデルの構築","ja":"ゲノムワイド関連解析によるビンクリスチン副作用発現関連遺伝子の同定と機械学習を用いた副作用発現予測モデルの構築"},"presenters":{"en":[{"name":"Yamada Hiroki"},{"name":"Ohmori Rio"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"山田 博貴"},{"name":"大森 理央"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"第60回日本薬学会中国四国支部学術大会","ja":"第60回日本薬学会中国四国支部学術大会"},"publication_date":"2021-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:121, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890571"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386563","label":"url"}],"presentation_title":{"en":"当院死亡患者の年齢・死因および併存合併症における糖尿病の影響","ja":"当院死亡患者の年齢・死因および併存合併症における糖尿病の影響"},"presenters":{"en":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第59回日本糖尿病学会中国四国地方会","ja":"第59回日本糖尿病学会中国四国地方会"},"publication_date":"2021-10-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:122, {"insert":{"user_id":"B000341201","type":"presentations","id":"39611504"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389086","label":"url"}],"presentation_title":{"en":"Resumption of myeloma cell sensitivity to proteasome inhibitors by PIM and Akt inhibition","ja":"PIMとAkt阻害は骨髄腫細胞におけるプロテアソーム阻害薬感受性を増強する"},"presenters":{"en":[{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"Sumitani Ryohei"},{"name":"丸橋 朋子"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"住谷 龍平"},{"name":"丸橋 朋子"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"The 83rd Annual Meeting of the Japanese Society of Hematology","ja":"The 83rd Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2021-09-24","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:123, {"insert":{"user_id":"B000341201","type":"presentations","id":"39161461"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387139","label":"url"}],"presentation_title":{"en":"Expansion of γδT cells by CELMoDs and enhancement of their anti-myeloma effects by elotuzumab","ja":"CELMoDsを用いたγδT細胞増幅法とエロツズマブによるγδT細胞の抗骨髄腫作用の増強法の開発"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Inoue Yusuke"},{"name":"Tenshin Hirofumi"},{"name":"Oda Asuka"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"The 83rd Annual Meeting of Japanese Society of Hematology","ja":"第83回日本血液学会学術集会"},"publication_date":"2021-09-23","invited":true,"languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:124, {"insert":{"user_id":"B000341201","type":"presentations","id":"38890572"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386562","label":"url"}],"presentation_title":{"en":"糖尿病の有無からみた当院死亡患者の年齢・死因および併存合併症に関する検討","ja":"糖尿病の有無からみた当院死亡患者の年齢・死因および併存合併症に関する検討"},"presenters":{"en":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"細木 美苗"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"粟飯原 賢一"}]},"event":{"en":"第21回日本内分泌学会四国支部学術集会","ja":"第21回日本内分泌学会四国支部学術集会"},"publication_date":"2021-09-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:125, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593232"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022198805","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394179","label":"url"}],"presentation_title":{"en":"血液がんにおける線虫がん検査 N-NOSEの検討(Detection of hematological malignancies using N-NOSE(Nematode-NOSE))","ja":"血液がんにおける線虫がん検査 N-NOSEの検討(Detection of hematological malignancies using N-NOSE(Nematode-NOSE))"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"上野 宜久"},{"name":"Yoshida Sumiko"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"高橋 真美子"},{"name":"丸橋 朋子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"広津 崇亮"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"上野 宜久"},{"name":"吉田 守美子"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"丸橋 朋子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"広津 崇亮"},{"name":"安倍 正博"}]},"event":{"en":"日本血液学会学術集会","ja":"日本血液学会学術集会"},"publication_date":"2021-09","promoter":{"en":"(一社)日本血液学会","ja":"(一社)日本血液学会"},"is_international_presentation":false},"priority":"input_data"} line:126, {"insert":{"user_id":"B000341201","type":"presentations","id":"43679127"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/VC28480633","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389359","label":"url"}],"presentation_title":{"en":"肝臓アミロイドーシスに対する超音波エラストグラフィの診断的有用性.","ja":"肝臓アミロイドーシスに対する超音波エラストグラフィの診断的有用性."},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"Harada Takeshi"},{"name":"Kagawa Kumiko"},{"name":"Susumu Nishio"},{"name":"Tomonari Tetsu"},{"name":"Abe Masahiro"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"髙橋 真美子"},{"name":"丸橋 朋子"},{"name":"原田 武志"},{"name":"賀川 久美子"},{"name":"Susumu Nishio"},{"name":"友成 哲"},{"name":"安倍 正博"}]},"event":{"en":"第83回日本血液学会学術集会","ja":"第83回日本血液学会学術集会"},"publication_date":"2021-09","languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:127, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593233"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/VC28480868","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388287","label":"url"}],"presentation_title":{"en":"PIMとAkt阻害による骨髄腫細胞のプロテアソーム阻害薬感受性の増強(Sensitization of myeloma cells to proteasome inhibitors by PIM and Akt inhibition)","ja":"PIMとAkt阻害による骨髄腫細胞のプロテアソーム阻害薬感受性の増強(Sensitization of myeloma cells to proteasome inhibitors by PIM and Akt inhibition)"},"presenters":{"en":[{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"Sumitani Ryohei"},{"name":"丸橋 朋子"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"住谷 龍平"},{"name":"丸橋 朋子"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"日本血液学会学術集会","ja":"日本血液学会学術集会"},"publication_date":"2021-09","promoter":{"en":"(一社)日本血液学会","ja":"(一社)日本血液学会"},"is_international_presentation":false},"priority":"input_data"} line:128, {"insert":{"user_id":"B000341201","type":"presentations","id":"43679128"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389293","label":"url"}],"presentation_title":{"en":"当院における先天性血友病患者(成人例)の実態調査∼移行期医療の重要性∼","ja":"当院における先天性血友病患者(成人例)の実態調査∼移行期医療の重要性∼"},"presenters":{"en":[{"name":"西條 早希"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"谷口 早紀"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"青田 桂子"},{"name":"菅 俊行"},{"name":"渡邊 浩良"},{"name":"大坂 朱美"},{"name":"Abe Masahiro"}],"ja":[{"name":"西條 早希"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"谷口 早紀"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"青田 桂子"},{"name":"菅 俊行"},{"name":"渡邊 浩良"},{"name":"大坂 朱美"},{"name":"安倍 正博"}]},"event":{"en":"第263回徳島医学会学術集会(令和3年度夏期)","ja":"第263回徳島医学会学術集会(令和3年度夏期)"},"publication_date":"2021-08","location":{"en":"Online","ja":"オンライン"},"is_international_presentation":false},"priority":"input_data"} line:129, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804661"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=375944","label":"url"}],"presentation_title":{"en":"アブスコパル効果を示した甲状腺原発形質細胞腫の1例","ja":"アブスコパル効果を示した甲状腺原発形質細胞腫の1例"},"presenters":{"en":[{"name":"庄野 隆志"},{"name":"Aoyama Mariko"},{"name":"南城 和正"},{"name":"山本 清成"},{"name":"Maki Hidenori"},{"name":"Inui Tomohiro"},{"name":"Sakamoto Shinichi"},{"name":"Kobayashi Tomoko"},{"name":"Nakamura Shingen"},{"name":"Takizawa Hiromitsu"},{"name":"Tangoku Akira"}],"ja":[{"name":"庄野 隆志"},{"name":"青山 万理子"},{"name":"南城 和正"},{"name":"山本 清成"},{"name":"牧 秀則"},{"name":"乾 友浩"},{"name":"坂本 晋一"},{"name":"小林 智子"},{"name":"中村 信元"},{"name":"滝沢 宏光"},{"name":"丹黒 章"}]},"event":{"en":"第33回日本内分泌外科学会総会","ja":"第33回日本内分泌外科学会総会"},"publication_date":"2021-06-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:130, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352910"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379398","label":"url"}],"presentation_title":{"en":"Detection of hematological malignancies using N-NOSE (Nematode-NOSE)","ja":"Detection of hematological malignancies using N-NOSE (Nematode-NOSE)"},"presenters":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"event":{"en":"Annals of Oncology","ja":"Annals of Oncology"},"publication_date":"2021-06","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:131, {"insert":{"user_id":"B000341201","type":"presentations","id":"33172859"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377112","label":"url"}],"presentation_title":{"en":"Development of combinatory treatment of Th1-like γδT cells with elotuzumab against osteoclasts as well as myeloma cells","ja":"Development of combinatory treatment of Th1-like γδT cells with elotuzumab against osteoclasts as well as myeloma cells"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Inoue Yusuke"},{"name":"Tenshin Hirofumi"},{"name":"Oda Asuka"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"第46回日本骨髄腫学会学術集会","ja":"第46回日本骨髄腫学会学術集会"},"publication_date":"2021-05-29","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:132, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312412"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378615","label":"url"}],"presentation_title":{"en":"糖尿病患者における歩行速度規定臨床因子の解析","ja":"糖尿病患者における歩行速度規定臨床因子の解析"},"presenters":{"en":[{"name":"Kaneko Yohsuke"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第64回日本糖尿病学会年次学術集会","ja":"第64回日本糖尿病学会年次学術集会"},"publication_date":"2021-05-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:133, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312413"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378613","label":"url"}],"presentation_title":{"en":"生体電気インピーダンス法による細胞外水分比および位相角と糖尿病患者における血中HbおよびHtレベルの連関解析","ja":"生体電気インピーダンス法による細胞外水分比および位相角と糖尿病患者における血中HbおよびHtレベルの連関解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Hori Taiki"},{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Kaneko Yohsuke"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"粟飯原 賢一"},{"name":"堀 太貴"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"安倍 正博"}]},"event":{"en":"第64回日本糖尿病学会年次学術集会","ja":"第64回日本糖尿病学会年次学術集会"},"publication_date":"2021-05-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:134, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312414"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378616","label":"url"}],"presentation_title":{"en":"糖尿病患者におけるDehydroepiandrosterone sulfate (DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義","ja":"糖尿病患者におけるDehydroepiandrosterone sulfate (DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Kaneko Yohsuke"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第64回日本糖尿病学会年次学術集会","ja":"第64回日本糖尿病学会年次学術集会"},"publication_date":"2021-05-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:135, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312415"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378614","label":"url"}],"presentation_title":{"en":"糖尿病患者における非アルコール性脂肪肝疾患および骨格筋異常症におけるDehydroepiandrosterone sulfate (DHEAS)の意義","ja":"糖尿病患者における非アルコール性脂肪肝疾患および骨格筋異常症におけるDehydroepiandrosterone sulfate (DHEAS)の意義"},"presenters":{"en":[{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Kaneko Yohsuke"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第64回日本糖尿病学会年次学術集会","ja":"第64回日本糖尿病学会年次学術集会"},"publication_date":"2021-05-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:136, {"insert":{"user_id":"B000341201","type":"presentations","id":"41565341"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394194","label":"url"}],"presentation_title":{"en":"1","ja":"1"},"presenters":{"en":[{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"Yamagami Hiroki"},{"name":"Aihara Ken-ichi"},{"name":"滝下 誠"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"粟飯原 賢一"},{"name":"滝下 誠"}]},"event":{"en":"第124回日本内科学会四国地方会","ja":"第124回日本内科学会四国地方会"},"publication_date":"2021-05-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:137, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352911"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388262","label":"url"}],"presentation_title":{"en":"腫大リンパ節に著明なアミロイド沈着を認めたリンパ形質細胞性リンパ腫の1例","ja":"腫大リンパ節に著明なアミロイド沈着を認めたリンパ形質細胞性リンパ腫の1例"},"presenters":{"en":[{"name":"Taiki HORI"},{"name":"Nakamura Shingen"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第124回日本内科学会四国地方会","ja":"第124回日本内科学会四国地方会"},"publication_date":"2021-05-09","languages":["jpn"],"location":{"en":"web","ja":"web"},"is_international_presentation":false},"priority":"input_data"} line:138, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593234"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2022176963","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388283","label":"url"}],"presentation_title":{"en":"骨髄腫細胞のプロテアソーム阻害薬の耐性機序におけるPIM2とAkt活性およびNRF2蓄積の役割(Mechanisms for the resistance to proteasome inhibitors in myeloma cells: the role of PIM2 and Akt kinase activation and NRF2 accumulation)","ja":"骨髄腫細胞のプロテアソーム阻害薬の耐性機序におけるPIM2とAkt活性およびNRF2蓄積の役割(Mechanisms for the resistance to proteasome inhibitors in myeloma cells: the role of PIM2 and Akt kinase activation and NRF2 accumulation)"},"presenters":{"en":[{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"李 政樹"},{"name":"飯田 真介"},{"name":"Abe Masahiro"}],"ja":[{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"李 政樹"},{"name":"飯田 真介"},{"name":"安倍 正博"}]},"event":{"en":"International Journal of Myeloma","ja":"International Journal of Myeloma"},"publication_date":"2021-05","promoter":{"en":"(一社)日本骨髄腫学会","ja":"(一社)日本骨髄腫学会"},"is_international_presentation":false},"priority":"input_data"} line:139, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/V617251113","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379401","label":"url"}],"presentation_title":{"en":"糖尿病患者における歩行速度規定臨床因子の解析","ja":"糖尿病患者における歩行速度規定臨床因子の解析"},"presenters":{"en":[{"name":"金子 遥祐"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Otoda Toshiki"},{"name":"Taniguchi Tatsuya"},{"name":"Aihara Ken-ichi"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"山上 紘規"},{"name":"Nakamura Shingen"}],"ja":[{"name":"金子 遥祐"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"乙田 敏城"},{"name":"谷口 達哉"},{"name":"粟飯原 賢一"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"山上 紘規"},{"name":"中村 信元"}]},"event":{"en":"Journal of the The Japan Diabetes Society","ja":"糖尿病"},"publication_date":"2021-05","languages":["jpn"],"promoter":{"en":"(一社)日本糖尿病学会","ja":"(一社)日本糖尿病学会"},"is_international_presentation":false},"priority":"input_data"} line:140, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352912"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/V617251394","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379400","label":"url"}],"presentation_title":{"en":"糖尿病患者におけるDehydroepiandrosterone sulfate(DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義","ja":"糖尿病患者におけるDehydroepiandrosterone sulfate(DHEAS)の糖尿病性腎臓病進展および高血圧症罹患における意義"},"presenters":{"en":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Journal of the The Japan Diabetes Society","ja":"糖尿病"},"publication_date":"2021-05","languages":["jpn"],"promoter":{"en":"(一社)日本糖尿病学会","ja":"(一社)日本糖尿病学会"},"is_international_presentation":false},"priority":"input_data"} line:141, {"insert":{"user_id":"B000341201","type":"presentations","id":"33322274"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378627","label":"url"}],"presentation_title":{"en":"生体電気インピーダンス法による細胞外水分比および位相角は糖尿病患者の血中HbおよびHtレベルを規定する","ja":"生体電気インピーダンス法による細胞外水分比および位相角は糖尿病患者の血中HbおよびHtレベルを規定する"},"presenters":{"en":[{"name":"Hori Taiki"},{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Kaneko Yohsuke"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"堀 太貴"},{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"event":{"en":"第94回日本内分泌学会学術総会","ja":"第94回日本内分泌学会学術総会"},"publication_date":"2021-04-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:142, {"insert":{"user_id":"B000341201","type":"presentations","id":"33322275"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378625","label":"url"}],"presentation_title":{"en":"Dehydroepiandrosterone sulfate (DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる","ja":"Dehydroepiandrosterone sulfate (DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Kaneko Yohsuke"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第94回日本内分泌学会学術総会","ja":"第94回日本内分泌学会学術総会"},"publication_date":"2021-04-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:143, {"insert":{"user_id":"B000341201","type":"presentations","id":"33322276"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378622","label":"url"}],"presentation_title":{"en":"生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する","ja":"生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する"},"presenters":{"en":[{"name":"Kaneko Yohsuke"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第94回日本内分泌学会学術総会","ja":"第94回日本内分泌学会学術総会"},"publication_date":"2021-04-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:144, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021212390","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379433","label":"url"}],"presentation_title":{"en":"生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する","ja":"生活習慣病患者の歩行速度は骨格筋量よりも筋力が規定する"},"presenters":{"en":[{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Folia endocrinologica Japonica","ja":"日本内分泌学会雑誌"},"publication_date":"2021-04","languages":["jpn"],"promoter":{"en":"(一社)日本内分泌学会","ja":"(一社)日本内分泌学会"},"is_international_presentation":false},"priority":"input_data"} line:145, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352913"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021212236","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379432","label":"url"}],"presentation_title":{"en":"Dehydroepiandrosterone sulfate(DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる","ja":"Dehydroepiandrosterone sulfate(DHEAS)高値は糖尿病性腎臓病進展および高血圧症罹患のリスクとなる"},"presenters":{"en":[{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"安井 沙耶"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Folia endocrinologica Japonica","ja":"日本内分泌学会雑誌"},"publication_date":"2021-04","languages":["jpn"],"promoter":{"en":"(一社)日本内分泌学会","ja":"(一社)日本内分泌学会"},"is_international_presentation":false},"priority":"input_data"} line:146, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352914"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021211939","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379431","label":"url"}],"presentation_title":{"en":"Dehydroepiandrosterone sulfate(DHEAS)は生活習慣病患者における非アルコール性脂肪肝疾患およびダイナペニアの発症抑制因子である","ja":"Dehydroepiandrosterone sulfate(DHEAS)は生活習慣病患者における非アルコール性脂肪肝疾患およびダイナペニアの発症抑制因子である"},"presenters":{"en":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Folia endocrinologica Japonica","ja":"日本内分泌学会雑誌"},"publication_date":"2021-04","languages":["jpn"],"promoter":{"en":"(一社)日本内分泌学会","ja":"(一社)日本内分泌学会"},"is_international_presentation":false},"priority":"input_data"} line:147, {"insert":{"user_id":"B000341201","type":"presentations","id":"39359772"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387554","label":"url"}],"presentation_title":{"en":"HIV感染血友病患者における臨床的特徴と今後の課題","ja":"HIV感染血友病患者における臨床的特徴と今後の課題"},"presenters":{"en":[{"name":"石田 卓也"},{"name":"Miki Hirokazu"},{"name":"髙橋 真美子"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"丸橋 朋子"},{"name":"岡本 秀樹"},{"name":"Okada Naoto"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"Tomonari Tetsu"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Aota Keiko"},{"name":"Watanabe Hiroyoshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"石田 卓也"},{"name":"三木 浩和"},{"name":"髙橋 真美子"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"丸橋 朋子"},{"name":"岡本 秀樹"},{"name":"岡田 直人"},{"name":"矢野 由美子"},{"name":"高橋 真理"},{"name":"友成 哲"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"青田 桂子"},{"name":"渡邊 浩良"},{"name":"安倍 正博"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2021-03-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:148, {"insert":{"user_id":"B000341201","type":"presentations","id":"39611505"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=389085","label":"url"}],"presentation_title":{"en":"造血幹細胞移植(allo-SCT)が奏効したMLL遺伝子変異合併CML急性転化(CML-BP)の2例","ja":"造血幹細胞移植(allo-SCT)が奏効したMLL遺伝子変異合併CML急性転化(CML-BP)の2例"},"presenters":{"en":[{"name":"Tomoko Maruhashi"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Masafumi Nakamura"},{"name":"Kawata Shiyori"},{"name":"Mizuguchi Makiko"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Mamiko Takahashi"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"丸橋 朋子"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 昌史"},{"name":"川田 知代"},{"name":"水口 槇子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"第43回日本造血細胞移植学会総会","ja":"第43回日本造血細胞移植学会総会"},"publication_date":"2021-03-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:149, {"insert":{"user_id":"B000341201","type":"presentations","id":"41593235"},"force":{"see_also":[{"@id":"https://search.jamas.or.jp/link/ui/2021177035","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=394172","label":"url"}],"presentation_title":{"en":"∼抗酸菌症にチームで立ち向かう∼最新の知見と新たな光∼ 無菌手洗い装置によるMycobacterium chimaeraの偽アウトブレイク","ja":"∼抗酸菌症にチームで立ち向かう∼最新の知見と新たな光∼ 無菌手洗い装置によるMycobacterium chimaeraの偽アウトブレイク"},"presenters":{"en":[{"name":"Azuma Momoyo"},{"name":"Nakamura Shingen"},{"name":"吉田 志緒美"}],"ja":[{"name":"東 桃代"},{"name":"中村 信元"},{"name":"吉田 志緒美"}]},"event":{"en":"Japanese Journal of Chemotherapy","ja":"日本化学療法学会雑誌"},"publication_date":"2021-03","promoter":{"en":"(公社)日本化学療法学会","ja":"(公社)日本化学療法学会"},"is_international_presentation":false},"priority":"input_data"} line:150, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352915"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021177035","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379426","label":"url"}],"presentation_title":{"en":"~抗酸菌症にチームで立ち向かう~最新の知見と新たな光~ 無菌手洗い装置によるMycobacterium chimaeraの偽アウトブレイク","ja":"~抗酸菌症にチームで立ち向かう~最新の知見と新たな光~ 無菌手洗い装置によるMycobacterium chimaeraの偽アウトブレイク"},"presenters":{"en":[{"name":"Azuma Momoyo"},{"name":"Nakamura Shingen"},{"name":"吉田 志緒美"}],"ja":[{"name":"東 桃代"},{"name":"中村 信元"},{"name":"吉田 志緒美"}]},"event":{"en":"Japanese Journal of Chemotherapy","ja":"日本化学療法学会雑誌"},"publication_date":"2021-03","languages":["jpn"],"promoter":{"en":"(公社)日本化学療法学会","ja":"(公社)日本化学療法学会"},"is_international_presentation":false},"priority":"input_data"} line:151, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352916"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021143847","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379425","label":"url"}],"presentation_title":{"en":"当院生活習慣病患者における骨格筋量に影響を与える因子の検討","ja":"当院生活習慣病患者における骨格筋量に影響を与える因子の検討"},"presenters":{"en":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Folia endocrinologica Japonica","ja":"日本内分泌学会雑誌"},"publication_date":"2021-01","languages":["jpn"],"promoter":{"en":"(一社)日本内分泌学会","ja":"(一社)日本内分泌学会"},"is_international_presentation":false},"priority":"input_data"} line:152, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352917"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021143846","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379424","label":"url"}],"presentation_title":{"en":"当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討","ja":"当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討"},"presenters":{"en":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"Folia endocrinologica Japonica","ja":"日本内分泌学会雑誌"},"publication_date":"2021-01","languages":["jpn"],"promoter":{"en":"(一社)日本内分泌学会","ja":"(一社)日本内分泌学会"},"is_international_presentation":false},"priority":"input_data"} line:153, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804662"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=372430","label":"url"}],"presentation_title":{"en":"機械学習による遺伝情報を用いた抗がん剤投与の味覚障害発現予測モデルの構築","ja":"機械学習による遺伝情報を用いた抗がん剤投与の味覚障害発現予測モデルの構築"},"presenters":{"en":[{"name":"Takei Minori"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"武井 みのり"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"第59回中国四国支部学術大会","ja":"第59回中国四国支部学術大会"},"publication_date":"2020-12-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:154, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804663"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=372429","label":"url"}],"presentation_title":{"en":"ゲノム情報を用いた機械学習によるシタラビン投与後の副作用発現予測モデルの構築","ja":"ゲノム情報を用いた機械学習によるシタラビン投与後の副作用発現予測モデルの構築"},"presenters":{"en":[{"name":"Endoh Yuka"},{"name":"Tashima Hozumi"},{"name":"岡田 直人"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"遠藤 優香"},{"name":"田島 穂澄"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"第59回中国四国支部学術大会","ja":"第59回中国四国支部学術大会"},"publication_date":"2020-12-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:155, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352918"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021179002","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379429","label":"url"}],"presentation_title":{"en":"急性転化をきたしたAYA世代慢性骨髄性白血病の1例","ja":"急性転化をきたしたAYA世代慢性骨髄性白血病の1例"},"presenters":{"en":[{"name":"清重 尚希"},{"name":"Sumitani Ryohei"},{"name":"水口 槙子"},{"name":"中村 昌史"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"高橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"賀川 久美子"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"曽賀 愛未"},{"name":"一宮 由貴"},{"name":"Yamamoto Yuri"}],"ja":[{"name":"清重 尚希"},{"name":"住谷 龍平"},{"name":"水口 槙子"},{"name":"中村 昌史"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"曽賀 愛未"},{"name":"一宮 由貴"},{"name":"山本 由理"}]},"event":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"publication_date":"2020-12","languages":["jpn"],"promoter":{"en":"Tokushima Medical Association","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:156, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352919"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021178981","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379428","label":"url"}],"presentation_title":{"en":"意識障害,高アンモニア血症を呈した78歳男性","ja":"意識障害,高アンモニア血症を呈した78歳男性"},"presenters":{"en":[{"name":"高原 実香"},{"name":"Yamamoto Nobuaki"},{"name":"Miyamoto Ryosuke"},{"name":"Fujita Koji"},{"name":"Izumi Yuishin"},{"name":"Sumitani Ryohei"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Shimazu Hideki"},{"name":"西田 善彦"}],"ja":[{"name":"高原 実香"},{"name":"山本 伸昭"},{"name":"宮本 亮介"},{"name":"藤田 浩司"},{"name":"和泉 唯信"},{"name":"住谷 龍平"},{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"島津 秀紀"},{"name":"西田 善彦"}]},"event":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"publication_date":"2020-12","languages":["jpn"],"promoter":{"en":"Tokushima Medical Association","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:157, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352920"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021178967","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379427","label":"url"}],"presentation_title":{"en":"Daratumumab投与による輸血関連検査への影響とその対策","ja":"Daratumumab投与による輸血関連検査への影響とその対策"},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"李 悦子"},{"name":"佃 恵里加"},{"name":"小田 直輝"},{"name":"瀧本 朋美"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"高橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Nakamura Shingen"}],"ja":[{"name":"三木 浩和"},{"name":"李 悦子"},{"name":"佃 恵里加"},{"name":"小田 直輝"},{"name":"瀧本 朋美"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"中村 信元"}]},"event":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"publication_date":"2020-12","languages":["jpn"],"promoter":{"en":"Tokushima Medical Association","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:158, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352921"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021102731","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379415","label":"url"}],"presentation_title":{"en":"リツキシマブもしくはリツキシマブ併用化学療法を要した濾胞性リンパ腫の十二指腸病変の検討","ja":"リツキシマブもしくはリツキシマブ併用化学療法を要した濾胞性リンパ腫の十二指腸病変の検討"},"presenters":{"en":[{"name":"宮田 好裕"},{"name":"板垣 達三"},{"name":"藤本 美幸"},{"name":"答島 章公"},{"name":"滝下 誠"},{"name":"日比野 真吾"},{"name":"Nakamura Shingen"}],"ja":[{"name":"宮田 好裕"},{"name":"板垣 達三"},{"name":"藤本 美幸"},{"name":"答島 章公"},{"name":"滝下 誠"},{"name":"日比野 真吾"},{"name":"中村 信元"}]},"event":{"en":"日本消化器病学会四国支部例会プログラム・抄録集","ja":"日本消化器病学会四国支部例会プログラム・抄録集"},"publication_date":"2020-12","languages":["jpn"],"promoter":{"en":"日本消化器病学会-四国支部","ja":"日本消化器病学会-四国支部"},"is_international_presentation":false},"priority":"input_data"} line:159, {"insert":{"user_id":"B000341201","type":"presentations","id":"33414423"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=380407","label":"url"}],"presentation_title":{"en":"ウイルス関連血球貪食症候群が疑われたアグレッシブNK細胞白血病の1例","ja":"ウイルス関連血球貪食症候群が疑われたアグレッシブNK細胞白血病の1例"},"presenters":{"en":[{"name":"市原 聖也"},{"name":"Sumitani Ryohei"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"市原 聖也"},{"name":"住谷 龍平"},{"name":"中村 昌史"},{"name":"水口 槙子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"第123回日本内科学会四国地方会","ja":"第123回日本内科学会四国地方会"},"publication_date":"2020-11-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:160, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804664"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374380","label":"url"}],"presentation_title":{"en":"潰瘍性大腸炎とバセドウ病の治療中に汎血球減少を契機に自己免疫性胃炎が判明した一例","ja":"潰瘍性大腸炎とバセドウ病の治療中に汎血球減少を契機に自己免疫性胃炎が判明した一例"},"presenters":{"en":[{"name":"金山 涼加"},{"name":"Kurahashi Kiyoe"},{"name":"明比 祐子"},{"name":"Okamoto Koichi"},{"name":"Nakamura Shingen"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"},{"name":"Takayama Tetsuji"},{"name":"Abe Masahiro"}],"ja":[{"name":"金山 涼加"},{"name":"倉橋 清衛"},{"name":"明比 祐子"},{"name":"岡本 耕一"},{"name":"中村 信元"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"},{"name":"高山 哲治"},{"name":"安倍 正博"}]},"event":{"en":"第123回日本内科学会四国地方会","ja":"第123回日本内科学会四国地方会"},"publication_date":"2020-11-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:161, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352923"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=388263","label":"url"}],"presentation_title":{"en":"アミカシンによるAPTT偽延長を来したSerratia marcescens菌血症の1例","ja":"アミカシンによるAPTT偽延長を来したSerratia marcescens菌血症の1例"},"presenters":{"en":[{"name":"Kaneko Yohsuke"},{"name":"Nakamura Shingen"},{"name":"Hosoki Minae"},{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Taiki HORI"},{"name":"滝下 誠"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"金子 遥祐"},{"name":"中村 信元"},{"name":"細木 美苗"},{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"堀 太貴"},{"name":"滝下 誠"},{"name":"粟飯原 賢一"}]},"event":{"en":"第123回日本内科学会四国地方会","ja":"第123回日本内科学会四国地方会"},"publication_date":"2020-11-12","languages":["jpn"],"location":{"en":"web","ja":"web"},"is_international_presentation":false},"priority":"input_data"} line:162, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352922"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379437","label":"url"}],"presentation_title":{"en":"潰瘍性大腸炎とバセドウ病の治療中にLDH著明高値を伴った汎血球減少を契機に自己免疫性胃炎が判明した1例","ja":"潰瘍性大腸炎とバセドウ病の治療中にLDH著明高値を伴った汎血球減少を契機に自己免疫性胃炎が判明した1例"},"presenters":{"en":[{"name":"金山 涼加"},{"name":"Nakamura Shingen"}],"ja":[{"name":"金山 涼加"},{"name":"中村 信元"}]},"event":{"en":"第123回日本内科学会四国地方会","ja":"第123回日本内科学会四国地方会"},"publication_date":"2020-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:163, {"insert":{"user_id":"B000341201","type":"presentations","id":"33414424"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=380478","label":"url"}],"presentation_title":{"en":"Immediate accumulation of anti-apoptotic PIM2 in myeloma cells by proteasome inhibitors","ja":"プロテアソーム阻害薬による骨髄腫細胞の抗アポトーシス因子PIM2の急速な蓄積"},"presenters":{"en":[{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"小田 明日香"},{"name":"Harada Takeshi"},{"name":"Sumitani Ryohei"},{"name":"Oura Masahiro"},{"name":"Kagawa Kumiko"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Ri Masaki"},{"name":"Shinsuke Iida"},{"name":"Abe Masahiro"}],"ja":[{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"住谷 龍平"},{"name":"大浦 雅博"},{"name":"賀川 久美子"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Ri Masaki"},{"name":"Shinsuke Iida"},{"name":"安倍 正博"}]},"event":{"en":"第82回日本血液学会学術集会","ja":"第82回日本血液学会学術集会"},"publication_date":"2020-10-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:164, {"insert":{"user_id":"B000341201","type":"presentations","id":"33414425"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=380461","label":"url"}],"presentation_title":{"en":"Critical roles of the TAK1-c-Myc loop as a novel therapeutic target for ATL","ja":"ATL新規治療標的としてのTAK1-c-Myc相互連関の重要な役割"},"presenters":{"en":[{"name":"Ohhra Masahiro"},{"name":"Harada Takeshi"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"Inoue Yusuke"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiroo Hasegawa"},{"name":"Hiroshi Fujiwara"},{"name":"Abe Masahiro"}],"ja":[{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"井上 雄介"},{"name":"曽我部 公子"},{"name":"住谷 龍平"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"Hiroo Hasegawa"},{"name":"Hiroshi Fujiwara"},{"name":"安倍 正博"}]},"event":{"en":"第82回日本血液学会学術集会","ja":"第82回日本血液学会学術集会"},"publication_date":"2020-10-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:165, {"insert":{"user_id":"B000341201","type":"presentations","id":"33192557"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377252","label":"url"}],"presentation_title":{"en":"不動は骨吸収と骨髄腫進展を促進させる","ja":"不動は骨吸収と骨髄腫進展を促進させる"},"presenters":{"en":[{"name":"Tanimoto Kotaro"},{"name":"Hiasa Masahiro"},{"name":"Tenshin Hirofumi"},{"name":"Ashtar Mohannad"},{"name":"Shimizu Sou"},{"name":"Higa Yoshiki"},{"name":"Teramachi Jumpei"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"谷本 幸多朗"},{"name":"日浅 雅博"},{"name":"天眞 寛文"},{"name":"ASHTAR MOHANNAD"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"寺町 順平"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2020-10-09","languages":["jpn"],"promoter":{"en":"第38回日本骨代謝学会学術集会","ja":"第38回日本骨代謝学会学術集会"},"is_international_presentation":false},"priority":"input_data"} line:166, {"insert":{"user_id":"B000341201","type":"presentations","id":"33192558"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377249","label":"url"}],"presentation_title":{"en":"抗腫瘍薬が誘導するROSは破骨細胞分化を促進する:Xanthine oxidase阻害剤febuxostatの治療効果.","ja":"抗腫瘍薬が誘導するROSは破骨細胞分化を促進する:Xanthine oxidase阻害剤febuxostatの治療効果."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Ashtar Mohannad"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Shimizu Sou"},{"name":"Higa Yoshiki"},{"name":"Harada Takeshi"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"ASHTAR MOHANNAD"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"原田 武志"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2020-10-09","languages":["jpn"],"promoter":{"en":"第38回日本骨代謝学会学術集会","ja":"第38回日本骨代謝学会学術集会"},"location":{"en":"web開催","ja":"web開催"},"is_international_presentation":false},"priority":"input_data"} line:167, {"insert":{"user_id":"B000341201","type":"presentations","id":"33175904"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377114","label":"url"}],"presentation_title":{"en":"Versatile anti-myeloma effects by elotuzumab: impact on γδT cells and osteoclasts","ja":"Versatile anti-myeloma effects by elotuzumab: impact on γδT cells and osteoclasts"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Inoue Yusuke"},{"name":"Tenshin Hirofumi"},{"name":"Oda Asuka"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Sumitani Ryohei"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"井上 雄介"},{"name":"天眞 寛文"},{"name":"小田 明日香"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"住谷 龍平"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"安倍 正博"}]},"event":{"en":"The 82nd Annual Meeting of Japanese Soceity of Hematology","ja":"The 82nd Annual Meeting of Japanese Soceity of Hematology"},"publication_date":"2020-10-09","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:168, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352924"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021142607","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379423","label":"url"}],"presentation_title":{"en":"高1,25(OH)2D血症による高Ca血症を来したホジキンリンパ腫の一例","ja":"高1,25(OH)2D血症による高Ca血症を来したホジキンリンパ腫の一例"},"presenters":{"en":[{"name":"Kurahashi Kiyoe"},{"name":"村井 純平"},{"name":"堀 太貴"},{"name":"Sumitani Ryohei"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Kanai Mai"},{"name":"Sakurai Akiko"},{"name":"原 倫世"},{"name":"桝田 志保"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"},{"name":"松本 俊夫"},{"name":"Abe Masahiro"},{"name":"Fukumoto Seiji"}],"ja":[{"name":"倉橋 清衛"},{"name":"村井 純平"},{"name":"堀 太貴"},{"name":"住谷 龍平"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"金井 麻衣"},{"name":"櫻井 明子"},{"name":"原 倫世"},{"name":"桝田 志保"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"},{"name":"福本 誠二"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2020-10","languages":["jpn"],"promoter":{"en":"(一社)日本骨代謝学会","ja":"(一社)日本骨代謝学会"},"is_international_presentation":false},"priority":"input_data"} line:169, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352926"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021142602","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379418","label":"url"}],"presentation_title":{"en":"抗腫瘍薬が誘導するROSは破骨細胞分化を促進する Xanthine oxidase阻害剤febuxostatの治療効果","ja":"抗腫瘍薬が誘導するROSは破骨細胞分化を促進する Xanthine oxidase阻害剤febuxostatの治療効果"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"アシテル モハナッド"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Shimizu Sou"},{"name":"比嘉 佳基"},{"name":"Harada Takeshi"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"アシテル モハナッド"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"清水 宗"},{"name":"比嘉 佳基"},{"name":"原田 武志"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts"},"publication_date":"2020-10","languages":["eng"],"promoter":{"en":"(一社)日本骨代謝学会","ja":"(一社)日本骨代謝学会"},"is_international_presentation":false},"priority":"input_data"} line:170, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352927"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021110649","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379417","label":"url"}],"presentation_title":{"en":"結節性紅斑と悪性腫瘍関連血球貪食症候群を惹起した骨髄異形成症候群の1例","ja":"結節性紅斑と悪性腫瘍関連血球貪食症候群を惹起した骨髄異形成症候群の1例"},"presenters":{"en":[{"name":"Oura Masahiro"},{"name":"Nakamura Shingen"},{"name":"堀 太貴"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Kobayashi Tomoko"},{"name":"Oya Takeshi"},{"name":"Abe Masahiro"}],"ja":[{"name":"大浦 雅博"},{"name":"中村 信元"},{"name":"堀 太貴"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"小林 智子"},{"name":"尾矢 剛志"},{"name":"安倍 正博"}]},"event":{"en":"The Japanese Journal of Clinical Hematology","ja":"臨床血液"},"publication_date":"2020-10","languages":["jpn"],"promoter":{"en":"(一社)日本血液学会-東京事務局","ja":"(一社)日本血液学会-東京事務局"},"is_international_presentation":false},"priority":"input_data"} line:171, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352928"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2021110639","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379416","label":"url"}],"presentation_title":{"en":"クロスミキシングテストの特徴的な所見が診断の契機となったプレカリクレイン欠乏症の1例","ja":"クロスミキシングテストの特徴的な所見が診断の契機となったプレカリクレイン欠乏症の1例"},"presenters":{"en":[{"name":"中村 昌史"},{"name":"Miki Hirokazu"},{"name":"Oura Masahiro"},{"name":"川田 知代"},{"name":"堀 太貴"},{"name":"村井 純平"},{"name":"Sumitani Ryohei"},{"name":"Sogabe Kimiko"},{"name":"高橋 真美子"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"菅崎 幹樹"},{"name":"徳永 尚樹"},{"name":"Ikegame Akishige"},{"name":"森下 英理子"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 昌史"},{"name":"三木 浩和"},{"name":"大浦 雅博"},{"name":"川田 知代"},{"name":"堀 太貴"},{"name":"村井 純平"},{"name":"住谷 龍平"},{"name":"曽我部 公子"},{"name":"高橋 真美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"菅崎 幹樹"},{"name":"徳永 尚樹"},{"name":"池亀 彰茂"},{"name":"森下 英理子"},{"name":"安倍 正博"}]},"event":{"en":"The Japanese Journal of Clinical Hematology","ja":"臨床血液"},"publication_date":"2020-10","languages":["jpn"],"promoter":{"en":"(一社)日本血液学会-東京事務局","ja":"(一社)日本血液学会-東京事務局"},"is_international_presentation":false},"priority":"input_data"} line:172, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312416"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378611","label":"url"}],"presentation_title":{"en":"当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討","ja":"当院生活習慣病患者における握力と歩行速度に影響を与える因子の検討"},"presenters":{"en":[{"name":"Yamagami Hiroki"},{"name":"Yasui Saya"},{"name":"Kaneko Yohsuke"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"山上 紘規"},{"name":"安井 沙耶"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第20回日本内分泌学会四国支部学術集会","ja":"第20回日本内分泌学会四国支部学術集会"},"publication_date":"2020-09-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:173, {"insert":{"user_id":"B000341201","type":"presentations","id":"33312417"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378610","label":"url"}],"presentation_title":{"en":"当院生活習慣病患者における骨格筋量に影響を与える因子の検討","ja":"当院生活習慣病患者における骨格筋量に影響を与える因子の検討"},"presenters":{"en":[{"name":"Yasui Saya"},{"name":"Yamagami Hiroki"},{"name":"Kaneko Yohsuke"},{"name":"Hori Taiki"},{"name":"Nakamura Shingen"},{"name":"Taniguchi Tatsuya"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Soeki Takeshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"安井 沙耶"},{"name":"山上 紘規"},{"name":"金子 遥祐"},{"name":"堀 太貴"},{"name":"中村 信元"},{"name":"谷口 達哉"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"添木 武"},{"name":"粟飯原 賢一"}]},"event":{"en":"第20回日本内分泌学会四国支部学術集会","ja":"第20回日本内分泌学会四国支部学術集会"},"publication_date":"2020-09-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:174, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352929"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379434","label":"url"}],"presentation_title":{"en":"若年で発症しアトピー性皮膚炎に合併した化膿性脊椎炎の1例","ja":"若年で発症しアトピー性皮膚炎に合併した化膿性脊椎炎の1例"},"presenters":{"en":[{"name":"堀 大貴"},{"name":"Nakamura Shingen"},{"name":"Harada Takeshi"},{"name":"Sumitani Ryohei"},{"name":"村井 純平"},{"name":"高松 信敏"},{"name":"Tezuka Fumitake"},{"name":"Abe Masahiro"}],"ja":[{"name":"堀 大貴"},{"name":"中村 信元"},{"name":"原田 武志"},{"name":"住谷 龍平"},{"name":"村井 純平"},{"name":"高松 信敏"},{"name":"手束 文威"},{"name":"安倍 正博"}]},"event":{"en":"第123回日本内科学会四国地方会","ja":"第123回日本内科学会四国地方会"},"publication_date":"2020-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:175, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352930"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020345347","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379411","label":"url"}],"presentation_title":{"en":"血液凝固因子製剤の在庫適正化に向けた取り組みによる薬剤廃棄額の削減効果","ja":"血液凝固因子製剤の在庫適正化に向けた取り組みによる薬剤廃棄額の削減効果"},"presenters":{"en":[{"name":"Okada Naoto"},{"name":"神農 麻里奈"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Watanabe Hiroyoshi"},{"name":"Goda Mitsuhiro"},{"name":"Chuma Masayuki"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Abe Masahiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"岡田 直人"},{"name":"神農 麻里奈"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"渡邊 浩良"},{"name":"合田 光寛"},{"name":"中馬 真幸"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"安倍 正博"},{"name":"石澤 啓介"}]},"event":{"en":"Journal of Japnese Society of Hospital Pharmacists","ja":"日本病院薬剤師会雑誌"},"publication_date":"2020-07","languages":["jpn"],"promoter":{"en":"(一社)日本病院薬剤師会","ja":"(一社)日本病院薬剤師会"},"description":{"en":"血友病治療に用いる血液凝固因子製剤(coagulation factor:以下,CF)は高価である一方で,在庫流動性が低いという製剤的性質を有するが,これまで適切な在庫管理法の報告はない.徳島大学病院は2017年4月から,診療科と連携したCFの在庫適正化の取り組みを開始した.取り組み開始前である2015年4月~2017年3月の期間と,取り組み開始後である2017年4月~2019年3月の期間における血友病患者数,CF調剤薬剤数に差はなかったが,取り組み開始後のCF廃棄額は取り組み開始前と比較して78.4","ja":"血友病治療に用いる血液凝固因子製剤(coagulation factor:以下,CF)は高価である一方で,在庫流動性が低いという製剤的性質を有するが,これまで適切な在庫管理法の報告はない.徳島大学病院は2017年4月から,診療科と連携したCFの在庫適正化の取り組みを開始した.取り組み開始前である2015年4月~2017年3月の期間と,取り組み開始後である2017年4月~2019年3月の期間における血友病患者数,CF調剤薬剤数に差はなかったが,取り組み開始後のCF廃棄額は取り組み開始前と比較して78.4"},"is_international_presentation":false},"priority":"input_data"} line:176, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352931"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020387831","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379412","label":"url"}],"presentation_title":{"en":"骨髄異形成症候群の患者に生じた晩発性皮膚ポルフィリン症の1例","ja":"骨髄異形成症候群の患者に生じた晩発性皮膚ポルフィリン症の1例"},"presenters":{"en":[{"name":"山崎 佳那子"},{"name":"祖川 麻衣子"},{"name":"Murao Kazutoshi"},{"name":"Kubo Yoshiaki"},{"name":"Oura Masahiro"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"}],"ja":[{"name":"山崎 佳那子"},{"name":"祖川 麻衣子"},{"name":"村尾 和俊"},{"name":"久保 宜明"},{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"賀川 久美子"}]},"event":{"en":"The Nishinihon Journal of Dermatology","ja":"西日本皮膚科"},"publication_date":"2020-06","languages":["jpn"],"promoter":{"en":"日本皮膚科学会-西部支部","ja":"日本皮膚科学会-西部支部"},"is_international_presentation":false},"priority":"input_data"} line:177, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352932"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020325988","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379410","label":"url"}],"presentation_title":{"en":"特徴的な形態像を呈し鑑別に苦慮したIgDκ型多発性骨髄腫の一症例","ja":"特徴的な形態像を呈し鑑別に苦慮したIgDκ型多発性骨髄腫の一症例"},"presenters":{"en":[{"name":"秦 真公人"},{"name":"菅崎 幹樹"},{"name":"井上 雄介"},{"name":"多田 智紀"},{"name":"吉田 裕子"},{"name":"Nakao Takayuki"},{"name":"Sumitani Ryohei"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Takayama Tetsuji"}],"ja":[{"name":"秦 真公人"},{"name":"菅崎 幹樹"},{"name":"井上 雄介"},{"name":"多田 智紀"},{"name":"吉田 裕子"},{"name":"中尾 隆之"},{"name":"住谷 龍平"},{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"高山 哲治"}]},"event":{"en":"Journal of the Japanese Society for Laboratory Hematology","ja":"日本検査血液学会雑誌"},"publication_date":"2020-06","languages":["jpn"],"promoter":{"en":"(一社)日本検査血液学会","ja":"(一社)日本検査血液学会"},"is_international_presentation":false},"priority":"input_data"} line:178, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352933"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020295714","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379408","label":"url"}],"presentation_title":{"en":"高ビタミンD血症による高Ca血症を来したホジキンリンパ腫の一例","ja":"高ビタミンD血症による高Ca血症を来したホジキンリンパ腫の一例"},"presenters":{"en":[{"name":"村井 純平"},{"name":"堀 太貴"},{"name":"川田 知代"},{"name":"Sumitani Ryohei"},{"name":"宇高 憲吾"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Miki Hirokazu"},{"name":"桝田 志保"},{"name":"Endo Itsuro"},{"name":"Fukumoto Seiji"}],"ja":[{"name":"村井 純平"},{"name":"堀 太貴"},{"name":"川田 知代"},{"name":"住谷 龍平"},{"name":"宇高 憲吾"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"三木 浩和"},{"name":"桝田 志保"},{"name":"遠藤 逸朗"},{"name":"福本 誠二"}]},"event":{"en":"Shikoku Acta Medica","ja":"Shikoku Acta Medica"},"publication_date":"2020-04","languages":["eng"],"promoter":{"en":"徳島医学会","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:179, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804665"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364213","label":"url"}],"presentation_title":{"en":"機械学習を用いたゲノム情報によるシタラビン投与の副作用発現予測モデルの構築","ja":"機械学習を用いたゲノム情報によるシタラビン投与の副作用発現予測モデルの構築"},"presenters":{"en":[{"name":"Endoh Yuka"},{"name":"Tashima Hozumi"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"遠藤 優香"},{"name":"田島 穂澄"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"日本薬学会 第140年会","ja":"日本薬学会 第140年会"},"publication_date":"2020-03-26","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:180, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804666"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364212","label":"url"}],"presentation_title":{"en":"遺伝情報を用いた機械学習による抗がん剤投与の味覚障害発現予測モデルの構築","ja":"遺伝情報を用いた機械学習による抗がん剤投与の味覚障害発現予測モデルの構築"},"presenters":{"en":[{"name":"Takei Minori"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"武井 みのり"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"日本薬学会 第140年会","ja":"日本薬学会 第140年会"},"publication_date":"2020-03-26","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:181, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020320800","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379409","label":"url"}],"presentation_title":{"en":"機械学習を用いたゲノム情報によるシタラビン投与の副作用発現予測モデルの構築","ja":"機械学習を用いたゲノム情報によるシタラビン投与の副作用発現予測モデルの構築"},"presenters":{"en":[{"name":"遠藤 優香"},{"name":"田島 穂澄"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"遠藤 優香"},{"name":"田島 穂澄"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"日本薬学会年会要旨集","ja":"日本薬学会年会要旨集"},"publication_date":"2020-03","languages":["jpn"],"promoter":{"en":"(公社)日本薬学会","ja":"(公社)日本薬学会"},"is_international_presentation":false},"priority":"input_data"} line:182, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352934"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020390660","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379413","label":"url"}],"presentation_title":{"en":"徳島県におけるがん生殖医療の現状と課題","ja":"徳島県におけるがん生殖医療の現状と課題"},"presenters":{"en":[{"name":"Abe Akiko"},{"name":"Iwasa Takeshi"},{"name":"Yamamoto Yuri"},{"name":"Morimoto Masami"},{"name":"Nakamura Shingen"},{"name":"Kuwahara Akira"}],"ja":[{"name":"阿部 彰子"},{"name":"岩佐 武"},{"name":"山本 由理"},{"name":"森本 雅美"},{"name":"中村 信元"},{"name":"桑原 章"}]},"event":{"en":"Journal of Fertility Preservation","ja":"日本がん·生殖医療学会誌"},"publication_date":"2020-01","languages":["jpn"],"promoter":{"en":"(NPO)日本がん・生殖医療学会","ja":"(NPO)日本がん・生殖医療学会"},"is_international_presentation":false},"priority":"input_data"} line:183, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804667"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2020239069","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=367678","label":"url"}],"presentation_title":{"en":"TAK1阻害は関節リウマチにおけるNLRP3インフラマソーム誘導性の炎症および骨破壊を抑制する","ja":"TAK1阻害は関節リウマチにおけるNLRP3インフラマソーム誘導性の炎症および骨破壊を抑制する"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Bat-Erdene Ariunzaya,"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2019-10-12","languages":["jpn"],"promoter":{"en":"第37回日本骨代謝学会学術集会","ja":"第37回日本骨代謝学会学術集会"},"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:184, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804668"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=367676","label":"url"}],"presentation_title":{"en":"不動性骨吸収の亢進は骨髄内の骨髄腫進展を促進させる.","ja":"不動性骨吸収の亢進は骨髄内の骨髄腫進展を促進させる."},"presenters":{"en":[{"name":"Tanimoto Kotaro"},{"name":"Hiasa Masahiro"},{"name":"Iwasa Akihiko"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Ashtar Mohannad"},{"name":"Iwasa Masami"},{"name":"小田 明日香"},{"name":"曾我部 公子,"},{"name":"Oura Masahiro"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"谷本 幸多朗"},{"name":"日浅 雅博"},{"name":"岩浅 亮彦"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"ASHTAR MOHANNAD"},{"name":"岩佐 昌美"},{"name":"小田 明日香"},{"name":"曾我部 公子,"},{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2019-10-12","languages":["jpn"],"promoter":{"en":"第37回日本骨代謝学会学術集会","ja":"第37回日本骨代謝学会学術集会"},"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:185, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804669"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363704","label":"url"}],"presentation_title":{"en":"TAK1阻害は関節リウマチにおけるNLRP3インフラマソーム誘導性の炎症および骨破壊を抑制する.","ja":"TAK1阻害は関節リウマチにおけるNLRP3インフラマソーム誘導性の炎症および骨破壊を抑制する."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第37回日本骨代謝学会学術集会","ja":"第37回日本骨代謝学会学術集会"},"publication_date":"2019-10-12","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:186, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804670"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363700","label":"url"}],"presentation_title":{"en":"不動性骨吸収の亢進は骨髄内の骨髄腫進展を促進させる","ja":"不動性骨吸収の亢進は骨髄内の骨髄腫進展を促進させる"},"presenters":{"en":[{"name":"谷本 幸太朗"},{"name":"Hiasa Masahiro"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Ashtar Mohannad"},{"name":"Iwasa Masami"},{"name":"小田 明日香"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"谷本 幸太朗"},{"name":"日浅 雅博"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"ASHTAR MOHANNAD"},{"name":"岩佐 昌美"},{"name":"小田 明日香"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第37回日本骨代謝学会学術集会","ja":"第37回日本骨代謝学会学術集会"},"publication_date":"2019-10-12","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:187, {"insert":{"user_id":"B000341201","type":"presentations","id":"33352935"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=379399","label":"url"}],"presentation_title":{"en":"D-index-guided early antifungal therapy for persistent FN in patients with hematological malignancies (CEDMIC trial)","ja":"D-index-guided early antifungal therapy for persistent FN in patients with hematological malignancies (CEDMIC trial)"},"presenters":{"en":[{"name":"Emiko Sakaida"},{"name":"Yoshinobu Kanda"},{"name":"Shunichi Kimura"},{"name":"Nakamura Shingen"},{"name":"Kazuo Tamura"}],"ja":[{"name":"Emiko Sakaida"},{"name":"Yoshinobu Kanda"},{"name":"Shunichi Kimura"},{"name":"中村 信元"},{"name":"Kazuo Tamura"}]},"event":{"en":"Annals of Oncology","ja":"Annals of Oncology"},"publication_date":"2019-10","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:188, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804671"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=353417","label":"url"}],"presentation_title":{"en":"自家末梢血幹細胞移植患者の口腔ケアによる口腔粘膜炎障害の低減効果","ja":"自家末梢血幹細胞移植患者の口腔ケアによる口腔粘膜炎障害の低減効果"},"presenters":{"en":[{"name":"Sogawa Yuka"},{"name":"Yoshioka Masami"},{"name":"南 明香"},{"name":"Fukui Makoto"},{"name":"Hinode Daisuke"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"}],"ja":[{"name":"十川 悠香"},{"name":"吉岡 昌美"},{"name":"南 明香"},{"name":"福井 誠"},{"name":"日野出 大輔"},{"name":"中村 信元"},{"name":"安倍 正博"}]},"event":{"en":"第68回日本口腔衛生学会総会","ja":"第68回日本口腔衛生学会総会"},"publication_date":"2019-05-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:189, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804672"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364953","label":"url"}],"presentation_title":{"en":"長期にわたる血小板減少が先行した芽球性形質細胞様樹状細胞腫瘍の1例","ja":"長期にわたる血小板減少が先行した芽球性形質細胞様樹状細胞腫瘍の1例"},"presenters":{"en":[{"name":"安宅 克博"},{"name":"Nakamura Shingen"},{"name":"Oura Masahiro"},{"name":"Sogabe Kimiko"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Nishioka Yasuhiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"安宅 克博"},{"name":"中村 信元"},{"name":"大浦 雅博"},{"name":"曽我部 公子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"西岡 安彦"},{"name":"安倍 正博"}]},"event":{"en":"第120回日本内科学会四国地方会","ja":"第120回日本内科学会四国地方会"},"publication_date":"2019-05-12","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:190, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804673"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=349990","label":"url"}],"presentation_title":{"en":"ゲノムワイド関連解析を用いたテイコプラニン・バンコマイシン投与による皮疹発現および血中濃度関連遺伝子座の同定","ja":"ゲノムワイド関連解析を用いたテイコプラニン・バンコマイシン投与による皮疹発現および血中濃度関連遺伝子座の同定"},"presenters":{"en":[{"name":"Tanigaki Yuto"},{"name":"Yamaguchi Yuta"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"谷垣 雄都"},{"name":"山口 裕大"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"日本薬学会 第139年会","ja":"日本薬学会 第139年会"},"publication_date":"2019-03-21","languages":["jpn"],"location":{"en":"Chiba","ja":"千葉"},"is_international_presentation":false},"priority":"input_data"} line:191, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738095"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347326","label":"url"}],"presentation_title":{"en":"ゲノムワイド関連解析を用いたビンクリスチンによる末梢神経障害発現関連遺伝子の同定","ja":"ゲノムワイド関連解析を用いたビンクリスチンによる末梢神経障害発現関連遺伝子の同定"},"presenters":{"en":[{"name":"Ohmori Rio"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"大森 理央"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2018-11-10","languages":["jpn"],"location":{"en":"Yonago","ja":"米子"},"is_international_presentation":false},"priority":"input_data"} line:192, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738096"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347325","label":"url"}],"presentation_title":{"en":"CYP遺伝子多型とバンコマイシンの副作用発現及び血中濃度との関連解析","ja":"CYP遺伝子多型とバンコマイシンの副作用発現及び血中濃度との関連解析"},"presenters":{"en":[{"name":"Yamaguchi Yuta"},{"name":"Tanigaki Yuto"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Sato Youichi"}],"ja":[{"name":"山口 裕大"},{"name":"谷垣 雄都"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"佐藤 陽一"}]},"event":{"en":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2018-11-10","languages":["jpn"],"location":{"en":"Yonago","ja":"米子"},"is_international_presentation":false},"priority":"input_data"} line:193, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804674"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=352152","label":"url"}],"presentation_title":{"en":"Mechanisms of TAK1 over-activation in myeloma cells and TAK1-mediated myeloma growth and bone destruction","ja":"Mechanisms of TAK1 over-activation in myeloma cells and TAK1-mediated myeloma growth and bone destruction"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Harada Takeshi"},{"name":"Masami Iwasa"},{"name":"Fujii Shiroh"},{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Oura Masahiro"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"Ariunzaya Bat-Erdene"},{"name":"原田 武志"},{"name":"岩佐 昌美"},{"name":"藤井 志朗"},{"name":"曽我部 公子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"大浦 雅博"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第80回日本血液学会学術集会","ja":"第80回日本血液学会学術集会"},"publication_date":"2018-10-13","languages":["eng"],"location":{"en":"Osaka","ja":"Osaka"},"is_international_presentation":false},"priority":"input_data"} line:194, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804675"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=355743","label":"url"}],"presentation_title":{"en":"HDAC阻害による骨髄腫細胞のIFN-γ-STAT1- PD-L1経路の増強効果","ja":"HDAC阻害による骨髄腫細胞のIFN-γ-STAT1- PD-L1経路の増強効果"},"presenters":{"en":[{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Ariunzaya Bat-Erdene"},{"name":"小田 明日香"},{"name":"Sogabe Kimiko"},{"name":"Oura Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Ariunzaya Bat-Erdene"},{"name":"小田 明日香"},{"name":"曽我部 公子"},{"name":"大浦 雅博"},{"name":"寺町 順平"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"第80回日本血液学会学術集会","ja":"第80回日本血液学会学術集会"},"publication_date":"2018-10-12","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:195, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804676"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351430","label":"url"}],"presentation_title":{"en":"Roles of ROS in induction of bone disease and cancer treatment-induced bone loss in myeloma.","ja":"Roles of ROS in induction of bone disease and cancer treatment-induced bone loss in myeloma."},"presenters":{"en":[{"name":"Mohannad Ashtar"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Asuka Oda"},{"name":"Masami Iwasa"},{"name":"Harada Takeshi"},{"name":"Bat Erdene Ariunzaya"},{"name":"Sogabe Kimiko"},{"name":"Masahiro Oura"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"ASHTAR MOHANNAD"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"Asuka Oda"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Ariunzaya Bat-Erdene"},{"name":"曽我部 公子"},{"name":"Masahiro Oura"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 80th Annual Meeting of the Japanese Society of Hematology","ja":"The 80th Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2018-10-12","languages":["eng"],"promoter":{"en":"Japanese Society of Hematology","ja":"Japanese Society of Hematology"},"location":{"en":"Osaka","ja":"Osaka"},"is_international_presentation":false},"priority":"input_data"} line:196, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804677"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351429","label":"url"}],"presentation_title":{"en":"Inverse regulation of c-FLIP-mediated survival in myeloma cells and osteoclasts by TRAIL.","ja":"Inverse regulation of c-FLIP-mediated survival in myeloma cells and osteoclasts by TRAIL."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Masami Iwasa"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Sogabe Kimiko"},{"name":"Masahiro Oura"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"曽我部 公子"},{"name":"Masahiro Oura"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 80th Annual Meeting of the Japanese Society of Hematology","ja":"The 80th Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2018-10-12","languages":["eng"],"promoter":{"en":"Japanese Society of Hematology","ja":"Japanese Society of Hematology"},"location":{"en":"Osaka","ja":"Osaka"},"is_international_presentation":false},"priority":"input_data"} line:197, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804678"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351428","label":"url"}],"presentation_title":{"en":"Impact of denervation-induced paralysis and mechanical unloading on tumor expansion in myeloma.","ja":"Impact of denervation-induced paralysis and mechanical unloading on tumor expansion in myeloma."},"presenters":{"en":[{"name":"Tanimoto Kotaro"},{"name":"Hiasa Masahiro"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Asuka Oda"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Masami Iwasa"},{"name":"Sogabe Kimiko"},{"name":"Masahiro Oura"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"谷本 幸多朗"},{"name":"日浅 雅博"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"Asuka Oda"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"曽我部 公子"},{"name":"Masahiro Oura"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 80th Annual Meeting of the Japanese Society of Hematology","ja":"The 80th Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2018-10-12","languages":["eng"],"promoter":{"en":"Japanese Society of Hematology","ja":"Japanese Society of Hematology"},"location":{"en":"Osaka","ja":"Osaka"},"is_international_presentation":false},"priority":"input_data"} line:198, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804679"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351424","label":"url"}],"presentation_title":{"en":"The effects of cathepsin K inhibition on osteocytes: its role in bone restoration in MM bone disease.","ja":"The effects of cathepsin K inhibition on osteocytes: its role in bone restoration in MM bone disease."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Tanimoto Kotaro"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Ashtar Mohannad"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Sogabe Kimiko"},{"name":"Masahiro Oura"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Asuka Oda"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"谷本 幸多朗"},{"name":"Ariunzaya Bat-Erdene"},{"name":"ASHTAR MOHANNAD"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"曽我部 公子"},{"name":"Masahiro Oura"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"Asuka Oda"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 80th Annual Meeting of the Japanese Society of Hematology","ja":"The 80th Annual Meeting of the Japanese Society of Hematology"},"publication_date":"2018-10-12","languages":["eng"],"promoter":{"en":"Japanese Society of Hematology","ja":"Japanese Society of Hematology"},"location":{"en":"Osaka","ja":"Osaka"},"is_international_presentation":false},"priority":"input_data"} line:199, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804680"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351407","label":"url"}],"presentation_title":{"en":"カテプシンK阻害による多発性骨髄腫骨病変部の骨量 回復プロセスにおける骨細胞の役割.","ja":"カテプシンK阻害による多発性骨髄腫骨病変部の骨量 回復プロセスにおける骨細胞の役割."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第36回日本骨代謝学会学術集会","ja":"第36回日本骨代謝学会学術集会"},"publication_date":"2018-07-26","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Nagasaki","ja":"長崎"},"is_international_presentation":false},"priority":"input_data"} line:200, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804681"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351406","label":"url"}],"presentation_title":{"en":"TAK1阻害はTRAILによる破骨細胞活性化作用を遮断 させると同時にTRAILの抗骨髄腫作用を増強する","ja":"TAK1阻害はTRAILによる破骨細胞活性化作用を遮断 させると同時にTRAILの抗骨髄腫作用を増強する"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第36回日本骨代謝学会学術集会","ja":"第36回日本骨代謝学会学術集会"},"publication_date":"2018-07-26","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Nagasaki","ja":"長崎"},"is_international_presentation":false},"priority":"input_data"} line:201, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804682"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351404","label":"url"}],"presentation_title":{"en":"TAK1による破骨細胞に対するTRAILの生存・細胞死シグナル制御機構.","ja":"TAK1による破骨細胞に対するTRAILの生存・細胞死シグナル制御機構."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Tanimoto Kotaro"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"谷本 幸多朗"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第4回日本骨免疫学会","ja":"第4回日本骨免疫学会"},"publication_date":"2018-06-24","languages":["jpn"],"promoter":{"en":"日本骨免疫学会","ja":"日本骨免疫学会"},"location":{"en":"Okinawa","ja":"沖縄"},"is_international_presentation":false},"priority":"input_data"} line:202, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804683"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351402","label":"url"}],"presentation_title":{"en":"神経切断による麻痺と免荷の骨髄腫の進展への影響.","ja":"神経切断による麻痺と免荷の骨髄腫の進展への影響."},"presenters":{"en":[{"name":"Tanimoto Kotaro"},{"name":"Hiasa Masahiro"},{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Ashtar Mohannad"},{"name":"Bat-Erdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Sogabe Kimiko"},{"name":"大浦 雅弘"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"谷本 幸多朗"},{"name":"日浅 雅博"},{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"ASHTAR MOHANNAD"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"曽我部 公子"},{"name":"大浦 雅弘"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第4回日本骨免疫学会","ja":"第4回日本骨免疫学会"},"publication_date":"2018-06-24","languages":["jpn"],"promoter":{"en":"日本骨免疫学会","ja":"日本骨免疫学会"},"location":{"en":"Okinawa","ja":"沖縄"},"is_international_presentation":false},"priority":"input_data"} line:203, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804684"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=355742","label":"url"}],"presentation_title":{"en":"Amplification of the IFN- γ -STAT1- PD-L1 pathway in myeloma cells by panobinostat","ja":"パノビスタットによる骨髄腫細胞のIFN-γ-STAT1- PD-L1経路の増強"},"presenters":{"en":[{"name":"Iwasa Masami"},{"name":"Harada Takeshi"},{"name":"Ariunzaya Bat-Erdene"},{"name":"小田 明日香"},{"name":"前田 悠作"},{"name":"高橋 真美子"},{"name":"Oura Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Ariunzaya Bat-Erdene"},{"name":"小田 明日香"},{"name":"前田 悠作"},{"name":"高橋 真美子"},{"name":"大浦 雅博"},{"name":"寺町 順平"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"The 43rd Annual Meeting of the Japanese Society of Myeloma","ja":"The 43rd Annual Meeting of the Japanese Society of Myeloma"},"publication_date":"2018-05-12","languages":["jpn"],"location":{"en":"Chiba","ja":"千葉"},"is_international_presentation":false},"priority":"input_data"} line:204, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738097"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342583","label":"url"}],"presentation_title":{"en":"HDAC1/3 inhibition disrupts the IRF4-Pim-2 pathway to induce effective myeloma cell death","ja":"HDAC1/3 inhibition disrupts the IRF4-Pim-2 pathway to induce effective myeloma cell death"},"presenters":{"en":[{"name":"Harada Takeshi"},{"name":"Asuka Oda"},{"name":"Teramachi Jumpei"},{"name":"Ariunzaya Bat-Erdene"},{"name":"Masami Iwasa"},{"name":"Yusaku Maeda"},{"name":"Nakamura Shingen"},{"name":"Masahiro Oura"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Teru Hideshima"},{"name":"Kenneth C. Anderson"},{"name":"Abe Masahiro"}],"ja":[{"name":"原田 武志"},{"name":"Asuka Oda"},{"name":"寺町 順平"},{"name":"Ariunzaya Bat-Erdene"},{"name":"岩佐 昌美"},{"name":"Yusaku Maeda"},{"name":"中村 信元"},{"name":"Masahiro Oura"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"Teru Hideshima"},{"name":"Kenneth C. Anderson"},{"name":"安倍 正博"}]},"event":{"en":"The 43rd Annual Meeting of the Japanese Society of Myeloma","ja":"The 43rd Annual Meeting of the Japanese Society of Myeloma"},"publication_date":"2018-05-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:205, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738098"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=334338","label":"url"}],"presentation_title":{"en":"テイコプラニン投与による副作用発現および血中濃度とCYP遺伝子多型との関連解析","ja":"テイコプラニン投与による副作用発現および血中濃度とCYP遺伝子多型との関連解析"},"presenters":{"en":[{"name":"Tanigaki Yuto"},{"name":"Sato Youichi"},{"name":"Yamaguchi Yuta"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Yamauchi Aiko"}],"ja":[{"name":"谷垣 雄都"},{"name":"佐藤 陽一"},{"name":"山口 裕大"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"山内 あい子"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-22","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:206, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738099"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=334337","label":"url"}],"presentation_title":{"en":"シタラビン投与による副作用発現と代謝経路関連遺伝子多型の関連解析","ja":"シタラビン投与による副作用発現と代謝経路関連遺伝子多型の関連解析"},"presenters":{"en":[{"name":"Tashima Hozumi"},{"name":"Sato Youichi"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Yamauchi Aiko"}],"ja":[{"name":"田島 穂澄"},{"name":"佐藤 陽一"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"山内 あい子"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-22","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:207, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738100"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351855","label":"url"}],"presentation_title":{"en":"Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition","ja":"Disruption of myeloma cell-bone marrow interaction by TAK-1 inhibition"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Asuka Oda"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Iwasa Masami"},{"name":"Oura Masahiro"},{"name":"Maeda Yusaku"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Asuka Oda"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"岩佐 昌美"},{"name":"大浦 雅博"},{"name":"前田 悠作"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第80回日本血液学会学術集会","ja":"第80回日本血液学会学術集会"},"publication_date":"2017-10-20","languages":["eng"],"location":{"en":"Tokyo","ja":"Tokyo"},"is_international_presentation":false},"priority":"input_data"} line:208, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738101"},"force":{"see_also":[{"@id":"http://35jsbmr.com/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339438","label":"url"}],"presentation_title":{"en":"TRAILは破骨細胞を活性化させるが,TAK1阻害により骨髄腫細胞とともに破骨細胞にもTRAILのアポトーシス誘導活性が惹起できる","ja":"TRAILは破骨細胞を活性化させるが,TAK1阻害により骨髄腫細胞とともに破骨細胞にもTRAILのアポトーシス誘導活性が惹起できる"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Baterdene Ariunzaya"},{"name":"Iwasa Masami"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"Baterdene Ariunzaya"},{"name":"岩佐 昌美"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 35th Annual Meeting of the Japanese Society for Bone and Mineral Research (oral talk)","ja":"第35回 日本骨代謝学会学術集会"},"publication_date":"2017-07-29","languages":["jpn"],"location":{"en":"Hakata","ja":"博多"},"is_international_presentation":false},"priority":"input_data"} line:209, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738102"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325619","label":"url"}],"presentation_title":{"en":"ビンクリスチンによる副作用発現とMDR1遺伝子多型との関連性","ja":"ビンクリスチンによる副作用発現とMDR1遺伝子多型との関連性"},"presenters":{"en":[{"name":"Ohmori Rio"},{"name":"Sato Youichi"},{"name":"Kiguchi Misaki"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Yamauchi Aiko"}],"ja":[{"name":"大森 理央"},{"name":"佐藤 陽一"},{"name":"木口 美沙妃"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"山内 あい子"}]},"event":{"en":"第20回日本医薬品情報学会総会・学術大会","ja":"第20回日本医薬品情報学会総会・学術大会"},"publication_date":"2017-07-09","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:210, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738103"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325618","label":"url"}],"presentation_title":{"en":"バンコマイシン投与による副作用発現及び血中濃度とCYP遺伝子多型との関連解析","ja":"バンコマイシン投与による副作用発現及び血中濃度とCYP遺伝子多型との関連解析"},"presenters":{"en":[{"name":"Yamaguchi Yuta"},{"name":"Sato Youichi"},{"name":"Tanigaki Yuto"},{"name":"Okada Naoto"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Ishizawa Keisuke"},{"name":"Abe Masahiro"},{"name":"Yamauchi Aiko"}],"ja":[{"name":"山口 裕大"},{"name":"佐藤 陽一"},{"name":"谷垣 雄都"},{"name":"岡田 直人"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"石澤 啓介"},{"name":"安倍 正博"},{"name":"山内 あい子"}]},"event":{"en":"第20回日本医薬品情報学会総会・学術大会","ja":"第20回日本医薬品情報学会総会・学術大会"},"publication_date":"2017-07-09","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:211, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738104"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339384","label":"url"}],"presentation_title":{"en":"TAK1阻害はTRAILの抗骨髄腫作用を増強するともに骨吸収促進活性を抑制活性に変換する.","ja":"TAK1阻害はTRAILの抗骨髄腫作用を増強するともに骨吸収促進活性を抑制活性に変換する."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Ariunzaya Baterdene"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Ariunzaya Baterdene"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第42回日本骨髄腫学会","ja":"第42回日本骨髄腫学会"},"publication_date":"2017-05-28","languages":["jpn"],"promoter":{"en":"日本骨髄腫学会","ja":"日本骨髄腫学会"},"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:212, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804685"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=343461","label":"url"}],"presentation_title":{"en":"骨形成誘導による骨髄腫細胞のエネルギー代謝の抑制","ja":"骨形成誘導による骨髄腫細胞のエネルギー代謝の抑制"},"presenters":{"en":[{"name":"天知 良太"},{"name":"Nakamura Shingen"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"バットエルデネ アリウンザヤ"},{"name":"Teramachi Jumpei"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"中村 信元"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"バットエルデネ アリウンザヤ"},{"name":"寺町 順平"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第42回日本骨髄腫学会学術集会","ja":"第42回日本骨髄腫学会学術集会"},"publication_date":"2017-05-27","languages":["jpn"],"promoter":{"en":"日本骨髄腫学会","ja":"日本骨髄腫学会"},"location":{"en":"日本赤十字看護大学 広尾キャンパス","ja":"日本赤十字看護大学 広尾キャンパス"},"is_international_presentation":false},"priority":"input_data"} line:213, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738105"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330802","label":"url"}],"presentation_title":{"en":"膵炎を契機に急性骨髄性白血病と診断した1例","ja":"膵炎を契機に急性骨髄性白血病と診断した1例"},"presenters":{"en":[{"name":"住谷 龍平"},{"name":"Nakamura Shingen"}],"ja":[{"name":"住谷 龍平"},{"name":"中村 信元"}]},"event":{"en":"第115回内科学会四国地方会","ja":"第115回内科学会四国地方会"},"publication_date":"2016-12-03","languages":["jpn"],"location":{"en":"松山","ja":"松山"},"is_international_presentation":false},"priority":"input_data"} line:214, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738090"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2017163115","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=368470","label":"url"}],"presentation_title":{"en":"発熱と下肢対麻痺で発症した血管内大細胞型B細胞性リンパ腫の2例","ja":"発熱と下肢対麻痺で発症した血管内大細胞型B細胞性リンパ腫の2例"},"presenters":{"en":[{"name":"岡本 恵暢"},{"name":"Nakamura Shingen"},{"name":"上村 宗範"},{"name":"Sumitani Ryohei"},{"name":"高橋 真美子"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Miki Hirokazu"}],"ja":[{"name":"岡本 恵暢"},{"name":"中村 信元"},{"name":"上村 宗範"},{"name":"住谷 龍平"},{"name":"高橋 真美子"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"三木 浩和"}]},"event":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"publication_date":"2016-12","promoter":{"en":"Tokushima Medical Association","ja":"徳島医学会"},"is_international_presentation":false},"priority":"input_data"} line:215, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738091"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330804","label":"url"}],"presentation_title":{"en":"IVLBCLに対する自家PBSCT後にITP,小脳に限局した進行性多巣性白質脳症(PML)を発症した1剖検例","ja":"IVLBCLに対する自家PBSCT後にITP,小脳に限局した進行性多巣性白質脳症(PML)を発症した1剖検例"},"presenters":{"en":[{"name":"Sogabe Kimiko"},{"name":"Nakamura Shingen"}],"ja":[{"name":"曽我部 公子"},{"name":"中村 信元"}]},"event":{"en":"第115回日本内科学会四国地方会","ja":"第115回日本内科学会四国地方会"},"publication_date":"2016-11-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:216, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738092"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330803","label":"url"}],"presentation_title":{"en":"化学療法中や造血幹細胞移植後に発症した偽痛風の3例","ja":"化学療法中や造血幹細胞移植後に発症した偽痛風の3例"},"presenters":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"event":{"en":"第115回日本内科学会四国地方会","ja":"第115回日本内科学会四国地方会"},"publication_date":"2016-11-27","languages":["jpn"],"location":{"en":"Matsuyama","ja":"松山"},"is_international_presentation":false},"priority":"input_data"} line:217, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738106"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333278","label":"url"}],"presentation_title":{"en":"30. 天真寛文, 寺町順平, 小田明日香, 天知良太, , ,破骨細胞系細胞はアポトーシス誘引因子TRAILを生存促進・破骨細胞形成誘導因子として利用する:TAK1-Pim-2経路の役割","ja":"30. 天真寛文, 寺町順平, 小田明日香, 天知良太, , ,破骨細胞系細胞はアポトーシス誘引因子TRAILを生存促進・破骨細胞形成誘導因子として利用する:TAK1-Pim-2経路の役割"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第19回日本癌と骨病変研究会","ja":"第19回日本癌と骨病変研究会"},"publication_date":"2016-11-11","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:218, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738107"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=329186","label":"url"}],"presentation_title":{"en":"非HIV関連進行性多巣性白質脳症の3例","ja":"非HIV関連進行性多巣性白質脳症の3例"},"presenters":{"en":[{"name":"Matsui Naoko"},{"name":"Yamazaki Hiroki"},{"name":"Nakamura Shingen"},{"name":"Izumi Yuishin"},{"name":"中道 一生"},{"name":"西條 政幸"},{"name":"Kaji Ryuji"}],"ja":[{"name":"松井 尚子"},{"name":"山崎 博輝"},{"name":"中村 信元"},{"name":"和泉 唯信"},{"name":"中道 一生"},{"name":"西條 政幸"},{"name":"梶 龍兒"}]},"event":{"en":"第21回日本神経感染症学会","ja":"第21回日本神経感染症学会"},"publication_date":"2016-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:219, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738108"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333913","label":"url"}],"presentation_title":{"en":"Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma.","ja":"Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma."},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Mori Hiroshi"},{"name":"Ochi Yasuo"},{"name":"Amachi Ryota"},{"name":"Oda Asuka"},{"name":"Hiasa Masahiro"},{"name":"Harada Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"森 裕史"},{"name":"越智 保夫"},{"name":"天知 良太"},{"name":"小田 明日香"},{"name":"日浅 雅博"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The 77th Annual Meeting of the Japanese Society of Hematology","ja":"第77回日本血液学会学術集会,"},"publication_date":"2016-10-16","languages":["jpn"],"location":{"en":"Kanazawa","ja":"金沢"},"is_international_presentation":false},"priority":"input_data"} line:220, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738109"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333898","label":"url"}],"presentation_title":{"en":"TAK1 inhibition subverts TRAIL-mediated osteoclastogenesis.","ja":"TAK1 inhibition subverts TRAIL-mediated osteoclastogenesis."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会,","ja":"第77回日本血液学会学術集会,"},"publication_date":"2016-10-16","languages":["jpn"],"location":{"en":"Kanazawa","ja":"金沢"},"is_international_presentation":false},"priority":"input_data"} line:221, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738110"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333897","label":"url"}],"presentation_title":{"en":"Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment.","ja":"Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment."},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"遠藤 逸郎"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"遠藤 逸郎"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会,","ja":"第77回日本血液学会学術集会,"},"publication_date":"2016-10-16","languages":["jpn"],"location":{"en":"Kanazawa","ja":"金沢"},"is_international_presentation":false},"priority":"input_data"} line:222, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738111"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333895","label":"url"}],"presentation_title":{"en":"Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFb1 in mouse gingival epithelial cells","ja":"Amelotin gene expression is temporarily being upregulated at the initiation of apoptosis induced by TGFb1 in mouse gingival epithelial cells"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"Amachi Ryota"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"岩浅 正美"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"遠藤 逸郎"},{"name":"川谷 誠"},{"name":"長田 裕之"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"天知 良太"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"岩浅 正美"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"遠藤 逸郎"},{"name":"川谷 誠"},{"name":"長田 裕之"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会,","ja":"第77回日本血液学会学術集会,"},"publication_date":"2016-10-16","languages":["jpn"],"location":{"en":"Kanazawa","ja":"金沢"},"is_international_presentation":false},"priority":"input_data"} line:223, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738112"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330807","label":"url"}],"presentation_title":{"en":"Alteration of Pim-2 synthesis and degradation in myeloma cells by anti-myeloma agents.","ja":"Alteration of Pim-2 synthesis and degradation in myeloma cells by anti-myeloma agents."},"presenters":{"en":[{"name":"Nakamura Shingen"}],"ja":[{"name":"中村 信元"}]},"event":{"en":"日本血液学会総会","ja":"日本血液学会総会"},"publication_date":"2016-10-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:224, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738113"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330806","label":"url"}],"presentation_title":{"en":"Panobinostat and proteasome inhibitors cooperatvely degrade Sp1 to cause myeloma cell death","ja":"Panobinostat and proteasome inhibitors cooperatvely degrade Sp1 to cause myeloma cell death"},"presenters":{"en":[{"name":"ariunzaya"},{"name":"Nakamura Shingen"}],"ja":[{"name":"ariunzaya"},{"name":"中村 信元"}]},"event":{"en":"日本血液学会総会","ja":"日本血液学会総会"},"publication_date":"2016-10-13","languages":["eng"],"location":{"en":"横浜","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:225, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738114"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=321706","label":"url"}],"presentation_title":{"en":"TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma","ja":"TAK-1 inhibition disrupts Pim-2-associated and Pim-2-independent key signaling pathways to effectively suppress tumor growth and restore bone formation in myeloma"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Nakamura Shingen"},{"name":"Kurahashi Kiyoe"},{"name":"Kondo Takeshi"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"中村 信元"},{"name":"倉橋 清衛"},{"name":"近藤 剛史"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第78回 日本血液学会学術集会","ja":"第78回 日本血液学会学術集会"},"publication_date":"2016-10-13","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:226, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738115"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333270","label":"url"}],"presentation_title":{"en":"リベロマイシンAによる酸性環境での骨髄腫細胞の治療抵抗性の克服","ja":"リベロマイシンAによる酸性環境での骨髄腫細胞の治療抵抗性の克服"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"Amachi Ryota"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"川谷 誠"},{"name":"長田 裕之"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"天知 良太"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"川谷 誠"},{"name":"長田 裕之"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07)","ja":"日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07)"},"publication_date":"2016-07-23","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:227, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738116"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333269","label":"url"}],"presentation_title":{"en":"破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される","ja":"破骨細胞はTAK1の発現誘導を介しアポトーシスを抑制しTRAILにより成熟活性化される"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07)","ja":"日本骨代謝学会学術集会プログラム抄録集 (1349-0761)34回 Page183(2016.07)"},"publication_date":"2016-07-23","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:228, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738117"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=315919","label":"url"}],"presentation_title":{"en":"骨髄腫腫瘍進展と骨破壊病変形成におけるTAK1-Pim-2経路の役割","ja":"骨髄腫腫瘍進展と骨破壊病変形成におけるTAK1-Pim-2経路の役割"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"原田 武志"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"原田 武志"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2016-07-21","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:229, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738118"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=315917","label":"url"}],"presentation_title":{"en":"Pim-2は骨髄腫における破骨細胞形成促進の 必須媒介因子である","ja":"Pim-2は骨髄腫における破骨細胞形成促進の 必須媒介因子である"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"Tenshin Hirofumi"},{"name":"Nakamura Shingen"},{"name":"Amachi Ryota"},{"name":"Fujii Shiroh"},{"name":"Watanabe Keiichiro"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"天眞 寛文"},{"name":"中村 信元"},{"name":"天知 良太"},{"name":"藤井 志朗"},{"name":"渡邉 佳一郎"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第41回日本骨髄腫学会学術集会","ja":"第41回日本骨髄腫学会学術集会"},"publication_date":"2016-05-29","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:230, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738119"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333268","label":"url"}],"presentation_title":{"en":"TRAILは破骨細胞に細胞死を誘導せず,破骨細胞分化・生存を促進する.","ja":"TRAILは破骨細胞に細胞死を誘導せず,破骨細胞分化・生存を促進する."},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第41回日本骨髄腫学会","ja":"第41回日本骨髄腫学会"},"publication_date":"2016-05-28","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:231, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738120"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=318986","label":"url"}],"presentation_title":{"en":"Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment","ja":"Mechanism of the TRPV1 up-regulatation in myeloma cells and adaptation to an acidic microenvironment"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"Oda A"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki H"},{"name":"Kagawa Kumiko"},{"name":"Fujii Shiroh"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"Oda A"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"Miki H"},{"name":"賀川 久美子"},{"name":"藤井 志朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会","ja":"第77回日本血液学会学術集会"},"publication_date":"2015-10-16","languages":["eng"],"promoter":{"en":"日本血液学会","ja":"日本血液学会"},"location":{"en":"Kanazawa","ja":"Kanazawa"},"is_international_presentation":false},"priority":"input_data"} line:232, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738121"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=318931","label":"url"}],"presentation_title":{"en":"Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma","ja":"Potent induction of bone formation by anti-resorptive cathepsin K inhibitor in myeloma"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"Mori H"},{"name":"Ochi Y"},{"name":"Amachi Ryota"},{"name":"Oda A"},{"name":"Hiasa Masahiro"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki H"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"Mori H"},{"name":"Ochi Y"},{"name":"天知 良太"},{"name":"Oda A"},{"name":"日浅 雅博"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Miki H"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会","ja":"第77回日本血液学会学術集会"},"publication_date":"2015-10-16","languages":["eng"],"promoter":{"en":"日本血液学会","ja":"日本血液学会"},"location":{"en":"Kanazawa","ja":"Kanazawa"},"is_international_presentation":false},"priority":"input_data"} line:233, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738122"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311249","label":"url"}],"presentation_title":{"en":"Potent suppression of osteoclastogenesis in myeloma by Pim inhibition","ja":"Potent suppression of osteoclastogenesis in myeloma by Pim inhibition"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会","ja":"第77回日本血液学会学術集会"},"publication_date":"2015-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:234, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738123"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311247","label":"url"}],"presentation_title":{"en":"Tumor reduction and bone restoration in myeloma by TAK-1 inhibition","ja":"Tumor reduction and bone restoration in myeloma by TAK-1 inhibition"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"Oda Asuka"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Harada Takeshi"},{"name":"Watanabe Keiichiro"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"Oda Asuka"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"Harada Takeshi"},{"name":"渡邉 佳一郎"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第77回日本血液学会学術集会","ja":"第77回日本血液学会学術集会"},"publication_date":"2015-10","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:235, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738124"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=298378","label":"url"}],"presentation_title":{"en":"Pim阻害による骨髄種骨病変の治療:破骨細胞形成の抑制","ja":"Pim阻害による骨髄種骨病変の治療:破骨細胞形成の抑制"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2015-07-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:236, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738125"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=298376","label":"url"}],"presentation_title":{"en":"骨髄腫腫瘍進展と骨破壊病変形成における TAK-1の枢軸的役割","ja":"骨髄腫腫瘍進展と骨破壊病変形成における TAK-1の枢軸的役割"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Amachi Ryota"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Haneji Tatsuji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"天知 良太"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"羽地 達次"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2015-07-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:237, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738126"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=296633","label":"url"}],"presentation_title":{"en":"TRAILは破骨細胞分化・生存を促進する:TAK-1による生と死の運命制御","ja":"TRAILは破骨細胞分化・生存を促進する:TAK-1による生と死の運命制御"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第1回日本骨免疫学会","ja":"第1回日本骨免疫学会"},"publication_date":"2015-07-01","languages":["jpn"],"location":{"en":"宮古島市","ja":"宮古島市"},"is_international_presentation":false},"priority":"input_data"} line:238, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738127"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=296631","label":"url"}],"presentation_title":{"en":"酸環境での骨髄腫細胞のDR4発現抑制:酸によるエピジェネティックな遺伝子発現制御","ja":"酸環境での骨髄腫細胞のDR4発現抑制:酸によるエピジェネティックな遺伝子発現制御"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Tenshin Hirofumi"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Fujii Shiroh"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天眞 寛文"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"藤井 志朗"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第1回日本骨免疫学会","ja":"第1回日本骨免疫学会"},"publication_date":"2015-07-01","languages":["jpn"],"location":{"en":"宮古島市","ja":"宮古島市"},"is_international_presentation":false},"priority":"input_data"} line:239, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738128"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/P903280150","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310950","label":"url"}],"presentation_title":{"en":"酸性環境での骨髄腫細胞のTRPV1の発現亢進と酸環境への適応","ja":"酸性環境での骨髄腫細胞のTRPV1の発現亢進と酸環境への適応"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Watanabe Keiichiro"},{"name":"Tenshin Hirofumi"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Kondo Takeshi"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"渡邉 佳一郎"},{"name":"天眞 寛文"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"近藤 剛史"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2015-07","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:240, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738129"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/P903280150","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310693","label":"url"}],"presentation_title":{"en":"アポトーシス誘導因子TRAILによる破骨細胞分化・生存の促進","ja":"アポトーシス誘導因子TRAILによる破骨細胞分化・生存の促進"},"presenters":{"en":[{"name":"Tenshin Hirofumi"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天眞 寛文"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2015-07","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:241, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738130"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311244","label":"url"}],"presentation_title":{"en":"Pim阻害による骨髄腫骨吸収亢進の抑制","ja":"Pim阻害による骨髄腫骨吸収亢進の抑制"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"Amachi Ryota"},{"name":"Tenshin Hirofumi"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"天知 良太"},{"name":"天眞 寛文"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第40回日本骨髄腫学会学術集会","ja":"第40回日本骨髄腫学会学術集会"},"publication_date":"2015-05-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:242, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738131"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=298374","label":"url"}],"presentation_title":{"en":"TAK-1は骨髄腫腫瘍進展と骨破壊病変形成の枢軸的な媒介因子である","ja":"TAK-1は骨髄腫腫瘍進展と骨破壊病変形成の枢軸的な媒介因子である"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"Amachi Ryota"},{"name":"Tenshin Hirofumi"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"原田 武志"},{"name":"天知 良太"},{"name":"天眞 寛文"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第40回日本骨髄腫学会学術集会","ja":"第40回日本骨髄腫学会学術集会"},"publication_date":"2015-05-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:243, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738132"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303544","label":"url"}],"presentation_title":{"en":"Pim阻害薬と抗骨髄腫治療薬の併用効果の検討","ja":"Pim阻害薬と抗骨髄腫治療薬の併用効果の検討"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"安倍 正博"}]},"event":{"en":"第40回 日本骨髄腫学会","ja":"第40回 日本骨髄腫学会"},"publication_date":"2015-05","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:244, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738133"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=306696","label":"url"}],"presentation_title":{"en":"Pneumocystis jiroveciに対しST合剤の脱感作療法を行った4症例の検討","ja":"Pneumocystis jiroveciに対しST合剤の脱感作療法を行った4症例の検討"},"presenters":{"en":[{"name":"Nakano Mayuri"},{"name":"Yoshijima Terumi"},{"name":"Hanibuchi Masaki"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Nishioka Yasuhiko"}],"ja":[{"name":"中野 万有里"},{"name":"吉嶋 輝実"},{"name":"埴淵 昌毅"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"西岡 安彦"}]},"event":{"en":"第89回日本感染症学会総会","ja":"第89回日本感染症学会総会"},"publication_date":"2015-04-16","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:245, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738134"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303545","label":"url"}],"presentation_title":{"en":"当院で経験した重症熱性血小板減少症候群の3例","ja":"当院で経験した重症熱性血小板減少症候群の3例"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Azuma Momoyo"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"}],"ja":[{"name":"中村 信元"},{"name":"東 桃代"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"}]},"event":{"en":"第89回 日本感染症学会","ja":"第89回 日本感染症学会"},"publication_date":"2015-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:246, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738135"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=298498","label":"url"}],"presentation_title":{"en":"当院で経験した重症熱性血小板減少症候群の3例","ja":"当院で経験した重症熱性血小板減少症候群の3例"},"presenters":{"en":[{"name":"丸橋 朋子"},{"name":"Nakamura Shingen"},{"name":"曽我部 公子"},{"name":"八木 ひかる"},{"name":"高橋 真美子"},{"name":"宇高 憲吾"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Saijo Atsuro"},{"name":"Nakano Mayuri"},{"name":"Azuma Momoyo"},{"name":"Nishioka Yasuhiko"},{"name":"近藤 憲保"},{"name":"井内 新"},{"name":"藤田 博己"},{"name":"馬原 文彦"}],"ja":[{"name":"丸橋 朋子"},{"name":"中村 信元"},{"name":"曽我部 公子"},{"name":"八木 ひかる"},{"name":"高橋 真美子"},{"name":"宇高 憲吾"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"西條 敦郎"},{"name":"中野 万有里"},{"name":"東 桃代"},{"name":"西岡 安彦"},{"name":"近藤 憲保"},{"name":"井内 新"},{"name":"藤田 博己"},{"name":"馬原 文彦"}]},"event":{"en":"第250回徳島医学会学術集会","ja":"第250回徳島医学会学術集会"},"publication_date":"2015-02-01","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:247, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738136"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=296661","label":"url"}],"presentation_title":{"en":"Therapeutic impact of Pim inhibition on myeloma bone disease: blockade of NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis","ja":"Therapeutic impact of Pim inhibition on myeloma bone disease: blockade of NF-B-mediated suppression of osteoblastogenesis and stimulation of osteoclastogenesis"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"原田 武志"},{"name":"Amachi Ryota"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"原田 武志"},{"name":"天知 良太"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"日本血液学会","ja":"日本血液学会"},"publication_date":"2014-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:248, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738137"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=295771","label":"url"}],"presentation_title":{"en":"酸が惹起する骨髄腫細胞の酸感受と生存シグナルの悪循環","ja":"酸が惹起する骨髄腫細胞の酸感受と生存シグナルの悪循環"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Teramachi Jumpei"},{"name":"小田 明日香"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"渡邉 佳一郎"},{"name":"寺町 順平"},{"name":"小田 明日香"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2014-07","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:249, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738138"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287373","label":"url"}],"presentation_title":{"en":"Pim-2キナーゼはTNF-αによる骨芽細胞分化抑制および破骨細胞形成促進の必須媒介因子である:Pim阻害薬の骨髄腫骨病変改善効果","ja":"Pim-2キナーゼはTNF-αによる骨芽細胞分化抑制および破骨細胞形成促進の必須媒介因子である:Pim阻害薬の骨髄腫骨病変改善効果"},"presenters":{"en":[{"name":"Teramachi Jumpei"},{"name":"Hiasa Masahiro"},{"name":"小田 明日香"},{"name":"Amachi Ryota"},{"name":"Nakamura Shingen"},{"name":"Endo Itsuro"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"}],"ja":[{"name":"寺町 順平"},{"name":"日浅 雅博"},{"name":"小田 明日香"},{"name":"天知 良太"},{"name":"中村 信元"},{"name":"遠藤 逸朗"},{"name":"松本 俊夫"},{"name":"安倍 正博"}]},"event":{"en":"第32回日本骨代謝学会学術集会","ja":"第32回日本骨代謝学会学術集会"},"publication_date":"2014-07-25","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:250, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738139"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303543","label":"url"}],"presentation_title":{"en":"多発性骨髄腫におけるガラクトマンナン抗原検査の有用性","ja":"多発性骨髄腫におけるガラクトマンナン抗原検査の有用性"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Azuma Momoyo"}],"ja":[{"name":"中村 信元"},{"name":"東 桃代"}]},"event":{"en":"Kansenshōgaku Zasshi","ja":"感染症学雑誌"},"publication_date":"2014","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:251, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738140"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=281192","label":"url"}],"presentation_title":{"en":"Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with Bortezomib","ja":"Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with Bortezomib"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Mori H"},{"name":"Udaka K"},{"name":"Iwasa M"},{"name":"Hanson D"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki H"},{"name":"Kagawa Kumiko"},{"name":"Endo Itsuro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Mori H"},{"name":"Udaka K"},{"name":"Iwasa M"},{"name":"Hanson D"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Miki H"},{"name":"賀川 久美子"},{"name":"遠藤 逸朗"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第75回日本血液学会学術集会","ja":"第75回日本血液学会学術集会"},"publication_date":"2013-10-11","languages":["eng"],"promoter":{"en":"日本血液学会","ja":"日本血液学会"},"location":{"en":"Sapporo","ja":"Sapporo"},"is_international_presentation":false},"priority":"input_data"} line:252, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738141"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279386","label":"url"}],"presentation_title":{"en":"著名な汎血球減少と肝筋逸脱酵素高値を呈した神経性食欲不振症の一例","ja":"著名な汎血球減少と肝筋逸脱酵素高値を呈した神経性食欲不振症の一例"},"presenters":{"en":[{"name":"大黒 由加里"},{"name":"Kondo Takeshi"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"倉橋 清衛"},{"name":"Kuroda Akio"},{"name":"Endo Itsuro"},{"name":"Aihara Ken-ichi"},{"name":"Matsuhisa Munehide"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"大黒 由加里"},{"name":"近藤 剛史"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"倉橋 清衛"},{"name":"黒田 暁生"},{"name":"遠藤 逸朗"},{"name":"粟飯原 賢一"},{"name":"松久 宗英"},{"name":"松本 俊夫"}]},"event":{"en":"第13回日本内分泌学会四国支部学術集会","ja":"第13回日本内分泌学会四国支部学術集会"},"publication_date":"2013-09-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:253, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738142"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269441","label":"url"}],"presentation_title":{"en":"赤芽球癆を合併した多中心性Castleman病の1例","ja":"赤芽球癆を合併した多中心性Castleman病の1例"},"presenters":{"en":[{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"竹内 恭子"},{"name":"原田 武志"},{"name":"岩佐 昌美"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"竹内 恭子"},{"name":"原田 武志"},{"name":"岩佐 昌美"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"event":{"en":"日本内科学会第107回四国地方会","ja":"日本内科学会第107回四国地方会"},"publication_date":"2012-12-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:254, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738143"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=265514","label":"url"}],"presentation_title":{"en":"腎生検にてγ重鎖沈着症が疑われた糸球体沈着症の一例","ja":"腎生検にてγ重鎖沈着症が疑われた糸球体沈着症の一例"},"presenters":{"en":[{"name":"Matsuura Motokazu"},{"name":"Yamada Satoshi"},{"name":"Shibata Eriko"},{"name":"Watase Kenji"},{"name":"Kishi Fumi"},{"name":"Kishi Seiji"},{"name":"Mima Akira"},{"name":"Nagai Kojiro"},{"name":"Abe Hideharu"},{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Doi Toshio"}],"ja":[{"name":"松浦 元一"},{"name":"山田 諭"},{"name":"柴田 恵理子"},{"name":"渡瀬 謙仁"},{"name":"岸 史"},{"name":"岸 誠司"},{"name":"美馬 晶"},{"name":"長井 幸二郎"},{"name":"安部 秀斉"},{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"土井 俊夫"}]},"event":{"en":"第42回日本腎臓学会西部学術大会","ja":"第42回日本腎臓学会西部学術大会"},"publication_date":"2012-10-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:255, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738144"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269301","label":"url"}],"presentation_title":{"en":"Pim inhibition preferentially induces anti-myeloma activity in an acidic milien","ja":"Pim inhibition preferentially induces anti-myeloma activity in an acidic milien"},"presenters":{"en":[{"name":"Fujii Shiroh"},{"name":"Abe Masahiro"},{"name":"Amachi Ryota"},{"name":"Watanabe Keiichiro"},{"name":"Hiasa Masahiro"},{"name":"竹内 恭子"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"藤井 志朗"},{"name":"安倍 正博"},{"name":"天知 良太"},{"name":"渡邉 佳一郎"},{"name":"日浅 雅博"},{"name":"竹内 恭子"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"松本 俊夫"}]},"event":{"en":"第74回日本血液学会学術集会","ja":"第74回日本血液学会学術集会"},"publication_date":"2012-10-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:256, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738145"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=265727","label":"url"}],"presentation_title":{"en":"Pim-2 acts as a common downstream mediator to suppress bone formation in myeloma.","ja":"Pim-2 acts as a common downstream mediator to suppress bone formation in myeloma."},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Takeshi Harada"},{"name":"Shirou Fujii"},{"name":"Watanabe Keiichiro"},{"name":"Amachi Ryota"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"Takeshi Harada"},{"name":"Shirou Fujii"},{"name":"渡邉 佳一郎"},{"name":"天知 良太"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"event":{"en":"第74回に本血液学会","ja":"第74回に本血液学会"},"publication_date":"2012-10-20","invited":true,"languages":["eng"],"promoter":{"en":"日本血液学会","ja":"日本血液学会"},"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":false},"priority":"input_data"} line:257, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738146"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269314","label":"url"}],"presentation_title":{"en":"徳島県のエイズ拠点病院におけるHIV感染症及び後天性免疫不全症候群の現状","ja":"徳島県のエイズ拠点病院におけるHIV感染症及び後天性免疫不全症候群の現状"},"presenters":{"en":[{"name":"原田 武志"},{"name":"Ozaki Shuji"},{"name":"岩佐 昌美"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"柴田 泰伸"},{"name":"重清 俊雄"},{"name":"岡田 直人"},{"name":"長尾 多美子"},{"name":"鈴木 麗子"},{"name":"Sakiyama Shoji"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"原田 武志"},{"name":"尾崎 修治"},{"name":"岩佐 昌美"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"柴田 泰伸"},{"name":"重清 俊雄"},{"name":"岡田 直人"},{"name":"長尾 多美子"},{"name":"鈴木 麗子"},{"name":"先山 正二"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"event":{"en":"第245回徳島県医学会学術総会","ja":"第245回徳島県医学会学術総会"},"publication_date":"2012-07-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:258, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738147"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=254735","label":"url"}],"presentation_title":{"en":"カテプシンK 阻害剤KK1-300-01 は骨髄腫骨病変部の骨破壊を抑制し骨形成を惹起する","ja":"カテプシンK 阻害剤KK1-300-01 は骨髄腫骨病変部の骨破壊を抑制し骨形成を惹起する"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"遠藤 逸郎"},{"name":"森 裕史"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"遠藤 逸郎"},{"name":"森 裕史"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第30回日本骨代謝学会学術大会","ja":"第30回日本骨代謝学会学術大会"},"publication_date":"2012-07-21","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:259, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738148"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=254736","label":"url"}],"presentation_title":{"en":"酸性環境は骨髄腫細胞にDR4 の発現抑制とcFLIP の活性化を惹起しTRAIL に対する抵抗性を獲得させる","ja":"酸性環境は骨髄腫細胞にDR4 の発現抑制とcFLIP の活性化を惹起しTRAIL に対する抵抗性を獲得させる"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Abe Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Hiasa Masahiro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"天知 良太"},{"name":"安倍 正博"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"日浅 雅博"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第30回日本骨代謝学会学術集会","ja":"第30回日本骨代謝学会学術集会"},"publication_date":"2012-07-19","languages":["jpn"],"promoter":{"en":"Japanese Society for Bone and Mineral Research","ja":"日本骨代謝学会"},"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:260, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738149"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269313","label":"url"}],"presentation_title":{"en":"腰痛と副腎不全症状で発症した両側副腎原発DLBCLの1例","ja":"腰痛と副腎不全症状で発症した両側副腎原発DLBCLの1例"},"presenters":{"en":[{"name":"大黒 由加里"},{"name":"Nakamura Shingen"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"},{"name":"Miki Hirokazu"}],"ja":[{"name":"大黒 由加里"},{"name":"中村 信元"},{"name":"岩佐 昌美"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"松本 俊夫"},{"name":"三木 浩和"}]},"event":{"en":"日本内科学会第106回四国地方会","ja":"日本内科学会第106回四国地方会"},"publication_date":"2012-06-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:261, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738150"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269271","label":"url"}],"presentation_title":{"en":"徳島県における多発性骨髄腫の治療成績の検討","ja":"徳島県における多発性骨髄腫の治療成績の検討"},"presenters":{"en":[{"name":"原田 武志"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"中野 綾子"},{"name":"Kagawa Kumiko"},{"name":"竹内 恭子"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"event":{"en":"第109回日本内科学会総会・講演会","ja":"第109回日本内科学会総会・講演会"},"publication_date":"2012-04-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:262, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738151"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269304","label":"url"}],"presentation_title":{"en":"Lenalidomide 治療中の多発性骨髄腫患者におけるCRP上昇の検討","ja":"Lenalidomide 治療中の多発性骨髄腫患者におけるCRP上昇の検討"},"presenters":{"en":[{"name":"原田 武志"},{"name":"Ozaki Shuji"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"中野 綾子"},{"name":"Kagawa Kumiko"},{"name":"竹内 恭子"},{"name":"Abe Masahiro"},{"name":"柴田 泰伸"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"原田 武志"},{"name":"尾崎 修治"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"安倍 正博"},{"name":"柴田 泰伸"},{"name":"松本 俊夫"}]},"event":{"en":"第51回日本血液学会中国四国地方会","ja":"第51回日本血液学会中国四国地方会"},"publication_date":"2012-03-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:263, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738152"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269293","label":"url"}],"presentation_title":{"en":"遺伝子組み替えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例","ja":"遺伝子組み替えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例"},"presenters":{"en":[{"name":"Kagawa Kumiko"},{"name":"原田 武志"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"竹内 恭子"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"賀川 久美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"竹内 恭子"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"event":{"en":"第34回日本造血細胞移植学会","ja":"第34回日本造血細胞移植学会"},"publication_date":"2012-02-25","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:264, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738153"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269274","label":"url"}],"presentation_title":{"en":"遺伝子組み換えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例","ja":"遺伝子組み換えヒトトロンボモジュリン投与中に硬膜下血腫を来した同腫骨髄移植2症例"},"presenters":{"en":[{"name":"Kagawa Kumiko"},{"name":"原田 武志"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"竹内 恭子"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"賀川 久美子"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"竹内 恭子"},{"name":"安倍 正博"},{"name":"松本 俊夫"}]},"event":{"en":"第34回日本造血細胞移植学会","ja":"第34回日本造血細胞移植学会"},"publication_date":"2012-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:265, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738154"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253630","label":"url"}],"presentation_title":{"en":"Targeting an acidic microenvironment by reveromycin A to overcome drug resistance to myeloma cells and ameliorate bone disease.","ja":"Targeting an acidic microenvironment by reveromycin A to overcome drug resistance to myeloma cells and ameliorate bone disease."},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Cui Q"},{"name":"Hiasa Masahiro"},{"name":"Kawatani M"},{"name":"Harada T"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Nakano A"},{"name":"Kagawa K"},{"name":"Takeuchi K"},{"name":"Osada H"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Cui Q"},{"name":"日浅 雅博"},{"name":"Kawatani M"},{"name":"Harada T"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"Nakano A"},{"name":"Kagawa K"},{"name":"Takeuchi K"},{"name":"Osada H"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本骨髄腫研究会総会","ja":"第36回日本骨髄腫研究会総会"},"publication_date":"2011-11-12","languages":["eng"],"location":{"en":"Tokyo","ja":"Tokyo"},"is_international_presentation":false},"priority":"input_data"} line:266, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738155"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253570","label":"url"}],"presentation_title":{"en":"Pimキナーゼ阻害による腫瘍進展と骨破壊の抑制","ja":"Pimキナーゼ阻害による腫瘍進展と骨破壊の抑制"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Yata Ken-ichiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"矢田 健一郎"},{"name":"松本 俊夫"}]},"event":{"en":"第73回日本血液学会","ja":"第73回日本血液学会"},"publication_date":"2011-10-14","languages":["jpn"],"location":{"en":"Nagoya","ja":"名古屋"},"is_international_presentation":false},"priority":"input_data"} line:267, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738156"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253079","label":"url"}],"presentation_title":{"en":"不明熱で発症し皮膚生検が診断に有効であった血管内リンパ腫の1例","ja":"不明熱で発症し皮膚生検が診断に有効であった血管内リンパ腫の1例"},"presenters":{"en":[{"name":"Fujioka Keisuke"},{"name":"Saijo Atsuro"},{"name":"Toyoda Yuko"},{"name":"Kakiuchi Souji"},{"name":"Hanibuchi Masaki"},{"name":"Azuma Masahiko"},{"name":"Nishioka Yasuhiko"},{"name":"Takeuchi Kyoko"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Kagawa Kumiko"},{"name":"Abe Masahiro"},{"name":"Mizutani Tomoya"}],"ja":[{"name":"藤岡 啓介"},{"name":"西條 敦郎"},{"name":"豊田 優子"},{"name":"柿内 聡司"},{"name":"埴淵 昌毅"},{"name":"吾妻 雅彦"},{"name":"西岡 安彦"},{"name":"竹内 恭子"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"賀川 久美子"},{"name":"安倍 正博"},{"name":"水谷 友哉"}]},"event":{"en":"第243回徳島医学会学術集会","ja":"第243回徳島医学会学術集会"},"publication_date":"2011-07","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:268, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2012111920","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253461","label":"url"}],"presentation_title":{"en":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する","ja":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2011-07-28","languages":["jpn"],"promoter":{"en":"第29回日本骨代謝学会学術大会","ja":"第29回日本骨代謝学会学術大会"},"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:269, {"insert":{"user_id":"B000341201","type":"presentations"},"similar_merge":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2012111981","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253460","label":"url"}],"presentation_title":{"en":"リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制","ja":"リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"川谷 誠"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"長田 裕之"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"川谷 誠"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"長田 裕之"},{"name":"松本 俊夫"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2011-07-28","languages":["jpn"],"promoter":{"en":"第29回日本骨代謝学会学術大会","ja":"第29回日本骨代謝学会学術大会"},"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:270, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738093"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2012111920","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248826","label":"url"}],"presentation_title":{"en":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する","ja":"Pimキナーゼの阻害は骨芽細胞分化を促進し,骨髄腫骨病変の形成と腫瘍進展を抑制する"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Watanabe Keiichiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"渡邉 佳一郎"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2011","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:271, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738094"},"force":{"see_also":[{"@id":"http://search.jamas.or.jp/link/ui/2012111981","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248825","label":"url"}],"presentation_title":{"en":"リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制","ja":"リベロマイシンAによる酸性環境がもたらす骨髄腫薬剤耐性の克服と骨病変形成の抑制"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"川谷 誠"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"長田 裕之"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"川谷 誠"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"長田 裕之"},{"name":"松本 俊夫"}]},"event":{"en":"The Annual Meeting of the Japanese Society for Bone and Mineral Research Program & Abstracts","ja":"日本骨代謝学会学術集会プログラム抄録集"},"publication_date":"2011","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:272, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738157"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231803","label":"url"}],"presentation_title":{"en":"Reveromycin A prevents bone destruction and suppresses tumor growth in myeloma","ja":"Reveromycin A prevents bone destruction and suppresses tumor growth in myeloma"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Nakamura Shingen"},{"name":"Hirokazu Miki"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Hiroyuki Osada"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"Makoto Kawatani"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinno"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"中村 信元"},{"name":"Hirokazu Miki"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"Hiroyuki Osada"},{"name":"松本 俊夫"}]},"event":{"en":"第72回日本血液学会","ja":"第72回日本血液学会"},"publication_date":"2010-12-26","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:273, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738158"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232124","label":"url"}],"presentation_title":{"en":"Bortezomib-induced osteoblast differentiation is hampered by excessive ER stress","ja":"Bortezomib-induced osteoblast differentiation is hampered by excessive ER stress"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Watanabe Keiichiro"},{"name":"Ikegame Akishige"},{"name":"Hiasa Masahiro"},{"name":"Hirokazu Miki"},{"name":"Ayako Nakano"},{"name":"Asuka Oda"},{"name":"Hiroe Amo"},{"name":"Tasashi Jinno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"渡邉 佳一郎"},{"name":"池亀 彰茂"},{"name":"日浅 雅博"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"神野 雅"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"event":{"en":"第72回日本血液学会","ja":"第72回日本血液学会"},"publication_date":"2010-09-25","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:274, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738159"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231806","label":"url"}],"presentation_title":{"en":"Bone marrow stromal cells supress TACE activity in monocytes to induce osteoclastogenesis","ja":"Bone marrow stromal cells supress TACE activity in monocytes to induce osteoclastogenesis"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"三木 浩和"},{"name":"Yata Ken-ichiro"},{"name":"Watanabe Keiichiro"},{"name":"Ozaki Shuji"},{"name":"Asaoka Kenzo"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"矢田 健一郎"},{"name":"渡邉 佳一郎"},{"name":"尾崎 修治"},{"name":"淺岡 憲三"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第72回日本血液学会","ja":"第72回日本血液学会"},"publication_date":"2010-09-25","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:275, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738160"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231801","label":"url"}],"presentation_title":{"en":"Bone marrow stromal cells attenuate gama delta T","ja":"Bone marrow stromal cells attenuate gama delta T"},"presenters":{"en":[{"name":"Qu Cui"},{"name":"Abe Masahiro"},{"name":"Hirokazu Miki"},{"name":"Nakamura Shingen"},{"name":"Watanabe Keiichiro"},{"name":"Ikegame Akishige"},{"name":"Hiasa Masahiro"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinnno"},{"name":"Takeshi Harada"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Qu Cui"},{"name":"安倍 正博"},{"name":"Hirokazu Miki"},{"name":"中村 信元"},{"name":"渡邉 佳一郎"},{"name":"池亀 彰茂"},{"name":"日浅 雅博"},{"name":"Ayako Nakano"},{"name":"Tadashi Jinnno"},{"name":"Takeshi Harada"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"event":{"en":"第72回日本血液学会","ja":"第72回日本血液学会"},"publication_date":"2010-09-25","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:276, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738161"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231772","label":"url"}],"presentation_title":{"en":"骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する","ja":"骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"三木 浩和"},{"name":"Yata Ken-ichiro"},{"name":"Watanabe Keiichiro"},{"name":"Ozaki Shuji"},{"name":"Asaoka Kenzo"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"矢田 健一郎"},{"name":"渡邉 佳一郎"},{"name":"尾崎 修治"},{"name":"淺岡 憲三"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第28回日本骨代謝学会","ja":"第28回日本骨代謝学会"},"publication_date":"2010-07-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:277, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738162"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231771","label":"url"}],"presentation_title":{"en":"リベロマイシンAは骨髄腫骨破壊病変の形成と腫瘍進展を抑制する","ja":"リベロマイシンAは骨髄腫骨破壊病変の形成と腫瘍進展を抑制する"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Abe Masahiro"},{"name":"Makoto Kawatani"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"Tanaka Eiji"},{"name":"長田 裕之"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"安倍 正博"},{"name":"Makoto Kawatani"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"田中 栄二"},{"name":"長田 裕之"},{"name":"松本 俊夫"}]},"event":{"en":"第28回日本骨代謝学会","ja":"第28回日本骨代謝学会"},"publication_date":"2010-07-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:278, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738163"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231811","label":"url"}],"presentation_title":{"en":"ボルテゾミブによる骨芽細胞分化の促進は過剰な小胞体ストレスによって抑制される","ja":"ボルテゾミブによる骨芽細胞分化の促進は過剰な小胞体ストレスによって抑制される"},"presenters":{"en":[{"name":"Nakamura Shingen"},{"name":"Abe Masahiro"},{"name":"Qu Cui"},{"name":"Watanabe Keiichiro"},{"name":"Ikegame Akishige"},{"name":"Hiasa Masahiro"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"神野 雅"},{"name":"原田 武志"},{"name":"Fujii Shiroh"},{"name":"Kagawa Kumiko"},{"name":"Takeuchi Kyoko"},{"name":"Ozaki Shuji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"中村 信元"},{"name":"安倍 正博"},{"name":"Qu Cui"},{"name":"渡邉 佳一郎"},{"name":"池亀 彰茂"},{"name":"日浅 雅博"},{"name":"三木 浩和"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"神野 雅"},{"name":"原田 武志"},{"name":"藤井 志朗"},{"name":"賀川 久美子"},{"name":"竹内 恭子"},{"name":"尾崎 修治"},{"name":"松本 俊夫"}]},"event":{"en":"第28回日本骨代謝学会","ja":"第28回日本骨代謝学会"},"publication_date":"2010-07-21","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:279, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738164"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300591","label":"url"}],"presentation_title":{"en":"心筋への広範な直接浸潤を来したNK/T cell lymphoma 鼻型の一例","ja":"心筋への広範な直接浸潤を来したNK/T cell lymphoma 鼻型の一例"},"presenters":{"en":[{"name":"Kagawa Kumiko"},{"name":"Yata Ken-ichiro"},{"name":"田中 修"},{"name":"Nakamura Shingen"},{"name":"Miki Hirokazu"},{"name":"Takeuchi Kyoko"},{"name":"Abe Masahiro"},{"name":"Ozaki Shuji"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"}],"ja":[{"name":"賀川 久美子"},{"name":"矢田 健一郎"},{"name":"田中 修"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"竹内 恭子"},{"name":"安倍 正博"},{"name":"尾崎 修治"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"}]},"event":{"en":"第48回に本血液学会中国四国地方会","ja":"第48回に本血液学会中国四国地方会"},"publication_date":"2009-03-07","languages":["jpn"],"location":{"en":"Matsuyama","ja":"松山"},"is_international_presentation":false},"priority":"input_data"} line:280, {"insert":{"user_id":"B000341201","type":"presentations","id":"41042839"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393454","label":"url"}],"presentation_title":{"en":"Muscle and lipid mass of blood disease.","ja":"血液疾患における筋肉量,脂肪量の検討"},"presenters":{"en":[{"name":"Nishizoe Hikaru"},{"name":"Fujii Mizuki"},{"name":"Nakamura Shingen"},{"name":"Takao Shoichiro"},{"name":"Yamashita Michiko"}],"ja":[{"name":"西添 ひかる"},{"name":"藤井 観月"},{"name":"中村 信元"},{"name":"髙尾 正一郎"},{"name":"山下 理子"}]},"event":{"en":"THE TOKUSHIMA JOURNAL OF MEDICAL TECHNOLOGY","ja":"徳島県臨床検査技師会誌"},"publication_date":"2022-12","languages":["jpn"],"promoter":{"en":"徳島県臨床検査技師会","ja":"徳島県臨床検査技師会"},"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:281, {"insert":{"user_id":"B000341201","type":"presentations","id":"32804686"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374129","label":"url"}],"presentation_title":{"en":"アブスコパル効果を示した甲状腺原発形質細胞腫の1例","ja":"アブスコパル効果を示した甲状腺原発形質細胞腫の1例"},"presenters":{"en":[{"name":"庄野 隆志"},{"name":"Aoyama Mariko"},{"name":"南城 和正"},{"name":"山本 清成"},{"name":"Maki Hidenori"},{"name":"Inui Tomohiro"},{"name":"Sakamoto Shinichi"},{"name":"Kobayashi Tomoko"},{"name":"Nakamura Shingen"},{"name":"Takizawa Hiromitsu"},{"name":"Tangoku Akira"}],"ja":[{"name":"庄野 隆志"},{"name":"青山 万理子"},{"name":"南城 和正"},{"name":"山本 清成"},{"name":"牧 秀則"},{"name":"乾 友浩"},{"name":"坂本 晋一"},{"name":"小林 智子"},{"name":"中村 信元"},{"name":"滝沢 宏光"},{"name":"丹黒 章"}]},"event":{"en":"第49回中国四国甲状腺外科研究会(ハイブリッド開催)","ja":"第49回中国四国甲状腺外科研究会(ハイブリッド開催)"},"publication_date":"2021-02-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:282, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738165"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=306569","label":"url"}],"presentation_title":{"en":"胸腺腫瘍に合併した赤芽球癆の二例-病態解明へのアプローチ-","ja":"胸腺腫瘍に合併した赤芽球癆の二例-病態解明へのアプローチ-"},"presenters":{"en":[{"name":"梶田 敬介"},{"name":"Nakamura Shingen"},{"name":"曽我部 公子"},{"name":"藤野 ひかる"},{"name":"丸橋 朋子"},{"name":"Fujii Shiroh"},{"name":"Miki Hirokazu"},{"name":"Kagawa Kumiko"},{"name":"Toba Hiroaki"},{"name":"阿部 正博"}],"ja":[{"name":"梶田 敬介"},{"name":"中村 信元"},{"name":"曽我部 公子"},{"name":"藤野 ひかる"},{"name":"丸橋 朋子"},{"name":"藤井 志朗"},{"name":"三木 浩和"},{"name":"賀川 久美子"},{"name":"鳥羽 博明"},{"name":"阿部 正博"}]},"event":{"en":"第252回徳島医学会学術集会","ja":"第252回徳島医学会学術集会"},"publication_date":"2016-02-14","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:283, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738166"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269448","label":"url"}],"presentation_title":{"en":"The cathepsinK inhibitor ONO-KK1-300-01 (ONO-KK1) prevents bone destruction and restores bone formation in myeloma bone lesions","ja":"The cathepsinK inhibitor ONO-KK1-300-01 (ONO-KK1) prevents bone destruction and restores bone formation in myeloma bone lesions"},"presenters":{"en":[{"name":"Watanabe Keiichiro"},{"name":"Amachi Ryota"},{"name":"Hiasa Masahiro"},{"name":"Nakamura Shingen"},{"name":"Endo Itsuro"},{"name":"Mori Hiroshi"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"渡邉 佳一郎"},{"name":"天知 良太"},{"name":"日浅 雅博"},{"name":"中村 信元"},{"name":"遠藤 逸朗"},{"name":"Mori Hiroshi"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"Bone Seminar","ja":"Bone Seminar"},"publication_date":"2012-08-25","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:284, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738167"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=268425","label":"url"}],"presentation_title":{"en":"酸環境は骨髄腫細胞のTRAILに対する抵抗性を増強する","ja":"酸環境は骨髄腫細胞のTRAILに対する抵抗性を増強する"},"presenters":{"en":[{"name":"Amachi Ryota"},{"name":"Abe Masahiro"},{"name":"Watanabe Keiichiro"},{"name":"Kagawa Kumiko"},{"name":"藤井 志郎"},{"name":"原田 武志"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"小田 明日香"},{"name":"Hiasa Masahiro"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"天知 良太"},{"name":"安倍 正博"},{"name":"渡邉 佳一郎"},{"name":"賀川 久美子"},{"name":"藤井 志郎"},{"name":"原田 武志"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"小田 明日香"},{"name":"日浅 雅博"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第3回骨バイオサイエンス研究会","ja":"第3回骨バイオサイエンス研究会"},"publication_date":"2012-07-14","languages":["jpn"],"location":{"en":"Okayama","ja":"岡山"},"is_international_presentation":false},"priority":"input_data"} line:285, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738168"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253620","label":"url"}],"presentation_title":{"en":"Pimキナーゼの阻害による骨髄腫の進展抑制","ja":"Pimキナーゼの阻害による骨髄腫の進展抑制"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"Watanabe Keiichiro"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Miki Hirokazu"},{"name":"Nakamura Shingen"},{"name":"Fujii Shiroh"},{"name":"原田 武志"},{"name":"Ozaki Shuji"},{"name":"Tanaka Eiji"},{"name":"Asaoka Kenzo"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"渡邉 佳一郎"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"三木 浩和"},{"name":"中村 信元"},{"name":"藤井 志朗"},{"name":"原田 武志"},{"name":"尾崎 修治"},{"name":"田中 栄二"},{"name":"淺岡 憲三"},{"name":"松本 俊夫"}]},"event":{"en":"癌と骨病変研究会","ja":"癌と骨病変研究会"},"publication_date":"2011-11-18","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:286, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738169"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232127","label":"url"}],"presentation_title":{"en":"骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する","ja":"骨髄間質細胞は,単球のTACE活性を抑制し樹状細胞分化を抑制し破骨細胞文化を誘導する"},"presenters":{"en":[{"name":"Hiasa Masahiro"},{"name":"Abe Masahiro"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"Takeuchi Kyoko"},{"name":"Kagawa Kumiko"},{"name":"Nakamura Shingen"},{"name":"三木 浩和"},{"name":"Yata Ken-ichiro"},{"name":"Watanabe Keiichiro"},{"name":"Ozaki Shuji"},{"name":"Asaoka Kenzo"},{"name":"Tanaka Eiji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"日浅 雅博"},{"name":"安倍 正博"},{"name":"中野 綾子"},{"name":"小田 明日香"},{"name":"天羽 宏枝"},{"name":"竹内 恭子"},{"name":"賀川 久美子"},{"name":"中村 信元"},{"name":"三木 浩和"},{"name":"矢田 健一郎"},{"name":"渡邉 佳一郎"},{"name":"尾崎 修治"},{"name":"淺岡 憲三"},{"name":"田中 栄二"},{"name":"松本 俊夫"}]},"event":{"en":"第17回徳島骨代謝研究会","ja":"第17回徳島骨代謝研究会"},"publication_date":"2010-11-05","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:287, {"insert":{"user_id":"B000341201","type":"presentations","id":"1738170"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301890","label":"url"}],"presentation_title":{"en":"一酸化炭素中毒を契機に発見された急性心筋梗塞の一例","ja":"一酸化炭素中毒を契機に発見された急性心筋梗塞の一例"},"presenters":{"en":[{"name":"倉橋 清衛"},{"name":"Nakamura Shingen"},{"name":"Yoshida Sumiko"},{"name":"Endo Itsuro"},{"name":"Aihara Ken-ichi"},{"name":"Fujinaka Yuichi"},{"name":"Matsumoto Toshio"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"}],"ja":[{"name":"倉橋 清衛"},{"name":"中村 信元"},{"name":"吉田 守美子"},{"name":"遠藤 逸朗"},{"name":"粟飯原 賢一"},{"name":"藤中 雄一"},{"name":"松本 俊夫"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"}]},"event":{"en":"第9回徳島総合診療研究会","ja":"第9回徳島総合診療研究会"},"publication_date":"2009-07-14","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/229265/researchmap/presentations.jsonl, 7boJ844B7kacV6CWqS-E) ==== ====== BulkResult(B000341201, 2LoJ844B7kacV6CWoi8l) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:46Z","end_datetime":"2024-04-18T21:42:46Z","estimated_end_datetime":"2024-04-18T21:42:47Z","total_items":59} --- success {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:46Z","end_datetime":"2024-04-18T21:42:46Z","estimated_end_datetime":"2024-04-18T21:42:47Z","total_items":59} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46128753","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/46128753","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46128753]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46113962","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/46113962","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46113962]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45781403","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/45781403","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45781403]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45822809","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/45822809","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45822809]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45822810","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/45822810","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45822810]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45822811","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/45822811","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45822811]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"42377956","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/42377956","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=42377956]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"40107350","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/40107350","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=40107350]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"42547182","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/42547182","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=42547182]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"42260854","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/42260854","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=42260854]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"43213466","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/43213466","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43213466]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"43207400","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/43207400","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207400]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"41302472","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/41302472","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41302472]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"38753846","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/38753846","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=38753846]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"38890566","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/38890566","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=38890566]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"37854954","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/37854954","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=37854954]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"36164916","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/36164916","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=36164916]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"39359771","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/39359771","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39359771]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"37663004","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/37663004","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=37663004]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"35163656","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/35163656","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=35163656]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33352905","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/33352905","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33352905]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"29515115","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/29515115","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=29515115]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"33352906","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/33352906","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352906]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"36183959","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/36183959","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =36183959]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"33352907","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/33352907","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352907]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33290861","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/33290861","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33290861]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33352908","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/33352908","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33352908]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"29515109","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/29515109","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=29515109]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32804688","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/32804688","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804688]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32804689","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/32804689","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804689]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"24878643","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/24878643","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=24878643]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"32804690","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/32804690","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =32804690]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"26416723","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/26416723","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=26416723]。"}]} {"no":1,"line":34,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"26416726","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/26416726","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=26416726]。"}]} {"no":1,"line":35,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"26880634","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/26880634","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=26880634]。"}]} {"no":1,"line":36,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167263","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167263","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167263]。"}]} {"no":1,"line":37,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167257","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167257","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167257]。"}]} {"no":1,"line":38,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167283","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167283","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167283]。"}]} {"no":1,"line":39,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167258","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167258","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167258]。"}]} {"no":1,"line":40,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167259","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167259","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167259]。"}]} {"no":1,"line":41,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167260","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167260","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167260]。"}]} {"no":1,"line":42,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167261","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167261","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167261]。"}]} {"no":1,"line":43,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167262","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167262","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167262]。"}]} {"no":1,"line":44,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167264","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167264","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167264]。"}]} {"no":1,"line":45,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167266","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167266","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167266]。"}]} {"no":1,"line":46,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167256","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167256","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167256]。"}]} {"no":1,"line":47,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167267","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167267","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167267]。"}]} {"no":1,"line":48,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167268","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167268","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167268]。"}]} {"no":1,"line":49,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167269","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167269","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167269]。"}]} {"no":1,"line":50,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"25911417","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/25911417","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=25911417]。"}]} {"no":1,"line":51,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167271","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167271","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167271]。"}]} {"no":1,"line":52,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167272","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167272","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167272]。"}]} {"no":1,"line":53,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167273","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167273","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167273]。"}]} {"no":1,"line":54,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167274","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167274","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167274]。"}]} {"no":1,"line":55,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167275","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167275","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167275]。"}]} {"no":1,"line":56,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167276","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167276","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167276]。"}]} {"no":1,"line":57,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167277","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167277","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167277]。"}]} {"no":1,"line":58,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167278","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167278","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167278]。"}]} {"no":1,"line":59,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"15167279","link":"https://api.researchmap.jp/zxcvbnm-2/published_papers/15167279","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=15167279]。"}]} ====== BulkResult(B000341201, 2LoJ844B7kacV6CWoi8l) : End ====== ====== BulkResult(B000341201, 3roJ844B7kacV6CWpC_T) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:50Z","end_datetime":"2024-04-18T21:42:50Z","estimated_end_datetime":"2024-04-18T21:42:51Z","total_items":10} --- success {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:50Z","end_datetime":"2024-04-18T21:42:50Z","estimated_end_datetime":"2024-04-18T21:42:51Z","total_items":10} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"43514557","link":"https://api.researchmap.jp/zxcvbnm-2/misc/43514557","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43514557]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"41593237","link":"https://api.researchmap.jp/zxcvbnm-2/misc/41593237","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593237]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"41593236","link":"https://api.researchmap.jp/zxcvbnm-2/misc/41593236","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593236]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"33352909","link":"https://api.researchmap.jp/zxcvbnm-2/misc/33352909","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352909]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"misc","id":"11921831","link":"https://api.researchmap.jp/zxcvbnm-2/misc/11921831","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=11921831]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"force","type":"misc","id":"32804635","link":"https://api.researchmap.jp/zxcvbnm-2/misc/32804635","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804635]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"force","type":"misc","id":"32804636","link":"https://api.researchmap.jp/zxcvbnm-2/misc/32804636","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804636]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"force","type":"misc","id":"11921861","link":"https://api.researchmap.jp/zxcvbnm-2/misc/11921861","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=11921861]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"force","type":"misc","id":"11921863","link":"https://api.researchmap.jp/zxcvbnm-2/misc/11921863","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=11921863]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"force","type":"misc","id":"11921864","link":"https://api.researchmap.jp/zxcvbnm-2/misc/11921864","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=11921864]。"}]} ====== BulkResult(B000341201, 3roJ844B7kacV6CWpC_T) : End ====== ====== BulkResult(B000341201, 4boJ844B7kacV6CWpS-j) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:55Z","end_datetime":"2024-04-18T21:42:55Z","estimated_end_datetime":"2024-04-18T21:42:56Z","total_items":6} --- success {"code":304,"status":"completion","start_datetime":"2024-04-18T21:42:55Z","end_datetime":"2024-04-18T21:42:55Z","estimated_end_datetime":"2024-04-18T21:42:56Z","total_items":6} {"no":1,"line":1,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"32804637","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/32804637","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804637]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"32804638","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/32804638","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804638]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"12940224","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/12940224","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=12940224]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"12940225","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/12940225","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=12940225]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"12940226","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/12940226","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=12940226]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"force","type":"books_etc","id":"12940227","link":"https://api.researchmap.jp/zxcvbnm-2/books_etc/12940227","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=12940227]。"}]} ====== BulkResult(B000341201, 4boJ844B7kacV6CWpS-j) : End ====== ====== BulkResult(B000341201, 5LoJ844B7kacV6CWpy9W) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-18T21:43:00Z","end_datetime":"2024-04-18T21:43:00Z","estimated_end_datetime":"2024-04-18T21:43:01Z","total_items":12} --- success {"code":304,"status":"completion","start_datetime":"2024-04-18T21:43:00Z","end_datetime":"2024-04-18T21:43:00Z","estimated_end_datetime":"2024-04-18T21:43:01Z","total_items":12} {"no":1,"line":1,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804644","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804644","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804644]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804645","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804645","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804645]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804646","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804646","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804646]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"force","type":"awards","id":"3035220","link":"https://api.researchmap.jp/zxcvbnm-2/awards/3035220","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=3035220]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"awards","id":"3035221","link":"https://api.researchmap.jp/zxcvbnm-2/awards/3035221","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=3035221]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804647","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804647","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804647]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804648","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804648","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804648]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"force","type":"awards","id":"3035224","link":"https://api.researchmap.jp/zxcvbnm-2/awards/3035224","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=3035224]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804649","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804649","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804649]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804650","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804650","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804650]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804651","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804651","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804651]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"force","type":"awards","id":"32804652","link":"https://api.researchmap.jp/zxcvbnm-2/awards/32804652","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804652]。"}]} ====== BulkResult(B000341201, 5LoJ844B7kacV6CWpy9W) : End ====== ====== BulkResult(B000341201, 7boJ844B7kacV6CWqS-E) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-18T21:43:08Z","end_datetime":"2024-04-18T21:43:09Z","estimated_end_datetime":"2024-04-18T21:43:11Z","total_items":287} --- success {"code":304,"status":"completion","start_datetime":"2024-04-18T21:43:08Z","end_datetime":"2024-04-18T21:43:09Z","estimated_end_datetime":"2024-04-18T21:43:11Z","total_items":287} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42921408","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42921408","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42921408]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42921409","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42921409","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42921409]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41379389","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41379389","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41379389]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41379390","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41379390","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41379390]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42283817","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42283817","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42283817]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890567","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890567","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890567]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890568","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890568","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890568]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39161458","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39161458","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39161458]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39161459","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39161459","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39161459]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39876171","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39876171","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39876171]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312411","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312411","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312411]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804653","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804653","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804653]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804654","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804654","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804654]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804655","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804655","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804655]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804656","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804656","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804656]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804657","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804657","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804657]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804658","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804658","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804658]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804659","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804659","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804659]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738060","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738060","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738060]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804660","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804660","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804660]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738061","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738061","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738061]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738062","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738062","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738062]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738063","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738063","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738063]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738064","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738064","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738064]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738065","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738065","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738065]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738066","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738066","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738066]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738067","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738067","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738067]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738068","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738068","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738068]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738069","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738069","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738069]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738070","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738070","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738070]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738071","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738071","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738071]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738072","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738072","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738072]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738073","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738073","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738073]。"}]} {"no":1,"line":34,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738074","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738074","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738074]。"}]} {"no":1,"line":35,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738075","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738075","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738075]。"}]} {"no":1,"line":36,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738076","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738076","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738076]。"}]} {"no":1,"line":37,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738077","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738077","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738077]。"}]} {"no":1,"line":38,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738078","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738078","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738078]。"}]} {"no":1,"line":39,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738079","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738079","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738079]。"}]} {"no":1,"line":40,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738080","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738080","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738080]。"}]} {"no":1,"line":41,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738081","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738081","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738081]。"}]} {"no":1,"line":42,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738082","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738082","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738082]。"}]} {"no":1,"line":43,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738083","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738083","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738083]。"}]} {"no":1,"line":44,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738084","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738084","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738084]。"}]} {"no":1,"line":45,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738085","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738085","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738085]。"}]} {"no":1,"line":46,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738086","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738086","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738086]。"}]} {"no":1,"line":47,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738087","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738087","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738087]。"}]} {"no":1,"line":48,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738088","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738088","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738088]。"}]} {"no":1,"line":49,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738089","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738089","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738089]。"}]} {"no":1,"line":50,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45827861","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/45827861","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45827861]。"}]} {"no":1,"line":51,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44251427","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/44251427","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44251427]。"}]} {"no":1,"line":52,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"44251427","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/44251427"} {"no":1,"line":53,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43919279","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43919279","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43919279]。"}]} {"no":1,"line":54,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43919280","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43919280","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43919280]。"}]} {"no":1,"line":55,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44251428","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/44251428","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44251428]。"}]} {"no":1,"line":56,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43919281","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43919281","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43919281]。"}]} {"no":1,"line":57,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43919282","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43919282","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43919282]。"}]} {"no":1,"line":58,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43919283","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43919283","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43919283]。"}]} {"no":1,"line":59,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45822812","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/45822812","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45822812]。"}]} {"no":1,"line":60,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43307763","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43307763","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43307763]。"}]} {"no":1,"line":61,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43213469","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43213469","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43213469]。"}]} {"no":1,"line":62,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42547183","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42547183","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42547183]。"}]} {"no":1,"line":63,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42547184","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42547184","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42547184]。"}]} {"no":1,"line":64,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42547185","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42547185","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42547185]。"}]} {"no":1,"line":65,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42369584","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42369584","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42369584]。"}]} {"no":1,"line":66,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42369585","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42369585","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42369585]。"}]} {"no":1,"line":67,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42369586","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42369586","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42369586]。"}]} {"no":1,"line":68,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42369587","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42369587","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42369587]。"}]} {"no":1,"line":69,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41399560","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41399560","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41399560]。"}]} {"no":1,"line":70,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41399561","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41399561","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41399561]。"}]} {"no":1,"line":71,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41399562","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41399562","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41399562]。"}]} {"no":1,"line":72,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565336","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565336","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565336]。"}]} {"no":1,"line":73,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593217","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593217","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593217]。"}]} {"no":1,"line":74,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593218","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593218","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593218]。"}]} {"no":1,"line":75,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41379391","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41379391","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41379391]。"}]} {"no":1,"line":76,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565337","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565337","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565337]。"}]} {"no":1,"line":77,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42283818","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42283818","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42283818]。"}]} {"no":1,"line":78,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593219","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593219","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593219]。"}]} {"no":1,"line":79,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550744","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550744","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550744]。"}]} {"no":1,"line":80,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43457306","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43457306","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43457306]。"}]} {"no":1,"line":81,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41379392","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41379392","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41379392]。"}]} {"no":1,"line":82,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43207401","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43207401","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207401]。"}]} {"no":1,"line":83,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41379393","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41379393","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41379393]。"}]} {"no":1,"line":84,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42064979","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42064979","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42064979]。"}]} {"no":1,"line":85,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550745","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550745","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550745]。"}]} {"no":1,"line":86,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565338","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565338","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565338]。"}]} {"no":1,"line":87,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565339","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565339","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565339]。"}]} {"no":1,"line":88,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550746","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550746","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550746]。"}]} {"no":1,"line":89,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550747","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550747","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550747]。"}]} {"no":1,"line":90,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593220","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593220","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593220]。"}]} {"no":1,"line":91,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550748","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550748","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550748]。"}]} {"no":1,"line":92,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550749","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550749","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550749]。"}]} {"no":1,"line":93,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42283819","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42283819","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42283819]。"}]} {"no":1,"line":94,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42283820","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/42283820","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42283820]。"}]} {"no":1,"line":95,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39161460","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39161460","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39161460]。"}]} {"no":1,"line":96,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43207402","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43207402","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207402]。"}]} {"no":1,"line":97,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43207403","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43207403","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207403]。"}]} {"no":1,"line":98,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43207404","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43207404","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207404]。"}]} {"no":1,"line":99,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43207405","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43207405","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43207405]。"}]} {"no":1,"line":100,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890569","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890569","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890569]。"}]} {"no":1,"line":101,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890570","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890570","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890570]。"}]} {"no":1,"line":102,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593221","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593221","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593221]。"}]} {"no":1,"line":103,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593222","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593222","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593222]。"}]} {"no":1,"line":104,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593223","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593223","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593223]。"}]} {"no":1,"line":105,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593224","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593224","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593224]。"}]} {"no":1,"line":106,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550750","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550750","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550750]。"}]} {"no":1,"line":107,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550751","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550751","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550751]。"}]} {"no":1,"line":108,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593225","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593225","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593225]。"}]} {"no":1,"line":109,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593226","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593226","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593226]。"}]} {"no":1,"line":110,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593227","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593227","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593227]。"}]} {"no":1,"line":111,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593228","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593228","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593228]。"}]} {"no":1,"line":112,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41578980","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41578980","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41578980]。"}]} {"no":1,"line":113,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41578981","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41578981","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41578981]。"}]} {"no":1,"line":114,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593229","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593229","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593229]。"}]} {"no":1,"line":115,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593230","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593230","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593230]。"}]} {"no":1,"line":116,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"36577028","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/36577028","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =36577028]。"}]} {"no":1,"line":117,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565340","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565340","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565340]。"}]} {"no":1,"line":118,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39550752","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39550752","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39550752]。"}]} {"no":1,"line":119,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593231","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593231","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593231]。"}]} {"no":1,"line":120,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"35944945","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/35944945","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =35944945]。"}]} {"no":1,"line":121,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890571","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890571","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890571]。"}]} {"no":1,"line":122,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39611504","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39611504","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39611504]。"}]} {"no":1,"line":123,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39161461","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39161461","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39161461]。"}]} {"no":1,"line":124,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38890572","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/38890572","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38890572]。"}]} {"no":1,"line":125,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593232","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593232","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593232]。"}]} {"no":1,"line":126,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43679127","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43679127","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43679127]。"}]} {"no":1,"line":127,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593233","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593233","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593233]。"}]} {"no":1,"line":128,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"43679128","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/43679128","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43679128]。"}]} {"no":1,"line":129,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804661","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804661","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804661]。"}]} {"no":1,"line":130,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352910","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352910","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352910]。"}]} {"no":1,"line":131,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33172859","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33172859","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33172859]。"}]} {"no":1,"line":132,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312412","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312412","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312412]。"}]} {"no":1,"line":133,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312413","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312413","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312413]。"}]} {"no":1,"line":134,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312414","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312414","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312414]。"}]} {"no":1,"line":135,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312415","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312415","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312415]。"}]} {"no":1,"line":136,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41565341","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41565341","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41565341]。"}]} {"no":1,"line":137,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352911","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352911","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352911]。"}]} {"no":1,"line":138,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593234","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593234","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593234]。"}]} {"no":1,"line":139,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"33312412","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312412"} {"no":1,"line":140,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352912","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352912","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352912]。"}]} {"no":1,"line":141,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33322274","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33322274","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33322274]。"}]} {"no":1,"line":142,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33322275","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33322275","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33322275]。"}]} {"no":1,"line":143,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33322276","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33322276","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33322276]。"}]} {"no":1,"line":144,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"33322276","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33322276"} {"no":1,"line":145,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352913","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352913","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352913]。"}]} {"no":1,"line":146,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352914","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352914","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352914]。"}]} {"no":1,"line":147,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39359772","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39359772","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39359772]。"}]} {"no":1,"line":148,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39611505","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/39611505","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39611505]。"}]} {"no":1,"line":149,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41593235","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41593235","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41593235]。"}]} {"no":1,"line":150,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352915","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352915","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352915]。"}]} {"no":1,"line":151,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352916","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352916","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352916]。"}]} {"no":1,"line":152,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352917","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352917","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352917]。"}]} {"no":1,"line":153,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804662","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804662","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804662]。"}]} {"no":1,"line":154,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804663","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804663","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804663]。"}]} {"no":1,"line":155,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352918","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352918","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352918]。"}]} {"no":1,"line":156,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352919","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352919","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352919]。"}]} {"no":1,"line":157,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352920","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352920","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352920]。"}]} {"no":1,"line":158,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352921","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352921","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352921]。"}]} {"no":1,"line":159,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33414423","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33414423","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33414423]。"}]} {"no":1,"line":160,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804664","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804664","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804664]。"}]} {"no":1,"line":161,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352923","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352923","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352923]。"}]} {"no":1,"line":162,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352922","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352922","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352922]。"}]} {"no":1,"line":163,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33414424","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33414424","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33414424]。"}]} {"no":1,"line":164,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33414425","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33414425","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33414425]。"}]} {"no":1,"line":165,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33192557","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33192557","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33192557]。"}]} {"no":1,"line":166,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33192558","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33192558","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33192558]。"}]} {"no":1,"line":167,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33175904","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33175904","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33175904]。"}]} {"no":1,"line":168,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352924","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352924","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352924]。"}]} {"no":1,"line":169,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"33352926","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352926"} {"no":1,"line":170,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352927","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352927","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352927]。"}]} {"no":1,"line":171,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352928","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352928","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352928]。"}]} {"no":1,"line":172,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312416","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312416","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312416]。"}]} {"no":1,"line":173,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33312417","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33312417","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33312417]。"}]} {"no":1,"line":174,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352929","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352929","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352929]。"}]} {"no":1,"line":175,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352930","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352930","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352930]。"}]} {"no":1,"line":176,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352931","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352931","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352931]。"}]} {"no":1,"line":177,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352932","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352932","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352932]。"}]} {"no":1,"line":178,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352933","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352933","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352933]。"}]} {"no":1,"line":179,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804665","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804665","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804665]。"}]} {"no":1,"line":180,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804666","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804666","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804666]。"}]} {"no":1,"line":181,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"32804665","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804665","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=32804665]。"}]} {"no":1,"line":182,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352934","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352934","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352934]。"}]} {"no":1,"line":183,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804667","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804667","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804667]。"}]} {"no":1,"line":184,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804668","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804668","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804668]。"}]} {"no":1,"line":185,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804669","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804669","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804669]。"}]} {"no":1,"line":186,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804670","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804670","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804670]。"}]} {"no":1,"line":187,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33352935","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/33352935","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33352935]。"}]} {"no":1,"line":188,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804671","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804671","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804671]。"}]} {"no":1,"line":189,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804672","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804672","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804672]。"}]} {"no":1,"line":190,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804673","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804673","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804673]。"}]} {"no":1,"line":191,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738095","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738095","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738095]。"}]} {"no":1,"line":192,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738096","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738096","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738096]。"}]} {"no":1,"line":193,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804674","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804674","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804674]。"}]} {"no":1,"line":194,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804675","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804675","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804675]。"}]} {"no":1,"line":195,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804676","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804676","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804676]。"}]} {"no":1,"line":196,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804677","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804677","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804677]。"}]} {"no":1,"line":197,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804678","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804678","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804678]。"}]} {"no":1,"line":198,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804679","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804679","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804679]。"}]} {"no":1,"line":199,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804680","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804680","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804680]。"}]} {"no":1,"line":200,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804681","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804681","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804681]。"}]} {"no":1,"line":201,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804682","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804682","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804682]。"}]} {"no":1,"line":202,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804683","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804683","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804683]。"}]} {"no":1,"line":203,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804684","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804684","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804684]。"}]} {"no":1,"line":204,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738097","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738097","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738097]。"}]} {"no":1,"line":205,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738098","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738098","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738098]。"}]} {"no":1,"line":206,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738099","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738099","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738099]。"}]} {"no":1,"line":207,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738100","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738100","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738100]。"}]} {"no":1,"line":208,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738101","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738101","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738101]。"}]} {"no":1,"line":209,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738102","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738102","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738102]。"}]} {"no":1,"line":210,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738103","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738103","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738103]。"}]} {"no":1,"line":211,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738104","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738104","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738104]。"}]} {"no":1,"line":212,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804685","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804685","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804685]。"}]} {"no":1,"line":213,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738105","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738105","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738105]。"}]} {"no":1,"line":214,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738090","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738090","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738090]。"}]} {"no":1,"line":215,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738091","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738091","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738091]。"}]} {"no":1,"line":216,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738092","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738092","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738092]。"}]} {"no":1,"line":217,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738106","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738106","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738106]。"}]} {"no":1,"line":218,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738107","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738107","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738107]。"}]} {"no":1,"line":219,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738108","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738108","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738108]。"}]} {"no":1,"line":220,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738109","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738109","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738109]。"}]} {"no":1,"line":221,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738110","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738110","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738110]。"}]} {"no":1,"line":222,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738111","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738111","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738111]。"}]} {"no":1,"line":223,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738112","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738112","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738112]。"}]} {"no":1,"line":224,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738113","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738113","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738113]。"}]} {"no":1,"line":225,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738114","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738114","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738114]。"}]} {"no":1,"line":226,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738115","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738115","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738115]。"}]} {"no":1,"line":227,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738116","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738116","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738116]。"}]} {"no":1,"line":228,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738117","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738117","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738117]。"}]} {"no":1,"line":229,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738118","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738118","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738118]。"}]} {"no":1,"line":230,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738119","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738119","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738119]。"}]} {"no":1,"line":231,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738120","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738120","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738120]。"}]} {"no":1,"line":232,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738121","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738121","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738121]。"}]} {"no":1,"line":233,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738122","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738122","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738122]。"}]} {"no":1,"line":234,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738123","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738123","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738123]。"}]} {"no":1,"line":235,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738124","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738124","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738124]。"}]} {"no":1,"line":236,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738125","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738125","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738125]。"}]} {"no":1,"line":237,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738126","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738126","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738126]。"}]} {"no":1,"line":238,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738127","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738127","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738127]。"}]} {"no":1,"line":239,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738128","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738128","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738128]。"}]} {"no":1,"line":240,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738129","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738129","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738129]。"}]} {"no":1,"line":241,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738130","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738130","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738130]。"}]} {"no":1,"line":242,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738131","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738131","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738131]。"}]} {"no":1,"line":243,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738132","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738132","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738132]。"}]} {"no":1,"line":244,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738133","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738133","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738133]。"}]} {"no":1,"line":245,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738134","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738134","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738134]。"}]} {"no":1,"line":246,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738135","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738135","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738135]。"}]} {"no":1,"line":247,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738136","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738136","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738136]。"}]} {"no":1,"line":248,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738137","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738137","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738137]。"}]} {"no":1,"line":249,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738138","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738138","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738138]。"}]} {"no":1,"line":250,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738139","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738139","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738139]。"}]} {"no":1,"line":251,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738140","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738140","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738140]。"}]} {"no":1,"line":252,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738141","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738141","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738141]。"}]} {"no":1,"line":253,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738142","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738142","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738142]。"}]} {"no":1,"line":254,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738143","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738143","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738143]。"}]} {"no":1,"line":255,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738144","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738144","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738144]。"}]} {"no":1,"line":256,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738145","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738145","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738145]。"}]} {"no":1,"line":257,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738146","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738146","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738146]。"}]} {"no":1,"line":258,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738147","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738147","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738147]。"}]} {"no":1,"line":259,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738148","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738148","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738148]。"}]} {"no":1,"line":260,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738149","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738149","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738149]。"}]} {"no":1,"line":261,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738150","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738150","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738150]。"}]} {"no":1,"line":262,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738151","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738151","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738151]。"}]} {"no":1,"line":263,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738152","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738152","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738152]。"}]} {"no":1,"line":264,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738153","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738153","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738153]。"}]} {"no":1,"line":265,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738154","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738154","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738154]。"}]} {"no":1,"line":266,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738155","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738155","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738155]。"}]} {"no":1,"line":267,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738156","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738156","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738156]。"}]} {"no":1,"line":268,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"1738093","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738093","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1738093]。"}]} {"no":1,"line":269,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"1738094","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738094","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1738094]。"}]} {"no":1,"line":270,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738093","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738093","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738093]。"}]} {"no":1,"line":271,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738094","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738094","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738094]。"}]} {"no":1,"line":272,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738157","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738157","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738157]。"}]} {"no":1,"line":273,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738158","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738158","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738158]。"}]} {"no":1,"line":274,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738159","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738159","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738159]。"}]} {"no":1,"line":275,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738160","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738160","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738160]。"}]} {"no":1,"line":276,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738161","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738161","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738161]。"}]} {"no":1,"line":277,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738162","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738162","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738162]。"}]} {"no":1,"line":278,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738163","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738163","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738163]。"}]} {"no":1,"line":279,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738164","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738164","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738164]。"}]} {"no":1,"line":280,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41042839","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/41042839","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41042839]。"}]} {"no":1,"line":281,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"32804686","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/32804686","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32804686]。"}]} {"no":1,"line":282,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738165","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738165","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738165]。"}]} {"no":1,"line":283,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738166","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738166","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738166]。"}]} {"no":1,"line":284,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738167","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738167","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738167]。"}]} {"no":1,"line":285,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738168","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738168","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738168]。"}]} {"no":1,"line":286,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738169","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738169","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738169]。"}]} {"no":1,"line":287,"code":304,"action":"insert","action_type":"force","type":"presentations","id":"1738170","link":"https://api.researchmap.jp/zxcvbnm-2/presentations/1738170","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=1738170]。"}]} ====== BulkResult(B000341201, 7boJ844B7kacV6CWqS-E) : End ======